Quarterlytics / Consumer Cyclical / Food Distribution / Tate & Lyle

Tate & Lyle

tate · LSE Consumer Cyclical
Claim this profile
Ticker tate
Exchange LSE
Sector Consumer Cyclical
Industry Food Distribution
Employees 5001-10,000
← All annual reports
FY2018 Annual Report · Tate & Lyle
Sign in to download
Loading PDF…
Improving lives

for generations

T

a

t

e

&

L

y

l

e

A

n

n

u

a

l

R

e

p

o

r

t

2

0

1

8

Annual Report 2018

 
 
 
 
 
Group statutory results

Sales1 (£m) 

Profit before tax1 (£m) 

Diluted earnings  
per share1 (pence) 

Net debt (£m) 

 £2 710m

 £286m

 56.1p

 £392m

2
7
5
3

2
7
1
0

2
3
5
5

2
8
6

2
3
3

5
4
.
2

5
6
.
1

4
5
2

4
3
4

3
9
2

1
2
6

2
5
.
9

16

17

18

16

17

18

16

17

18

16

17

18

Alternative performance measures

Return on capital 
employed2 (%) 

Adjusted profit  
before tax1,2 (£m) 

Adjusted diluted  
earnings per share1,2 
(pence)

 16.2%

 £301m

 50.1p

1
6
.
2

1
4
.
3

1
1
.
3

3
0
1

2
7
1

1
9
3

5
0
.
1

4
7
.
1

3
4
.
5

Adjusted free  
cash flow2 (£m) 

 £196m

1
9
6

1
7
4

5
3

16

17

18

16

17

18

16

17

18

16

17

18

1  Continuing operations only.
2  Adjusted results and a number of other terms and performance measures used in this Annual Report are not directly defined within accounting standards.  

For clarity, we have provided descriptions of the various metrics and their reconciliations to the most directly comparable measures reported in IFRS, and the 
calculations, where relevant, of any ratios, in Notes 1 and 4.

 
 
 
 
 
 
Tate & Lyle is a global provider of 
solutions and ingredients for food, 
beverage and industrial markets.

Inspired by our purpose of 
improving lives for generations,  
we work with our customers to 
make food and drink healthier  
and tastier. Through our expertise 
in key categories, we deliver 
sweetness, texture and fibre 
enrichment to products enjoyed  
by millions of people every day.

This Annual Report is also available on the Company’s website, www.tateandlyle.com.

Strategic Report
02  Our purpose

08  At a glance

09  Our business

10  Chairman’s Statement

12  Chief Executive’s Review

16  Executive Committee

18  Business Model

20  Marketplace

22  Key Performance Indicators

24  Food & Beverage Solutions

27  Primary Products

30 

Innovation and Commercial Development

31  Global Operations

32  Group Financial Results

38  Risks

42  Our People

45  Business Conduct

46  Environment, Health and Safety

50  Community Involvement

Governance
52  Board of Directors

56 

 Chairman’s introduction to 
Corporate Governance

57  Corporate Governance

66  Audit Committee Report

70  Nominations Committee Report

72  Directors’ Remuneration Report

90  Directors’ Report

91  Directors’ Statement of Responsibilities

Financial Statements
92 

 Independent Auditors’ Report to the 
Members of Tate & Lyle PLC

100   Consolidated Income Statement

101   Consolidated Statement of 
Comprehensive Income

102   Consolidated Statement of 

Financial Position

103   Consolidated Statement of Cash Flows

104   Consolidated Statement of Changes 

in Equity

105   Notes to the Consolidated 
Financial Statements

169   Parent Company Financial Statements

Useful Information
177   Group Five-year Summary

179   Additional Information

180   Information for Investors

181   Glossary

183   Definitions/explanatory notes

Trademarks
SPLENDA® and the SPLENDA®  
logo are trademarks of Heartland  
Consumer Products LLC.

Definitions/cautionary statement
Please see the explanatory notes on page 183.

www.tateandlyle.com  1

Strategic ReportGovernanceFinancial StatementsUseful InformationOur purpose...

2  Tate & Lyle PLC Annual Report 2018

Through our purpose, we 
believe we can successfully 
grow our business and have  
a positive impact on society.

Our purpose is to improve lives for generations. Our purpose inspires us 
and informs what we do. It motivates us and makes us strive to do our 
best. Our purpose is our passion – it’s in our DNA.

Reducing calorie intake

Enhancing taste 

From soft drinks and smoothies to biscuits and 
bars, from soups and sauces to gravies and 
seasonings, our solutions are used to enhance the 
taste, texture and flavour of food and drink enjoyed 
by people all over the world.

SPLENDA® Sucralose  
has removed more than

85

trillion  
calories

from people’s diets globally  
over the last 26 years. That is  
the equivalent of over 21 million  
tonnes of sugar.

Stabilising food 

Education on nutrition

Our stabiliser business has  
been helping to improve food  
for over a century. Founded in 
Germany in the 19th century,  
it started its business by sterilising 
food at high temperatures so it 
could be canned or bottled to 
make it safer for long sea voyages.

Our child health improvement programme in three 
schools in Shanghai, China, is helping children, 
parents and teachers learn about the importance 
of diet, nutrition, and maintaining an active lifestyle.

 See more on page 50

www.tateandlyle.com  3

Strategic ReportGovernanceFinancial StatementsUseful InformationFor a changing world...

4  Tate & Lyle PLC Annual Report 2018

Modern life is changing the  
way we work, eat and play.  
Our purpose drives us to find 
innovative solutions to meet 
changing consumer demands.

The rise of technology, together  
with changes in diets and lifestyles, 
has caused many people to lead a 
more sedentary, less active way of 
life. People are generally eating too 
much and moving too little, and 
progressively unbalanced lifestyles 
are affecting their health. The 
incidence of diseases like obesity  
and diabetes, and digestive health 
concerns, are increasing rapidly.

However, while over two billion people 
are either overweight or obese, one in 
nine people in the world do not have 
enough food to eat. No matter where 
you look, societies are facing significant 
food and health-related challenges.

By delivering our purpose, we believe 
Tate & Lyle can help make a difference.

Digestive health

Diabetes

Daily fibre intake is below recommended levels

40

30

20

10

0

Recommended range 25-38 grammes

21

16

12

23

18

17

UK

US

China

Japan

Mexico

Brazil

  Sources: see page 183.

422m

adults globally are estimated to  
suffer from diabetes

Source: World Health Organization 
2014 data; adult is 18 years or older.

www.tateandlyle.com  5

Strategic ReportGovernanceFinancial StatementsUseful InformationTo improve lives  
for generations

6  Tate & Lyle PLC Annual Report 2018

Working in partnership with  
our customers and other 
stakeholders, we bring our 
purpose to life every day.

Our purpose is to improve lives for 
generations by helping people make 
healthier and tastier choices when 
they eat and drink, and lead a more 
balanced lifestyle. By doing this, we 
believe we can deliver meaningful 
benefits for consumers, our 
customers, employees and the 
communities we live in.

Through our ingredients, people and 
expertise, we are passionate about 
making a positive difference to 
people’s lives. By delivering nutrition 
while maintaining great taste to 
products consumed by millions of 
people every day, we don’t just feed 
people, we feed them well.

Living our purpose

Helping people make 
healthier choices  
by reducing sugar, 
calories and fat from 
their food and drink,  
or adding more fibre 
and protein.

Helping people 
understand the need to 
balance the calories they 
consume with the 
calories they burn 
through physical activity.

g

Educatio

n o

ealthier e a ti n
       H

We deliver our 
purpose by focusing 
on four areas

B

a

l

a

n

c

e

d

 life

style    

s

r

P e

g

o n al wellbein

n

n

u

t

r

i

t

i

o

n

Helping people gain a 
better understanding of 
the link between food 
and health.

Helping to promote 
physical, emotional and 
mental health in the 
workplace and local 
communities.

www.tateandlyle.com  7

Strategic ReportGovernanceFinancial StatementsUseful Information 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
At a glance

Origins
Founded in the UK by  
Henry Tate in 1859

Henry Tate & Sons and 
Abram Lyle & Sons 
merged their 
businesses 
to form  
Tate & Lyle  
in 1921

People

55

different nationalities  
work at Tate & Lyle

Values

Safety  
Integrity  
Respect

Categories
Strong technical expertise in  
beverages, dairy, and soups, 
sauces and dressings 

Financials
Listed as Tate.L on the 
London Stock Exchange 
within the FTSE 250

Laboratories

18application and technical service 

centres across the world 
supporting customers in  
their local markets

Sales1

Adjusted profit before tax1

 £2.7bn
 £301m

1 See footnotes on inside front cover.

People
More than

4,100

employees worldwide

Global
Plants, labs and offices in over  
30 locations worldwide

Markets
Leading positions in sweeteners, 
texturants, fibres, stabilisation, 
and industrial starches 

Raw materials

1.4macres of corn processed at our 

manufacturing facilities in the US 
each year

8  Tate & Lyle PLC Annual Report 2018

Our business

We employ more than 4,100 people across the world and our ingredients and 
solutions are sold or distributed in over 120 countries. 

Business divisions1

Food & Beverage Solutions
Provides solutions for customers globally that  
meet consumer demand for healthier and tastier  
food and drink. 

Primary Products
Provides high volume food and industrial  
products primarily for customers in the  
North American market.

 Read more on pages 24 to 26

 Read more on pages 27 to 29

Supported by two global teams

Innovation and Commercial Development
Manages the innovation pipeline and uses leading-edge 
science to develop solutions for our customers which 
help reduce sugar, calories and fat, and add fibre.

Global Operations
Manages the safe, efficient and cost-effective  
operation of our manufacturing assets, and ensures  
our ingredients reach customers on time and to the 
right specification.

 Read more on page 30

 Read more on page 31

1  Our two business divisions have been renamed and reportable segments have been amended. Read more on page 12.

www.tateandlyle.com  9

Strategic ReportGovernanceFinancial StatementsUseful InformationChairman’s Statement

Year of strong  
delivery

Results
I am pleased to report that Tate & Lyle delivered a strong 
performance in the year ended 31 March 2018 with profits  
and earnings per share both well ahead of the prior year.  
Cash generation remained strong and the balance sheet  
is robust, providing flexibility to support future growth. 

Progressive dividend
The Board is recommending a final dividend of 20.3p  
per share bringing the total dividend for the year ending  
31 March 2018 to 28.7p per share, an increase of 2.5%.  
This reflects the Board’s confidence in the business, while  
at the same time continuing to rebuild dividend sustainability. 
Looking ahead, the Board remains committed to a 
progressive policy of growing our dividend over time, taking 
into account the earnings prospects and investment needs 
of the business. 

A bright future
I am delighted that, on 1 April 2018, Nick Hampton 
became our new Chief Executive. Nick succeeded  
Javed Ahmed who, after eight years of outstanding 
service, decided to step down from this role and retire 
from the Company. Javed retires with the Board’s deep 
gratitude and very best wishes for the future.

Nick had previously been our Chief Financial Officer for 
three years, during which time he demonstrated a strong 
track record of delivering results, inspiring colleagues 
and preparing the business for the exciting mission 
which he articulates in the following pages. The Board is 
very confident that Nick has the experience, energy and 
vision to lead Tate & Lyle through the next phase of its 
growth and development as a world-class technology-
based and service-driven ingredients business.

As you will read in his report, Nick has already made a strong 
start in his new role, with programmes already underway to 
sharpen focus on our customers, accelerate our portfolio’s 
development, and simplify and drive productivity. At the same 
time, Nick and his management team are injecting new clarity  
of purpose and dynamism into the organisation to align our 
teams more effectively, increase their agility and improve  
their execution.

10  Tate & Lyle PLC Annual Report 2018

“Since joining the Board over a 
year ago, I have visited many 
of the Group’s facilities 
across the world and I am 
always impressed and 
energised by the passion, 
commitment and enthusiasm 
of our teams wherever I go.” 

Summary
Tate & Lyle is a strong company in a good financial position. 
While we continue to face an evolving and sometimes challenging 
geopolitical landscape, we do so with confidence given the solid 
foundations upon which the Company has been built. Under 
Nick’s leadership, I am excited about the future of Tate & Lyle, 
and our ability to unlock the growth potential of the business.  
I look forward to working with him to realise that potential, and 
drive growth and value for our shareholders in the years ahead.

Gerry Murphy 
Chairman 

23 May 2018

Delivering responsibly
Protecting our people, and the environment, are foundational  
to our business. At the start of the 2017 calendar year, we 
undertook an extensive Group-wide review of all our safety 
processes and procedures, supported by an independent external 
expert consultancy. The review provided important insights into 
how we think about and manage safety, and how we can improve 
our safety culture. The outcome is our comprehensive new 
Group-wide ‘Journey to Environmental, Health and Safety (EHS) 
Excellence’, launched in January 2018, more details of which can 
be found on pages 46 and 47. Our ultimate goal is to have no 
accidents and no injuries, and the Board remains focused on 
creating a safer Tate & Lyle for all our employees, contractors 
and visitors.

Our environmental performance showed a pleasing improvement 
in the 2017 calendar year, with positive progress in our primary 
carbon footprint, waste sent to landfill and water usage. Our energy 
use remained largely unchanged.

Board changes
There were a number of changes to the Board during the year.  
As presaged in last year’s Annual Report, Liz Airey retired from 
the Board at the 2017 Annual General Meeting. Then, on  
31 October 2017, having served on the Board for a year, Jeanne 
Johns stepped down as a non-executive director and chairman  
of the Corporate Responsibility Committee due to new 
commitments. On behalf of the Board, I would like to thank  
Liz and Jeanne for their contributions to Tate & Lyle. 

As mentioned earlier, Javed Ahmed retired as Chief Executive 
and from the Board on 1 April 2018, succeeded by Nick Hampton. 
In April, we announced that Imran Nawaz will be joining the 
Company, and the Board, on 1 August 2018, as our new Chief 
Financial Officer.

Governance
To give the Board greater and more direct oversight of certain 
critical areas of corporate responsibility, in particular safety, the 
Board has decided to dissolve the Corporate Responsibility 
Committee and allocate its duties between the main Board and 
the Audit Committee. Further details of this change can be found 
in my Corporate Governance report on page 56. 

People
The strong financial performance of the Company in the year 
ended 31 March 2018 is a reflection of the hard work and skill of 
all our colleagues at Tate & Lyle. On behalf of the Board, I would 
like to thank our management team and all our employees for 
their contribution in delivering another successful year. Since 
joining the Board over a year ago, I have visited many of the 
Group’s facilities across the world and I am always impressed 
and energised by the passion, commitment and enthusiasm of 
our teams wherever I go.

www.tateandlyle.com  11

Strategic ReportGovernanceFinancial StatementsUseful InformationChief Executive’s Review

Accelerating business 
performance

I am delighted and honoured to be appointed as Tate & Lyle’s 
Chief Executive. Tate & Lyle has both a proud and long heritage, 
and an exciting future. As global demand for healthier, tastier 
food with a better nutritional balance continues to grow, we have 
the potential and opportunity to deliver benefits not only for our 
shareholders but also for society at large, including our 
customers, consumers, the communities in which we operate, 
and our employees. I look forward to working with Gerry, the 
Board, the management team, and all our employees to drive 
Tate & Lyle’s business forward in the years ahead.

Overview of Group performance
Tate & Lyle delivered a year of strong profit and cash 
performance. At the same time, we made good progress 
strengthening the commercial business, improving operational 
disciplines, and investing for future growth.

Adjusted profit before tax increased by 11% (13% in constant 
currency) to £301 million with adjusted operating profit growth  
in all businesses.

We have decided to rename our business divisions and change 
how we report. The Group will continue to operate in two 
divisions, Food & Beverage Solutions (which includes Sucralose 
and was previously named Speciality Food Ingredients) and 
Primary Products (previously named Bulk Ingredients). The 
Food & Beverage Solutions division will be reported across 
two reportable segments (Food & Beverage Solutions and 
Sucralose) reflecting their different economic characteristics 
and how we manage them.  

Key highlights

•  Group delivers strong financial results 
•  Food & Beverage Solutions performs well with good 
volume momentum. Sucralose also performed well

•  Another year of excellent performance in Primary Products
•  Strong balance sheet with cash generation supporting 

progressive dividend

•  Programmes underway to sharpen customer focus, 
accelerate portfolio development and simplify and 
drive productivity

•  New leadership team in place.

12  Tate & Lyle PLC Annual Report 2018

Our business
Our two divisions have been renamed  
and reporting amended.

Two business divisions

Food & Beverage Solutions (including Sucralose)  
previously Speciality Food Ingredients

Primary Products 
previously Bulk Ingredients

Three reportable segments

Food & Beverage Solutions

Sucralose

Primary Products

The Food & Beverage Solutions segment had an encouraging 
year, with volume 3% higher. It was especially pleasing to see a 
return to volume growth in the important North American 
market, where we saw success from our focus on higher growth 
sub-segments and key categories. In the other regions of the 
world, volume growth continued to be good. Adjusted operating 
profit increased by 5% (8% in constant currency) to £137 million 
reflecting both higher volume and the recovery of our stabiliser 
business (previously named Food Systems). Investments in the 
longer-term development of the business in the first half 
moderated profit growth. 

Sales of New Products, which represent products in the first 
seven years after launch, grew by 15% to US$121 million.  
Our innovation capability is well established with each of our 
sweeteners, texturants and health and wellness platforms 
contributing to growth.

Sucralose adjusted operating profit increased by 6% (5% in 
constant currency) to £55 million, with lower operating costs 
driving higher margins.

Primary Products delivered particularly good results. Adjusted 
operating profit increased by 28% (30% in constant currency) to 
£166 million. The performance in the core business was driven by 
a combination of strong commercial and operational execution, 
and firm margins. Profits from Commodities increased by  
£24 million to £32 million mainly reflecting market opportunities 
across co-products and gains from corn sourcing.

Profits from our joint venture businesses were 14% lower at  
£28 million.

Adjusted diluted earnings per share from continuing operations 
increased by 6% (7% in constant currency) to 50.1p.

Cash generation continued to be excellent. Adjusted free cash 
flow increased by £22 million to £196 million reflecting stronger 
operating results and lower capital expenditure. Net debt at  
£392 million, was £60 million lower. Return on capital employed 
increased by 190 bps to 16.2%. 

Our balance sheet remains robust and the Group is well 
positioned for the future.

Progress in the year
During the year, we continued to invest to underpin future growth 
in Food & Beverage Solutions and to support cash delivery from 
Primary Products.

Our business and presence in the emerging markets continues to 
grow. The challenges of both over- and under-nutrition in these 
regions means that our customers are increasingly seeking 
solutions which reduce sugar, calories and fat, and enrich 
products with fibre. While demand for more natural and healthier 
food is increasing, consumers will not compromise on taste. 
Making healthy food tastier, and tasty food healthier in categories 
like dairy and beverages is a challenge that our food scientists 
are especially well equipped to meet. During the year we 
expanded our food application laboratories in Shanghai, 
Singapore and Mexico City. At each site, we added new customer-
facing facilities as well as pilot scale equipment to enable 
customers to work with us to design, trial and benchmark 
different recipe formulations. These new laboratories are already 
making a material difference to the way we serve our customers 
in these regions.

We continue to bring new products to market both through our 
in-house innovation capabilities and by establishing strategic 
partnerships. For example, in April 2017, we entered into an 
exclusive partnership with Sweet Green Fields, one of the largest 
fully integrated global stevia players, to bring their leading 
stevia-based sweetening solutions to our customers worldwide. 

Our purpose

I passionately believe in our purpose of improving lives 
for generations; that we can successfully grow our 
business and make a positive impact on society. Part of 
my role as Chief Executive is to make sure our purpose 
is central to everything we do, and to give our people 
the support and opportunity they need to live it. As I 
travel around the Group, I am deeply aware of the 
passion and pride our people have to make a difference 
to the world we live in, both today and for the future – 
to improve lives for generations.

www.tateandlyle.com  13

Strategic ReportGovernanceFinancial StatementsUseful InformationStrategy

Our strategy is to grow our business by:

•  Growing Food & Beverage Solutions by building leading 
positions in three categories globally – beverages, dairy, 
and soups, sauces and dressings – and in two or three 
additional categories in each region where we have local 
expertise. Managing Sucralose to generate cash

•  Driving value from Primary Products by optimising its 
portfolio to deliver steady earnings and generate cash.

Primary Products is predominantly anchored in the more stable 
North American market, with strong market positions in 
high-volume sweeteners and industrial starches, and supported 
by scale, cost competitive assets.

Underpinning our business is a reputation built over many years 
as a trusted supplier, with highly skilled people motivated by a 
strong sense of purpose to improve people’s lives by enabling 
healthier food choices.

Actions to accelerate business performance
Leveraging these strengths and our strong balance sheet, we are 
implementing three programmes to accelerate business 
performance: 

1. Sharpen focus on customers and key categories
•  Focus our growth strategy on three categories globally – 

beverages, dairy, and soups, sauces and dressings – and two 
or three additional categories in each region where we have 
local expertise

•  Reorganise our commercial teams to reflect how our 

customers are organised in these categories 

•  Integrated Food Systems into Food & Beverage Solutions to 

provide one approach for customers.

2. Accelerate portfolio development
•  Accelerate development and commercialisation of  

new products

•  Develop more external partnerships and alliances to  

catalyse innovation

•  Increase emphasis on acquisitions and joint ventures.

3. Simplify and drive productivity
•  Target US$100 million of productivity savings over the next  

four years

•  Simplify the business, reduce costs, and increase efficiencies 

across the supply chain

•  Productivity benefits expected to be paced evenly across the 

four years, and will be invested to grow the business, improve 
customer service, and support margin progression. 

Chief Executive’s Review continued

Reflecting the encouraging progress demonstrated over the  
first year of this partnership, in May 2018, we extended our 
relationship by acquiring a 15% shareholding in Sweet  
Green Fields.

We are also working in partnership with Codexis, a leading 
protein engineering company and expert in enzymes, to create 
novel enzymatic routes to new product development from starch 
and other source materials. 

We continued to invest in our manufacturing footprint to drive 
long-term growth. In October, we announced our intention to 
more than double capacity of maltodextrin at our facility in 
Boleraz, Slovakia. This expansion is expected to be completed in 
2019, and will enable us to meet growing customer demand for 
maltodextrins, particularly in the infant food sector in Europe, 
Middle East and Africa, and Asia Pacific. Then, in December,  
we completed the expansion of our polydextrose fibre plant in 
Nantong, China. This expansion, which increases capacity by 
more than three times from when the facility was acquired by 
Tate & Lyle in 2014, will help support local and global demand for 
our fibres. Finally, in March, our joint venture DuPont Tate & Lyle 
Bio Products announced an expansion to its manufacturing 
facility in Loudon, Tennessee, to increase annual production of its 
bio-based 1,3-propanediol by 35 million pounds. This expansion, 
which is expected to be completed in 2019, will help meet 
growing customer demand for higher-performing ingredients 
from a petroleum-free, more sustainable and renewable source. 

Executive management team
During the year, we further strengthened the executive 
management team with the appointment in September of Andrew 
Taylor as President, Innovation and Commercial Development 
and Melissa Law as President, Global Operations. Andrew 
previously worked at The Boston Consulting Group, where he was 
a Senior Partner and Managing Director, leading the global 
Innovation Practice. Before joining Tate & Lyle, Melissa worked at 
Baker Hughes, where she led the Global Specialties Chemicals 
Division, a major part of its Oilfield Service portfolio. Together 
with Imran Nawaz, formerly of Mondele-z International, who will 
join us as Chief Financial Officer in August 2018, the executive 
team has a good blend of company experience, industry 
knowledge, and a fresh perspective, and is well set to lead the 
business into the next phase of its development.

An integrated business with a strong value 
proposition
Tate & Lyle operates as one integrated business going to market 
as two trading divisions. Food & Beverage Solutions and Primary 
Products each has a distinct role to play, and both are important to 
the Group’s future. They share common assets and we manage 
them together to optimise overall returns for shareholders.

Food & Beverage Solutions, which operates in the large and 
growing global food ingredients market, combines a deep 
understanding of sweetness, texture and fibre enrichment with 
expertise in key categories of beverages, dairy, and soups, 
sauces, and dressings, to tailor solutions for our customers. 
These solutions help meet growing global consumer demand for 
food and drink with less sugar, calories and fat and more fibre. 
While food is global, taste is local, so our customers also value 
our ability to deliver solutions in their local markets.

14  Tate & Lyle PLC Annual Report 2018

Investment case
Our businesses have a clear focus...

Primary 
Products

Food & Beverage 
Solutions

Sucralose

Manage for stable earnings;  
cash generation

Growth driver;  
top and bottom line growth

Manage for cash;  
high return on assets

to deliver returns...

Earnings per share1 – accelerate growth

Organic return on capital employed2  – improve returns

Dividend – maintain progressive dividend policy

Investment case 
In Food & Beverage Solutions, we expect to accelerate revenue 
growth and deliver margin accretion, while managing Sucralose 
for cash; and in Primary Products optimise product mix to 
underpin stable earnings and cash flow delivery. As the three 
programmes we are implementing gather momentum, we expect 
growth in earnings per share in constant currency to accelerate, 
organic return on capital employed in constant currency to 
improve, and strong cash generation to support our progressive 
dividend policy. 

Tate & Lyle is in a strong financial position. We generate a good 
return on our assets and have a strong balance sheet with 
modest leverage. We believe the appropriate leverage over the 
longer term for our business lies in the range of 1x to 2x net 
debt:EBITDA, giving us flexibility to invest and grow the business. 
To maintain our financial position and investment grade credit 
rating, we will apply clear capital allocation priorities: 

•  Invest in sustainable organic growth
•  Fund acquisitions, partnerships or joint ventures to accelerate 

growth

•  Maintain our progressive dividend policy
•  Return surplus capital to shareholders.

Overall, we are in a strong financial position with clear priorities 
to accelerate growth.

Environment, health and safety
Following a Group-wide safety review completed during the year, 
we concluded that our safety and environmental performance are 
closely linked and should be co-ordinated and managed holistically. 
As a result of this, during the year a new environmental, health 
and safety (EHS) strategy was developed to deliver and sustain 
EHS excellence across all our locations for all our employees and 
contractors. More information about this programme can be 
found on pages 46 and 47.

People
Our employees across Tate & Lyle bring a huge amount of energy 
and passion to work every day, and I would like to thank them for 
their hard work and dedication. Our strong performance this year 
is a testament to their talent and commitment and, in my first 
year as Chief Executive, I look forward to working with them.

Outlook
For the year ending 31 March 2019, we expect growth in earnings 
per share1 in constant currency to be in a mid-single digit range, 
albeit towards the lower end due to energy and transport cost 
inflation in North America and a strong year of Commodities 
performance in fiscal 2018. 

Summary
Tate & Lyle enters the 2019 financial year in a good position.  
We have a strong value proposition aligned to growing global 
trends of sugar, calorie and fat reduction, fibre enrichment and 
demand for cleaner labels. We have set out three clear priorities 
for the business – to sharpen our focus on our customers, 
accelerate portfolio development, and simplify the business and 
drive productivity – and actions to deliver these priorities are 
already underway. 

With our clear strategy, talented people, and strong sense of 
purpose, I am confident we have a strong business capable of 
delivering sustained returns.

Nick Hampton
Chief Executive

23 May 2018

1  Adjusted diluted earnings per share from continuing operations in constant currency. 
2  In constant currency.

www.tateandlyle.com  15

Strategic ReportGovernanceFinancial StatementsUseful Information 
Executive Committee

Our executive team

Responsible for delivering our strategy and achieving business results.

From left to right
Rowan Adams, Rob Luijten, Nick Hampton, Joan Braca, Robert Gibber, Melissa Law, Andrew Taylor and Jim Stutelberg.

16  Tate & Lyle PLC Annual Report 2018

Nick Hampton

Melissa Law

Chief Executive
Nick became the Chief Executive on 1 April 2018. He joined  
Tate & Lyle as Chief Financial Officer in September 2014. Prior  
to joining Tate & Lyle, he held a number of senior roles over a 
20-year career at PepsiCo, including as PepsiCo’s CFO Europe; 
President, West Europe Region; and Senior Vice President 
Commercial, Europe.

President, Global Operations
Melissa joined Tate & Lyle in September 2017. Prior to joining 
Tate & Lyle, Melissa worked for Baker Hughes, a GE company, 
where she led the Global Specialties Chemicals Division, with 
prior executive roles for the company’s Australian and Gulf of 
Mexico operations. Melissa’s 20 years of experience ranges 
across R&D, operations, marketing, commercial and sales. 

Joan Braca

Rowan Adams

President, Food & Beverage Solutions
Joan joined Tate & Lyle in 2013 as Senior Vice President and 
General Manager, Asia Pacific. She was then appointed 
President, Food & Beverage Solutions from November 2014. 
Prior to joining Tate & Lyle, Joan spent nearly 20 years with 
Rohm and Haas Company in a variety of operational and general 
management roles in the US, Europe and Asia Pacific.

Jim Stutelberg

President, Primary Products
Jim joined Tate & Lyle in 2014 from Pennsylvania-based  
PPG Industries Inc. where he led its Americas Automotive 
Coatings business. Prior to that, he spent 16 years with Dow 
Corning Corporation in a variety of senior marketing, sales and 
general management roles, including five years working in 
Shanghai, China.

Andrew Taylor

President, Innovation and Commercial Development
Andrew joined Tate & Lyle in September 2017. Prior to joining 
Tate & Lyle, Andrew worked for the global management 
consultancy firm The Boston Consulting Group (BCG), where he 
was a Senior Partner and Managing Director. From 2008, he also 
led BCG’s global Innovation Practice. 

Executive Vice President, Corporate Affairs
Rowan joined Tate & Lyle in 2001 from National Westminster 
Bank. During his career at Tate & Lyle he has held a number  
of senior roles and was appointed Executive Vice President, 
Corporate Affairs in November 2014 with global responsibility  
for public affairs, communications and risk.

Robert Gibber

Executive Vice President, General Counsel
Rob joined Tate & Lyle in 1990 as a commercial lawyer having 
started his career in private practice. He was appointed General 
Counsel in 1997 and was Company Secretary between 2001 and 
2012. Rob has global responsibility for Legal and Quality.

Rob Luijten

Executive Vice President, Human Resources
Rob joined Tate & Lyle as Executive Vice President, Human 
Resources in 2010. Prior to joining Tate & Lyle, he was Human 
Resources Director for Africa, Middle East and Asia for BG Group 
PLC. He also spent ten years with GE Plastics in a number of 
senior human resources roles in both Europe and Asia.

Imran Nawaz

Chief Financial Officer (from 1 August 2018)
As announced on 17 April 2018, Imran will join Tate & Lyle 
and become the Chief Financial Officer with effect from  
1 August 2018. Imran joins Tate & Lyle from Mondele-z 
International where he has held the position of Senior Vice 
President Finance Europe since 2014. 

www.tateandlyle.com  17

Strategic ReportGovernanceFinancial StatementsUseful InformationBusiness Model

How we create value

Our ingredients and solutions are valuable to our customers because they are highly 
functional and help meet growing consumer and societal needs. They add taste, 
texture, nutrition and functionality to products consumed and used by millions of 
people every day. 

The revenue from the sale of our ingredients and solutions generates income which, after meeting 
our costs, helps fund business investments, and provide returns to shareholders through dividends.

How our business works

Consumer insight
We use our expertise in areas  
such as sensory, culinary and 
marketing to obtain a deep 
understanding of what the  
consumer wants. This insight  
drives our new product 
development programme, and  
how we collaborate with  
our customers.

Customers

Deliver
We aim to deliver our 
ingredients to customers on 
time, in full and to the right 
specification. For Food & 
Beverage Solutions, this is a 
complex process with multiple 
ingredients travelling around 
the world. For Primary 
Products, volumes are larger 
but products generally travel 
relatively shorter distances  
to customers.

Innovation
Our teams of scientists  
and nutritionists continuously 
research and test ingredients 
to create solutions for our 
customers. We work closely 
with our customers to 
understand their needs. 
Engaging with them earlier 
and throughout the innovation 
process helps drive quicker 
adoption cycles.

Manufacture
Most of our ingredients are  
made from agricultural crops, mostly 
corn. They are mainly produced at 
large-volume corn wet mills (shared 
by both divisions) and smaller  
blending facilities. Safety, quality, 
traceability and environmental  
impact are high priorities in our  
raw material sourcing and  
production processes.

Local solutions 
Consumer taste and texture 
preferences are different across  
the world, which is why we have a 
global network of application labs. 
Customers come to our labs to 
work with our food scientists to 
reformulate their products using 
our ingredients for their  
local markets. 

18  Tate & Lyle PLC Annual Report 2018

What drives us

Our purpose is to improve lives for generations. This is what drives us. Inspired by our purpose, we work with our customers to make 
food and drink healthier and tastier. We do this by delivering sweetness, texture, fibre enrichment and stabilisation to products 
consumed by millions of people every day. We focus on three categories globally: beverages, dairy, and soups, sauces and dressings; 
and on a regional basis categories such as bakery and bars and biscuits. Our solutions are valuable to our customers because they 
help meet growing consumer and societal needs for food which is lower in sugar, calories and fat, and with more fibre, in the face of 
growing global levels of obesity and diabetes, and digestive health issues. Our industrial products, including our large portfolio of 
industrial starches, are also valuable to our customers as they enhance product performance across a wide range of markets – from 
paper production to adhesives, to applications in building supplies, oil drilling and more.

What makes us different

We have key strengths which, in combination, differentiate us in the market.

Leading functional expertise 
We have strong technical expertise in the intersection of 
sweetness, texture, stabilisation and fibre enrichment, through 
our leading portfolio of sweeteners, highly functional speciality 
starches, and fibres with specific nutritional and health benefits. 

Deep category understanding 
Through our teams of food scientists, nutritionists and other 
experts, we have an increasingly deep understanding, globally  
and locally, of the categories we focus on such as beverages,  
dairy, and soups, sauces and dressings.

Delivering tailored solutions 
The combination of functional expertise and deep category 
understanding, together with our strong innovation pipeline, 
enables us to deliver tailored solutions for our customers which 
meet growing consumer demand for healthier and tastier food 
and drink.

Customer focus
Both divisions look to develop strong customer relationships  
built on a partnership approach. We are a trusted service 
provider and provide local, regional and global services to fit  
our customers’ needs.

Large scale manufacturing base 
Our scale manufacturing base and know-how enable us to  
drive operational efficiencies and a high level of product quality. 
They also provide a cost effective supply of ingredients and 
solutions for distribution through our global supply chain.

Talented people 
Our people are passionate, dedicated and highly skilled.  
We invest in training and developing our employees and also 
recruit high-calibre talent to ensure we have the right people, 
teams and skills to grow our business.

What underpins our business

Safety
Protecting our people is foundational to 
our business. Our ultimate goal is to have 
no accidents and no injuries, and this year 
we implemented a new approach to 
enhance our safety programme.

Values
Our Values of safety, integrity and respect 
define what we stand for and how we 
behave with our customers, suppliers, 
investors, partners, the communities in 
which we operate, and each other.

Board oversight
The Board of Directors oversees the 
activities of the Group through regular 
meetings, its committees, and visits  
to our operations around the world.

  Read more on pages 46 and 47

  Read more on page 42

  Read more on page 57

www.tateandlyle.com  19

Strategic ReportGovernanceFinancial StatementsUseful InformationMarketplace

Markets in which we operate 

Food & Beverage Solutions

Ingredients and solutions which add 
specific functionality and value to 
customers’ products

It serves customers globally, with an 
increasing presence in higher  
growth markets such as Asia Pacific  
and Latin America. 

Size1 
c.US$55 billion
Annual growth2
c.4-5%

The market

Food & Beverage Solutions (which 
includes Sucralose) provides ingredients 
and solutions which help customers 
meet increasing consumer demand for 
healthier and tastier food and drink.  

Where we operate

We focus on four areas of the market:

•  Sweeteners – Products include high 
intensity sweeteners (e.g. SPLENDA® 
Sucralose) and speciality sweeteners 
(e.g. DOLCIA PRIMA® Allulose)
•  Texturants – Products include  

REZISTA® Corn-based Starches and 
CLARIA® Clean-Label Starches 

Key market drivers

Healthier 
With obesity and diabetes on the rise 
worldwide, consumers are looking to 
reduce sugar, calories and fat in their 
food and drink while also adding 
beneficial ingredients such as fibre  
and protein.

•  Health and wellness – Products  
include fibres (e.g. PROMITOR® 
Soluble Fibre), and oat protein

•  Stabilisers – Customised ingredient 
blends providing high functionality 
such as viscosity and stability  
(e.g. HAMULSION®).

Clean label
Consumers want to understand the 
ingredients on food and drink labels. 
Increasingly, they are choosing products 
with labels with ingredients they feel are 
less processed, or they perceive to be 
simpler or ‘natural’.

How we deliver solutions

We work in partnership with our 
customers to reformulate their existing 
products, or create new products,  
to make food and drink healthier  
and tastier.

Enrichment
Our diverse portfolio of fibres offers a 
range of nutritional and functional 
benefits, while delivering exceptional 
digestive tolerance.

Sugar and calorie reduction 
Through our portfolio of sweeteners and 
fibres, we create solutions that help 
reduce sugar and calories without giving 
up the sweetness and texture 
consumers want.

Texture
Our range of starches provide key 
functionality for foods such as 
thickening, shelf-stability and fat 
reduction, while still providing the 
texture consumers want.

We take these products and, using our 
technical expertise, we provide solutions 
for our customers in categories such  
as beverages, dairy, and soups, sauces 
and dressings. 

Free from
Intolerance to certain ingredients is 
leading to increased demand for 
allergen-free foods such as dairy-free. 

Convenience
Convenience often comes at the cost of 
nutrition. Consumers want food and 
drink that offer fast, ‘grab-and-go’ 
nutrition, and provide healthier choices.

Stabilisation
Through our in-depth knowledge of 
ingredients and complex food systems, 
we create customised stabiliser systems 
(highly functional ingredient blends) that 
ensure products maintain stability, and 
appetising texture, throughout their 
shelf life.

1  IHS 2014; Speciality Chemicals update Program: Food Additives; Leatherhead 2014: The Global Food Additives Market; and other sources. 
2  Leatherhead; LMC International; Company analysis; data as at 2013, five year CAGR 2009-2013.

20  Tate & Lyle PLC Annual Report 2018

Primary Products

High volume ingredients which  
are largely undifferentiated and 
compete primarily on quality,  
service and price

The market

Primary Products provides high volume 
food and industrial products to 
customers who operate on a large scale. 
It primarily serves the North American 
market. Its products, derived mainly 
from corn, meet customer needs in the 

Where we operate

Sweeteners
Sweeteners provide sweetness  
and mouthfeel to regular carbonated  
soft drinks and other foods and drinks.

Key market drivers

Industry capacity utilisation
Our ingredients are produced  
mainly at four large corn wet mills in  
the US and two smaller mills in Europe. 
Supply/demand balance is a key driver 
of profitability in the US corn wet milling 
industry. Supply/demand in the industry 
was well balanced during the year. 

How we drive value

As it operates in mature markets,  
Primary Products aims to create value  
by focusing on: 

•  optimising product mix and margins
•  maintaining a mix of tolling and 

non-tolling contracts

•  continuously driving productivity  

and efficiency

food and beverage, paper and packaging 
industries. It also sells co-products as 
animal feed to customers globally. The 
end-markets it serves are mostly 
mature and consolidated. 

% of Primary Products profit from 
North America 
>90%

Industrial starches
Industrial starches strengthen and 
improve the surface conditions of paper 
and cardboard, and are also used in 
adhesives for building products. 

Acidulants
Acidulants are used mainly to enhance 
flavour and preserve foods, beverages  
and pharmaceuticals. 

Commodities
Commodities include co-products such 
as corn gluten meal and corn gluten feed 
(sold mainly as animal feed) and corn oil. 
We also produce some ethanol at our 
Loudon, Tennessee facility.

Corn market
The US corn wet milling industry 
processes around 9% of the US corn 
crop. Recent harvests have been strong 
with corn inventory high and prices 
relatively low and stable. Corn is largely  
a pass-through cost.

Sweetener demand
Demand in the US for regular carbonated 
soft drinks, the main end-market for our 
sweeteners, has declined modestly over the 
last three years, broadly offset by growth in 
other markets including exports to Mexico.

We seek to steadily re-deploy primary 
capacity in our corn wet mills to support 
growth in Food & Beverage Solutions to 
maintain good utilisation of our assets.

•  reducing exposure to commodity 

markets where we can, by dampening 
volatility by using conservative 
hedging strategies; actively managing  
co-product sales; and investing in our 
corn elevator storage network to 
secure raw material supply

•  maintaining capital expenditure 

discipline.

www.tateandlyle.com  21

Strategic ReportGovernanceFinancial StatementsUseful InformationKey Performance Indicators

Measuring progress

Delivering our strategy

We focus on a number of financial performance measures to ensure our  
strategy successfully delivers increased value for our shareholders.

  Read more on pages 12 to 15

Sales of Food & 
Beverage Solutions

Adjusted profit  
before tax1

Return on capital 
employed1

Adjusted operating 
cash flow1

£
8
3
4
m

£
8
5
0
m

£
7
4
1
m

£
3
0
1
m

£
2
7
1
m

£
1
9
3
m

1
6
.
2
%

1
4
.
3
%

1
1
.
3
%

£
2
9
9
m

£
2
7
3
m

£
1
2
4
m

16

17

18

16

17

18

16

17

18

162

17

18

+2%

+13%

+190 bps

+10%

in constant currency

in constant currency

How we calculate it

As reported, continuing 
operations only, excludes 
Sucralose.

As reported, continuing 
operations only.

The percentage return of the 
Group’s earnings from continuing 
operations on its invested capital.

Adjusted operating cash flow is 
defined as adjusted free cash flow 
from continuing operations, adding 
back net interest and tax paid, 
retirement cash contributions,  
and excluding derivative and 
margin call movements within 
working capital.

Why we measure it

To ensure we are successful  
in growing the business.

Comments

To track the underlying 
performance of the business and 
to ensure sales growth translates 
into increased profits.

To ensure that we continue  
to generate a strong rate  
of return on the assets that we 
employ and have a disciplined 
approach to capital investment.

To track how efficient we are in 
turning increased profit into cash 
and to ensure that working 
capital is managed effectively.

Sales were 2% higher in constant 
currency, mainly driven by higher 
volume in all regions, including a 
return to volume growth in North 
America. Sales in Asia Pacific 
and Latin America were 5% 
higher in constant currency. 

Adjusted operating profit was 13% 
higher in constant currency, and 
11% higher in reported currency, 
with profit higher in all our 
businesses. Primary Products 
performed especially strongly, with 
profits 30% higher. 

The return generated on capital 
employed increased during the 
year driven by higher earnings. 
The return on capital employed 
remains well ahead of our 
weighted average cost of capital.

Adjusted operating cash flow 
increased to £299 million, 
benefiting from stronger 
operating performance and lower 
capital expenditure, with cash 
cover of the dividend increasing.

1  Adjusted results and a number of other terms and performance measures used in this Annual Report are not defined within accounting standards. For clarity, 

we have provided descriptions of the various metrics and their reconciliations to the most directly comparable measures reported in IFRS, and the calculations, 
where relevant, of any ratios, in Notes 1 and 4.

2  Restated to reflect exclusion of operating post-retirement benefit costs.

22  Tate & Lyle PLC Annual Report 2018

Maintaining financial flexibility

Acting safely4

We look at measures of financial 
strength to ensure we have the flexibility 
to grow the business.

Protecting our people is foundational 
to our business, which is why we have 
key performance indicators for safety. 

  Read more on pages 32 to 37

  Read more on pages 46 and 47

Net debt to EBITDA 
multiple1, 3

Interest cover1, 3

Recordable 
incident rate

Lost-work 
case rate

1
.
2

0
.
9 0
.
8

1
3
.
9

1
4
.
6

1
0
.
7

0
.
7
6

0
.
7
6

0
.
7
6

0
.
1
9

0
.
1
6

0
.
1
1

16

17

18

16

17

18

15

16

17

15

16

17

0.1x

decrease

0.7x

increase

Flat

0.08

increase

How we calculate it

The number of times the 
Group’s net borrowing exceeds 
its earnings.

The number of times the 
Group’s earnings exceed 
interest payments made to 
service its debt.

How we calculate it

The number of injuries per 
200,000 hours that required 
more than first aid, for 
employees and contractors.

The number of injuries that 
resulted in lost-work days per 
200,000 hours, for employees 
and contractors.

Why we measure it

Why we measure it

To ensure that we have the appropriate level of financial gearing 
and that we generate sufficient profits to service our debt. These 
measures are a key focus for banks and providers of both debt and 
equity capital.

Ensuring safe and healthy conditions at all our locations is 
essential to our operation as a successful business.

Comments

Comments

The net debt to EBITDA ratio strengthened to 0.8 times. Cash flow 
generation was strong and net debt decreased by £60 million. 
EBITDA increased by 6%. Our net debt to EBITDA ratio remains 
comfortably ahead of our internal threshold of 2.0 times. Interest 
cover increased to 14.6 times, again comfortably ahead of our 
internal minimum threshold of 5.0 times.

For employees and contractors, the 2017 calendar year saw an 
unchanged recordable incident rate for the third year running. 
However, the number of lost-work cases increased by 50% (or four 
incidents). Total hours worked decreased by 8% following the 
closure of the Singapore Sucralose facility and the completion of 
major capital expenditure projects in 2016. There were no fatalities 
in 2017. The two fatalities which occurred in calendar year 2016, 
are recorded separately and are not included in the rates above.

3  Ratios calculated under the Group’s bank covenants definitions and reported on a proportionate consolidation basis. 
4  Measured on a calendar year basis.

www.tateandlyle.com  23

Strategic ReportGovernanceFinancial StatementsUseful InformationFood & Beverage Solutions

Commentary for Sucralose is provided separately on page 26.

Food & Beverage Solutions 

Volume growth and encouraging performance while we continue to invest for 
longer-term growth. 

Year ended 31 March 
Continuing operations

Volume
North America
Asia Pacific and Latin America
Europe, Middle East and Africa
Total

Sales
North America
Asia Pacific and Latin America
Europe, Middle East and Africa
Total

Adjusted operating profit

2018 
Volume  
change

1% 
7% 
6% 
3% 

2018 
£m

416
184
250
850

137

2017 
£m

420
176
238
834

129

Change 
%

(1%)
4% 
5% 
2% 

5%

Constant  
currency 
change 
%

-%
5%
1%
2%

8%

The Group has made changes to its reportable segments which are explained on page 12.

Key highlights

Food & Beverage Solutions
•  Good performance with profit 8% higher in constant 

currency

•  Volume growth improved to 3%, with volume growth in 

North America 

•  Re-focused growth strategy on key categories to align 

with customer

•  New Products progress with sales 15% higher
•  Expanded application labs in Asia Pacific and  

Latin America. 

Sucralose
•  Adjusted operating profit 5% higher in constant 

currency with margin growth.

“ With our clear category focus 
and strong solutions portfolio, 
we are well-placed to benefit 
from growing global demand for 
healthier food and drink.”

Joan Braca 
President, Food & Beverage Solutions

24  Tate & Lyle PLC Annual Report 2018

 
 
Improving lives, 
making food healthier

How do you make a delicious tasting yoghurt with reduced sugar, fat  
and calories, enriched with fibre, and with the texture consumers love?  
Our ability to combine our understanding of sweetness, texture and fibre 
enrichment, with our expertise in the dairy category, makes this possible  
by tailoring the right solution for our customers in their local markets.

SPLENDA® Sucralose
Sweetens without adding calories

CLARIA® Functional 
Clean-Label Starch
Provides clean-label texture  
and mouthfeel, and replaces fat

PROMITOR® Soluble Fibre 
Contributes added fibre, provides 
mouthfeel, and allows calorie  
and sugar reduction

HAMULSION® 
Stabiliser Systems
Thickens, stabilises, 
optimises cost,  
and provides  
consistent mouthfeel

Our solutions help our customers meet growing global consumer trends: 

Addressing global consumer trends

1 in 4

84%

81%

products launched globally  
contains a clean-label claim1

of US consumers report limiting  
the amount of sugar in their diets2

of US consumers say taste is  
the primary driver of purchase3

Sources

1  Innova Market Insights analysis for Tate & Lyle, May 2016.

2  Mintel, ‘Insights on Health, Sugar & Sweeteners and Beverages’ May 2017.

3  Food International Council Foundation – 2018 Food and Health Survey.

www.tateandlyle.com  25

Strategic ReportGovernanceFinancial StatementsUseful InformationFood & Beverage Solutions continued

Volume grew by 3%, with growth in all regions, including a return 
to growth in North America. Sales were 2% higher in constant 
currency at £850 million. Adjusted operating profit was 8% higher 
in constant currency reflecting both higher volume and the 
recovery of our stabiliser business (formerly Food Systems) 
following the successful consolidation of our blending facilities  
in Europe and the lapping of the £5 million write down of an 
unrecoverable debt. 

During the year, we invested in the expansion of customer-facing 
applications laboratories in the emerging markets and invested 
in our offer to customers by selectively balancing competitive 
price positioning and growing margins. These decisions, together 
with increasing North American transport costs, moderated 
profit growth in the second half of the year.

The effect of currency translation was to increase sales by  
£1 million, but reduce adjusted operating profit by £2 million.

North America
In North America, market conditions continued to be challenging 
as the overall US food and beverage market remained flat with 
consumers increasingly seeking alternatives to traditional 
brands, and many of our largest customers experiencing end 
market softness. Despite this, volume grew 1% as we:  
(1) continued to win new business in targeted higher-growth 
sub-categories across dairy, bakery and health and nutrition, 
where our technical depth and expertise are providing increasing 
value to our customers; (2) developed our business in customer 
channels growing faster than the market, such as food service 
and own label; and (3) gained share in our larger food and 
beverage customers. 

Sales in constant currency were flat at £416 million, reflecting 
product mix and pass through of lower corn costs. 

Asia Pacific and Latin America
In Asia Pacific and Latin America, volume was 7% higher, with 
especially strong growth in China and Mexico. Sales increased by 
5% in constant currency to £184 million. 

In Latin America, Mexico saw double digit volume growth, with 
particularly strong demand for sweeteners helped by favourable 
market dynamics. In Brazil, we delivered double digit volume 
growth, mainly driven by texturant and sweetener sales in the 
dairy category. Weakness in the Venezuelan market led to double 
digit decline in volume in the Andean region. 

In Asia Pacific, we delivered strong double digit volume growth  
in China with good growth in dairy and beverages, while in  
South Eastern Asia volume was lower due to a competitive 
sweetener market.

During the year, we expanded our customer-facing applications 
facilities in Shanghai, Singapore and Mexico City, and completed 
the expansion of manufacturing capacity at our polydextrose fibre 
facility in Nantong, China. 

Europe, Middle East and Africa
In Europe, Middle East and Africa, volume increased by 6% driven 
by double digit volume growth both in Southern Europe, where 
sweetener demand in beverages was strong, and in Central 
Europe, reflecting good demand for our texturant solutions in 
soups, sauces and dressings. In Russia, stabiliser volume was 
significantly lower following a customer credit issue in the prior 
year. Sales at £250 million increased by 1% in constant currency, 
impacted by lower mix of stabiliser sales.

26  Tate & Lyle PLC Annual Report 2018

To meet increasing customer demand, during the year we 
announced an expansion of maltodextrin capacity at our facility  
in Slovakia, which is expected to come on line in the 2019 
calendar year. 

New Products
Volume of New Products grew by 24%. Sales increased by 15% to 
US$121 million or £91 million (2017 – US$105 million or  
£81 million). 

Higher sales in texturants were led by growth in clean label 
starches and in our range of Non-GMO products. Our CLARIA® 
line of functional clean label starches continues to perform well, 
with a new line of instant starches released in the year and a 
promising customer pipeline. We continue to broaden our offering 
of Non-GMO solutions in line with this growing consumer trend.

The replacement of sugar in beverages led to higher sales of  
our stevia portfolio of products, with PUREFRUITTM, our monk 
fruit extract high intensity sweetener, also performing well.  
In April 2017, we entered into an exclusive partnership with  
Sweet Green Fields, one of the largest fully integrated stevia 
players. Reflecting the encouraging progress demonstrated  
over the first year of this partnership, in May 2018, we extended 
our relationship by acquiring a 15% shareholding in Sweet  
Green Fields.

Sucralose

Value-based strategy delivering returns.

Volume
Sales
Adjusted operating profit

2018 
£m

2017 
£m

Change 
%

146
55

162 
52 

(12%)
(10%)
6% 

Constant 
currency 
change 
%

(9%)
5% 

The Group has made changes to its reportable segments which are explained 
on page 12.

As expected, Sucralose volume reduced by 12% reflecting the 
sale of excess inventory in the first half of the comparative year 
following the completion of the transition to our facility in 
McIntosh, Alabama in March 2016. Pricing was firm with sales 
9% lower in constant currency at £146 million. While volume was 
lower, our McIntosh facility continued to operate well and at close 
to capacity, delivering lower operating costs, and adjusted 
operating profit was 5% higher in constant currency at  
£55 million. 

While overall market demand for sucralose continues to grow 
over the longer term, market prices are expected to moderate 
reflecting increases in industry supply from Chinese manufacturers.

The effect of currency translation was to reduce sales by  
£1 million, with no impact on adjusted operating profit.

Primary Products

Strong performance, firm margins and consistent execution. 

Primary Products

2018 
Volume  
change

3% 
0% 

1% 

2018 
£m

2017 
£m

Change 
%

Constant  
currency 
change 
%

1 714

1 757

(2%)

(1%)

134
32

166

121
8

129

10%
311%

28%

11%
333%

30%

Year ended 31 March 
Continuing operations

Volume
North American Sweeteners
North American Industrial Starches

Total Primary Products 

Sales
Total Primary Products

Adjusted operating profit
Sweeteners and Starches 
Commodities

Total Primary Products

The Group has made changes to its reportable segments which are explained on page 12.

Key highlights
•  Strong performance with profit 30% higher
•  Robust margins in balanced supply/demand industry
•  North American Sweeteners volume 3% higher
•  £13 million increase in Sweeteners and Industrial 

Starches profit

•  Good mix management and customer service 
•  Commodities profit £24 million higher in constant currency. 

“ We remain focused on delivering 
steady earnings and cash, and 
optimising our portfolio to 
deliver incremental value.”

Jim Stutelberg
President, Primary Products

www.tateandlyle.com  27

Strategic ReportGovernanceFinancial StatementsUseful Information 
 
Primary Products continued

Improving lives,  
for everyday needs

From adding great taste to beverages, to making paper smoother, to helping 
cardboard boxes stay sealed, our sweeteners, starches and acidulants are used 
to help make the lives of millions of people easier and more enjoyable every day. 

Packaging tape
Our range of STA-TAPETM starches are 
used in the manufacture of brown 
paper tape for sealing cardboard boxes. 
STA-TAPETM starches adhere very well 
and help to protect package contents 
during transit. They also provide a 
‘security seal’ for products, as the tape 
can’t be lifted and re-stuck. 

Soft drinks
High fructose corn syrup is 
used as a sweetener in soft 
drinks and beverages. Citric 
acid can also be used to 
improve taste or add a distinct 
sour flavour impact.

Paper
Our starches, such as ETHYLEX® and 
STA-LOK®, are used in the production 
of paper to increase strength and 
stability, and provide a smoother 
surface. Our starches help improve 
everyday items such as magazines, 
writing paper, cardboard and tissues.

28  Tate & Lyle PLC Annual Report 2018

North American Free Trade Agreement (NAFTA)
The United States, Canada, and Mexico commenced discussions 
in August 2017 to modernise NAFTA. NAFTA is very important to 
the US food and agriculture sector, and Mexico in particular is a 
key export market for the corn wet milling industry, notably for 
high fructose corn syrup. As at the date of this Annual Report, 
talks between the three parties are ongoing, and we continue to 
monitor the situation closely.

Prior to the commencement of the talks on NAFTA, in June 2017 
the US Department of Commerce and the Mexican Secretariat of 
Economy agreed revised Sugar Suspension Agreements. These 
Agreements, originally put in place in 2014, suspend the 
anti-dumping and countervailing duty investigations on imports of 
Mexican sugar into the US. They also limit the amount of sugar 
that Mexican companies can export to the US, and set price floors 
for that sugar. The revised Agreements maintain a productive US 
trading relationship with Mexico, and preserve cross-border 
trade of sweeteners between the two countries.

Using the whole corn kernel

Tate & Lyle uses every part of the corn kernel; nothing is 
wasted. Corn is broken down into 58% corn starch (used to 
make food and industrial ingredients); 22% corn gluten 
feed (made from the hull and fibre and used in cattle feed); 
4% corn gluten meal (extracted from the endosperm and 
used in aquaculture feed and pet food); 3% corn oil (made 
from the germ and used by the food industry); and the 
remaining 13% is water. 

Endosperm

Starch

Starch 
and 
gluten

Source: Tate & Lyle analysis.

Hull and 
fibre

Germ

Volume increased by 1% with North American sweetener growth 
and robust demand.

Adjusted operating profit of £166 million increased by 30% in 
constant currency. Sweeteners and Starches adjusted operating 
profit increased by 11% in constant currency, benefiting from 
strong commercial and supply chain execution, solid demand, 
and moderate margin gains secured in the 2017 calendar year 
contracting round. In the second half, increasing energy and 
transport costs held back profit growth. Commodities contributed 
profits of £32 million, an increase of £24 million.

The effect of currency translation was to decrease sales by  
£20 million and adjusted operating profit by £2 million.

The US corn wet milling industry remains relatively well 
balanced, reflecting firm overall demand with modestly declining 
US domestic demand for high fructose corn syrup offset by 
growing sweetener demand in some end-use categories, 
including the brewing industry, other fermentation uses and 
sweetener exports to Mexico.

Corn prices
For the fourth consecutive year, the US corn crop was good with 
strong yields resulting in high closing US inventories. Corn prices 
varied through the year, trading mostly in the $3.30 to $3.90 per 
bushel range, in advance of the 2017 crop. US corn prices moved 
modestly higher in the first quarter of the 2018 calendar year 
reflecting concerns of a smaller crop in Argentina and increased 
exports by the US. 

North American Sweeteners
Volume increased 3%, led by stable demand in the US and growth 
in export volume to Mexico. Unit margins for contracts renewed 
for the 2017 calendar year increased, reflecting successful 
contracting and continued good industry supply demand balance. 
Unit margins further benefited from product mix management 
and efficiency initiatives. 

The 2018 calendar year contracting round delivered unit margins 
broadly in line with the previous year.

North American Industrial Starches
North American Industrial Starches volume was flat compared 
with the prior year. Overall demand for paper remains steady  
with growing demand for packaging and tissue, offsetting 
declines in printing and writing paper. Demand for starches  
in construction materials also remained steady in a relatively 
stable US housing market.

Commodities
Commodities had a strong year delivering profits of £32 million, 
£24 million higher than the prior year. The stronger performance 
mainly reflected gains from the sourcing of corn and stronger 
co-products profits. Profits from corn gluten feed, a co-product 
used for animal nutrition, strengthened reflecting improved 
market conditions and better realised prices during the year. 
Profits from our network of corn elevators also increased.

US ethanol cash margins remained towards the low-end of the 
historical range with industry inventories high.

www.tateandlyle.com  29

Strategic ReportGovernanceFinancial StatementsUseful InformationInnovation and Commercial Development

Using science to  
make food better

Innovation and Commercial Development (ICD) is an important 
part of our growth strategy. ICD brings together scientific and 
commercial functions into one team to provide an integrated 
approach to developing and commercialising new products and 
technologies. The team uses its deep understanding of consumer 
trends and food and beverage categories, along with leading-
edge science, to create solutions for customers which address 
growing demand for healthier and tastier food and drink.

ICD is based at our global Commercial and Food Innovation Centre 
in Chicago, USA. At the Centre, we offer our customers a full range 
of facilities and services including sensory evaluation, culinary 
development, human nutrition and regulatory expertise, state-of-
the-art research and application laboratories, and a pilot plant. 
Through the Centre, and our global network of applications and 
technical services laboratories, we work closely with our customers 
to develop new products and bring them to market quickly. 

ICD supports both business divisions and focuses mostly on four 
food and beverage platforms where we have strong expertise. 
Each platform has a clear strategic focus aligned to large market 
opportunities.

•  Sweeteners: we promote sugar substitution through a range 
of low-calorie and no-calorie alternatives to sugar. Reducing 
calories is an increasingly important priority for both 
consumers and governments

•  Texturants: we deliver highly functional and ‘clean-label’ 

starches. In the food industry, starches are used to provide 
texture and shelf stability

•  Health and wellness: we offer soluble fibres and a range of 
oat-based ingredients which support healthy digestion and 
have other functional benefits such as replacing fat, sugar  
and calories

•  Stabilisation and functional systems: these help food  

preserve its structure, for example, by preventing oil and  
water emulsions from separating, ice crystals from forming, 
and fruit from settling in products such as jams and yoghurts.

ICD consists of five areas working together as one team.

•  Research and development: we use leading-edge science to 
deliver innovative new products which target large market 
opportunities

•  Platform management: we use research to develop strategies 
for our four platforms aligned to large market opportunities
•  Strategic marketing: our market research programme keeps 
us up to date with consumer and category trends. Our own 
primary research is supplemented by insights from syndicated 
research services such as Euromonitor

•  Regulatory and nutrition: we support our business and our 

customers by undertaking pre-clinical and clinical research to 
provide key scientific knowledge about our ingredients, and to 
navigate regulatory processes in markets across the world
•  Open innovation: we complement our in-house science by 
developing relationships with universities and research 
institutions specialising in food science and technologies.  
We also seek to identify and develop opportunities across our 
platforms. Tate & Lyle Ventures also invests in early-stage 
companies in the food ingredient and technology space.

We manage our innovation pipeline through a rigorous,  
multi-step stage gate process with clear milestones.  
Through this process, we assess the size and viability of an  
idea from conception through to final launch into the market.

Protecting our science 

We protect our intellectual property by patenting our 
innovations and processes. During the year we had 88 new 
patents granted. In total, at 31 March 2018, we had 384 
patents in issue and more than 370 patents pending.

Focus on five scientific competencies

Organic chemistry

Biochemistry

Separations science

Formulations science

Particle design

30  Tate & Lyle PLC Annual Report 2018

Global Operations

Delivering operational 
excellence

Our Global Operations team is responsible for the delivery of 
high-quality products to our customers across the world. It’s 
their job to run our plants safely, efficiently and cost-effectively, 
making sure that our ingredients reach customers on time, in 
full, and to the right specification. The team works closely with 
Food & Beverage Solutions and Primary Products to serve 
customers through a flexible and efficient supply chain.

Raw material sourcing and procurement
Like all large companies, we have a global procurement team  
to manage sourcing efficiently. Most of our ingredients and 
solutions are produced from agricultural crops, principally corn, 
and so we have a separate sourcing team for raw materials.  
They work closely with farmers and other commercial partners  
to ensure we have a reliable and secure supply. In the US, where 
most of our plants are located, we have a network of storage 
elevators to manage the cost effectiveness, security and 
sustainability of our corn supply. At harvest time, due to high 
volumes, corn is delivered either to our elevators or is delivered 
direct from farmers. We receive deliveries at our plants by rail 
car, truck or barge. 

Manufacturing
In the US, we have four major corn wet mills, three in the 
mid-west and one in Tennessee, which serve US domestic 
customers and those in Latin America and Asia Pacific.  
In Europe, principally serving European customers, we have  
a corn wet mill in the Netherlands and one in Slovakia. 

All our corn wet mills make ingredients for both business 
divisions. Other key sites include our Sucralose facility in the  
US, and our citric acid plants in the US and Brazil. Smaller 
manufacturing sites include an oat-based fibres facility in 
Sweden and a polydextrose fibre facility in China.

Logistics 
Global Operations manages the storage, transportation and 
delivery of products from our plants to our customers. We have  
a global planning process supported by regional planning 
resources for Food & Beverage Solutions, and a global network 
of warehouses and transfer stations where we keep products 
close to our customers. This process means we have the 
flexibility to respond to our customers’ needs.

Customer service 
Our customer service teams for Food & Beverage Solutions and 
Primary Products sit within Global Operations. The teams are 
regional so that they can offer the best customer experience from 
order receipt to delivery.

Continuous improvement 
A dedicated Continuous Improvement team leads productivity, 
efficiency and reliability projects across Tate & Lyle. By using 
innovative approaches and established continuous improvement 
methodologies, such as Lean and Six Sigma, the team identifies 
and delivers projects to streamline processes, reduce process 
waste, and improve product quality. 

Environment, health and safety
Protecting our people and the world around us is foundational to 
our business. Global Operations is responsible for environmental, 
health and safety (EHS) performance across the Group. In 2017, 
we developed a new, global approach to EHS for everyone who 
works at Tate & Lyle. More details can be found on pages 46 to 49 
of this Annual Report.

Examples of two achievements during the year

Triple the fibre at Nantong, China 
In December 2017, we completed a 
project to expand capacity and upgrade 
processes at our STA-LITE® Polydextrose 
(fibre) facility in Nantong, China. This 
project has tripled capacity. As part of the 
expansion, manufacturing and quality 
processing were significantly enhanced, 
and an advanced environmental 
management infrastructure and  
system was implemented.

US energy efficiency certifications
Our corn wet mills in Lafayette South, 
Indiana and Loudon, Tennessee were 
awarded Energy Star Certification by the 
US Environmental Protection Agency 
(EPA) for outstanding energy efficiency 
performance in 2017, with Lafayette 
South achieving the best performance of 
all corn wet mills in the US. The award 
recognises industrial plants that are 
performing in the top 25% of similar 
facilities across the US for energy 
efficiency, and which meet strict energy 
performance levels set by the EPA.

www.tateandlyle.com  31

Strategic ReportGovernanceFinancial StatementsUseful InformationGroup Financial Results

Strong financial performance
+13%
+8%

Group adjusted profit before tax 
with profit growth in all businesses at 
constant currency

Food & Beverage Solutions profit1 
to £137 million with good volume momentum  
and New Products progress

+30%

Primary Products profit1 
to £166 million, 11% profit1 growth in Sweeteners and Starches;  
Commodities £24 million higher

+5%

Sucralose profit1
to £55 million

+15%

Sales from New Products2
to US$121 million

£53m

higher Group reported profit before tax
with improved trading and lower exceptional costs

+7%

Earnings per share3 
at constant currency

£60m

Net debt £60 million lower,
with adjusted free cash flow £22 million 
higher at £196 million

1  Adjusted operating profit, percentage change in constant currency. 
2  New Products represent products in the first seven years after launch. 
3  Adjusted diluted earnings per share from continuing operations.

32  Tate & Lyle PLC Annual Report 2018

Summary of financial results for the year ended 31 March 2018 (audited)

Year ended 31 March1 
Continuing operations unless otherwise stated

Sales
Adjusted operating profit
 – Food & Beverage Solutions

 – Sucralose

 – Primary Products
 – Central
Adjusted operating profit
Adjusted net finance expense
Share of profit after tax of joint ventures and associates
Adjusted profit before tax
Exceptional gain/(loss)
Amortisation of acquired intangible assets
Net retirement benefit interest
Profit before tax
Income tax (expense)/credit
Profit for the year – continuing operations
Profit for the year – discontinued operations
Profit for the year – total operations
Earnings per share – continuing operations (pence)
Basic
Diluted
Adjusted earnings per share – continuing operations (pence)
Basic
Diluted
Cash flow and net debt
Adjusted free cash flow
Net debt – At 31 March 

2018 
£m 

2017 
£m

2 710 

2 753 

Change 
%

(2%)

Constant 
currency 
change %
(1%)

5% 
6% 
28% 

8% 
5% 
30% 

14% 

15% 

(14%)
11% 

(14%)
13% 

137 
55 
166 
(58)
300 
(27)
28 
301 
2 
(12)
(5)
286 
(23)
263 
2 
265 

129 
52 
129 
(46)
264 
(25)
32 
271 
(19)
(12)
(7)
233 
22
255 
1 
256 

4%
4%

6%
6%

8%
7%

57.0p
56.1p

50.9p
50.1p

55.0p
54.2p

47.8p
47.1p

196
392 

174 
452 

Sales from continuing operations of £2,710 million were 2% lower 
(1% lower at constant currency) reflecting the impact of lower 
corn costs.

Adjusted profit before tax
Year ended 31 March 2018

On a statutory basis, profit before tax from continuing operations 
increased by £53 million to £286 million. Statutory diluted 
earnings per share from continuing operations increased by 1.9p 
to 56.1p as improved operating performance was largely offset by 
the effect of an increased statutory effective tax rate of 8.1% (2017 
– 9.6% credit reflecting the recognition of exceptional deferred 
tax credits). As a result of the increased current year tax charge, 
profit for the year from total operations increased only modestly 
to £265 million (2017 – £256 million).

Adjusted profit before tax from continuing operations was 11% 
higher than last year (13% in constant currency), at £301 million. 
Adjusted diluted earnings per share from continuing operations 
increased by 3.0p to 50.1p as increased profits were partially offset 
by a higher adjusted effective tax rate of 21.9% (2017 – 18.2%).

1  Adjusted results and a number of other terms and performance measures 

used in this Annual Report are not directly defined within accounting 
standards. For clarity, we have provided descriptions of the various metrics 
and their reconciliations to the most directly comparable measures reported 
in IFRS, and the calculations, where relevant, of any ratios, in Notes 1 and 4.

+£37m

+£8m

+£3m

£(4)m

£(14)m

£301m

£271m

Food &
Beverage
Solutions

2017
Adjusted
profit
before 
tax

Sucralose

Primary
Products

Joint
ventures

Interest/
central

2018
Adjusted
profit
before 
tax

www.tateandlyle.com  33

Strategic ReportGovernanceFinancial StatementsUseful InformationGroup Financial Results continued

Central costs 
Central costs, which include head office costs, treasury and 
reinsurance activities, were £12 million higher at £58 million 
reflecting higher captive insurance costs, following an increase  
in self-insured claims from the Group’s operations.

Net finance expense
Adjusted net finance expense from continuing operations,  
which excludes net retirement benefit interest, was £2 million 
higher at £27 million, mainly driven by lower capitalised interest 
(principally related to the construction of the Loudon co-generation 
facility, commissioned in the second half of the 2017 financial 
year) and the impact of increased US interest rates on floating 
rate debt.

Share of profit after tax of joint ventures  
and associates
The Group’s share of profit after tax of joint ventures and 
associates of £28 million was £4 million lower than the prior year 
reflecting lower profits in the Group’s Almex joint venture in 
Mexico due to the lapping of prior year non-trading gains, 
principally transactional currency gains.

Exceptional items from continuing operations
Operating exceptional credits from continuing operations of  
£2 million were recognised in respect of the disposal of an 
investment held as part of the Group’s venture fund portfolio 
(2017 – total net operating exceptional costs of £19 million).

In the year ended 31 March 2018, the Group recognised 
exceptional tax gains totalling £38 million, comprising two items: 
firstly, a credit of £36 million, reflecting mainly the revaluation 
downwards of net US deferred tax liabilities following the 
reduction in the US federal tax rate; and secondly, a net credit of 
£2 million following an increase in UK deferred tax assets 
resulting from changes in both UK and US tax legislation and 
anticipated changes to the Group’s internal financing 
arrangements. In the comparative year, the Group recognised 
exceptional deferred tax credits totalling £65 million. 

More details on the tax exceptional items can be found in Notes 7 
and 12.

Taxation
The adjusted effective tax rate on earnings for continuing 
operations for the year ended 31 March 2018 increased to 21.9% 
(2017 – 18.2%). 

Two factors drove the increase in the adjusted effective tax rate in 
the year: firstly, changes to UK legislation arising from the 
OECD’s Base Erosion and Profit Shifting (BEPS) project and 
consequent changes to the internal financing arrangements we 
use to fund our international businesses; and secondly, an 
increase in profits generated in the US, a jurisdiction with a 
higher rate of corporation tax during the year to 31 March 2018. 
The Group adjusted effective tax rate was at the lower end of the 
21% to 24% range anticipated coming into the year.

On 22 December 2017, the United States enacted the Tax Cuts 
and Jobs Act (‘US Tax Reforms’). This legislation reduced the 

headline rate of federal income tax in the United States to 21% 
(from 35%) from 1 January 2018, as well as introducing a number 
of incentives for companies to invest in the US and other changes 
to broaden the tax base in the US. Due to the efficiency of its 
internal financing arrangements the Group will generate modest 
benefit from the US Tax Reforms, with future upward pressure on 
the adjusted effective tax rate also removed. 

The reported effective tax rate on statutory earnings for the year 
was a charge of 8.1% (2017 – credit of 9.6%). The statutory tax 
charge was impacted by exceptional tax charges and credits in 
the year including the write down of deferred tax assets and 
liabilities related to legislation changes in the UK and US and 
anticipated changes to the Group’s internal financing 
arrangements. Legislation limiting the utilisation of carry forward 
losses in the UK was enacted in the year, resulting in a write off 
of part of a deferred tax asset created in the prior year, with a 
consequent charge to the statutory tax rate. Overall, exceptional 
tax gains in the 2018 financial year were £38 million compared to 
£65 million in the comparative year.

The recognition and measurement of deferred tax assets and 
liabilities is dependent on a number of key judgements, estimates 
and assumptions. Judgements relate principally to: the size and 
duration of future internal financing arrangements; the interest 
coupon payable on these arrangements; the future level of 
deductible expenses incurred in the UK; and foreign currency 
exchange rates. Changes in assumptions, along with future 
changes in legislation, could have a material impact on the 
amount of tax recognised in future accounting periods.

We estimate that the adjusted effective tax rate for the 2019 
financial year will be in the range of 20% to 22%. 

A list of key uncertainties affecting the Group’s adjusted and 
reported effective tax rates, as well as the factors that are 
expected to influence the sustainability of the Group’s effective 
tax rates in the future, are set out on pages 129 and 130.

Discontinued operations
The Group recognised a gain of £2 million from discontinued 
operations in respect of its former Moroccan operation (2017 
– profit of £1 million).

Earnings per share 
Adjusted basic earnings per share from continuing operations 
increased by 6% (8% in constant currency) to 50.9p and adjusted 
diluted earnings per share from continuing operations at 50.1p 
were 6% higher (7% in constant currency). 

Dividend 
The Board is recommending a 0.5p or 2.5% increase in the final 
dividend to 20.3p (2017 – 19.8p) per share. This increased final 
dividend makes a full year dividend of 28.7p (2017 – 28.0p) per 
share, up 2.5% on the prior year. Subject to shareholder approval, 
the proposed final dividend will be due and payable on 1 August 2018  
to all shareholders on the Register of Members on 22 June 2018.  
In addition to the cash dividend option, shareholders will continue 
to be offered a Dividend Reinvestment Plan (DRIP) alternative. 

34  Tate & Lyle PLC Annual Report 2018

Assets 
Gross assets of £2,571 million at 31 March 2018 were £200 million lower than at 31 March 2017, mainly reflecting the adverse impact 
of the weakening US dollar. 

Net assets increased by £35 million to £1,367 million as the profit for the year was partially offset by net exchange losses of £83 million 
and the dividend payment of £131 million.

Retirement benefits 
The Group maintains pension plans for its employees in a number of countries. Some of these arrangements are defined benefit 
pension schemes and, although we have closed the main UK scheme and the US salaried and hourly paid schemes to future accrual, 
certain obligations remain. In the US, we also provide medical benefits as part of retirement packages. 

The net surplus on the Group’s retirement benefits plans was £18 million, an improvement of £157 million from a net deficit at  
31 March 2017 of £139 million. The improvement was led by a reduction in the deficit of the US schemes largely as a result of foreign 
exchange movements from the weakening of the US dollar and by cash contributions. In addition to total regular cash contributions of 
£44 million in the year, the Group made an accelerated gross cash contribution to the US schemes of £56 million, in light of an 
opportunity to fund the schemes while taking advantage of a higher US tax deduction.

Under funding arrangements in connection with the 2016 triennial actuarial valuation, the Group has committed to make core  
funding contributions for the main UK scheme of £12 million per year and supplementary contributions of £6 million per year until  
31 March 2023 into a secured funding account, payable to the Trustee on certain triggering events. 

During the year ending 31 March 2019, the Group expects to contribute approximately £30 million to retirement benefit schemes, 
comprising £26 million to its defined benefit plans and £4 million in relation to retirement medical plans.

Cash flow and net debt

Adjusted operating profit from continuing operations 
Adjusted for:
Non-cash items in adjusted operating profit and working capital
Net retirement benefit obligations
Less: accelerated US defined benefit schemes contribution (exceptional cash flows)
Net retirement benefit obligations: underlying funding
Net interest and tax paid
Less: cash tax benefit on accelerated contribution (exceptional cash flows)
Net interest and tax paid: underlying
Capital expenditure
Adjusted free cash flow1

Year ended 31 March1

2018 
£m

300 

121
(94)
56
(38)
(36)
(20)
(56)
(131)
196 

2017 
£m

264 

162 
(36)
–
(36)
(63)
–
(63)
(153)
174 

Adjusted free cash flow (representing cash generated from continuing operations after net interest paid, income tax paid, and capital 
expenditure, and excluding the impact of exceptional items) was £196 million, £22 million higher than the prior year principally 
reflecting higher earnings and lower capital expenditure.

Capital expenditure of £131 million, which included a £20 million investment in intangible assets, was 0.9 times the depreciation and 
adjusted amortisation charge of £142 million and reflects continued investment in capacity as well as efficiency and sustaining 
investments. We expect capital expenditure for the 2019 financial year to be between £130 million and £150 million.

Other significant cash flows in arriving at net debt included: £26 million of dividends received from joint ventures; external dividend 
payments of £131 million; £27 million payments for the purchase of shares to satisfy share option commitments and a net £36 million 
accelerated funding payment to the US pension schemes (a gross payment of £56 million, less £20 million tax deduction). 

Overall net debt at 31 March 2018 of £392 million was £60 million lower than at 31 March 2017. Net debt decreased by £25 million in 
the year (2017 – decrease of £39 million) before the favourable impact of exchange rates. Foreign currency translation, mainly from 
the impact of the weakening US dollar, reduced net debt by £35 million. 

Year ended 31 March
Cash dividend cover2
Net debt (£m)
Leverage (net debt:EBITDA)1
Return on capital employed1

2018

1.5x
392
0.8x
16.2%

2017

1.3x
452
0.9x
14.3%

1  Adjusted results and a number of other terms and performance measures used in this Annual Report are not directly defined within accounting standards. For 

clarity, we have provided descriptions of the various metrics and their reconciliations to the most directly comparable measures reported in IFRS, and the 
calculations, where relevant, of any ratios, in Notes 1 and 4.

2  Cash dividend cover is calculated as adjusted free cash flow from continuing operations divided by cash dividends. 

www.tateandlyle.com  35

Strategic ReportGovernanceFinancial StatementsUseful InformationGroup Financial Results continued

Financial risk factors
Our key financial risk factors are market risks, such as foreign 
exchange, transaction and translation exposures, and credit and 
liquidity risks, as explained in Note 29.

Off balance sheet arrangements
In the ordinary course of business, to manage our operations and 
financing, we enter into certain performance guarantees and 
commitments for capital and other expenditure. We aim to 
optimise financing costs in respect of all financing transactions. 
Where it is economically beneficial, we choose to lease rather 
than purchase assets. Leases for property, plant and equipment 
where the lessee does not assume substantially all the risks and 
rewards of ownership are treated as operating leases, with 
annual rentals charged to the income statement over the term of 
the lease. Commitments under operating leases to pay rentals in 
future years totalled £274 million (2017 – £318 million) and 
related primarily to railcar leases in the US and our commitment 
for a gas pipeline to supply our Loudon facility. Rental charges for 
the year ended 31 March 2018 in respect of continuing operations 
were £35 million (2017 – £32 million).

Use and fair value of financial instruments
In the normal course of business we use both derivative and 
non-derivative financial instruments. The fair value of Group net 
debt at the year end was £398 million against a book value of 
£392 million (2017 – fair value £472 million, book value  
£452 million). Derivative financial instruments used to manage 
the interest rate and currency of borrowings had a fair value of 
£12 million liability (2017 – £21 million liability). The main types  
of instrument used are interest rate swaps and cross-currency 
interest rate swaps. The fair value of other derivative financial 
instruments hedging future currency and commodity 
transactions was £2 million liability (2017 – £2 million asset). 
When managing currency exposure, we use spot and forward 
purchases and sales, and options. The fair value of other 
derivative financial instruments accounted for as held for trading 
was a £13 million asset (2017 – £11 million asset).

Fair value estimation
The fair value of derivative financial instruments is based on the 
market price of comparable instruments at the balance sheet 
date if they are publicly traded. The fair value of the forward 
currency contracts was determined based on market forward 
exchange rates at the balance sheet date. The fair values of 
short-term deposits, receivables, payables, loans and overdrafts 
with a maturity of less than one year are assumed to approximate 
their book values. The fair values of bonds, bank and other loans, 

including finance lease liabilities due in more than one year,  
are estimated by discounting the future contractual cash flows  
at the current market interest rate available to the Group for 
similar financial instruments, adjusted for the fair valuation 
effects of currency and interest rate risk exposures, where  
those instruments form part of related hedging relationship 
agreements. The fair value of borrowings relating to the US 
Private Placement Notes is based on broker dealer quotations. 
The fair value of commodity forward contracts and options,  
and commodity futures is based on market prices and, where 
relevant, management’s estimate of basis and the price at which 
co-products will be bought or sold in the future. The values of 
certain items of merchandisable agricultural commodities that 
are included in inventories are based on market prices.

Going concern
The Directors are satisfied that the Group has adequate 
resources to continue to operate for a period not less than  
12 months from the date of approval of the financial statements 
and that there are no material uncertainties around their 
assessment. Accordingly, the Directors continue to adopt the 
going concern basis of accounting. 

Basis of preparation
The Group’s principal accounting policies are unchanged from 
the year ended 31 March 2017. A number of minor changes to 
accounting policies have been adopted during the year, although 
they have had no material effect on the Group’s financial statements. 

Details of the basis of preparation, including information in respect 
of the methodology used to calculate the Group’s alternative 
performance measures, can be found in Notes 1 and 4.

Impact of changes in exchange rates
The Group’s reported financial performance at average rates  
of exchange for the year ended 31 March 2018 was adversely 
impacted by currency translation compared to the prior year.  
The average and closing US dollar and euro exchange rates used 
to translate reported results were as follows:

Year ended 31 March

US dollar:sterling
Euro:sterling

Average rates 

Closing rates

2018

1.33
1.13

2017

1.30
1.19

2018

1.40
1.14

2017

1.25
1.17

For the year ended 31 March 2018, foreign exchange translation 
decreased Group adjusted profit before tax by £4 million (Food & 
Beverage Solutions by £2 million, Primary Products by £2 million 
with no change in Sucralose).

36  Tate & Lyle PLC Annual Report 2018

Changes to reporting segments 
The Group will continue to operate in two divisions, Food & Beverage Solutions (which includes Sucralose, and was previously named 
Speciality Food Ingredients) and Primary Products (previously named Bulk Ingredients). The Food & Beverage Solutions division will 
be reported across two reportable segments (Food & Beverage Solutions and Sucralose) reflecting their different economic 
characteristics and how we manage them. The segmental disclosure prepared in this Annual Report reflects this change from two 
reportable segments to three, and has been further amended to report Food Systems operations (the Group’s stabiliser solutions 
business) within the regional results of Food & Beverage Solutions, mirroring a change to the management of that business. 

Disclosure of the performance of the divisions is provided below in the form previously used at the 2017 financial year end for 
comparability purposes, together with restated comparatives for the six month period to 30 September 2017, which will serve as 
comparatives for the Group’s forthcoming half year results.

Food & Beverage Solutions and Sucralose results for the year ended 31 March 2018 in previous disclosure format 

Year ended 31 March  
Continuing operations

North America
Asia Pacific and Latin America
Europe, Middle East and Africa
Total: excluding SPLENDA® Sucralose 
and Food Systems

Volume 
change

1% 
8% 
8% 

2018 
£m

355 
147 
163 

2017 
£m

357 
148 
145 

Change 
%

(1%)
0% 
13% 

Sales

Constant 
currency 
change 
% 
1% 
1% 
9% 

Adjusted operating profit

2018 
£m

2017 
£m

Change 
%

Constant 
currency 
change 
% 

4%

665

650

2%

2%

118

125

(6%)

(4%)

Food Systems
SPLENDA® Sucralose

(5%)
(12%)

185 
146 

184 
162 

0% 
(10%)

(1%)
(9%)

19
55

4 
52 

353% 
6%

357%
5% 

3% 

996 

996 

0% 

0% 

192

181 

6%

7% 

Food & Beverage Solutions results for the six months to  
30 September 2017 on the revised disclosure format

Six months to 30 September 
Continuing operations

Volume
North America
Asia Pacific and Latin America
Europe, Middle East and Africa
Total

Sales
North America
Asia Pacific and Latin America
Europe, Middle East and Africa
Total

Adjusted operating profit

2017 
Volume 
change

0%
6%
6%
3%

2017 
£m

211
98
124
433

75

www.tateandlyle.com  37

Strategic ReportGovernanceFinancial StatementsUseful Information 
Risks

Managing our  
risks effectively

How we manage risk

ERM Programme

1
Identify  
risks

5
Review and 
monitor risks

2
Assess  
risks and  
interactions

4
Respond to and 
mitigate risks

3
Prioritise  
risks

Three lines of defence

O v ersight

3rd

2nd

1st

R

isk own e r
and con t

r

s

hip
o l

M

o

nitoring and   c o m p lia nce
Independent a s s u r

a

n

e

c

ERM Programme
Tate & Lyle’s enterprise risk management 
(ERM) programme facilitates a common, 
Group-wide approach to the identification, 
analysis and assessment of risks and  
the way risks are managed, controlled  
and monitored.

Three lines of defence 
We manage significant risks through three 
levels of defence. 

1. Risk ownership and control
Business and operational management  
is responsible for identifying risks and 
maintaining effective controls on a 
day-to-day basis, and for implementing 
policies and procedures that are consistent 
with that objective. Front line controls are 
updated regularly in response to the 
Group’s changing risk profile.

2. Monitoring and compliance 
Group functions support management in 
monitoring key risk areas, and ensuring the 
first line of defence is designed and 
operating as intended. These functions, 
including risk management, quality, ethics 
and compliance, and environment, health 
and safety, also identify current and 
emerging risks, and monitor the timely 
remediation of deficiencies.

3. Independent assurance 
The Group Audit and Assurance team 
(internal audit) and external assurance 
providers give independent assurance over 
the Group’s risk management, control, and 
governance processes and systems.

Oversight
The Board, Audit Committee and Executive 
Committee provide oversight and direction 
in accordance with their respective 
responsibilities. More information is in the 
governance section of this Annual Report. 

38  Tate & Lyle PLC Annual Report 2018

 
 
Risk framework
The Board has overall responsibility for the Group’s system  
of risk management and internal control, and for setting the 
Group’s risk appetite. The schedule of matters reserved to the 
Board ensures that the Board makes a robust assessment of the 
principal risks facing the Group, and determines the nature and 
extent of risk it is willing for the Group to take to achieve its 
strategic objectives.

Approach

Process to identify risks
The Group-wide risk management and reporting process helps  
to identify, assess, prioritise and mitigate risk. Principal risks are 
considered over a time period of three years. This annual process 
is both bottom-up and top-down. 

The top-down aspect involves the Board assessing what it 
believes to be the principal risks facing Tate & Lyle. The bottom-
up aspect involves a rolling programme of workshops, facilitated 
by the risk management team, held around the Group. These 
workshops identify current and potential risks which are then 
collated and reported through functional and divisional levels to 
the Executive Committee. Areas and behaviours which could 
potentially trigger risk combinations are also considered.

Through these processes, we identify the Group’s key business, 
strategic, financial, operational and compliance risks, and then 
develop action plans and controls to mitigate them as far as 
possible, to the extent deemed appropriate taking account of the 
Group’s risk appetite. The Board reviews these risks again, as 
well as emerging and black swan risks.

Risk appetite
As part of the annual risk assessment process, the Board and 
Executive Committee consider the nature and extent of the 
Group’s risk appetite. The results of this exercise are used as 
part of strategic planning activities, and in setting ongoing 
mitigating actions.

Managing risks
Individual executives are assigned responsibility for managing 
risks and their associated mitigating controls. As part of the 
process, senior executive management formally confirms once  
a year that risks are being managed appropriately within their 
operations and that controls have been examined and are effective. 
The confirmations and any exceptions are discussed at the Audit 
Committee and, where appropriate, reported to the Board.

The Executive Committee reviews the principal risks regularly 
and formally at least three times a year, and reports any changes 
in the level or velocity of the risks, and associated mitigating 
actions, to the Board. The Board reviews the principal risks at 
least every six months.

Principal risks
The Board has carefully considered the type and extent of the 
principal risks to the Group achieving its objectives. While the 
Group seeks to manage risk carefully, at the same time the 
Board recognises that some risk needs to be taken for the  
Group to achieve its strategic goals.

Over time, the Group’s risk profile evolves and the Board’s view  
of the principal risks is updated accordingly. Following a number 
of changes to the principal risks over the last few years, the 
Board decided this year that no changes to the principal risks 
were required.

The Board confirms that a robust assessment of the principal 
risks facing the Company, including those that would threaten its 
business model, performance, solvency and liquidity, has been 
carried out. The principal risks identified as part of the process 
undertaken during the year, together with examples of the 
mitigating actions being taken, are set out on pages 40 and 41. It 
is not possible to identify or anticipate every risk that may affect 
the Group.

Viability statement
In accordance with the provisions of the UK Corporate 
Governance Code, the Directors have assessed the viability of the 
Group, taking into account our current position and the potential 
impact of the principal risks we face.

Although the Group’s strategic plan, which the Board reviews 
annually, forecasts beyond three years, the current planning 
process provides for the preparation of a detailed financial  
plan over a three-year period, built bottom-up on a divisional 
basis, including anticipated capital and funding requirements.  
For this reason, the Directors have determined that a three-year 
period to 31 March 2021 is an appropriate period over which to 
assess viability.

To assess viability, we stress-tested the strategic plan under four 
downside scenarios which would stress the potential viability of 
the Group if one or more of the principal risks set out in this 
Annual Report were to occur. The potential impact of these 
scenarios was assessed individually, and in combinations, on 
both a gross (before mitigation) and a net (after mitigation) basis. 
The four downside scenarios modelled were: a major operational 
failure causing the shutdown of a large manufacturing facility for 
an extended period of time; a sharp decline in sales in one or 
more of our major product lines; the loss of one or more of our 
key global customers; and government actions or policies 
restricting or preventing our ability to operate in key markets.  
In each case, we assumed we would still be able to secure 
financing or re-financing in the capital markets in all plausible 
market conditions.

We measured the impact of these risks occurring by quantifying 
their financial impact on the strategic plan, and on the Group’s 
viability when set against measures including liquidity, credit 
rating and financial covenant requirements. We also considered 
operational and commercial impacts. The results of this stress 
testing showed that the Group would, over the three-year period, 
be able to withstand the impact of the most severe combination 
of the risks modelled if we made adjustments to our strategic 
plan and capital allocation priorities, and carried out other 
available mitigating actions.

Based on this assessment, the Directors confirm that they have a 
reasonable expectation that the Group will be able to continue in 
operation and meet its liabilities as they fall due over the period 
to 31 March 2021.

www.tateandlyle.com  39

Strategic ReportGovernanceFinancial StatementsUseful InformationRisks continued

Principal risks

Examples of how we manage the risk

Safety
Act safely and maintain the safe operation of our facilities
The safety of our employees, contractors, suppliers, and the 
communities in which we operate is paramount. We must operate 
within local laws, regulations, rules and ordinances relating to 
health, safety and the environment, including emissions. Failure to 
act safely, which could lead to loss of life or serious injury, may give 
rise to fines or penalties for breach of safety laws, interruptions in 
operations or loss of our licence to operate, liability payments and 
costs arising from injuries or damage, and damage to our reputation.

Strategy
Grow in food and beverage solutions
Our ability to deliver our strategy to grow our Food & Beverage Solutions 
business may be affected by a number of factors such as delivering 
growth in emerging markets, customers’ readiness to adopt new 
ingredients and incorporate them in new product launches, competitor 
actions, and growing key product or product families. Furthermore, 
failure to make acquisitions and create value by integrating them into 
the Group effectively, may also affect our ability to deliver growth. 
Failure to deliver our strategy over the longer term would negatively 
affect our credibility, reputation and profitability.

Innovation
Innovate and commercialise new products
Failure to identify important consumer trends and provide innovative 
solutions, and the inability to successfully commercialise new 
products, could impact the delivery of our strategy. This would affect 
our performance and reputation.

•  Health and safety policies and procedures are in place at all facilities with 

dedicated staff to ensure they are embedded and measured

•  Regular review of performance and policies by the Board
•  Maintenance of suitable insurance programme
•  Programme of global compliance audits
•  SafeStart® behavioural safety training programme rolled out across 

plants, offices and labs

•  During the year, a comprehensive review of Group-wide safety protocols, 

procedures and culture was undertaken with the support of an 
independent external expert consultancy. As a result, a new strategy and 
approach to safety was implemented called ‘Journey to EHS Excellence’
•  A new global environment, health and safety (EHS) organisation was put 
in place to support our Journey to EHS Excellence (see pages 46 and 47 
for more information).

•  Investments to increase sales and technical resources, and 

infrastructure, particularly in emerging markets (laboratories expanded 
in Shanghai, Singapore and Mexico City during the year)

•  New staff recruited and existing staff developed to upgrade skillsets in 

customer-facing areas and innovation

•  Global programme to increase customer focus in key areas such as 

customer account management, planning and execution
•  Programme put in place to sharpen focus on our customers 
•  Commercial organisation re-aligned to focus on key categories.

•  Innovation and Commercial Development team conducts research and 

works closely with customers and other external organisations to identify 
emerging consumer trends

•  Open innovation team actively scouts for breakthrough technologies and 

opportunities across industries and universities

•  Strategic marketing organisation provides support for new product 

launches and consumer and category insight

•  Prioritisation of ‘partnership’ opportunities with customers to accelerate 
development cycles and bring new ingredients to market more quickly
•  Tate & Lyle Ventures invests in early-stage companies in food science 
and technology by partnering with research institutions, entrepreneurs 
and other venture funds.

People
Attract, develop, engage and retain key personnel
The performance, knowledge and skills of employees are central to 
our success. We must attract, integrate, engage and retain the talent 
we need to deliver our strategy, and have the appropriate processes 
and culture in place. Being unable to retain key people and 
adequately plan for succession could have a negative impact on  
our performance.

•  Remuneration policies designed to attract, retain and reward employees 

with ability and experience to execute Group strategy

•  Talent development strategy to provide opportunities for employees, as 

well as training to close skills gaps

•  Single global performance management system and talent planning 

processes in place

•  Focus by the Board on succession planning for business-critical roles
•  Measurement of progress against cultural objectives, for example, global 

employee surveys.

Legal and compliance
Comply with legal and regulatory requirements,  
and our Code of Ethics
We operate in a variety of markets and are therefore exposed to a 
wide range of legal and regulatory frameworks. We must understand 
and comply with all applicable legislation. Any breach could have a 
financial impact and damage our reputation. 

Cyber security
Maintain the security of our information systems and data
A cyber security breach, whether as a result of human error, 
deliberate action or the failure of technology systems, could result in 
unauthorised access to or misuse of information systems, technology 
or data. This could cause harm to our assets, loss of data, business 
disruption, legal liabilities and damage to our reputation.

•  Regular monitoring and review of changes in law and regulation in areas 
such as health and safety, environment, quality, food safety, corporate 
governance and data protection

•  Legal teams maintain compliance policies in areas such as anti-trust and 

anti-corruption law; and provide ongoing training to employees

•  Ethics training provided to employees 
•  Full-time global Head of Ethics and Compliance appointed during the year
•  Whistleblowing process in place (Speak Up programme)
•  Compliance with the EU General Data Protection Regulation.

•  Cyber security enhancement programme in place focused on 

strengthening people, process and technology defences

•  Compulsory cyber security training
•  Cyber security breach scenario exercises
•  Advanced perimeter defences in place
•  Continuous vulnerability detection and defences
•  Separation of systems within plant network
•  Third-party Security Operations Centre providing 24/7 security 

monitoring, security event correlation and threat counter-measures.

40  Tate & Lyle PLC Annual Report 2018

Principal risks

Examples of how we manage the risk

Operations and supply chain
Maintain the continuous operation of our plant network and 
supply chain, including high standards of customer service
Operating plants involves many risks which could cause temporary 
or permanent breaks in production. We must have a robust sales 
and operations planning process to avoid disruption to the supply 
chain and maintain high standards of customer service. Failure to do 
any of these things could have a material adverse effect on our 
performance and reputation.

•  Preventive maintenance programme across the plant network
•  Ongoing programme to improve global supply chain processes
•  Business continuity capabilities in place to enable supply, as quickly as 

practicable, of product to customers from alternative sources in the event 
of a natural disaster or major equipment or plant failure

•  Dedicated internal resources allocated to key projects in conjunction with 

business teams to ensure business continuity is not compromised
•  Customer service managed by Global Operations as part of integrated 

end-to-end supply chain process.

Raw materials
Fluctuations in prices and availability of raw materials, 
energy, freight and other operating inputs
Our margins may be affected by fluctuations in crop prices due to 
factors such as alternative crops, co-product values and the 
variability of local or regional harvests caused by, for example, 
weather conditions, crop disease, climate change or crop yields.  
In some cases, due to the basis for pricing in sales contracts, or due 
to competitive markets, we may not be able to pass on to customers 
the full increase in raw material prices or higher energy, freight or 
other operating costs. Additionally, margins may be affected by 
customers not taking expected volumes.

Quality
Maintain the quality and safety of our products
The safety of the consumers of our products is critical. Poor quality 
or sub-standard products could have a negative impact on consumer 
safety and on our reputation and relationships with customers.

Consumer concerns and food regulation
Changes in consumer, customer or government 
attitudes to our products
Our freedom or ability to operate may be affected by changes in 
consumer or customer attitudes, food law and regulatory changes, 
campaigns targeted at specific ingredients or technologies or other 
factors that may impact the regulatory status or perception of our 
products or of their functionality, efficacy or use. We must ensure 
that the science behind our ingredients (for example, health claims, 
nutritional impact) is supported by credible sources, clearly 
communicated and understood by relevant regulatory authorities. 
Failure to do so may restrict the markets for our products.

Government regulations and trade policies
Changes in government regulations and/or trade 
policies
Government actions or policies causing changes in tariffs, customs 
duties, or imposing import/export limitations, or other barriers, may 
lead to our business incurring additional costs, or may restrict 
opportunities for growth or prevent or limit our ability to operate in 
certain markets. 

Financial controls
Maintain an effective system of internal financial controls
Without effective internal financial controls, we could be exposed to 
financial irregularities and losses from acts which could have a 
significant impact on the ability of the business to operate. We must 
safeguard business assets and ensure the accuracy and reliability of 
our records and financial reporting. 

•  Strategic relationships with suppliers and trading companies including 

multi-year agreements

•  Balanced portfolio of supply and tolling contracts in operation with 

customers to manage balance of raw material prices and product sales 
prices and volume risks

•  Raw material and energy purchasing policies to provide security of supply
•  Network of corn elevators to enhance security of supply
•  New or back-up supply sources in place in case primary suppliers face 

localised challenges

•  Use of derivatives and forward contracts where practical, to hedge and 

manage our exposure to raw material and co-product prices.

•  Strict quality control and product testing procedures to ensure products 

are released only with full quality control clearance

•  Quality policies, procedures and performance reviewed by the Board
•  Hazard Analysis and Critical Control Points plans updated at all plants to 

be fully compliant with new US Food Safety Modernization Act
•  Immediate response Recall Committee meets promptly if a recall  

event occurs

•  Third-party audit programme supplemented by internal global 

compliance audits

•  Regular recall simulation exercises.

•  Global regulatory team, supported by external consultants, monitors 

local regulatory requirements affecting our products

•  Global nutrition team initiates and monitors research and publications 
concerning the use and functionality of our ingredients and maintains 
global network of health and nutrition clinicians, academics and experts
•  Membership of trade organisations provides access to broader sources 
of information and ensures, where appropriate, a single voice for the 
industry on regulatory and public interest issues affecting our ingredients

•  Maintenance of relations with regulatory authorities
•  Provision of clear information on ingredients’ provenance and traceability
•  Research Advisory Group, chaired by a non-executive director and 

comprising leading scientific experts, reviews critical aspects of the 
Group’s innovation activities and provides guidance.

•  Programme in place to ensure that we actively engage in discussions 

with political parties, influencers and regulatory authorities in the main 
countries we operate in

•  Active member of relevant industry trade associations
•  Model in place enabling production across the plant network to be adapted 

or optimised in the event of market restrictions in certain countries
•  Operation of a global plant network means customers can be served 

from different countries if products from certain markets are restricted 
or become economically less attractive

•  Continue to invest in resources and infrastructure across different 

markets and geographies to diversify business mix.

•  Financial policies and standards are in place supported by procedures for 

key financial processes, for example, capital expenditure

•  Financial risks are monitored and managed through a number of forums, 

for example, the regional Control Environment Councils

•  Chief Executive and Chief Financial Officer undertake detailed quarterly 

business and financial reviews

•  Minimum control standards are confirmed at the half-year and at the end 

of the financial year

•  Automated controls are built into systems where possible.

www.tateandlyle.com  41

Strategic ReportGovernanceFinancial StatementsUseful InformationOur People

Working the Tate & Lyle way 

Every company talks about hiring the right people. For us, that 
means hiring people who believe in our purpose, who live our 
Values, and who give of their best to make our business a 
success. In return, Tate & Lyle constantly invests in our people’s 
skills and expertise through training and development, and by 
providing a workplace that is inspiring and welcoming to all. 

Policies
Our global human resources policies set out our position on 
topics such as equal opportunities, diversity and inclusion, 
employee training and reward. We have made these available on 
the Company’s intranet as well as communicating them across 
the Group.

Our policies covering ethical conduct and human rights include:

•  Our Code of Ethics and related internal and external 

communication and training (see page 45)

•  Our ‘Speak Up’ programme (system that supports 

whistleblowing) (see page 63)

•  Our global human resources policies as described above
•  Our standards in the supply chain and our anti-slavery and 

human trafficking statement (see page 45).

Values
Our Values of safety, integrity and respect are at the heart of how 
we work. They demonstrate what we stand for and how we 
behave with our customers, suppliers, investors, the 
communities we operate in, and with each other. In line with our 
Values, we believe that everyone should be safe at work and be 
treated fairly and with respect. 

Our team of Values Ambassadors together with our Employee 
Engagement Champions are responsible for promoting our 
Values and the right way of doing business to colleagues across 
the Group. 

Leadership behaviours
During the year, we reviewed our performance values and 
leadership framework in the context of the cultural and 
leadership behaviours we need to deliver our strategy. We 
decided to focus and simplify our approach by merging our 
previous leadership framework and performance values 
(achievement, accountability, creativity, speed and teamwork) into 
three leadership behaviours of partnership, agility and execution. 
We have started a programme to embed these behaviours across 
the Group and this will be a key priority in the year ahead. 

Employee profile (as at 31 March 2018)
At 31 March 2018, Tate & Lyle employed 4,192 people (2017 – 4,146). During the year, we continued to expand our commercial 
and technical teams in Asia Pacific and Latin America, and to add staff at our global Shared Service Centre in Poland.

Employees by division
As at 31 March 2018

Employees by geography
As at 31 March 2018

Primary  
Products

41%

Food & Beverage Solutions 

Central  
Functions

13%

Asia  
Pacific

5%

North America

51%

46%

Europe, Middle East 
and Africa

34%

Latin 
America

10%

42  Tate & Lyle PLC Annual Report 2018

Diversity and inclusion
All employees must feel able to contribute to the Group’s 
performance and have the opportunity to develop their abilities to 
the fullest. We are committed to creating a culture and workplace 
that encourages and values diversity and inclusion. Our policy is 
to employ the best candidates available in every position 
regardless of gender, sexual orientation, age, marital status, 
nationality, colour, disability, race, religion or philosophical 
beliefs, marriage or civil partnership, pregnancy, maternity, 
gender reassignment or ethnic or national origin.

A diverse workforce helps us reflect our customers and the 
communities we operate in, enabling us to understand and 
respond to their changing needs. During 2017, our diversity and 
inclusion work included:

•  Diversity and inclusion awareness training for senior managers 

– to date, more than 70 have been trained

•  Trialling unconscious bias training for hiring managers
•  Establishing a Diversity and Inclusion Council in our Global 

Operations unit to help work towards ensuring our employee 
mix at plant locations reflects the society and communities we 
work within

Using the UK Government’s methodology, Tate & Lyle has a 
median gender pay gap of 11% across all UK employees. This is 
the result of having fewer women in senior roles. Analysis of our 
employee population up to and including manager level – 
representing three-quarters of our UK employees shows no 
difference in median pay by gender. Across the Group, while 
female representation in our senior management population has 
risen by 47% since 2013, doubling the number of female senior 
managers, we recognise we have more work to do. 

Employee wellbeing
A key part of our purpose is to focus on how we can deliver an 
improvement in our employees’ personal wellbeing. During the 
year, we launched a taskforce to identify how we can enhance 
and support the wellbeing of our employees in the areas of 
physical, emotional and mental health. This builds on various 
initiatives already in place, including:

•  Continuing our participation in the Global Corporate Challenge 

for the fifth consecutive year – this saw 1,071 employees  
across the Group take more than one billion steps over  
100 days to help improve their fitness and encourage a more 
balanced lifestyle

•  Continued support for our Women’s Network, one of our 

•  Encouraging US employees to take part in a healthy eating and 

Employee Resource Groups, which ran career management and 
mentoring workshops at multiple locations

•  Improving female representation in our workforce from  

27% to 28%. 

UK gender pay gap
UK gender pay reporting legislation requires employers with 250 
or more employees in each employing business in the UK to 
publish calculations every year showing the pay gap between 
male and female employees. The number of employees we have 
in each of our two employing businesses in the UK is below the 
required threshold. Despite this, we have published details of our 
gender pay on the Company’s website, www.tateandlyle.com. 

lifestyle programme called ‘Naturally Slim’

•  Providing subsidised healthier food options in plant canteens 
•  Sponsoring team-based sports activities in different locations
•  Organising visits from external occupational health 

professionals at various locations.

Gender diversity (as at 31 March 2018)

Board of directors

Senior managers1

All employees

 Men – 78% (7)

  Women – 22% (2)

 Men – 74% (50)

  Women – 26% (18)

 Men – 72% (3,004)

  Women – 28% (1,188)

1  Gender diversity for senior managers, 
including statutory directors, is 80% 
(115) men and 20% (29) women.

www.tateandlyle.com  43

Strategic ReportGovernanceFinancial StatementsUseful InformationOur People continued

Employee engagement 
We believe that engaged and motivated employees will be happier 
and deliver better results for the Group. In 2017, we conducted 
our fourth global employee survey to learn about our employees’ 
opinions of Tate & Lyle, and to start conversations about how we 
can improve our workplace and ways of working. 86% of 
employees took part, with the overall survey score just above 3.7 
on a scale of 1 to 5 (where 5 is the best score). This shows a 
meaningful increase in positive attitudes from the previous 
survey in 2015, highlighting important progress as well as areas 
where we can improve. For example, employees told us they 
wanted more communications at a local team level; as a result 
we are making sure our management and leadership 
development programmes actively reinforce how managers and 
employees communicate through team meetings and face-to-
face dialogue. We also distributed engagement toolkits to 
managers and team leaders across the Group to help translate 
these results into action. 

Good internal communications are critical to creating and 
sustaining employee engagement. We communicate with our 
employees around the world through a number of channels 
including email, videos, our intranet, our Yammer internal social 
network, team meetings, employee town halls, and our global 
employee magazine. We publish the magazine every four months 
in English, with summaries in nine other languages. 

Employee reward and recognition 
Reward and recognition is a central part of our employee 
engagement strategy. We reward people based on their 
performance and contribution to our success, and ensure 
competitive and fair remuneration through regular benchmarking 
of roles. All arrangements are subject to Group and individual 
performance measures. 

We have a strong focus on non-financial recognition. This takes 
many forms, from localised recognition moments in team 
meetings, through to large events.

Employee development
We have a formal annual appraisal process. As part of this, we 
empower employees to take ownership of their careers with a 
personal development plan. Nurturing talent and supporting 
development is an important part of our culture. During 2017,  
this included: 

•  Investing in helping our employees and managers improve 

both their technical skills and their management and 
leadership capabilities

•  Implementing customer-focused development programmes 

across our frontline sales teams 

•  Providing a suite of online eLearning courses that enable 

employees around the world to access training via their smart 
phones and tablets

•  Updating our management development curriculum and 

launching both our flagship Global Leadership Programme and 
Future Leaders Pool to further strengthen our leaders.

Priorities for the year ahead
In the year ahead, priorities to continue developing our people 
include:

•  Further embed our new leadership behaviours of partnership, 

agility and execution

•  Increase awareness of diversity and inclusion throughout the 

Group, including rolling out unconscious bias training 
•  Roll out a Group-wide employee wellbeing programme
•  Introduce a quarterly Pulse Survey to measure employee 
engagement, alongside our annual employee surveys

•  Enhance our internal communications programme to further 
strengthen the link between our ingredients and our purpose 

•  Continue to deliver our employee recognition programme.

Extraordinary People Awards 2017

In 2017, we launched our first global Extraordinary People 
Awards. These awards celebrated individual employees 
nominated by their peers for their outstanding contribution 
to Tate & Lyle, our customers, and the communities in which 
we operate.

The awards ceremony was held in San Francisco, California, 
in October 2017 and was attended by the nominees, their 
guests and the senior management team.

Award categories included: Customer First; Safe Keeper; 
Star Performer; and Unsung Hero. There was also a special 
Chief Executive’s Award which was won by our VP, R&D 
Texturants for her outstanding work in delivering and 
promoting our texturant portfolio. 

44  Tate & Lyle PLC Annual Report 2018

Winners of our Extraordinary People Awards, held in San Francisco, 
California, in October 2017

Business Conduct

Doing business with integrity

At Tate & Lyle we believe in doing what is right, no matter what. 
Integrity is one of our three Values along with safety and respect, 
and we expect everyone at Tate & Lyle, and all who work with us, 
to act in accordance with our Values and live up to our standards. 
We set out what this means in our Code of Ethics (Code), which is 
publicised widely throughout the Group. It is supported by 
detailed policies and procedures. We encourage people to report 
any breaches through our Speak Up programme, which we 
publicise widely in our plants and offices, on our intranet and in 
other internal communications. As we say in the introduction to 
our Code, compromising our standards is never worth it.

Code of Ethics and conduct of commerical 
relationships
Our Code, available in 13 languages, defines the standards of 
behaviour we expect from everyone at Tate & Lyle, and those who 
work with us such as our business partners and suppliers. 
During 2017, our newly appointed Head of Ethics and Compliance 
led a review of the Code. As a result, an updated Code will be 
published in 2018. 

We are subject to anti-corruption and anti-bribery laws in all 
countries in which we operate, including the UK Bribery Act, 
which has extraterritorial reach. Our operations in emerging 
markets bring additional risk of bribery and corruption.  
Tate & Lyle has a zero-tolerance approach to bribery. Any breach 
of our Code in this area could result in reputational damage, 
criminal prosecution, significant fines and loss of future revenue. 
We also aim to ensure that the business practices of our 
suppliers, distributors and agents are in line with our ethics. 

In order to protect against bribery by both employees and third 
parties, a number of controls are in place. We support the Code 
with a set of standards including the Group Competition (Anti-
trust) Standard, Group Gifts and Hospitality Standard, Anti-Money 
Laundering and Anti-Corruption/Bribery Standard and Agents 
and Commissions Standard. In 2017, our legal team provided 
targeted training on our Code, helping colleagues uphold the 
Code and our standards. 

We conduct due diligence on our agents, and include relevant 
contractual terms in their agreements with us. Through our 
internal regional Control Environment Councils, we monitor risks 
to the business in relation to ethics and compliance and take 
necessary steps to address any shortcomings. 

Standards in our supply chain 
Our Code is part of our terms and conditions, contracts and other 
supplier engagements. We expect suppliers to comply with the 
standards set out in the Code. 

Our anti-slavery and human trafficking statement is available on the 
Company’s website, at www.tateandlyle.com/anti-slavery-statement.

Reporting concerns
We encourage our employees and business partners to come 
forward with any information concerning actual or alleged 
breaches of our Code. We provide an independent, anonymous 
third-party reporting service in 47 countries via a free phone 
number and by email. 

We promote our Speak Up programme internally through our 
employee communications and externally through the Company’s 
website. Members of our Speak Up Committee investigate any 
issues reported. 

Product safety and quality
Our Product Safety and Quality Policy sets out the standards 
required for our products. We have well-established processes in 
place to make sure we both comply with applicable laws in the 
country of production and sale, and satisfy all relevant food safety 
standards. These processes include in-process and finished 
product testing; a global compliance audit programme; annual 
product traceability and recall testing (both globally and locally at 
each facility); raw material, processing aids, packaging material 
and supplier risk assessments; environmental pathogen 
monitoring; robust food safety training and ongoing reviews of 
global food safety recalls/root causes to pressure test our controls. 
We use continuous improvement tools such as a first-pass quality 
and complaint index to improve our quality performance. 

Our global compliance audit programme includes local and 
global traceability and recall exercises, annual quality 
management site reviews and activities to track compliance with 
our Product Food Safety and Quality policies. Our aim is to ensure 
we follow up all results from our audit programme, and share the 
results across facilities to leverage best practice. We also 
monitor global regulatory food safety changes to make sure our 
programmes address emerging issues and reflect changing 
regulations. Every year our manufacturing facilities are externally 
certified in line with the Global Food Safety Initiative. We are 
pleased to report that all sites obtained an A/AA rating or 
equivalent indicating no major or critical food safety concerns. 

Priorities in the year ahead
•  Launch our updated Code of Ethics and training programme
•  Review and enhance policies and controls to protect against 

bribery by employees and third parties

•  Continue to promote our Speak Up programme, encouraging 

open and honest communication across Tate & Lyle.

www.tateandlyle.com  45

Strategic ReportGovernanceFinancial StatementsUseful InformationEnvironment, Health and Safety

On a journey to excellence 

Protecting our people and the world around us is foundational to 
the way we do business. Our ultimate goal is to provide a safe 
working environment for everyone and to reduce our impact on 
the environment to the minimum. 

Comprehensive review leads to a new  
EHS programme
In 2017, we undertook a comprehensive Group-wide safety 
review. The review was conducted by an independent external 
expert consultancy experienced in heavy processing industries. 
Our objective was to assess Tate & Lyle’s safety performance in 
terms of processes, organisation and culture, and to identify any 
opportunities for improvement. The review also looked at our 
global safety management systems, and included an all-employee 
safety culture survey. 

The review team reported their findings to the Board and the 
Executive Committee, highlighting areas where we performed 
well, such as occupational safety, and areas in need of 
improvements, such as process safety. A new strategy and 
approach to safety was developed and agreed with the Board to 
deliver excellence, over time, at all Tate & Lyle locations. 

The review also found that environmental performance is closely 
linked to safety performance. We therefore decided that our 
environmental, health and safety (EHS) programme and 
performance should be coordinated and managed holistically,  
led by a senior executive responsible for EHS within the Global 
Operations team. 

Journey to EHS Excellence
In January 2018, we launched our ‘Journey to EHS Excellence’  
for everyone working at Tate & Lyle, employees and contractors. 
This multi-year programme aims to deliver and sustain world-class 
EHS performance throughout the Group, with a key element being 
the commitment of and participation by all our Group’s leaders.

As part of the launch, we developed a new global EHS management 
system aligned with the requirements and terminology of 
international standards for environmental, occupational health 
and safety, and risk management (ISO 14001 and OHSAS 18001). 
The system includes a revised global EHS policy (available at 
www.tateandlyle.com) which include a number of principles 
designed to keep our people safe. These include areas such as 
working at height, combustible dust, railcar safety, and hot 
liquids, chemicals and steam. Each element sets out globally 
applicable requirements and expected results. 

Under the new system, we have also implemented a new ‘Stop 
Work Authority’ across the Group. Under this, all employees, 
contractors, and people who are conducting work or work-related 
activities under the control of Tate & Lyle, have the authority and 
responsibility to stop any activity they believe is not being done 
safely or poses an environmental risk. It does not matter how 
critical the activity is for our operations, we will always support a 
decision to stop work that is not being done safely or poses an 
environmental risk.

Going on a ‘tiger hunt’

A key part of our Journey to EHS Excellence is implementing a 
new hazard management process that helps identify and 
evaluate high-risk processes. As part of this, we classify all 
risks as either ‘lions’ or ‘tigers’. Both animals are predators 
but have very different hunting techniques. Lions hunt 
together in the open and are relatively easy to spot and avoid 
(like easy-to-identify occupational safety issues), while tigers 
are solitary hunters that hide and use surprise to catch their 
prey (like hard-to-identify process safety issues). 

Our review found that we were better at occupational safety 
than process safety, and so we decided to go ‘tiger hunting’. 
During 2017, we started to hold ‘tiger hunts’ at all our sites, 
and will complete this process in 2018. When we find a risk 
during a ‘tiger hunt’, we identify the safety barriers currently in 
place to mitigate it and, using a scenario-based audit, ensure 
they are working as intended. If not, we change them to make 
sure they do. 

‘Tiger hunt’ team in Kimstad, Sweden, January 2018

46  Tate & Lyle PLC Annual Report 2018

The overall aim of the new programme is to strengthen our 
workplace EHS culture: 

•  To prevent serious injury and loss of life
•  To provide clarity about the behaviour we expect from those 

who work for us and with us

•  To reduce our environmental impact by minimising water 

consumption, CO2 generation and waste to landfill, considering 
the entire life-cycle of our products, from sourcing raw 
materials to processing, packaging and transport of  
finished goods. 

Tracking the Journey
We will assess the performance of our new EHS management 
system, including compliance with the revised EHS policy, 
through periodic compliance audits, performance assessments, 
key performance indicator monitoring and cultural surveys.  
We will hold annual management reviews to drive compliance, 
improve performance and ensure the system continues to meet 
our global policy requirements. 

We provide updates on EHS performance and improvement 
programmes to the Executive Committee every month. In 
addition, we encourage senior executives to visit sites around the 
world to meet employees and contractors to discuss safety and 
identify key issues. The knowledge they gain from the front line is 
invaluable in helping us review and improve our EHS practices 
and address specific employee concerns.

Looking ahead to 2018, our priority is to roll out and embed the 
Journey to EHS Excellence across all Tate & Lyle sites. 

Safety performance
The 2017 calendar year saw an 8% reduction in incidents and an 
unchanged recordable incident rate for the third year running. 
However, the number of lost-work cases increased by 50% (or four 
incidents) compared to 2016, driven largely by an increase in 
ergonomic-related accidents. Total hours worked decreased by 8% 
following the closure of the Singapore Sucralose facility and the 
completion of major capital expenditure projects in 2016. Hands 
and fingers remained the most injured body parts at Tate & Lyle, 
with bruises, sprains and strains the most common injuries.  
We suffered no fatalities in 2017.

Safety performance by calendar year 

Employee
Contractor
Combined

Recordable incident rate

Lost-work case rate

2017

0.64
1.14
0.76

Change versus 2016

-14%
43%
0%

2017

0.10
0.44
0.19

Change versus 2016

-17%
340%
73%

Recordable incident rate

Lost-work case rate

Nature of accidents

Safety performance charts1

1
.
4
7

0
.
4
6

0
.
7
6

0
.
8
0

0
.
7
6

0
.
7
4

1
.
1
4

0
.
7
6

0
.
6
4

0
.
4
4

0
.
1
9

0
.
2
6

0
.
1
6

0
.
1
2

0
.
1
2

0
.
1
0

0
.
1
1

0
.
1
0

2015

2016

2017

2015

2016

2017

Number of injuries requiring treatment 
beyond first aid per 200,000 hours

Number of injuries that resulted in 
lost-work days per 200,000 hours

 Tate & Lyle employees

 Tate & Lyle employees

 Slip, trip or fall – 26%

 Contractors

 Combined

Number of incidents 
combined2 (2017)
49

(2016: 53)

 Contractors

 Combined

Number of lost-work cases 
combined2 (2017)
12

(2016: 8)

  Struck by or against an object – 31%

 Burns – 2%

  Ergonomics or manual handling – 27%

 Other – 14%

1  We report safety performance by calendar year and all employees at Tate & Lyle owned operations and joint ventures.
2  Tate & Lyle employees and contractors combined.

www.tateandlyle.com  47

Strategic ReportGovernanceFinancial StatementsUseful Information 
Environment, Health and Safety continued

Environmental performance
Our main environmental impacts are energy and carbon, water and waste. We consider our impacts principally within our own 
operations, but are increasingly focusing on the sustainability of our agricultural supply chain, particularly our principal raw material, 
corn. Our environmental performance in 2017 showed positive progress in our primary carbon footprint, waste to landfill and water 
usage. Our energy use remained largely unchanged. 

Environmental performance1 (by calendar year)

Primary carbon 
footprint
Tonnes CO2e per tonne  
of production

0
.
4
4
1

0
.
4
0
1

0
.
3
9
5

X
X
X

0
.
3
4
5

Energy use
Gigajoules (GJ) per tonne 
of production

Waste to landfill
Tonnes per 1,000 tonnes  
of production

Water use
Cubic metres per tonne  
of production

5
.
1
0

4
.
8
7

4
.
8
2

4
.
8
4

1
0
.
1
0

1
0
.
2
2

8
.
6
1

8
.
3
5

4
.
6
0

4
.
6
5

4
.
5
3

4
.
3
6

08

152

162

172

08

152

162

172

08

152

162

172

08

152

162

172

1  We report environmental performance by calendar year and for all qualifying sites – both Tate & Lyle owned and joint ventures. 
2  Refers to 2015, 2016 and 2017 data that has been externally assured by Bureau Veritas UK Ltd. Their assurance statement is at  

www.tateandlyle.com/about-us/corporate-responsibility.

Energy use and carbon emissions
Environmental considerations play a key part in our approach to 
business, with climate change risks and opportunities automatically 
considered as part of our strategic decision-making process. This 
approach has helped us reduce our CO2e emissions per tonne of 
production by 22%, and energy use per tonne of product by 5% 
since 2008. Since 2016, we have reduced our CO2e emissions by 
13%, although our energy use per tonne of production increased 
by 0.4% during that period. Emissions from electricity, heat, 
steam and cooling purchased (Scope 2) decreased by 31% mainly 
as a result of the co-generation project at our Loudon facility, 
which installed more efficient natural gas powered turbines. 

Our Group greenhouse gas emissions for the period 1 January  
to 31 December 2017 in tonnes of carbon dioxide equivalents 
(tCO2e) were:

Highlights of good practice
•  For the third year running, our Lafayette South corn wet mill in 
Indiana was awarded Energy Star status by the US Environmental 
Protection Agency (EPA). This award recognises industrial 
plants that are in the top 25% of similar facilities across  
the US for energy efficiency, and which meet strict energy 
performance levels. For the last three years, Lafayette South 
has achieved a perfect score, and in 2015 and 2016 was the 
only corn wet mill in the US with Energy Star certification

•  Our corn wet mill in Loudon, Tennessee also received its first 

Energy Star award from the EPA. This award follows the recent 
completion of a new gas-fired combined heat and power facility 
at Loudon, helping improve energy and operational efficiency 
and reduce greenhouse gas emissions.

From combustion of fuel and 
operation of facilities (Scope 1)
From electricity, heat, steam 
and cooling purchased (Scope 2)
In total (Scope 1 and 2)

Intensity 

2017

2016

1,949,248 
tCO2e
694,926  
tCO2e
2,644,174 
tCO2e
0.345 tCO2e2 
per metric 
tonne of 
production

1,975,058 
tCO2e
1,001,033 
tCO2e
2,976,091 
tCO2e
0.395 tCO2e2 
per metric 
tonne of 
production

48  Tate & Lyle PLC Annual Report 2018

Waste to landfill
We have reduced the amount of waste we send to landfill by 3% 
per tonne of production since 2016, and by 17% since 2008.

Water use
We assess water risks through a well-established enterprise-wide 
process designed to identify, assess, prioritise and mitigate risks 
associated with water use during manufacturing and throughout 
our supply chain. This approach has helped us to reduce water use 
per tonne of production by 4% in 2017, and by 5% since 2008. 

Highlights of good practice
•  Working with local Maliseet Indians, our plant in Houlton, 
Maine planted 400 trees to help protect water quality in a 
shared river

•  By making simple improvements to its air compressor cooling 
system, our plant in Van Buren, Arkansas reduced its water 
consumption by 25% for each unit of production in 2017.

Managing environmental risk
Through our new EHS system, we have introduced a process  
to continually measure and evaluate our environmental 
performance and take corrective actions as necessary. Through 
this system, we:

•  Use effective planning and documented information and action 

tracking to achieve our short-, medium- and long-term 
environmental goals

•  Employ a systematic approach to risk management that helps 

us protect the environment

•  Invest in improving our workers’ environmental knowledge, 
skills and capabilities throughout their career, helping them 
deliver environmental excellence

•  Comply with all relevant environmental requirements to 

demonstrate our duty of care to the environment

•  Systematically consider environmental impact during projects 
so we can simultaneously achieve the best possible outcomes 
and minimise ecological risks.

We are in the process of reviewing the publication by the Task 
Force on Climate-related Financial Disclosures and will take into 
consideration its recommendations during the coming year.

Environmental targets
Last year, we set ourselves three medium-term targets with a 2008 baseline to be met by 2020, for CO2e emissions, waste to landfill 
and sustainable sourcing. The table below summarises our progress against these targets.

Target by end of 2020
Reduce CO2e emissions 
from energy use by 19% per 
tonne of production (baseline 
year 2008)
Reduce waste to landfill by 
30% (baseline year 2008)
Implement sustainable 
agricultural sourcing 
programmes for our top 35 
agricultural raw materials 
and ingredients based on 
risk and spend (£)

Progress against target
Achieved 22% reduction in CO2e emissions per 
tonne of production since 2008.

Achieved 17% reduction in tonnes of waste per 
1,000 tonnes of production since 2008.
This year, we took the opportunity to review  
our sustainable sourcing programme. We have 
built a cross-functional team to add rigour to  
our risk assessment and ensure programmatic 
improvements are embedded in our business 
processes.

We will be finalising and implementing a new 
programme in 2018 and will describe it and our 
performance in next year’s Annual Report.

Commentary

Annual reduction driven by natural gas-fired 
co-generation facility commissioned at our 
Loudon, Tennessee facility at the end of 2016 
that replaces two coal-fired boilers.
Action plan in place to procure cost-effective 
landfill alternatives for major waste streams. 
As corn is one of our largest raw materials, we 
strengthened our engagement with the Corn 
Refiners Associations’ through committees and 
projects aimed at improving sustainable 
agricultural practices.

In 2017, Tate & Lyle committed to sponsoring 
the Conservation Technology Information Center 
(CTIC) Big Pine Creek Watershed Fieldprint 
Project aimed at improving sustainable agriculture 
through farm-specific conservation plans.

Sustainable sourcing
We focus our efforts on ways to improve sustainable agriculture practices within our corn supply chain, and work closely with key 
customers to help them meet their targets and realise their ambitions for sustainable agriculture. For example, we are members of 
Field to Market (www.fieldtomarket.org), the US alliance for sustainable agriculture, which helps define, measure and promote 
sustainability in US agriculture, particularly for corn production. 

www.tateandlyle.com  49

Strategic ReportGovernanceFinancial StatementsUseful InformationCommunity Involvement

More than a local business

Tate & Lyle has a proud history of community involvement, starting 
over 150 years ago with the founding of our original businesses by 
Henry Tate and Abram Lyle. Today, community involvement remains 
a strong part of our culture, with employees and teams across the 
world generously sharing their time, talent and resources to make a 
positive and lasting difference to the communities in which we work. 

Approach 
Supporting our purpose of improving lives for generations, the 
aim of our community involvement programme is to build 
stronger, healthier local communities. During the year, we 
reviewed and refreshed our community involvement programme 
to focus even more closely on this goal. As a result, we decided to 
concentrate on three main areas, with a particular emphasis on 
supporting children and young adults. 

•  Health: we support projects which improve the health and 

wellbeing of people of all ages, helping them understand the 
role nutrition and physical activity play in a well-balanced life 
•  Hunger: having enough nutritious food to eat is a basic human 
need and the foundation of a community’s health. We work 
with global and local experts to give people in need in our 
communities, and beyond, access to nutritious meals

•  Education: habits form at a young age. That is why we work with 

local schools, education foundations and other community partners 
to help prepare students for healthier, brighter futures. 

During 2017, in addition to supporting partnerships and 
programmes in the areas of health, hunger and education, we 
continued to work with the environmental charity Earthwatch 
(www.earthwatch.org) on a project to research sustainable stevia 
farming. We also made corporate donations to The American Red 
Cross to support relief efforts in areas of Texas ravaged by 
Hurricane Harvey in August 2017, and the devastating earthquake 
that hit Mexico City in September 2017.

Programmes and partnerships
We aim to work with local communities in the vicinity of our 
facilities. Within our broader global framework, we empower 
employees at each location to make their own decisions about 
which projects they wish to support and what partnerships they 
want to develop.

We regularly review our programme, and the partners and 
projects we support.

•  Our partners include registered charities, educational 

institutions and non-governmental agencies that meet our  
own high standards for delivering services and results

•  Our plan and budget for community involvement are developed 

and approved as part of our annual operating plan process
•  Ongoing evaluation of our partners and projects examines their 

reach, results and impact.

Healthy Eating, Happy Learning, 
Shanghai, China

With one in four children in China over the age of seven 
forecast to become overweight or obese by 20301, the 
government and nutrition organisations are looking for 
ways to address this challenge. In 2017, we partnered with 
the Shanghai Nutrition 
Society to launch the 
‘Healthy Eating, Happy 
Learning’ programme. 

The programme in 
summary
•  Two-year programme 

involving 1,000 students 
aged between six and 
nine in three schools

•  Two schools benefit from healthier lunches, nutrition and 
health education, and more physical activity, with the third 
school acting as a ‘control’

•  Parents and teachers learn about the importance of diet, 
nutrition and maintaining an active lifestyle. To support 
them, we hold family cooking lessons at our test kitchens 
in Shanghai

•  The health of all children involved is monitored regularly, 

with progress compared to the ‘control’ school
•  At the end of the two years, the programme’s 

methodology and results will be assessed to see if it 
could become a model to improve the lives of more 
children, schools and families within China.

1  Peking University School of Public Health 2017.

Overview of the year
In the year ended 31 March 2018, cash community spend and 
charitable donations were £479,000 (2017 – £660,000).

Cash community spend by area
Year end 31 March 2018

 Education – 33%

 Health – 32%

 Hunger – 12%

 Environment – 10%

 Other – 13%

50  Tate & Lyle PLC Annual Report 2018

Community involvement highlights during the year 

Health

We supported a number of programmes that helped  
people of all ages understand the role that healthy eating, 
nutrition, physical activity and mental wellness play in a  
well-balanced lifestyle.

•  We supported local community running clubs such as the 

Staley Striders in Decatur, Illinois

•  Employees at our Santa Rosa, Brazil site took part in a 
project to restore and update the local Physiotherapy 
Centre, AIDESA

•  Through our sponsorship of the United Way in the US, we 
helped to support local agencies like the Boys and Girls 
Club whose ‘Triple Play’ programme teaches children the 
importance of daily physical activity and good nutrition. 

Employees from Santa Rosa, Brazil working to restore the municipal 
Physiotherapy Centre for the local disabled community

Hunger

Making sure families across our communities have enough to 
eat remains a key area of support. Over the last year:

•  We supported students at Enders-Salk Elementary School 

near our Commercial and Food Innovation Centre, 
Chicago through the local district’s ‘Food 4 Thought’ 
programme. This provided a healthy breakfast to students 
every morning so they could start the school day with the 
energy to learn

•  We supported Crisis for Christmas providing food and 

shelter to homeless people in London, UK 

•  We sponsored the North Illinois Food Bank’s festive 

holiday meal programme, with our employees helping 
pack 30,000 food boxes for families in need over the 
Christmas period.

A joint team from our Commercial and Food Innovation Centre, Chicago 
and Sycamore, Illinois sites supporting a mobile food pantry organised by 
the Northern Illinois Food Bank

Education

Helping communities towards healthier, more positive 
futures calls for educational programmes that help 
community members of all ages and levels of education. 

•  In the US, we provided STEM-based teaching grants to 
classrooms in Decatur, Duluth, Lafayette, Loudon and 
McIntosh. These grants gave students from elementary to 
high school the chance to create, explore and connect with 
science, technology and maths

•  We funded a number of scholarships for college-bound 
students in the US, Vietnam and South Africa. These 
bursary programmes offered students the chance to 
undertake college or university-level coursework that 
counted towards a four-year degree.

Mathematics concepts come to life in Loudon County schools through our 
annual STEM grants

Non-financial information regulation
Under sections 414CA and 414CB of the Companies Act 2006,  
as amended by The Companies, Partnerships and Groups (Accounts 
and Non-Financial Reporting) Regulations 2016, Tate & Lyle is 
required to include in its Strategic Report, a non-financial 
information statement. Information required by these Regulations is 
included in Business Model (pages 18 and 19), Risks, Our People, 
Business Conduct, Environment, Health and Safety and Community 
Involvement reports from pages 38 to 51.

The Board approved the Strategic Report on pages 1 to 51  
of this Annual Report on 23 May 2018.

By order of the Board

Claire-Marie O’Grady
Company Secretary

www.tateandlyle.com  51

Strategic ReportGovernanceFinancial StatementsUseful InformationBoard of Directors 

Our Board

Dr Gerry Murphy

Chairman

Nick Hampton

Chief Executive

Paul Forman

Independent non-executive director

Lars Frederiksen

Douglas Hurt

Anne Minto OBE

Independent non-executive director

Senior Independent Director

Independent non-executive director

Imran Nawaz 
Imran Nawaz
Chief Financial Officer  
Chief Financial Officer  
(from 1 August 2018) 
(from 1 August 2018)
As announced on 17 April 2018, Imran 
As announced on 17 April 2018, Imran 
will join the Board and become the 
will join the Board and become the 
Chief Financial Officer with effect 
Chief Financial Officer with effect  
from 1 August 2018. Imran Nawaz 
from 1 August 2018. Imran Nawaz  
joins Tate & Lyle from Mondele-z 
joins Tate & Lyle from Mondelēz 
International where he has held the 
International where he has held the 
position of Senior Vice President 
position of Senior Vice President 
Finance Europe since 2014. 
Finance Europe since 2014.

Dr Ajai Puri

Independent  
non-executive director

Sybella Stanley

Independent  
non-executive director

52 
Tate & Lyle PLC Annual Report 2018 
52  Tate & Lyle PLC Annual Report 2018

 
 
 
 
 
Nick Hampton 
Chief Executive  
Date appointed to Board: September 2014 

Paul Forman 
Non-executive director  
Date appointed to Board: January 2015 

Independent: No 

Aged: 51 
Nationality: British 

Skills and expertise: 
Nick brings a wealth of food industry 
insights to the Board. His general 
management, financial and operational 
experience in senior management roles in 
a major multinational food and beverage 
business combined with his experience in 
leading transformational projects provides 
him with the skillset required to inspire and 
lead the Group. 

Current external commitments: 
  Non-executive director and Chairman of 
the Audit Committee of Great Portland 
Estates plc. 

Previous roles: 
Held a number of senior roles over a  
20-year career at PepsiCo, including Senior 
Vice President and Chief Financial Officer, 
Europe and President, West Europe  
Region and Senior Vice President 
Commercial, Europe. 

Independent: Yes  

Aged: 53  
Nationality: British 

Board Committees 

A

R

N

Skills and expertise:  
Paul has wide experience in global 
manufacturing, commercial, as well as 
strategy consultancy and M&A advisory 
services. He brings insight to the 
commercialisation of innovation pipelines 
and the implementation of business-to-
business customer and market-led 
strategies in a large multinational 
business-to-business context. His 
experience as a CEO of a number of  
global companies enables him to provide 
valuable insights to the Board. 

Current external commitments: 
  Chief Executive of Essentra plc. 

Previous roles: 
Group Chief Executive of Coats plc and Low 
& Bonar PLC. Served as a non-executive 
director at Brammer PLC.  

Dr Gerry Murphy 
Chairman and Chair of  
Nominations Committee 
Date appointed to Board: January 2017  

Independent: Yes on appointment 

Aged: 62  
Nationality: Irish  

Board Committees 

N

Skills and expertise: 
Gerry started his career in the food and 
drinks sector and received his PhD in food 
technology. He has held a number of chief 
executive roles and has also been an 
investor and independent director in a 
number of international listed companies. 
His significant business and board level 
experience and a detailed understanding of 
UK corporate governance requirements 
enable him to provide the Board with 
valuable leadership. 

Current external commitments: 
  Chairman of The Blackstone Group’s 

principal European entity 

  Chairman designate of Burberry Group plc. 

Previous roles: 
Senior Managing Director in Blackstone’s 
Private Equity group (2008 to 2017). CEO of 
Greencore Group plc, Exel plc, Carlton 
Communications plc and most recently 
Kingfisher plc (2003 to 2008). Held non-
executive directorships in Intertrust NV, 
British American Tobacco plc, Invest 
Europe, Merlin Entertainments plc, Reckitt 
Benckiser plc, Abbey National plc and 
Novar plc. 

Board Committees 
Certain responsibilities are delegated to 
three Board Committees, details of 
which are provided on pages 66 to 89. 

A

R

N

Audit Committee 

Remuneration Committee 

Nominations Committee 

www.tateandlyle.com  53 
www.tateandlyle.com  53

Strategic ReportGovernanceFinancial StatementsUseful Information 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Board of Directors continued 

Lars Frederiksen 
Non-executive director 
Date appointed to Board: April 2016 

Independent: Yes  

Aged: 59  
Nationality: Danish  

Board Committees 

R

N

Skills and expertise:  
As the former CEO of a global speciality 
food ingredients business, Lars led a 
successful business transformation and his 
insights will be invaluable to the Board as 
Tate & Lyle continues to evolve. He brings 
operational expertise and insights and an 
understanding of how to attract and retain 
talent in a global business. 

Current external commitments: 
  Chairman of Matas A/S 
  Non-executive director of Falck A/S 
  Chairman of the Danish Committee for 

Good Corporate Governance 

  Chairman of the Hedorf Foundation. 

Previous roles: 
CEO of Chr. Hansen Holding A/S from 2005 
until retirement in March 2013, leading a 
transformation of the business and a 
successful listing on the Copenhagen stock 
exchange during that period. Prior to 
becoming CEO, held various management 
positions at Chr. Hansen. 

Douglas Hurt 
Senior Independent Director and Chair 
of the Audit Committee 
Date appointed to Board: March 2010 

Anne Minto OBE 
Non-executive director and Chair of the 
Remuneration Committee 
Date appointed to Board: December 2012 

Independent: Yes  

Aged: 61  
Nationality: British 

Independent: Yes  

Aged: 64  
Nationality: British  

Board Committees 

Board Committees 

A

N

A

R

N

Skills and expertise: 
Douglas is a chartered accountant and has 
extensive experience as a former finance 
director of a global manufacturing and 
business-to-business engineering group, 
and also in senior management roles in the 
US and Europe, which provides the Board 
with valuable perspectives and insights into 
financial and operational issues. In addition, 
his understanding of the London investment 
community and pension matters supports 
the Board in its oversight and decision-
making roles. 

Current external commitments: 
  Senior Independent Director and 

chairman of the Audit Committee of 
Vesuvius plc 

  Non-executive director of BSI Group  
  Senior Independent Director and 

Chairman of the Audit Committee of 
Countryside Properties PLC. 

Previous roles: 
Finance Director of IMI plc and held  
a number of financial and operational  
roles, including US and European  
senior management positions,  
at GlaxoSmithKline plc. 

Skills and expertise: 
Anne’s extensive career in general 
management and human resources is 
particularly useful to the Board when 
considering succession planning, talent 
management, executive remuneration and 
other employee-related activities. She has a 
detailed understanding of how to attract 
and retain global talent and her roles on the 
boards of companies listed in both London 
and New York provide her with a detailed 
understanding of global executive 
remuneration practices and UK and US 
remuneration governance requirements. 

Current external commitments: 
  Non-executive director of ExlService 

Holdings, Inc. 

  Chairman of the University of Aberdeen 

Development Trust 

  Non-executive director of the Court of the 

University of Aberdeen.  

Previous roles: 
Non-executive director and chairman of the 
Remuneration Committee of Shire PLC 
(until April 2018). Group Director of Human 
Resources at Centrica plc from 2002 until 
retirement in 2011. Prior to that, held senior 
management roles at Shell UK and Smiths 
Group plc and was Deputy Director-General 
of the Engineering Employers’ Federation. 

Board Committees 
Certain responsibilities are delegated to 
three Board Committees, details of 
which are provided on pages 66 to 89. 

A

R

N

Audit Committee 

Remuneration Committee 

Nominations Committee 

54 
Tate & Lyle PLC Annual Report 2018 
54  Tate & Lyle PLC Annual Report 2018

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
Dr Ajai Puri 
Non-executive director and Chair of the 
Research Advisory Group 
Date appointed to Board: April 2012 

Independent: Yes  

Aged: 64  
Nationality: Indian/American 

Board Committees 

R

N

Skills and expertise: 
Ajai’s food science background and career 
in research and development in global food 
and beverage companies provides the 
Board with detailed technical knowledge 
and insights into market perceptions, 
nutrition and food and regulatory trends 
relevant to the speciality food ingredients 
business. His experience in the Asia Pacific 
region is of particular benefit as we 
continue to focus on growth in emerging 
markets. His work with regulatory bodies 
and knowledge of nutrition, science and 
food regulation provides him with the 
skillset required to chair the Research 
Advisory Group and to support the Board 
and Tate & Lyle with valuable insights  
into how leading-edge science and 
technology can be successfully deployed  
as part of the Group’s Food & Beverage 
Solutions portfolio. 

Current external commitments: 
  Non-executive director of Britannia 

Industries Limited 

  Non-executive director of Firmenich SA 
  Non-executive director of Global Alliance 

for Improved Nutrition (GAIN). 

Previous roles: 
President – Research, Development and 
Product Integrity and a member of the 
Executive Board of Koninklijke Numico N.V. 
from 2003 to 2007. Prior to this, held 
various management positions with  
The Coca-Cola Company, culminating  
in Senior Vice President Technical,  
The Minute Maid Company. 

Sybella Stanley 
Non-executive director  
Date appointed to Board: April 2016 

Gender diversity of Directors
At 23 May 2018

Independent: Yes  

Aged: 56  
Nationality: British 

Board Committees 

A

N

Skills and expertise: 
Sybella has extensive commercial and 
financial experience and brings a wealth of 
knowledge about the London investment 
community and substantial experience of 
communicating with this and other 
investment communities outside the UK. 
Her long career in corporate finance and 
M&A will be invaluable to the Board’s 
consideration of strategic opportunities.  

Current external commitments: 
  Director of Corporate Finance at RELX 

Group plc  

  Non-executive director of The Merchants 

Trust PLC 

  Member of the Department of Business, 

Energy and Industrial Strategy’s 
Industrial Development Advisory Board 
  Member of the Somerville College Oxford 

Development Board. 

Previous roles: 
Originally qualified as a barrister and, 
before joining RELX Group in 1997, was a 
member of the M&A advisory team at 
Citigroup and later Barings. 

 Male – 6

 Female – 2

Directors’ nationalities
At 23 May 2018

 British – 5 directors

 American – 1 director

 Irish – 1 director

 Danish – 1 director

Tenure of non-executive 
directors
At 23 May 2018

 Less than 3 years – 2 directors

 3 to 6 years – 2 directors

 Over 6 years – 2 directors

www.tateandlyle.com  55 
www.tateandlyle.com  55

Strategic ReportGovernanceFinancial StatementsUseful Information 
 
 
 
 
  
 
 
Chairman’s introduction to Corporate Governance 

“A year in which we enhanced  
the effectiveness of Board and  
Committee oversight.” 

Dr Gerry Murphy, Chairman 

Building on our strong 
governance culture 

Dear shareholder 

During the course of this year, we addressed the three key 
development areas identified in our 2017 board effectiveness  
review. Firstly, we reviewed the remits of the Audit and Corporate 
Responsibility Committees to address any areas of potential  
overlap. The outcome of this review is discussed in more detail 
below. Secondly, we undertook a project to align management and 
board reporting to minimise multiple reporting formats and to 
improve the quality of information to the Board. Lastly, we allocated 
more time in the Board calendar to focus on strategy. We reviewed 
how our two business divisions and our Innovation and Commercial 
Development (ICD) team are developing their organisational 
capabilities to support our strategy and product development. 

Review of the Corporate Responsibility (CR) 
Committee 
Our review of the remits of the Audit and CR Committees, and  
the outcome of our Group-wide safety review, prompted us to  
re-consider the role of the CR Committee.  

The Board recognises the importance of the role that companies 
play in society. We also note that developments in corporate 
governance are placing greater emphasis on the way in which 
companies and boards consider and report on how they discharge 
that role. Against that backdrop, the Directors considered that it 
would be appropriate for the Board, as a whole, to have greater 
visibility of the Group’s corporate responsibility activities.  

To that end, oversight of the main areas of the CR Committee’s 
remit: including safety, product quality, and sustainability have 
moved to the Board. Other topics will move to the Audit Committee.  

The Board proposes to keep this revised Board remit under review 
and does not rule out reinstating a corporate responsibility (or 
similar) committee in the future. 

review was positive. The main area identified for review in the  
2019 financial year was succession planning for non-executive 
directors. After a year in which the Board focused on the Chief 
Executive transition and the appointment of a new Chief Financial 
Officer, it is right that we should now turn our attention to succession 
planning for these other director roles. This will be a major focus for 
the Nominations Committee in the 2019 financial year. 

More details of the Board’s effectiveness review and the areas 
identified for further development can be found on page 61. 

Priorities for the 2019 financial year 
Our new Chief Executive has set out three key priorities to 
accelerate business performance as described on page 14. The 
Board’s focus in the 2019 financial year will be to support him as  
he implements these programmes with particular emphasis on:  

  Performance of the Food & Beverage Solutions division  
  Strategic initiatives, including acquisition opportunities and 

effective integration of any acquisitions made 

  Innovation pipeline 
  Reviewing talent management and our succession pipeline  
  The execution of ongoing programmes to strengthen our 

customer engagement and business execution. 

Shareholder engagement 
Following the publication of our Annual Report 2017, I met with a 
number of our larger shareholders and welcomed the opportunity 
to hear and discuss their views on business performance and 
governance matters. The Board values an open dialogue with 
investors and I, and my fellow Directors, look forward to meeting 
shareholders who are able to attend our Annual General Meeting 
on 26 July 2018.  

Board effectiveness 
This year, our Board effectiveness review was externally facilitated 
by Independent Audit. While there are areas in which the Board  
can seek to enhance its effectiveness, overall the outcome of the 

Gerry Murphy 
Chairman  

56 
Tate & Lyle PLC Annual Report 2018 
56  Tate & Lyle PLC Annual Report 2018

 
 
 
 
i

S
t
r
a
t
e
g
c
R
e
p
o
r
t

G
o
v
e
r
n
a
n
c
e

i

F
n
a
n
c
a
l

i

S
t
a
t
e
m
e
n
t
s

U
s
e
f
u
l

I

n
f
o
r
m
a
t
i
o
n

Corporate Governance 

Leadership 

Our governance structure 

  The Group’s primary decision-making body is the Board. It is accountable to shareholders for the Group’s financial and operational 

performance, and is responsible for setting the strategy and ensuring that risk is managed effectively. The Board maintains a 
schedule of items which it is required to consider and approve. We review this schedule regularly and update it to reflect 
developments in corporate governance and emerging practice. 

As shown in the diagram below, the Board has delegated certain responsibilities to a number of Committees. The Board retains 
overall accountability and the Committee Chairs are responsible for reporting back to the Board on the Committees’ activities. 
Minutes of the Committees’ meetings are made available to all Directors on the web-based Board portal. 

    Accountable to shareholders for the Group’s 
financial and operational performance 

  Sets the Group’s strategy 
  Oversees management’s implementation of 

the strategy 

The Board 
Chaired by Dr Gerry Murphy 
    Monitors the operational and financial 

performance of the Group 
  Sets the Group’s risk appetite 
  Ensures that appropriate risk management 
systems and internal controls are in place 

    Sets the Group’s ethics, culture and agrees 

the Group’s Values 

  Ensures good corporate governance 

practices are in place. 

Chief  
Executive 

Audit 
Committee 

Nominations 
Committee 

Remuneration 
Committee 

Chaired by Douglas Hurt 
  Oversees financial reporting, internal 

  Chaired by Dr Gerry Murphy  
  Makes recommendations to the 

  Chaired by Anne Minto 
  Recommends the Group’s 

financial controls and risk 
management systems, the risk 
management process, the internal 
audit function and the Group’s 
relationship with the external 
auditors. 

Board regarding the structure, size, 
composition and succession needs of 
the Board and its Committees 
  Reviews the performance of the 
executive directors. Oversees 
succession planning for Directors 
and senior management. 

Remuneration Policy for executive 
directors. Sets and monitors the 
level and structure of remuneration 
for the executive directors and other 
senior executives  

  Sets the Chairman’s fee. 

More on page 66 

More on page 70 

More on page 72 

Executive Committee 

Research Advisory Group 

Nick Hampton appointed Chief Executive on 1 April 2018 
Chaired by Javed Ahmed up until 1 April 2018 
  Recommends strategic and 
operating plans to the Board 
  Assists the Chief Executive in 
implementing the strategy 
agreed by the Board 

    Monitors the performance of the 
two business divisions and 
global support functions 

  Identifies, evaluates, manages 
and monitors risks facing  
the Group. 

Chaired by Dr Ajai Puri 
  Comprises external experts and 
senior Tate & Lyle managers 
  Reviews the innovation pipeline 

    Provides insights into how 
leading-edge science and 
technology could enhance  
the portfolio of the Group’s  
Food & Beverage Solutions 
business division. 

The Executive Committee is supported by a number of operational committees, including the Environment, Health and Safety (EHS) Advisory Board, 
Operations Committee, Capital Expenditure Committee, Cyber Security Committee, Business Continuity Committee, IS/IT Portfolio Review Committee and 
the Group Intellectual Property Committee. Committees may also be established for a finite period to oversee key strategic or operational priorities. 

 57 
www.tateandlyle.com 
www.tateandlyle.com  57

Strategic ReportGovernanceFinancial StatementsUseful Information 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Corporate Governance continued 

Key responsibilities of the Board 

  At the date of this Annual Report, the Board comprises the Chairman, one executive director and six non-executive directors.  

Their responsibilities are summarised below. There is a clear division of responsibilities: the Chairman leads the Board and the  
Chief Executive leads the business. 

  Chairman  

Responsible for the effective operation, 
leadership and governance of the Board 
  Chairs Board meetings, Nominations Committee meetings 

and the Annual General Meeting 

  Sets the Board agenda with the Chief Executive and  

Company Secretary 

  Facilitates active engagement by all Directors 
  Sets the style and tone of Board discussions 
  Ensures the Directors receive accurate, timely and  

clear information. 

Chief Executive 
Responsible for proposing strategy to the Board 
and delivering it 
  Runs the business 
  Communicates within the organisation the Board’s 

expectations with regard to culture, Values and behaviours 

  Ensures the Board is aware of current business issues. 

Chief Financial Officer1 
Responsible for the Group’s financial affairs 
  Contributes to the management of the Group’s business 
  Supports the Chief Executive with the development and 

implementation of the strategy. 

Non-executive directors  
Responsible for overseeing the delivery of the 
strategy within the risk appetite set by the Board 
  Advise and constructively challenge the executive directors. 

Senior Independent Director 
Responsible for ensuring that the Chairman’s 
performance is evaluated 
  Acts as a sounding board for the Chairman and supports him 

in the delivery of his objectives 

  Serves as an intermediary with the Chairman for other 

Directors if necessary 

  Maintains a comprehensive understanding of the major issues 

of shareholders and is available if shareholders have any 
concerns that they have been unable to resolve through the 
normal channels. 

Company Secretary 
Responsible for maintaining the governance and 
listing rules compliance framework 
  Supports the Chairman, Chief Executive and Committee Chairs
in setting agenda items for Board and Committee meetings 
  Advises the Board on developments in corporate governance, 

legislation and regulation 

  Assists the Chairman and the Chief Executive in ensuring 

that the Directors are provided with relevant information in 
a timely manner 

  Organises inductions for new Directors and ongoing training 

for all directors. 

1  Upon the appointment of Nick Hampton as Chief Executive effective 1 April 2018, the position of Chief Financial Officer has been vacant. Imran Nawaz will take up the 
role of Chief Financial Officer with effect from 1 August 2018. The responsibilities of the Chief Financial Officer during this interregnum have mainly remained with  
Nick Hampton with some delegated to the Group VP, Finance and Control. 

Compliance with the Code  
The UK Corporate Governance Code (the Code) issued by the Financial Reporting Council in April 2016 is the standard against which  
we are required to measure ourselves for the year ended 31 March 2018. Throughout the year, the Company has applied the principles 
and fully complied with the Code.  

The Code can be found at www.frc.org.uk. 

58 
Tate & Lyle PLC Annual Report 2018 
58  Tate & Lyle PLC Annual Report 2018

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
i

S
t
r
a
t
e
g
c
R
e
p
o
r
t

G
o
v
e
r
n
a
n
c
e

i

F
n
a
n
c
a
l

i

S
t
a
t
e
m
e
n
t
s

U
s
e
f
u
l

I

n
f
o
r
m
a
t
i
o
n

Board activity during the year ended 31 March 2018 

The Board holds six scheduled meetings each year at Group locations and an off-site meeting to discuss strategy. In the few instances 
where a Director is unable to attend a meeting, he or she generally provides comments in advance to the Chairman. This year’s 
scheduled meetings were held in London at the Group’s headquarters, at our plant in Koog, the Netherlands and at our Commercial 
and Food Innovation Centre in Chicago, USA. 

Strategy  
•  Undertook deep dives into each of our 

Primary Products and Food & Beverage 
Solutions divisions, considered the key 
growth drivers, markets and customers  
in each 

•  Reviewed the priorities identified for ICD 

in the 2019 financial year 

•  Considered a presentation on how 

consumer behaviour is changing and 
impacting the purchasing decisions of 
Tate & Lyle’s customers  

•  Reviewed the Group’s strategic plan. 

Financial 
•  Approved the payment of the interim dividend and recommended payment 

of the final dividend 

•  Considered and agreed treasury and tax matters 
•  Approved the tax strategy 
•  Approved the Annual Operating Plan for the year ending 31 March 2019 
•  Approved the Annual Report 2017, the half- and full-year results and 

associated announcements 

•  Regular review of financial performance and forecasts. 

Operational/commercial  
•  Reviewed the conclusions of the external review of safety 

Internal control and risk management 
•  Considered and agreed the Group’s risk appetite and 

across the Group 

principal risks 

•  Reviewed the content of, and implementation road map 
for, the Group’s new EHS strategy and received and 
considered regular progress updates 
•  Approved capital expenditure projects  
•  Reviewed the development of the innovation pipeline  

and considered the technical competencies required for  
our ICD unit. 

•  Assessed the effectiveness of our internal controls and 

risk management systems 

•  Agreed the Modern Slavery Act statement available on 

the Company’s website 

•  Agreed the Viability statement as disclosed in the Annual 

Report 2017 

•  Approved the adoption of a going concern basis of 

accounting in preparing the half- and full-year results.  

Governance and stakeholders  
•  Considered the output and recommendations from the Board 

effectiveness review 

•  Considered and approved the disbandment of the Corporate 

Responsibility Committee and the reallocation of its remit to the 
Board and the Audit Committee 

•  Discussed feedback from institutional shareholders and analysts 
•  Considered the implications of the FRC’s draft revised Corporate 

Governance Code and responded to the FRC’s consultation  
•  Reviewed and approved Directors’ conflicts of interest (if any). 

Leadership and employees  
•  Approved the appointment of Nick Hampton as 
Chief Executive and Imran Nawaz as Chief 
Financial Officer 

•  Endorsed the Chief Executive’s appointment of 
Melissa Law and Andrew Taylor to the Group 
Executive Committee 

•  Held Chairman-led Town Halls at our global 
Shared Services Centre in Poland and at our 
plant in Koog, the Netherlands 

•  Reviewed diversity, talent management and 
bench strength within the organisation. 

www.tateandlyle.com  59 
www.tateandlyle.com  59

Strategic ReportGovernanceFinancial StatementsUseful Information 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Corporate Governance continued 

Directors’ attendance at Board  
and Committee Meetings during the year 

Directors as at 31 March 2018 
Dr Gerry Murphy 
Javed Ahmed2 
Nick Hampton 
Liz Airey3 
Paul Forman 
Lars Frederiksen4 
Douglas Hurt 
Jeanne Johns5 
Anne Minto 
Dr Ajai Puri 
Sybella Stanley 

Number of meetings attended 

Audit  

Nominations 

Corporate 
Responsibility 

Board   
7/7   
7/7   
7/7   
1/2   
7/7   
6/7   
7/7   
3/4   
7/7   
7/7   
7/7   

Committee    
5/51   
n/a    
n/a    
2/2    
5/5    
n/a    
5/5    
n/a    
5/5    
n/a    
5/5    

Committee   
3/3   
0/0   
n/a   
0/1   
3/3   
2/3   
3/3   
1/1   
3/3   
3/3   
3/3   

Committee   
3/3   
n/a   
n/a   
n/a   
n/a   
3/3   
3/3   
2/2   
n/a   
3/3   
n/a   

Remuneration  
Committee  
7/71 
n/a  
n/a  
n/a  
7/7  
6/7  
n/a  
2/3  
7/7  
5/7  
n/a  

1  Although not a Committee member, attended the Committee meetings by invitation. 

2  Resigned as a Director with effect from 1 April 2018. 

3  Resigned as a Director with effect from 27 July 2017 and unable to attend one meeting due to a pre-existing commitment. 

4  Unable to attend one meeting due to a pre-existing commitment. 

5  Resigned as a Director with effect from 31 October 2017. 

Effectiveness 

The Board regularly reviews the balance of experience, skills, 
gender and diversity of thinking styles around the boardroom table 
to ensure that the composition of the Board and its Committees is 
appropriate for the Group as it continues to evolve and implement 
the strategy. The Board and its Committees carry out a formal 
effectiveness review process once a year which provides new 
insights into the operation of the Board and areas for development 
or particular focus. 

Board composition 
At the date of this Annual Report, the Board comprised eight 
Directors with deep knowledge and experience in diverse business 
sectors within global markets: the Chairman, who has no executive 
responsibilities; one executive director; and six non-executive 
directors. The names, skills and experience of the Directors are set 
out on pages 53 to 55. 

Appointment to the Board 
The Nominations Committee has responsibility for the appointment 
of non-executive and executive directors and recommends new 
appointments to the Board. During the year, the Nominations 
Committee carried out succession planning in respect of the roles 
of Chief Executive and Chief Financial Officer. The Board approved 
the Nominations Committee’s recommendation that Nick Hampton 
be appointed Chief Executive with effect from 1 April 2018 and that 
Imran Nawaz be appointed as Chief Financial Officer with effect 
from 1 August 2018. Further details about these appointment 
processes are set out in the Nominations Committee report on 
pages 70 and 71. 

Re-election of Directors 
The Code provides that all Directors should seek re-election on  
an annual basis and all Directors will seek re-election at the 
forthcoming AGM. The Directors standing for re-election, with  
the exception of Nick Hampton, do not have service contracts.  
Each Director goes through a formal performance review process 
as part of the annual Board effectiveness review. All Directors 
completed this process during the year and, in line with the Code, 
Douglas Hurt and Dr Ajai Puri, who have both served for over  
six years, have been subject to a particularly rigorous review. 

Independence 
The Code provides that the Board should state its reasons if it 
determines that a Director is independent notwithstanding the 
existence of relationships or circumstances which may appear 
relevant to its determination, including if the Director has served  
on the Board for more than nine years from the date of his or her 
first election.  

With the exception of Dr Gerry Murphy, who, as Chairman, is 
presumed under the Code not to be independent, the Board 
considers all the non-executive directors to be independent. 

Directors’ interests 
During the year, no Directors had a material interest in any 
contract with the Group, being a contract of significance in relation 
to the Group’s business. A statement of Directors’ interests in 
Company shares is set out on page 89. 

Directors’ induction programme 
In those years in which new Directors join the Board, the 
Company Secretary works with each Director to tailor an induction 
programme which covers strategy, operations (including safety 
and environmental performance), risk management and 
internal control. 

60 
Tate & Lyle PLC Annual Report 2018 
60  Tate & Lyle PLC Annual Report 2018

 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
i

S
t
r
a
t
e
g
c
R
e
p
o
r
t

G
o
v
e
r
n
a
n
c
e

i

F
n
a
n
c
a
l

i

S
t
a
t
e
m
e
n
t
s

U
s
e
f
u
l

I

n
f
o
r
m
a
t
i
o
n

2018 Board effectiveness review  
The Board’s review of its effectiveness was facilitated by Independent Audit Limited, using their online assessment service Thinking 
Board®. Their facilitation helped ensure that our review was rigorous and covered the important influences on the Board’s effectiveness. 
As independent advisors, they discussed with us the focus and coverage of our Board and Committee questionnaires, administered the 
questionnaires on a confidential basis, analysed the results independently from the Board and management, and presented the findings 
and their suggestions in a paper which was discussed with the Chairman and provided to all Directors. Independent Audit also met with 
the Board to share its views on the issues raised through our self-assessment. 

The main recommendations identified by the review and the actions agreed by the Board include: 

Issue/recommendation 

  Action 

Review Board and Committee 
composition 

    This will be a focus for the Nominations Committee in the 2019 financial year. 

Introduce non-executive 
directors-only sessions 

    Following Board meetings, short sessions for non-executive directors-only have been 
introduced. Non-executive directors also held two non-executive-only dinners during 
the year. 

Review the culture of the 
organisation  

    As we transition to our new Chief Executive and to a more purpose-led organisation,  
the Board has scheduled a review of the corporate culture in the 2019 financial year.  

Review the Group’s approach to 
reward in order to ensure it 
continues to align with the 
Group’s strategy 

Continue Board overseas visits 

Review Board information 

    This item will be considered by the Remuneration Committee in the 2019 financial year.  

    We propose to continue the individual non-executive director site visit programme 

whereby each non-executive director visits one Group site each year, as non-executive 
directors find this to be a valuable and informative experience. The Board will continue 
to host one meeting a year at the Group’s main US site, the global Commercial and 
Food Innovation Centre in Chicago, with visits to other locations in alternate years. 

    During the year, we engaged a third-party provider to assist in creating a corporate 
dashboard, which provides the Board with an ‘at a glance’ summary of the Group’s 
financial and non-financial performance. In addition, we reviewed and revised the 
content and presentation of Board materials, in particular to align management and 
Board information. We have found that these improvements in our Board materials 
facilitate a better Board discussion. 

Review of the Committees 
In addition to the Board effectiveness review, the chairs of the Audit 
and Remuneration Committees led the review of their Committee’s 
effectiveness with Independent Audit as facilitator. These reviews 
confirmed that all Committees continue to provide effective 
support to the Board. Areas for further focus are noted in the 
individual Committee reports. 

Review of individual Directors 
Dr Gerry Murphy led performance reviews of the non-executive 
directors, while the Nominations Committee reviewed the 
performance of the Chief Executive, Chief Financial Officer and the 
other members of the Executive Committee, in line with its terms 
of reference. These reviews confirmed that each Director 
continues to make an effective contribution to the Board’s work 
and is well-prepared and informed about issues they needed to 
consider. In each case, their commitment remains strong. 

Professional development and independent site 
visit programme 
Directors receive ongoing training and updates on relevant issues 
as appropriate, taking into account their individual qualifications 
and experience. The Company Secretary helps Directors undertake 
any other professional development they consider necessary to 
assist them in carrying out their duties.  

During the year, in addition to the Board’s visit to the Commercial 
and Food Innovation Centre in Chicago, USA, and to our plant in 
Koog, the Netherlands, the Chairman and/or various of the non-
executive directors visited six of the Group’s sites in Europe, three 
of the Group’s sites in the US, three of the Group’s sites in Asia  
and two of the Group’s sites in Latin America as part of their 
independent site visit programme. These visits provide Directors 
with the opportunity to interact with local management and to gain 
in-depth knowledge about the opportunities and challenges for the 
Group’s operations across the world. 

www.tateandlyle.com  61 
www.tateandlyle.com  61

Strategic ReportGovernanceFinancial StatementsUseful Information 
 
 
 
 
 
 
 
 
 
Accountability 

The Board is responsible for determining the nature and extent of 
the principal risks it is willing to take in achieving the Group’s 
strategic objectives and for maintaining sound risk management 
and internal control systems. 

Risk management and internal control 
A formal process is in place which aims to identify and evaluate 
risks and how they are managed, further details of which are set 
out on pages 38 and 39. 

The objective of the internal control system is to protect the 
Group’s assets and reputation and to ensure the reliability of 
financial information for both internal use and external publication. 
The systems of internal control and risk management cannot 
eliminate the risk of failure to achieve business objectives and can 
only provide reasonable, not absolute, assurance against material 
misstatement or loss. 

An overview of the Group’s internal control system is set out on 
page 63 with details of those people or functions responsible for 
managing or monitoring risks set out on page 64. 

2018 review of the effectiveness of the system of 
internal control  
The Board monitors the effectiveness of the Group’s systems of 
internal control and risk management throughout the year. Once a 
year, the Board, supported by the Audit Committee, conducts its 
own review of the effectiveness of the systems of risk management 
and internal control. As last year, the 2018 review was facilitated by 
Group Audit and Assurance and covered the period from the start 
of the financial year to the date of this Annual Report. The process 
included a two-stage review to facilitate discussion, with the Audit 
Committee discussing the results of the review at their meetings in 
March and May 2018. The Board then discussed the output at its 
meeting in May 2018. 

The 2018 review covered financial, operational and compliance 
controls, Values and behaviours, and the risk management 
process, and included questionnaires and representation letters 
completed by management. Group Audit and Assurance monitored 
and selectively checked the results of the review, ensuring that the 
responses from management were consistent with the results of 
its work during the year. As part of this process, areas for 
enhancements to internal controls, and associated action plans  
to deliver them, were identified. Delivery of these enhancements  
is being monitored by the Audit Committee or the Board  
as appropriate.  

The Board considers that none of the areas identified for 
improvement constituted a significant failing or weakness. 

Corporate Governance continued 

Advice and support 
All Directors have access to the advice and services of the 
Company Secretary, who is responsible for ensuring that the  
Board follows due process, and that the Company complies with 
applicable rules and regulations. 

There is also a formal procedure whereby Directors can  
obtain independent professional advice, if necessary, at the 
Company’s expense. 

Directors’ conflicts of interest 
Directors have a statutory duty to avoid situations in which they 
may have interests that conflict with those of the Company, unless 
that conflict is first authorised by the Board. As permitted under 
the Companies Act 2006, the Company’s Articles of Association 
allow Directors to authorise conflicts of interest and the Board has 
an established policy and set of procedures for managing and, 
where appropriate, authorising, actual or potential conflicts  
of interest. 

The key elements of those procedures are as follows: 

  Directors are required to disclose proposed new appointments 
to the Chairman before taking them on, to ensure that any 
potential conflicts of interest can be identified and addressed 
appropriately, for instance through the agreement and 
implementation of guidelines and protective measures regarding 
the ongoing management of any situational conflict 

  Directors are required to declare other situations which could 

result in a potential conflict of interest 

  Any potential conflicts of interest in relation to proposed 

Directors are considered by the Board prior to their appointment 

  The Board reviews Directors’ actual or potential conflicts of 

interest at least annually. 

During the year, the Board assessed and approved potential 
conflicts, together with guidelines and protective measures 
as appropriate. 

Directors’ indemnities and insurance cover 
As at the date of this Annual Report, the Company has agreed to 
indemnify the Directors, to the extent permitted by the Companies 
Act 2006, against claims from third parties in respect of certain 
liabilities arising out of, or in connection with, the execution of their 
powers, duties and responsibilities as Directors of the Company 
and any of its subsidiaries. The Directors are also indemnified 
against the cost of defending a criminal prosecution or a claim by 
the Company, its subsidiaries or a regulator, provided that where 
the defence is unsuccessful the Director must repay those defence 
costs. These indemnities are qualifying indemnity provisions for the 
purposes of Sections 232 to 234 of the Companies Act 2006, and 
copies are available for inspection at our registered office during 
business hours on any weekday except UK public holidays. 
Equivalent indemnities remain in force for Liz Airey, Jeanne Johns 
and Javed Ahmed who ceased to be Directors on 27 July 2017,  
31 October 2017 and 1 April 2018 respectively. 

The Company also maintains Directors’ and officers’ liability 
insurance cover, and reviews the level of cover each year. 

62 
Tate & Lyle PLC Annual Report 2018 
62  Tate & Lyle PLC Annual Report 2018

 
 
 
i

S
t
r
a
t
e
g
c
R
e
p
o
r
t

G
o
v
e
r
n
a
n
c
e

i

F
n
a
n
c
a
l

i

S
t
a
t
e
m
e
n
t
s

U
s
e
f
u
l

I

n
f
o
r
m
a
t
i
o
n

Key features of  
the internal  
control system 
The system has four broad areas 

Risk assessment 
•  Risk assessments are undertaken as part of 

‘business as usual’ as well as through a more 
formalised Enterprise Risk Management process. 

Tone from the top and business 
environment controls 
•  The Values framework (see page 42) 
•  The Group policies framework 
•  Business performance management processes, 
covering planning, budgeting and performance 
•  Schedule of matters reserved to the Board and 

terms of reference for Board Committees 

•  A clear organisational structure with responsibility, 
accountability and limits of authority clearly defined 
for employees 

•  Segregation of duties of employees. 

Information and communication 
controls 
•  Board and Executive Committee reporting 

framework 

•  Communication protocols for external 

communications 

•  Whistleblowing process. 

Monitoring controls 
•  Controls monitoring by dedicated teams covering, 

for instance, finance, safety, product quality, 
intellectual property and cyber security 

•  Framework of reviews by appropriately qualified 

people. 

Financial reporting internal control system 
This system covers the financial reporting process and the Group’s 
process for preparing consolidated accounts. It includes policies 
and procedures which require: 

  The maintenance of records that, in reasonable detail, 
accurately and fairly reflect transactions including the 
acquisition and disposal of assets 

  Reasonable assurance that transactions are recorded as 
necessary to permit preparation of financial statements in 
accordance with International Financial Reporting Standards 

  Reasonable assurance regarding the prevention or timely 

detection of unauthorised use of the Group’s assets. 

We also have specific disclosure controls and procedures around 
the approval of the Group’s financial statements. Twice a year, 
representatives from the business units certify that they have 
complied with the minimum control standards and that their 
reported information provides a true and fair view of the state of 
the financial affairs of their division and its results for the period. 
The results of this financial disclosure process are reported to the 
Audit Committee. 

Speak Up (whistleblowing) 
Speak Up, the Group’s whistleblowing programme, has been in 
place for a number of years in all operations controlled by the 
Group. This programme, which is monitored by the Audit 
Committee, is designed to enable employees, contractors, 
customers, suppliers and other stakeholders to raise concerns 
confidentially about conduct they consider contrary to the Group’s 
Values. It may include, for example, unsafe or unethical practices, 
or criminal offences. 

The Speak Up programme provides a number of ways to raise 
concerns including a telephone reporting line, email, and a web-
based reporting facility. These multilingual communication 
channels are operated by independent service providers who 
submit reports to the Speak Up Committee for investigation  
as necessary. 

Reports received during the year were kept strictly confidential and 
the concerns identified were referred to appropriate managers 
within the Group for resolution. Where appropriate, action was 
taken to address the issues raised. The reports were analysed and 
monitored to ensure the process continued to be effective. The 
Audit Committee received analysis of all reports submitted via the 
Speak Up programme during the year. 

www.tateandlyle.com  63 
www.tateandlyle.com  63

Strategic ReportGovernanceFinancial StatementsUseful Information 
 
 
 
 
 
 
 
 
 
 
 
 
 
Corporate Governance continued 

Internal control system 
Body 

  Responsibilities 

The Board 

    Determines the level of risk that it is prepared to accept in the business (risk appetite) 

  Agrees the Group’s principal risks for disclosure in the Annual Report 
  Oversees the strategies for managing principal risks. 

Audit and Corporate 
Responsibility 
Committees* 

    Review aspects of the risk management and internal control systems for risks within its remit and 

report to the Board 

  Discuss regular reports from the VP, Group Audit and Assurance (internal audit) 
  Carry out a formal review of the effectiveness of the internal control and risk management systems 

and report to the Board on the output of that review at least once a year (Audit Committee). 

Executive management     Works within the risk appetite and develops the mechanisms and processes to direct the 

organisation through setting the tone and expectations from the top, delegating authority and 
monitoring compliance. 

Line management 

    Manages risk and ensures that mitigation is operated across the business which is appropriate and in 

accordance with the accountability framework 

  Has primary responsibility for compliance with Group policies, our Values and legal requirements 
  Within certain functions, notably safety and product quality, separate assurance teams oversee the 

effective operation of controls. 

Employees 

    Manage risks within their predefined accountabilities 

  Are trained on, for example, safety, cyber security, competition law and anti-bribery and corruption to 

increase their awareness of risks (training may be tailored and/or mandatory). 

Group risk manager 

Risk management 
committees 

    Works with executive and line management to help identify, measure, mitigate, monitor and report 

principal risks. 

    Review certain risks and controls and monitor initiatives to strengthen controls 

  Comprise senior management and functional specialists 
  Examples include the Cyber Security Steering Committee which considers cyber security risks, and 
the regional Control Environment Councils which consider regional financial risks and controls. 

Global Audit  
and Assurance 
(internal audit) 

    Provides objective assessment of the appropriateness and effectiveness of the Group’s internal 

control systems to the Audit Committee (to the Corporate Responsibility Committee when in place) 
and to the Board 

  Has the authority to review any relevant aspect of the business and a duty to report on any 

material weaknesses 

  Develops and works to a risk-based internal audit plan which is approved by the Audit Committee and 

which is regularly updated. 

External specialists 

    Commissioned by the Board from time to time to supplement internal processes as appropriate. 

*  The Corporate Responsibility Committee was dissolved during the year. For more information see page 56. 

64 
Tate & Lyle PLC Annual Report 2018 
64  Tate & Lyle PLC Annual Report 2018

 
i

S
t
r
a
t
e
g
c
R
e
p
o
r
t

G
o
v
e
r
n
a
n
c
e

i

F
n
a
n
c
a
l

i

S
t
a
t
e
m
e
n
t
s

U
s
e
f
u
l

I

n
f
o
r
m
a
t
i
o
n

Annual General Meeting 
The AGM provides all shareholders with the opportunity to 
question the Board on matters put to the meeting, including this 
Annual Report. Shareholders who attended last year’s AGM 
received a presentation from the Chief Executive on the Group’s 
activities and performance. 

The 2018 AGM will be held at Glaziers Hall in London on Thursday 
26 July 2018 at 10.00 am. Full details are set out in the Notice of 
AGM. Resolutions are decided by means of a poll and the votes 
received in respect of each resolution, together with the number  
of abstentions, are announced through a regulatory information 
service and published on the Company’s website. Shareholders 
can choose to receive shareholder documentation, including the 
Annual Report, electronically or in paper format, and may submit 
proxy votes and any questions either electronically or by post. 

Investor calendar 

Set out below is a summary of our major investor activity  
during the year. 

April 2017 
•  Remuneration 

Committee Chairman 
consultation programme. 

  May 2017 

•  Full-year results issued 
•  Investor roadshow 
meetings in the UK. 

June 2017 
•  Investor roadshow 
meetings in the UK  
and US 

  July 2017 

•  Trading statement issued 
•  Annual General Meeting 

in UK. 

•  Investor conference in 

France 

•  Annual Report published. 

September 2017 
•  Investor conference  

in UK. 

  November 2017 

•  Half-year results issued 
•  Investor roadshow 
meetings in the UK  
and US 

•  Investor conferences in 
UK, France and US  
•  Chairman meeting with 

investors. 

December 2017 
•  North American investor 
group meeting in UK 
•  Investor conference  

in UK. 

  February 2018 

•  Trading statement issued 
•  Investor meetings in UK. 

Engagement with shareholders  
and others 

We are committed to maintaining an open dialogue with 
shareholders, debt investors and potential investors and recognise 
the importance of that relationship in the governance process. 

We have a focused investor relations programme that aims to help 
existing and potential investors understand the Group. We provide 
feedback from the investment community to all Directors regularly 
to ensure they understand the views expressed by major investors. 

Institutional investors  
The Chief Executive, Chief Financial Officer and VP, Investor  
and Media Relations maintain a programme of meetings with 
institutional shareholders from the UK, Europe, North America  
and Asia. 

During the year, Dr Gerry Murphy held meetings with a number  
of the Company’s larger institutional shareholders. In addition, 
following the announcement of the appointment of Nick Hampton 
as Chief Executive in January 2018, a number of larger institutional 
shareholders were offered meetings with Dr Gerry Murphy, 
although no investors required meetings. Anne Minto, Chair of the 
Remuneration Committee, offered meetings to the Company’s 
principal investors in relation to the Remuneration Policy renewal 
(see page 73 for more information). All Directors received periodic 
updates on investor communication activities.  

Analysts 
As well as the full-year and half-year results presentations to 
investors and analysts, we host conference calls after each trading 
update. We publish any presentations, together with the associated 
announcements, on the Company’s website and we also make any 
audio recordings available for a short period after each event. The 
Chief Financial Officer and VP, Investor and Media Relations also 
meet regularly with analysts. 

Independent feedback on our investor relations 
programme  
Each year, an external investor relations advisor undertakes a 
comprehensive review of investor perceptions of the Group, 
management, strategy and communications. The output from 
this review was presented to the Board in November 2017 and 
actions taken forward by management. Recommendations 
included broadening discussion of the drivers of North American 
performance in the Food & Beverage Solutions division, and a 
re-focusing of the Group’s investor targeting programme to 
focus on large UK active underweight investors, using 
management selectively.  

Other capital providers 
The Chief Financial Officer, Group Treasurer and VP, Investor  
and Media Relations regularly meet with our committed lending 
banks and bond holders and ratings agencies (Standard & Poor’s 
and Moody’s). 

Private (retail) shareholders 
We encourage private shareholders to provide feedback to the 
Board via the Company Secretary. We also include a questions 
card with the AGM documentation sent to shareholders so that 
those who cannot attend the meeting have the opportunity to 
ask questions. 

www.tateandlyle.com  65 
www.tateandlyle.com  65

Strategic ReportGovernanceFinancial StatementsUseful Information 
 
 
 
 
 
 
 
 
 
 
 
Audit Committee Report 

“This year, we oversaw the tender process  
to appoint new external auditors and an 
external review of the effectiveness of the 
Group Audit and Assurance function.” 

Douglas Hurt, Chair of the  
Audit Committee 

Dear shareholder  

As Audit Committee Chair, I am pleased to present the 
Committee’s report for the year. 

Committee governance 

In addition to our usual matters, including the financial results for 
the full year and half year, applicable accounting policies and going 
concern assumptions, we continued with our practice of looking 
in depth at certain aspects of the control environment. These 
included an impact assessment of new accounting standards, in 
particular IFRS 16, a review of the impact of recent US tax reform 
on the Group and a review of our Group Treasury function. Some 
members of the Committee also visited the Global Shared Services 
Centre in Łódz, Poland. Finance and operational leaders attended 
the Committee meetings at which these detailed reviews  
were held.  

As disclosed previously, the competitive external audit tender 
process took place during the year resulting in a recommendation by 
the Committee to the Board to appoint Ernst & Young LLP (EY) as 
external auditors. This recommendation was approved, and we 
announced our proposal to appoint EY as external auditors to the 
market on 3 August 2017. A resolution to appoint EY for the financial 
year commencing 1 April 2018 will be put to shareholders at the  
AGM on 26 July 2018. Details of the tender process can be found  
on page 69. 

On behalf of the Board, the Audit Committee would like to thank 
PwC for their significant contribution and support to Tate & Lyle 
over the years. We would also like to thank each firm that 
participated in the tender process. 

During the year, the effectiveness of the Group Audit and Assurance 
(internal audit) function was assessed by Grant Thornton. The review 
concluded that the function continues to operate effectively. Further 
details of this assessment are set out on page 69. 

As explained in the Chairman’s corporate governance statement 
on page 56, the Corporate Responsibility Committee was dissolved 
during the year. As a result, the remit of the Audit Committee will 
now include ethics and compliance, privacy law compliance, cyber 
and IS/IT controls. In addition, we will maintain our programme of 
in-depth review of the control environment.  

I look forward to meeting you at our forthcoming AGM. 

Douglas Hurt 
Chair of the Audit Committee 

66 
Tate & Lyle PLC Annual Report 2018 
66  Tate & Lyle PLC Annual Report 2018

Responsibilities 
The Committee assists the Board by overseeing financial reporting, 
internal controls, the risk management process, the internal audit 
function (Group Audit and Assurance) and our relationship with the 
external auditors. Further details of its responsibilities are in the 
Committee’s terms of reference, on the Company’s website, 
www.tateandlyle.com. 

Composition 
The Committee currently comprises of four independent Directors. 
Liz Airey was also a member of the Committee up until her 
resignation from the Board on 27 July 2017.  

The Code stipulates that: 

(i) 

the Committee as a whole shall have competence relevant to the 
sector in which the Company operates. The Committee considered 
that it does, as a whole, have extensive experience of global 
manufacturing and supply organisations, and of business-to-
business groups, some experience of commercialisation of 
innovation pipelines and a wealth of knowledge and understanding 
of the London investment community and governance matters. It 
continues to strengthen the competencies of its members through 
ongoing development programmes and updates. 

(ii)  at least one Committee member should have recent and relevant 

financial experience. Douglas Hurt met this requirement as he was 
Finance Director at IMI plc and is a Fellow of the Institute of 
Chartered Accountants in England and Wales. 

The Company Secretary is the secretary to the Committee. 

Meetings during the year 
Meetings are generally scheduled in line with key times in the 
Group’s financial reporting calendar. The Committee held five 
scheduled meetings during the year. Attendance during the  
year is set out on page 60. 

The Committee has also met once since the end of the financial 
year and prior to the signing of this Annual Report. 

The Chief Financial Officer; VP, Group Audit and Assurance;  
Group VP, Finance and Control; Executive VP, General Counsel; and 
representatives of the external auditors are normally invited to and 
attend each meeting. The Chairman of the Board and Chief Executive 
are also invited to and attend Committee meetings. In addition, senior 
finance and operational leaders attend and present to the Committee 
on an ad hoc basis, depending on the issues being discussed. 

 
 
 
i

S
t
r
a
t
e
g
c
R
e
p
o
r
t

G
o
v
e
r
n
a
n
c
e

i

F
n
a
n
c
a
l

i

S
t
a
t
e
m
e
n
t
s

U
s
e
f
u
l

I

n
f
o
r
m
a
t
i
o
n

Effectiveness 
The review of the Committee’s effectiveness was facilitated 
externally by Independent Audit. The output was discussed by the 
Committee. This concluded that the Committee continued to 
operate effectively and identified a number of areas to focus on 
next year which includes the risk management process, how the 
Group has implemented a three lines of defence model and 
effectiveness of the external auditors.  

Work undertaken during the year 
The Committee maintains a calendar of items for consideration at 
each meeting and reviews and updates it regularly. As well as the 
work referred to above, the Committee focused on four main 
areas: financial reporting; oversight of the external auditors; 
oversight of the internal audit function; and internal control and 
risk management. 

Financial reporting 
At each of its meetings, the Audit Committee reviewed and 
constructively challenged the accounting judgements and 
disclosures set out in the papers prepared by management  
and determined, with the help of the external auditors, the 
appropriateness of these. The significant issues considered by  
the Committee in relation to this year’s financial statements  
are listed on page 68. 

The Committee also considered management’s review of reported 
and adjusted earnings, reviewed and challenged the impairment 
assessments performed during the year, and satisfied itself that 
significant one-off items of income and expense had been correctly 
classified and appropriately disclosed. Papers on the Group’s 
existing and emerging litigation risks were also considered. 

External auditors 
PwC (or its predecessor firms) have been the Group’s auditors 
since 1989 (formally appointed at the Company’s annual general 
meeting on 24 January 1990). As disclosed previously, the financial 
year 2018 will be the last year in which PwC will perform the 
Group’s audit. 

In accordance with the Competition and Markets Authority 
Order and the Committee’s terms of reference, the Committee 
agreed the scope and the Chairman, on behalf of the Committee, 
negotiated and agreed the fee and scope of the statutory audit for 
the year ended 31 March 2018. 

Safeguarding the auditors’ independence 
The Committee operates a policy to safeguard the objectivity and 
independence of the external auditors. This policy sets out certain 
disclosure requirements by the external auditors to the 
Committee; restrictions on the employment of the external 
auditors’ former employees; and partner rotation. 

During the year, the Committee reviewed the processes that the 
external auditors have in place to safeguard their independence, 
and received a letter from the external auditors confirming that,  
in their opinion, they remained independent. 

Provision of non-audit services 
The policy also sets out the circumstances in which the external 
auditors may be permitted to undertake non-audit services and 
the services which are not permitted under any circumstances, 
such as the provision of remuneration advice and internal 
audit outsourcing.  

The Committee reviews the policy each year and considers 
quarterly reports which set out the ongoing non-audit services 
provided by the auditors and the fees incurred. Under our policy 
on non-audit services, which is in accordance with the Revised 
Ethical Standard 2016 published by the Financial Reporting 
Council, the Chief Financial Officer has authority to approve 
the permitted services up to £10,000 and the Chair of the 
Committee has authority to approve up to £100,000. In all other 
cases, the Committee must approve any proposed, permitted, 
non-audit services.  

A breakdown of the fees paid to the external auditors in respect of 
audit- and non-audit related work is included in Note 9. 

The total amount paid in respect of the Group audit and audit of 
subsidiaries was £2.3 million, and £131,000 was paid in respect of 
non-audit services. Fees paid in respect of non-audit services 
therefore comprised 6% of the total fees paid to PwC. 

Effectiveness of the external auditors 
Following the conclusion of the audit for the year ended 31 March 
2017, the Committee conducted an internal review of the 
effectiveness of the external auditors. As part of the process, the 
Committee reviewed the auditors’ performance against criteria set 
at the start of the audit, together with feedback from management 
at Group and divisional levels. It also considered: 

  The most recent report by the Financial Reporting Council 
(FRC) in May 2017 on the audit quality inspection of PwC  

  The FRC’s guidance on evaluating audit quality which 

suggested reviewing the external auditors’ competence in the 
following areas: 
–  making appropriate judgements about materiality 
–  identifying and focusing on the areas of greatest risk 
–  designing and carrying out effective audit procedures 
–  understanding and interpreting the evidence they obtain 
–  making reliable evaluations of that evidence 
–  reporting clearly and honestly. 

The Committee concluded that the external audit process  
was operating effectively and that PwC continued to provide 
effective and independent challenge to management. The review 
identified a number of recommendations where we could improve 
processes including: 

  Planning and communication for the US component of the audit  
  Clearer transparency and better communication regarding the 

financial impact of any changes of scope 

  Smooth transition to the new auditor. 

These were implemented and incorporated into the criteria set for 
the audit for the current year. The Committee discussed progress 
against these criteria regularly.  

www.tateandlyle.com  67 
www.tateandlyle.com  67

Strategic ReportGovernanceFinancial StatementsUseful Information 
 
 
 
 
 
 
 
 
 
 
 
Audit Committee Report continued 

Significant accounting matters considered by the Committee 

Area 

  Background 

  Committee’s activities and conclusion 

Commodity risk    We use commodity contracts to manage and 

hedge our corn positions in the US.  
The valuations of the corn book and the  
co-products produced as part of the corn wet 
milling process, which are both underpinned 
by a number of judgements, have a material 
impact on the reported results of the Group. 

  The Committee received regular updates on the key commodity risks 
and the risk management framework in place to mitigate these risks. 
The Committee also considered the work performed by the external 
auditors before concluding that the judgements made in determining  
the valuations of the corn and co-products positions were appropriate. 
This will continue to be a key area of focus for the Committee. 

Mr Hurt and Ms Stanley each visited our plant in Decatur as part of 
their individual site visits and held meetings with senior managers 
to gain a deeper understanding of the operations and management 
of Commodities. 

Taxation 

  We operate and pay taxes in a number  
of jurisdictions, which requires the 
interpretation of complex tax law.  
As such, we make provision for potential 
direct tax exposures with local tax authorities 
and reassess this as necessary at the half-
year and year-end. Our assessment is 
underpinned by a range of judgements from 
tax professionals and external advisors. 

  The Committee reviewed the key judgements made in estimating the 
Group’s tax charge along with the key disclosures, including a statement 
of tax principles, set out on page 34 and in Note 12. The Committee was 
satisfied that the judgements made in estimating the Group’s tax charge 
were reasonable, and that the disclosures were appropriate. 

The key factors likely to affect the future tax charge including recent 
US Tax reforms, as well as the key risks and uncertainties, were 
considered and the Committee agreed the disclosure of these factors 
in this Annual Report. 

The Committee reviewed the tax strategy statement during the year and 
recommended it for approval by the Board. 

The Committee considered the appropriateness of tax provisions at the 
balance sheet date, including amounts provided in respect of Group 
financing structures, US tax risks and global transfer pricing risks.  
The Committee concluded that the measurement and disclosure of 
these provisions were appropriate. 

Retirement 
obligations 

  We have significant retirement benefit 
obligations in the UK and the US, including 
unfunded retirement medical plans in the US. 
A number of judgements have to be made 
when calculating the fair value of the Group’s 
legacy retirement obligations. 

  The Committee discussed and constructively challenged the 
assumptions proposed and methodologies used by management and 
considered reports from the external auditors before agreeing that the 
assumptions were reasonable. The Committee also considered the 
appropriateness of the treatment and disclosure of the additional 
contribution to the US pension schemes. 

Impairments 

  We test all goodwill for impairment annually, 
and, additionally, test all assets where there 
has been a previous impairment or where an 
indicator of potential impairment is 
considered to exist. 

Capitalisation of 
development 
cost  

  Our R&D team develops and delivers 
innovative new products. The innovation 
pipeline is managed through a disciplined 
process and the development costs are 
capitalised at the appropriate stage in 
accordance with the Group’s policy. 

  The Committee reviewed the annual goodwill impairment assessment. 
The future performance of the underlying businesses, including the 
discount rates used and forecast assumptions and sensitivities, were 
discussed and constructively challenged. The Committee concluded  
that the assumptions were acceptable, and the conclusion that no 
impairments existed alongside the appropriate disclosure of sensitivities, 
were appropriate. 

  The Committee challenged the appropriateness of the Group’s 
capitalisation policy for development costs and reviewed management’s 
conclusion on the policy which included (1) determining the appropriate 
point to commence capitalisation which included technical, commercial 
and financial criteria, (2) the governance and process to ensure that  
the policy was appropriately and consistently applied and (3) the 
methodology adopted to capture and allocate development costs.  
The Committee concluded that the Group policy remained appropriate. 

68 
Tate & Lyle PLC Annual Report 2018 
68  Tate & Lyle PLC Annual Report 2018

 
 
 
i

S
t
r
a
t
e
g
c
R
e
p
o
r
t

G
o
v
e
r
n
a
n
c
e

i

F
n
a
n
c
a
l

i

S
t
a
t
e
m
e
n
t
s

U
s
e
f
u
l

I

n
f
o
r
m
a
t
i
o
n

External audit tender 
As anticipated last year, we completed a tender process to appoint 
a new external auditor for the financial year ending 31 March 2019. 
This coincides with the end of the current PwC audit engagement 
partner’s (John Waters) five-year term at the conclusion of the 
audit for the year ended 31 March 2018.  

The Audit Committee led the tender process, including agreeing the 
timetable, the tender shortlist, the objectives and the key selection 
criteria it would use in determining its recommendation to the Board. 
The key selection criteria included quality of the proposed team  
and firm, technical experience within the industry in which we 
operate and geographical coverage. The audit tender process  
was coordinated by a sub-committee comprising the Chair of the 
Audit Committee; the Chief Financial Officer; the VP, Group Audit  
and Assurance; Group VP, Finance and Control; and was supported 
by Group Procurement.  

An initial invitation to participate in the tender process was provided 
to a number of auditing firms, including both ‘Big 4’ and medium-
sized firms. Subsequent to this invitation, one firm outside the Big 4 
held a series of meetings with management and delivered a 
capability assessment against the Group’s audit tender criteria. 
However, it was determined that this firm did not possess the depth 
of appropriately skilled US resources to deliver an effective audit. 

A notification of audit tender was sent out subsequently setting out 
high-level key dates and key facts, and a timeline for lead partner 
selection early in the process, to ensure that the right person was 
leading the process for each firm, considered crucial to ensure  
that each firm submitted their most competitive bid. The lead 
partner for each audit firm that passed the initial assessment was 
subsequently selected by the Chair of the Audit Committee and the 
Chief Financial Officer. The Chief Executive was also invited to meet 
the preferred audit partner from each firm. 

The tender process included provision of a data room, meetings 
with management and finance team members. Each participant 
was also asked to consider and present responses on a number  
of key accounting matters presented during the tender process.  
All the steps culminated in each of the participants making a final 
presentation to the Audit Committee members, based on a prior 
written submission. The process captured and considered the 
views of other stakeholders, for example the Head of Group Tax  
and other senior finance leaders.  

At the conclusion of the process, the Audit Committee recommended 
to the Board that Ernst & Young LLP (EY) be appointed as external 
auditors with effect from the financial year ending on 31 March 2019. 
The Audit Committee believed that both EY and one other firm, 
KPMG LLP, were capable of performing a high-quality global  
audit, but had a reasoned preference for EY, based on the agreed 
selection criteria. 

The Board accepted the Audit Committee’s recommendation  
to appoint EY as external auditors and a resolution for the 
appointment of EY will be put to shareholders at the 2018 AGM.  
The Audit Committee confirms this recommendation is free from 
influence by third parties and that no restrictive contractual clause 
has been imposed on the Company. PwC will cease to hold office 
with effect from the conclusion of the 2018 AGM, having completed 
the audit of the Group’s financial statements for the year. 

The Audit Committee considers that the Company has complied 
with the Competition and Markets Authority’s Statutory Audit 
Services for Large Companies Market Investigation (Mandatory 
Use of Competitive Tender Processes and Audit Committee 
Responsibilities) Order 2014 for the financial year under review. 

Internal audit – Group Audit and Assurance 
Group Audit and Assurance (GAA) is an internal function that 
services the Board and all levels of management. It provides 
objective assurance to add value and improve the organisation’s 
operations. Its responsibilities include assessing the principal risks 
of the organisation and examining, evaluating and reporting on the 
adequacy and effectiveness of the systems of risk management 
and internal control as operated by management. Management 
remains responsible for identifying risks and for the design and 
operation of controls to manage risk. During the year, the 
Committee reviewed the remit, organisation, annual plan, 
resources and effectiveness of GAA and concluded that the 
function continues to operate effectively.  

The effectiveness review of the GAA function was facilitated  
by Grant Thornton during the year. The appointment of Grant 
Thornton followed a competitive tender process. The effectiveness 
review comprised interviews with various stakeholders including 
the Chair of the Audit Committee, the Chief Executive, the Chief 
Financial Officer, senior management and finance leaders, the 
external auditors and GAA team members; and involved reviewing 
documents including the GAA charter, audit plan, audit universe 
and associated risk assessments and audit papers and reports. 
The review concluded that GAA continues to operate effectively 
with some suggestions on areas for enhancement, for example 
audit report style and presentation. 

Internal control and risk management 
The Committee continued to receive and consider regular reports 
from management and the VP, Group Audit and Assurance on  
the effectiveness of the Group’s risk management system during 
the year. 

The reports from the latter included the findings from reviews of 
internal financial controls and actions to address any weaknesses 
in those controls. The Committee also reviewed the operation of 
the Group’s whistleblowing programme (Speak Up) and the 
analysis of reports submitted via the Speak Up programme, and 
approved the proposed plan of work presented by the new Head  
of Ethics and Compliance. See page 63 for further information  
on Speak Up. 

Throughout the year, the Committee focused in particular on 
strengthening the financial control environment and the impact of 
this on the financial reporting processes. The Committee reviewed 
controls to mitigate fraud risk and the Group assurance map, a tool 
which sets out the assurance processes and the three lines of 
defence model. It also considered the results of the annual review 
of the effectiveness of internal financial reporting controls, which 
took into account the Group Risk Manager’s support to the risk 
management process, and then reported to the Board. Further 
details about this review are on page 62. 

www.tateandlyle.com  69 
www.tateandlyle.com  69

Strategic ReportGovernanceFinancial StatementsUseful Information 
 
 
 
 
 
 
 
 
Nominations Committee Report 

“This year, the Committee focused on  
the Chief Executive transition and the 
appointment of a new Chief Financial Officer.” 

Dr Gerry Murphy, Chair of the  
Nominations Committee 

Dear shareholder 

This year, the Committee focused on Chief Executive succession 
with the appointment of Nick Hampton as Chief Executive 
designate in January 2018.  

Following Nick’s appointment, the Committee turned its attention 
to the appointment of a new Chief Financial Officer and, as 
announced on 17 April 2018, Imran Nawaz will join the Company 
and the Board on 1 August 2018.  

On behalf of the Board, I would like to thank Javed Ahmed, Nick 
Hampton, and my fellow non-executive directors for executing a 
smooth and effective succession process.  

With our senior leadership positions now established, the 
Nominations Committee and the Board will focus this year on 
succession planning for the non-executive director roles in order to 
ensure that the Board has the skills and experience necessary to 
support the new management team as it executes the Group’s 
strategy over the coming years. 

Gerry Murphy 
Chairman 

Committee governance 

Responsibilities 
The Committee assists the Board by reviewing the size and 
composition of the Board, including succession planning, and  
the leadership needs of the Group generally, recommending 
candidates for appointment as Directors and as Company 
Secretary and, in this financial year, the performance of each 
member of the Executive Committee. Further details of its 
responsibilities are in the Committee’s terms of reference,  
on the Company’s website, www.tateandlyle.com. 

Composition 
During the financial year under review, the Committee comprised 
the Chairman of the Company, the Chief Executive and all 
independent Directors. The Company Secretary is the secretary  
to the Committee. 

70 
Tate & Lyle PLC Annual Report 2018 
70  Tate & Lyle PLC Annual Report 2018

Meetings during the year 
Meetings are generally held around the time of scheduled Board 
meetings. The Committee held two scheduled meetings during  
the year and also met on one other occasion to discuss the 
appointment of the new Chief Executive. 

Attendance during the year is set out on page 60. 

The Executive VP, Human Resources and the VP, Global Talent are 
invited to attend and present to the Committee on an ad hoc basis, 
depending on the issues being discussed. 

Effectiveness 
Independent Audit led an externally facilitated review of the 
Committee’s effectiveness and the output was discussed by the 
Committee. This concluded that the Committee continued to 
operate effectively and confirmed that the focus for the coming 
year would be on Board succession planning. As a result of the 
effectiveness review, the Committee made a number of changes  
to its terms of reference. Those changes included removing the 
Chief Executive as a member of the Committee, moving annual 
oversight of performance of Executive Committee members to  
the Remuneration Committee for consideration in the context of 
variable pay outcomes and awards and adding oversight of senior 
management development, particularly in the context of potential 
Board succession, to the Committee’s remit. 

Work undertaken during the year 
The Committee maintains a calendar of items for consideration at 
each meeting and reviews and updates it regularly. 

Board succession planning  

Appointment of Nick Hampton as Chief Executive 
After eight years as the Chief Executive of the Company, Javed 
Ahmed indicated his desire to retire from the Company, at a time to 
be mutually agreed with the Committee, and to work with the 
Chairman and the Committee to effect an orderly succession 
process. The Committee retained Korn Ferry and Spencer Stuart  
to assist with the search for a new Chief Executive. Both advisors 
are signatories to the Voluntary Code of Conduct for Executive 
Search Firms and have a good understanding of the Group’s 
business, having been previously engaged in the identification of 
individuals to fill non-executive director roles and other senior 
executive roles. 

 
 
 
 
 
 
 
i

S
t
r
a
t
e
g
c
R
e
p
o
r
t

G
o
v
e
r
n
a
n
c
e

i

F
n
a
n
c
a
l

i

S
t
a
t
e
m
e
n
t
s

U
s
e
f
u
l

I

n
f
o
r
m
a
t
i
o
n

The Committee identified the skills and experience necessary and 
desirable for the role and the search advisors prepared lists of 
potential candidates meeting the specification. The Committee 
considered the list of candidates provided in the context of its 
knowledge and experience of Nick Hampton. Each of the non-
executive directors, and the Committee as a whole, met with  
Nick Hampton to understand his future strategy and plans for the 
Group, should he succeed to the role of Chief Executive. Having 
assessed his suitability for the role, and taking into account his 
performance as Chief Financial Officer since 2014, his significant 
contribution to the Group in that time and the positive views held of 
him by investors, the Board decided to appoint Nick Hampton as 
Chief Executive, with effect from 1 April 2018. 

Appointment of Imran Nawaz as Chief Financial Officer 
Following the decision to appoint Nick Hampton as Chief Executive, 
the Nominations Committee turned its attention to the recruitment 
of a Chief Financial Officer. The Committee appointed a  
sub-Committee comprising the Chairman, the Chair of the Audit 
Committee and the Chief Executive designate. The sub-committee 
drew up a detailed job specification and appointed Korn Ferry to 
assist with an external search, having determined that there were 
no ‘ready now’ internal candidates. Members of the sub-committee 
interviewed a number of candidates and before recommending  
his appointment to the Nominations Committee, the Chair of the 
Remuneration Committee also had the opportunity to meet  
with him. 

Following the recommendation of the Nominations Committee, 
Imran Nawaz will be appointed Chief Financial Officer and a 
director of the Board with effect from 1 August 2018. 

Board diversity 
The Board believes that a diverse and inclusive culture is a driver of 
superior business performance, growth and innovation. The Board 
has a clear policy on diversity that acknowledges that the Board’s 
perspective and approach can be greatly enhanced through 
gender, age and cultural diversity, notwithstanding the overriding 
principle that each member, and potential member, of the Board 
must be able to demonstrate the skills, experience and knowledge 
required to contribute to the overall effectiveness of the Board. 
Wherever feasible, the Committee uses search firms who are 
signatories to the Voluntary Code of Conduct for Executive Search 
Firms which seeks to address gender diversity on boards and best 
practice for the related search processes. 

As set out elsewhere in this report, when considering candidate 
directors, the Committee looked at a number of different criteria, 
including gender, age, culture and personal attributes such as 
thinking style. This was reflected in the long lists and shortlists of 
possible candidates.  

As at the date of this report, the Board comprises the Chairman, 
one executive director and six non-executive directors. Female 
representation (two Directors) equates to 25% of the Board. 

Diversity below the Board 
We recognise that to be a successful company, we must be both 
diverse and inclusive. We expect everyone, everywhere, to play a 
role in ensuring we become a truly diverse and inclusive 
organisation where differences are respected and everyone’s 
contributions are valued.  

Our Group human resources policy records our commitment to 
providing opportunities for all colleagues irrespective of (among 
other things) sex, race, ethnicity, colour, religion, background, age 
and sexual orientation.  

As described on page 43, among the measures we have in place to 
improve female representation in our senior management 
population, we now ensure that women are included on shortlists 
for all senior roles. 

Succession planning 
The Committee also considered succession plans for senior 
executive roles. During the year, members of the Committee 
participated in two new appointments to the Executive Committee: 
Melissa Law, President, Global Operations and Andrew Taylor, 
President, Innovation and Commercial Development. 

Performance evaluation 
The Committee evaluated the performance of each member of  
the Executive Committee and reported its conclusions to the 
Remuneration Committee. 

www.tateandlyle.com  71 
www.tateandlyle.com  71

Strategic ReportGovernanceFinancial StatementsUseful Information 
 
 
 
 
 
 
 
Directors’ Remuneration Report 

“Executive director succession  
has been a key focus for the 
Committee this year.” 

Anne Minto, Chair of the 
Remuneration Committee 

Dear shareholder  

As Chair of the Remuneration Committee, I am pleased to present 
our Remuneration Report (Report) for the financial year ended  
31 March 2018. 

This introduction provides context for the Committee’s decisions 
which were taken during the year, and summarises key points 
from the Report, including performance and incentive plan 
outcomes, and Committee activities. 

Business performance context 
As you will have read in the introductory statements in this Annual 
Report, we are pleased to report another year of progress, with 
good profit and cash delivery: 

  13% increase in adjusted profit before tax at constant currency 

with profit growth in all businesses  

  8% increase in Food & Beverage Solutions profit1 to £137 million,  

with good volume and New Products momentum  

  5% increase in Sucralose profit1 to £55 million 
  30% increase in Primary Products profit1 to £166 million, 11% 

profit1 growth in main business, Commodities £24 million higher 

  7% increase in earnings per share2 at constant currency  
  £53 million higher Group statutory profit before tax with 

improved trading and lower exceptional costs 

  Net debt £60 million lower, with adjusted free cash flow  

£22 million higher at £196 million 

  Proposed final dividend increased by 0.5p to 20.3p per share; 

making a total dividend of 28.7p, up 2.5%. 

1  Adjusted operating profit, percentage change in constant currency.  
2  Adjusted diluted earnings per share from continuing operations. 

Note: Food & Beverage Solutions metrics relate to the reportable segment. 

72 Tate & Lyle PLC Annual Report 2018 
72  Tate & Lyle PLC Annual Report 2018

Incentive outcomes for the year  
The headline incentive outcomes for the year were as follows:  

Annual bonus plan: awards for the year reflect good profit and 
cash performance relative to stretching targets set at the start of 
the year. Food & Beverage Solutions (F&B Solutions) sales volume 
is ahead of prior year, but below the stretching target we set at the 
start of the year. As a result, bonus awards for the year are 
between target and maximum levels. 

Performance Share Plan (PSP): awards made in 2015 reached the 
end of their three-year performance period. Adjusted return on 
capital employed in the year to 31 March 2018 of 17.5% exceeded 
the maximum vesting requirement (and is well in excess of our 
cost of capital). Earnings per share compound annual growth of 
16.1% over the three-year period exceeds the maximum vesting 
requirement. Accordingly, the PSP awards made in 2015 will vest 
in full. 

Total remuneration outcomes are above ’target’ but below 
‘maximum’ policy levels, which the Committee considers to  
be consistent with the performance and financial health of  
the business. 

Key Committee activities during the year 
In addition to the responsibilities of the Committee (which are 
described in summary on page 79), the Committee spent significant 
time on matters relating to the following key items during the year: 

  Executive director appointments: the Committee carefully 

considered and approved remuneration terms in respect of the 
executive director appointments we have announced, operating 
within the Remuneration Policy (Policy) that shareholders 
approved in July 2017. Nick Hampton, who has served as Chief 
Financial Officer (CFO) since September 2014, was appointed 
Chief Executive (CEO) with effect from 1 April 2018. Javed Ahmed 
retired as CEO on 1 April 2018. Imran Nawaz will join as CFO 
with effect from 1 August 2018. Further details are provided in 
this Report and key terms are summarised on page 85. 

 
 
 
 
 
 
 
i

S
t
r
a
t
e
g
c
R
e
p
o
r
t

G
o
v
e
r
n
a
n
c
e

i

F
n
a
n
c
a
l

i

S
t
a
t
e
m
e
n
t
s

U
s
e
f
u
l

I

n
f
o
r
m
a
t
i
o
n

Taking account of institutional shareholders’ views on the levels 
of executive director pension provision, the Committee has taken 
the decision to reduce the level of pension contribution the 
Company will make for each role going forward: the CEO will 
receive 25% of salary (reflecting Nick Hampton’s contractual 
commitment made on appointment in 2014), and the CFO will 
receive 20% of salary (contribution rates were previously 35% and 
25%, respectively). As a result of securing internal succession to 
the CEO the Committee believes it has successfully lowered 
overall executive director remuneration going forward.  

  Senior executive appointments: during the year, key 

appointments at Executive Committee level were made to 
ensure we continue to have a strong balance of skills and 
experience across the broader executive team. The Committee 
has carefully considered appropriate remuneration terms for 
each of these appointments and transitions in turn. 

  Engaged with shareholders ahead of Policy renewal at last 
year’s AGM: we renewed our Policy at the 2017 AGM, and 
although we were not making any material changes, we 
maintained open lines of communication with our largest 
shareholders to ensure that the Committee’s decisions were 
fully informed by shareholder views.  

  Regulatory and governance developments: the Committee 

receives regular updates on regulatory, institutional shareholder and 
governance developments to ensure that the Committee’s decisions 
take Group strategy and the needs of the business into account, 
while reflecting investor and governance expectations around good 
practice. In the spirit of engagement, and in support of good 
governance principles, the Committee input into the Company’s 
response to the BEIS Corporate Governance consultation, and the 
subsequent FRC consultation recommendations on the Corporate 
Governance Code. 

Engagement with workforce  
Pending the outcome from the FRC Corporate Governance 
consultation, the Board and Remuneration Committee have been 
considering how our approach to engagement with the workforce 
may be further developed and broadened over time. 

Gender pay 
Although we employ a relatively small proportion of our people in 
the UK (our two employing businesses in the UK are each below 
the 250 employee threshold for reporting), the Committee has also 
spent time reviewing the UK regulatory requirements relating to 

gender pay, as well as the actions taken in the business to drive 
gender balance. As discussed in Our People report (see page 43), 
we aim to attract a diverse workforce that reflects the communities 
in which we operate. We firmly believe that all employees 
contribute to the performance of the Group and should have equal 
opportunity to develop according to their individual abilities. 

Accelerating business performance  
The CEO’s statement sets out a number of actions that have  
been initiated to accelerate business performance, in particular  
to sharpen our focus on our customers and key categories, 
accelerate portfolio development, and to simplify and drive 
productivity. During the year ahead, the Committee expects to 
review our current remuneration arrangements to ensure they 
support these business goals. At this stage, we expect any changes 
to be within the scope of our existing Policy, and we will consult 
with shareholders, as appropriate, later in the year with a view to 
implementing any changes for the year ending 31 March 2020.  

Remuneration Policy and shareholder approval 
Our Policy was approved by shareholders at the 2017 AGM with 
97% of votes in favour.  

The Committee is satisfied that this Policy continues to provide  
for a strong alignment between Group performance and the 
remuneration of executive directors and, as stated in this  
Report, we intend to continue to operate within this approved  
Policy during the financial year ending 31 March 2019. 

A resolution to approve the Report, which contains key information 
on the way in which our Policy has been implemented during the 
year ended 31 March 2018, will be proposed at the AGM on  
26 July 2018.  

In closing, I would like to thank my fellow members of the 
Remuneration Committee for their diligence and engagement 
through the year, particularly with regard to the additional matters 
we have considered in relation to our executive director 
appointments. Additionally, I would like to personally thank our 
advisors Deloitte and the members of the internal team for the 
excellent support they have provided to the Committee. 

Anne Minto OBE 
Chair of the Remuneration Committee

About this Report 

  This Report has been prepared in accordance with the requirements of the Companies Act 2006 (the Act) and Schedule 8 to the Large 
and Medium-sized Companies and Groups (Accounts and Reports) Regulations 2008, the Listing Rules of the UK Listing Authority and 
the UK Corporate Governance Code. PricewaterhouseCoopers LLP have audited such content as required by the Act (the information 
on pages 86 to 89 marked as ‘(audited)’. 

Key sections of this Report are as follows:  

  At a glance 

74  Remuneration strategy and key  

principles 

Directors’ Remuneration Policy  
76  Directors’ Remuneration Policy 

statements  

74  Overview of remuneration  

77  Key components of Directors’ 

framework 

remuneration 

75  Performance highlights and  

incentive outcomes for the year  
75  Remuneration Policy scenarios for  

the year to which this Report relates  

  Annual Report on Remuneration 

79  The Remuneration Committee 
81  Directors’ salaries and fees 
81  Annual bonus 
83  Long-term incentive – Performance Share Plan 
85  Executive director changes during the year 
86  Single figure table and other audited disclosures 
89  Directors’ shareholdings and share interests 

www.tateandlyle.com  73 
www.tateandlyle.com  73

Strategic ReportGovernanceFinancial StatementsUseful Information 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
Directors’ Remuneration Report continued 

At a glance 

We received strong shareholder support for our Directors’ Remuneration Policy (Policy) at the 2017 AGM, and no changes are proposed for 
the year ahead. 

Incentive pay outcomes reflect strong financial performance during the year leading to total executive director remuneration outcomes for 
the year at between ‘target’ and ‘stretch’ levels. 

Remuneration strategy and key principles 

  The Group’s remuneration strategy and supporting principles, which apply consistently to employees, managers and executives, are 

summarised below: 

The Group’s remuneration strategy is to provide competitive packages that enable the Group to recruit, retain and 
motivate high-calibre individuals in the markets in which we operate so that we may deliver superior operational 
performance and outstanding financial results 

    Base pay and benefits are referenced to the comparative local 
market, taking account of company size and operations  
  For all employees, our pay for performance framework  

  Our approach is intended to be equitable and transparent and 
operate across the Group, recognising that we recruit talented 
individuals and operate in an international market  

provides for meaningful differentiation in salary progression  
and opportunities for career progression, based on each 
individual’s contribution  

  Below executive level, key individuals who have a specific 

accountability for driving annual and longer-term performance 
may be selected to participate variously in our sales incentive 
plan, the annual bonus plan, and the Performance Share Plan  
  Incentive opportunities for eligible roles provide meaningful 

rewards for superior performance and encourage the 
achievement of genuinely stretching short-term and  
long-term objectives 

  All aspects of remuneration are designed to encourage a focus on 

long-term, sustained performance and risk management. Outcomes 
must be achieved in a way that is consistent with the Group’s Values 
and Code of Ethics, and that foster sustainable, profitable growth 
  Alignment with shareholders’ long-term interests is carefully 

preserved, for example, through: a significant proportion of senior 
executive pay being based on performance; effective governance 
around remuneration decisions; a considered approach to setting 
performance targets; the adoption of shareholding guidelines at 
senior executive levels; and malus and claw back provisions on 
incentive awards.  

Overview of our executive director remuneration framework: no changes proposed for the year 

  Base salary and employment benefits 

  Market competitive elements to attract the right calibre of executives (including 

health cover, car and defined contribution retirement benefits). Retirement benefit 
levels are reduced: 25% for CEO (previously 35%) and 20% for CFO (previously 25%) 

  Annual bonus1  

  Rewards achievement against annual performance objectives: 

2017-2018 metrics: 
  Profit 
  F&B Solutions volume 
  Cash flow 

  Max cash bonus is 100% of salary 
  Max opportunity is 175% of salary 
  Any award over 100% is paid in shares, deferred for two years 
  Chief Executive target: 75% of salary  
  Chief Financial Officer target: 50% of salary. 

  Performance Share Plan1:  

  Supports the Group’s strategy to create shareholder value from profitable Food & 

  Group profit growth (25%)  
  F&B Solutions profit growth (25%)  
  Group ROCE (50%)  
  Pre 2016: EPS (50%), ROCE (50%) 

Beverage Solutions-led growth and to motivate and retain senior talent: 
  Max award is 300% of salary 
  15% vesting at ‘threshold’ 
  Awards since 2016 subject to a three-year performance period plus a two-year 

post vesting holding period – five years in total. 

Shareholding requirements 

  Chief Executive – 4 times salary 

Chief Financial Officer – 3 times salary  

  Claw back and malus provisions 

  Apply for two years after a bonus award or vesting of PSP awards 

Key: Number of years:  Performance period  Deferral/holding period „ Ongoing requirements 
1  Food & Beverage Solutions metrics relate to the reportable segment. 

74  Tate & Lyle PLC Annual Report 2018
74 
Tate & Lyle PLC Annual Report 2018 

 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Key Performance Indicators for financial year 2018  

Our remuneration arrangements have a clear link to key performance indicators (KPIs) which are aligned with our  
business strategy. 

Sales of Food & 
Beverage Solutions 
+2% 

in constant currency 

Adjusted profit  
before tax1 
+13% 

in constant currency 

Return on capital 
employed1 
+190bps 

Adjusted operating  
cash flow1 
+10% 

1  Adjusted results and a number of other terms and performance measures used in this Annual Report are not defined within accounting standards.  

For clarity, we have provided descriptions of the various metrics and their reconciliations to the most directly comparable measures reported in IFRS,  
and the calculations where relevant of any ratios, in Notes 1 and 4. 

Performance highlights and incentive outcomes for the year  

Annual bonus  
Metric 
Group adjusted profit before tax  
Food & Beverage Solutions volume  
Adjusted operating cash flow 

  Target1 
  £297m 
  +4% vs prior year 
  £281m 

  Actual1 
  £319m 
  +3% vs prior year 
  £321m 

  vs target 
  +7.4% (+£22m) 
  -1% 
  +14.2% (+£40m) 

Bonus award to Chief Executive and Chief Financial Officer: 72% of maximum 

1  Bonus targets and actual performance are assessed at constant (budget) exchange rates. 

 See page 82 for more detail 

Performance Share Plan (2015 Award) 
Adjusted diluted EPS from continuing operations (50%) 

Targets  
(threshold-stretch) 

Actual 
(2015-2018) 

  6% – 15% compound annual 

  16.1% (above stretch) 

growth over three years 

Adjusted ROCE on continuing operations (50%) 

  12.6% – 15.6% at the end of the 

  17.5%2 (above stretch) 

performance period 

100% of the award made in 2015 will vest, based on the combination of EPS and ROCE performance.  

2  ROCE performance is shown under proportionate accounting, consistent with the basis on which the targets for the 2015 award were established. 

 See page 83 for more detail 

Remuneration Policy scenarios and actual outcome for the year  

  Chief Executive (£000s) – Javed Ahmed 

Chief Financial Officer (£000s) – Nick Hampton 

£1 014

£1 339

£2 637

£4 439

£3 672

49%

28%

23%

41%

21%
38%

48%

24%

28%

100%

25%
75%

Total
£5m

£4m

£3m

£2m

£1m

£0m

Below 
threshold

Threshold

Target

Stretch

Actual

 Base and benefits  Annual bonus  Performance Share Plan 

Total
£5m

£4m

£3m

£2m

£1m

£0m

£670

£906

£1 721

£3 166

£2 776

50%

29%

21%

52%

24%

24%

46%

15%
39%

26%
74%

Threshold

Target

Stretch

Actual

100%

Below 
threshold

www.tateandlyle.com  75 
www.tateandlyle.com  75

Strategic ReportGovernanceFinancial StatementsUseful Information 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Directors’ Remuneration Report continued 

Directors’ Remuneration Policy 

The Directors’ Remuneration Policy (Policy) was formally approved by shareholders at the AGM on 27 July 2017 (with 97% of votes cast to 
support the resolution) and it remains our intention that the Policy will apply for a period of three years from the date of that AGM. 

We operate in an international context 

  The charts below illustrate the international nature of our business. Although we are UK-listed and headquartered in London, UK, a 
very significant proportion of our sales, employees and shareholders are based outside the UK. Accordingly, it is important that our 
remuneration arrangements are competitive in that international context. 

  Our sales1 

  Our people 

  Our shareholders2 

 United Kingdom – 1%

 United States – 70%

 Other European countries – 12%

 Rest of world – 17%

 UK – 6%

 Europe (excluding UK), 
 Middle East and Africa – 28%

 North America – 51%

 Latin America – 10%

 Asia Pacific – 5%

  1  Sales by destination (from continuing operations) as per Note 5. 

2  Analysis of shareholder register as at 3 April 2018. 

 UK – 48%

 North America – 26%

 Other European countries – 24%

 Rest of world – 2%

Consideration of shareholder views 
The remuneration strategy described here was largely established in 2010 following a review and extensive consultation with major 
shareholders. Shareholders endorsed the continuing use of the Performance Share Plan as our long-term incentive at the AGM in 2016, 
and formally approved the Policy most recently at the AGM in 2017.  

The Chair of the Remuneration Committee engages with our major institutional shareholders each year specifically on remuneration 
topics, alongside the Board’s shareholder engagement programme.  

The Committee also receives regular updates on investors’ views and corporate governance matters. These lines of communication 
ensure that emerging best practice principles are factored into the Committee’s decision-making during the year. 

Statement of consideration of employment conditions in the Group 
The principles on which we base remuneration decisions for executives (as described on page 74) are broadly consistent with those on 
which we base remuneration decisions for all employees. In particular, the Committee takes into account the general pay and employment 
conditions of other employees of the Group when making decisions on executive directors’ remuneration. This includes considering the 
levels of base salary increase for employees below executive level, and ensuring that the same principles apply in setting performance 
targets for executives’ incentives as for other relevant employees of the Group. The Committee also reviews information on bonus 
payments and share awards made to the broader management of the Group when determining awards and outcomes at executive  
director level.  

As noted in the opening statement, pending the outcome from the FRC Corporate Governance Code review, the Board and Remuneration 
Committee have been considering how our approach to engagement with the workforce may be further developed and broadened  
over time.  

Gender pay 
Although we employ a relatively small proportion of our people in the UK (our two employing businesses in the UK are each below the 250 
employee threshold for reporting), the Committee has also spent time reviewing the UK reporting requirements relating to gender pay, as 
well as the actions taken in the business to drive gender balance. As discussed in Our People report (see page 43), we aim to attract a 
diverse workforce that reflects the communities in which we operate. We firmly believe that all employees contribute to the performance 
of the Group and should have equal opportunity to develop fully according to their individual abilities. 

76  Tate & Lyle PLC Annual Report 2018
76 
Tate & Lyle PLC Annual Report 2018 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Key components of Directors’ remuneration 

As a Committee, we believe that our approach to remuneration provides an effective overall framework that is aligned with long-term 
success and returns to shareholders. 

Executive directors’ remuneration consists of base salary, annual bonus, long-term incentives, and retirement and other benefits as 
described in the table below. Malus and claw back provisions apply to incentive awards following release, and a strong alignment with 
shareholders’ interests is maintained through significant personal shareholding requirements imposed on each Director. 

Remuneration framework (summary) 
Each component has a clear purpose, and the variable elements are driven by KPIs which have a clear link to strategy. 

Providing market competitive fixed remuneration to attract the right calibre of executive 

Base salary and 
employment 
benefits 

See page 81 

  Base salary decisions are referenced to the comparative local market taking account of company size and 
operations and personal performance. Increases are typically limited to the general increase for Group 
employees in the same local market 

  Retirement benefits are provided by way of defined contribution, or equivalent cash arrangements. Contribution 

levels are reduced from 1 April 2018: 25% for CEO (previously 35%) and 20% for CFO (previously 25%) 

  Other benefits may include car (or allowance), health insurance and life cover. 

Supporting near-term growth goals by rewarding strong annual financial performance 

Annual bonus1  
Key drivers: 
  Profit 
  F&B Solutions 

volume 
  Cash flow. 

See page 81 

  Target bonus is 50% of salary for the CFO and 75% of salary for the CEO 
  Maximum cash bonus is 100% of salary. Maximum total bonus opportunity is 175% of salary, with any award 

over 100% paid in shares, which are deferred for two years 

  Metrics relate to profitability, Food & Beverage Solutions volume growth and cash flow. Profit performance  

is the most important of these metrics: no bonus is payable if performance is below a minimum level, 
regardless of performance against other metrics; and profit performance has the greatest impact on  
overall bonus outcomes. 

Supporting the Group’s strategy by incentivising sustained profit growth and capital efficiency over successive 
three-year performance periods, and retaining senior executive talent 

Performance  
Share Plan1  
Key drivers 
(awards from 2016): 
  F&B Solutions 

adjusted operating 
profit (25%) 
  Group adjusted 
profit before tax 
(25%) 

  Group adjusted 
ROCE (50%). 

  The maximum award that may be made to executive directors is 300% of salary  
  If the threshold level of performance is achieved across all metrics, 15% of the award will vest. 
Awards made in 2015 and vesting in 2018 
  50% relates to the ROCE performance achieved in the final year of the performance period: the threshold 

requirement for ROCE performance is 12.6% and full vesting requires ROCE performance of 15.6%, both being 
in excess of our weighted average cost of capital 

  50% relates to EPS growth over the three-year performance period: the threshold requirement is 6% compound 

growth p.a. and full vesting of that element requires 15% compound growth p.a. 

Awards made from 2016 
  25% relates to Food & Beverage Solutions adjusted operating profit, consistent with the desire to grow our Food 
& Beverage Solutions segment and investment case. Threshold is 8% and full vesting requires 13% compound 
growth p.a. 

See page 83 

  25% relates to Group adjusted operating profit, a key performance metric to drive sustainable long-term 

profitable growth. Threshold is 5% and full vesting requires 10% compound growth p.a. 

  50% relates to Group adjusted ROCE, driving efficient investment for value-added returns from the total 
business. Threshold is 12% and full vesting requires 16% in the final year of the performance period 
  Executive directors will be required to hold shares for a two-year period after the end of the three-year 
performance period (i.e. the combination of performance and holding period will be five years in total), 
demonstrating a strong long-term alignment with shareholder interests. 

To focus on sustainable value creation over time and to strengthen long-term alignment of interests between 
senior executives and the Group’s shareholders 

  Shareholding 
requirements 
  Claw back/malus 
  Overriding factors. 

  Executive directors are subject to individual minimum share ownership requirements which must be retained 

for the duration of employment: Chief Executive (4x salary); Chief Financial Officer (3x salary) 

  Share ownership requirements extend to Executive Committee members (at three times base salary), and to a 

broader group of executives in senior leadership roles (at a level equal to their base salary) 

  Claw back and malus provisions apply for two years following bonus awards or the vesting of PSP awards 
  Safety and broader corporate responsibility matters are specific factors that the Committee may factor into 

decisions on pay and annual incentive plan outcomes. 

1  Food & Beverage Solutions metrics relate to the reportable segment. 

www.tateandlyle.com  77 
www.tateandlyle.com  77

Strategic ReportGovernanceFinancial StatementsUseful Information 
 
 
 
 
Directors’ Remuneration Report continued 

Directors’ Remuneration Policy 
The Directors’ Remuneration Policy (Policy) was formally approved by shareholders at the AGM on 27 July 2017 (with 97% of votes cast to 
support the resolution) and it remains our intention that the Policy will apply for a period of three years from the date of that AGM. 

No changes have been made to the Policy, and we intend to operate within this Policy during the financial year ending 31 March 2019. 
The Policy is published on pages 78 to 85 of our Annual Report 2017, and is available on the Company’s website 
(www.tateandlyle.com/annualreport2017). 

The Committee retains discretion on specific aspects of Policy and implementation, as described in the Policy, along with an overriding 
discretion to determine bonus outcomes and judge the level at which share awards vest, to ensure that payments are consistent with the 
underlying financial health and performance of the business, within the maximum opportunity stated in the policy tables. 

The Committee may make minor changes to the Policy without seeking shareholder approval, for example, to benefit the administration 
arrangements, or to take account of changes in legislation. Any such changes would be disclosed in the relevant Annual Report. 

Service contracts 
The Group’s policy regarding executive directors’ service contracts and appointment terms is to take account of market practice, and to 
ensure that provisions in relation to notice periods or termination payments are not excessive, as well as to ensure that contracts provide 
appropriate protection for the Group, for example, in relation to restrictions on competition, solicitation of customers or employees, and 
the protection of intellectual property. Executive directors are employed under service contracts that provide for six months’ notice from 
the executive and 12 months’ notice from the Group. 

The Chairman and non-executive directors have letters of appointment and do not have service contracts or notice periods. Under the 
terms of their appointment, they are usually expected to serve on the Board for between three and nine years, subject to their re-election 
by shareholders. The Chairman and non-executive directors receive a fee for their services, and do not participate in the Group’s incentive 
or pension schemes, do not receive any other benefits, and have no right to compensation if their appointment is terminated. 

Service contracts for executive directors and letters of appointment for the Chairman and non-executive directors are available for 
inspection at the Company’s registered office. 

Executive directors’ external appointments 
The Board believes that the Group can benefit from executive directors holding external non-executive directorships. Such appointments 
are subject to approval by the Board and are normally restricted to one position for each executive director. Fees may be retained by the 
executive director concerned.  

78  Tate & Lyle PLC Annual Report 2018
78 
Tate & Lyle PLC Annual Report 2018 

 
 
 
Annual Report on Remuneration 

Statement of shareholder voting 
The Remuneration Policy was approved by shareholders at the AGM on 27 July 2017. The last Annual Report on Remuneration was 
approved by shareholders at the AGM on 27 July 2017. The following voting outcomes were disclosed after the AGM: 

Resolution 
Directors’ Remuneration Policy  
Annual Report on Remuneration 

Total for  
(number of 

votes)   
295 458 658   
291 846 638   

Total against 
(number of 

votes)   
8 622 530   
12 218 602   

% of vote   
97.16   
95.98   

Votes   
withheld1 
(number of  
 votes)  
79 6622 
6102 

% of vote   
2.84   
4.02   

1  Votes withheld are not counted in the calculation of the proportion of votes for or against a resolution.  
2  On 27 July 2017, there were 465,684,612 ordinary shares in issue, excluding treasury shares. 

Implementation of the Remuneration Policy in the financial year ending 31 March 2019 
The Committee intends that the Policy approved by the shareholders at the AGM on 27 July 2017, will apply for a period of three years from 
that date.  

Resolution to approve the Annual Report on Remuneration at the 2018 AGM 
A resolution to approve this Annual Report on Remuneration will be proposed at the AGM on 26 July 2018. 

The Remuneration Committee 

Meetings during the year  
The Remuneration Committee comprised the following independent non-executive directors during the year: Anne Minto (Chair),  
Paul Forman, Lars Frederiksen, Jeanne Johns (until 31 October 2017), and Dr Ajai Puri. The Committee met seven times during the year. 
Membership and attendance during the year are set out on page 60. 

The Committee met twice after the end of the financial year, and before the signing of this Annual Report. The Company Secretary serves 
as secretary to the Committee. The Chairman of the Board; the Chief Executive; the Executive VP, Human Resources; the VP, Global 
Compensation and Benefits; and the Executive VP, General Counsel are normally invited to attend meetings to assist the Committee, 
although none is present or involved when his or her own remuneration is discussed. The Committee’s external advisor (Deloitte LLP) 
attends each meeting to provide independent advice, and also provides regular updates to the Committee on relevant corporate 
governance and market-related developments. 

Main responsibilities of the Remuneration Committee  

  The Committee has a formal calendar of items for consideration. The main responsibilities of the Committee include: 

    Assessing the appropriateness of executive remuneration in  
the context of the Group’s strategy and priorities as well as 
overall competitiveness, taking into account data from 
independent, external sources 

  Setting the detailed remuneration of the executive directors, 

designated members of senior management, and the Company 
Chairman (in consultation with the Chief Executive), including: 
base salary or fees; annual bonus; long-term incentives; 
benefits; and contractual terms 

  Setting performance targets for awards made to senior 

executives under the annual bonus plan and the long-term 
incentive plan, and reviewing performance outcomes 
  Reviewing the broader operation of the annual bonus and 

Performance Share Plans, including participation and overall 
award levels 

  Reviewing its own effectiveness each year. 

  The Committee’s terms of reference, which are reviewed annually, are available on the Company’s website, www.tateandlyle.com. 

Committee advisor 
The Committee appointed Deloitte LLP to act as our external advisor following a review and competitive tender process during 2012.  
As part of its annual processes, the Committee considered and confirmed that advice received during the year from Deloitte LLP was 
objective and independent. Deloitte LLP is a signatory to the Remuneration Consultants’ Code of Conduct; this gives the Committee 
additional confidence that the advice received is objective and independent of conflicts of interest. Fees charged by Deloitte LLP for the 
provision of remuneration advice to the Committee amounted to £51,700 for the year ended 31 March 2018, with fees being charged  
on a time incurred basis. During the year ended 31 March 2018, Deloitte LLP also provided services to the rest of the Group on corporate 
finance, consulting, systems, tax compliance and accounting. 

www.tateandlyle.com  79 
www.tateandlyle.com  79

Strategic ReportGovernanceFinancial StatementsUseful Information 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
Directors’ Remuneration Report continued 

Chart showing total shareholder return and Chief Executive’s pay  
The chart illustrates the cumulative total shareholder return (TSR) performance of the Company against the FTSE 100 and FTSE 250 
Indices over the past nine years. These Indices are considered to provide an appropriate comparison as they represent a broad equity 
market with constituents comparable in size and complexity to the Company over the period to which the chart relates. The graph shows 
the value of £100 invested in each Index and the Company in the nine years from 31 March 2009. 

 Tate & Lyle PLC (ordinary shares)
450

 FTSE 100

 FTSE 250

)
£
(
d
e
t
s
e
v
n

i

0
0
1
£
f
o
e
u
l
a
v
d
e
x
e
d
n

I

400

350

300

250

200

150

100

50

0
31 March 
31 March 
2009 
2009

31 March 
31 March 
2010 
2010

31 March 
31 March 
2011 
2011

31 March 
31 March 
2012 
2012

31 March 
31 March 
2013 
2013

31 March 
31 March 
2014 
2014

31 March 
31 March 
2015 
2015

31 March 
31 March 
2016 
2016

31 March 
31 March 
2017 
2017

31 March 
31 March 
2018 
2018

Chief Executive’s1 total remuneration (£000s per single figure table) 

Javed Ahmed 

977    

3 277    

11 1982   

5 367    

2 728    

1 312    

nil    

170    

n/a    

n/a    

996    

n/a    

2 139    

3 239    

n/a    

n/a    

Iain Ferguson 

Annual bonus 
(% of 
maximum) 
LTI vesting (% 
of maximum) 

86%    

100%    

58%    

18%    

1.6%    

0%    

77%    

80%    

0%    

81%    

100%    

100%    

67.7%    

0%    

10.9%    

50%    

1  Javed Ahmed served as Chief Executive since his appointment on 1 October 2009 until 1 April 2018. Iain Ferguson was Chief Executive prior to 1 October 2009.  
2  The total remuneration figure shown for the year ended 31 March 2012 includes one-off compensatory appointment awards.  

Comparison of movement in Chief Executive and broader employee remuneration  

Change in value: year ended 31 March 2018 vs 31 March 2017 
Chief Executive 
Broader employee population2 

Base salary   
0%   
3%   

Value of 
benefits1    Annual bonus3 
-10% 
-8% 

-2%   
8%   

1  No changes to benefit policies were made in respect of the Chief Executive or employees during the year. The percentage change in the employee benefits figure is the 

result of differences in employee participation levels and changes in the cost of insured benefits, including healthcare. 

2  The broader employee population refers to a global population of salaried employees for salary comparison and the UK employee population for the benefits 

comparison, reflecting the context in which executive directors’ salaries and benefits are determined. For the bonus comparisons, it refers to the global group of 
participants in the annual bonus plan so that the combination of business performance across our divisions that contributes to the Group’s results is appropriately 
represented. 

3  Includes deferred shares where applicable. 

Relative importance of spend on pay  

Remuneration paid to or receivable by employees of the Group (continuing operations) 
Distributions to shareholders (by way of dividend and purchase of ordinary shares) 

Year ended  
31 March 2018   
£336m   
£158m   

Year ended  
31 March 2017   
£328m   
£148m   

% change 
2.4%  
6.8% 

The year-on-year variance in employee remuneration is attributable to factors including foreign exchange rate movements (reflecting our 
significant US employee base) as well as variable pay arrangements driven by Group financial performance. 

See Notes 10, 14 and 22 for further information. 

80  Tate & Lyle PLC Annual Report 2018
80 
Tate & Lyle PLC Annual Report 2018 

3 672   
n/a   

72%   

100%   

 
  
  
  
  
  
  
  
  
  
 
 
  
  
  
  
 
 
 
   
 
 
  
 
 
 
 
 
 
 
Directors’ salaries and fees  

Base salary 
Nick Hampton was appointed Chief Executive with effect from 1 April 2018 (previously Chief Financial Officer). As Chief Executive,  
Nick Hampton receives an annual salary of £665,000 from 1 April 2018.  

Imran Nawaz has been appointed Chief Financial Officer with effect from 1 August 2018 and will receive an annual salary of £470,000.  

Executive directors’ external appointments  
Nick Hampton was appointed as a non-executive director of Great Portland Estates plc on 17 October 2016, and received fees of £69,350 in 
the year to 31 March 2018 which he is entitled to retain. 

Chairman’s and non-executive directors’ fees  
Fees are reviewed annually, in accordance with our stated Policy, by the Committee (excluding the Chairman) in respect of the Chairman’s 
fee, and by the Chairman and the executive directors in respect of other non-executive directors’ fees. 

At the 2018 review, taking into account the competitiveness of current fees against the comparable market position, and the time 
commitment required of each role and the level of increase applicable to UK employees, it was agreed that fees would be increased as 
summarised in the table below. 

Fees (per annum) as at 1 April (£) 
Basic fees 
Non-executive director 
Senior Independent Director 
Supplemental fees (per annum) 
Chair of Audit Committee 
Chair of Remuneration Committee 
Chair of Research Advisory Group 

2018   

2017   

% change 

68 000   
78 800   

18 050   
13 550   
25 200   

66 350   
76 900   

17 600   
13 200   
24 600   

2.5% 
2.5% 

2.5% 
2.5% 
2.5% 

Dr Gerry Murphy (appointed Chairman on 1 April 2017) receives a total annual fee of £350,000 which will not be reviewed until 2019. 

Annual bonus 

Overview 

  The bonus is based on performance against three objectives: Group profitability; Food & Beverage Solutions volume growth; and Group 
operating cash flow. Before any bonus is payable, a minimum level of Group profit must be achieved, regardless of performance 
against the other metrics. 

For each performance metric, there is a corresponding multiplier, which varies between threshold, target and stretch levels of 
performance. Once the minimum profit level is achieved, bonuses are calculated by applying the multipliers, which have the effect of 
increasing or decreasing the value of the bonus depending on performance against each metric in turn. 

Target bonus  
(% of base salary) 
Chief Executive 
(75%)  
Chief Financial 
Officer (50%) 

Step 1 
Profitability 
multiplier (once 
minimum level is 
achieved) 

X 

Step 2 
F&B Solutions 
volume growth 
multiplier 

X 

Step 3  
Operating cash 
flow multiplier 

X 

= 

Bonus achieved 
(as % of base 
salary) 

At target level of performance, the multiplier is one for each metric, so if performance is ‘at target’ against each metric, the result is a 
‘target’ bonus outcome. To achieve the maximum payout, performance against all three metrics must be at or above the stretch level. 
Profit performance is the most important of the three metrics, so multipliers for the profitability factor are more heavily geared than for 
the other two metrics, that is, improvements in profitability have a significantly greater impact on bonus payments. All multipliers and their 
weightings are agreed by the Committee when targets are set at the start of the year, reflecting the importance of each of the metrics in 
the context of the progress made against the Group’s long-term business strategy. 

The maximum bonus opportunity is 175%. Above a certain level of performance, the bonus calculation for the Chief Executive is made on 
the basis that the bonus ‘target’ is 50% (rather than 75%) of salary. 

Malus and claw back provisions 
Both the cash and share elements are subject to malus and claw back provisions for a period of 24 months following the award. This 
means that they may be recouped in whole or in part, at the discretion of the Committee, in the exceptional event that results were found 
to have been misstated or if an executive director commits an act of gross misconduct. 

www.tateandlyle.com  81 
www.tateandlyle.com  81

Strategic ReportGovernanceFinancial StatementsUseful Information 
 
 
 
   
   
 
 
 
 
   
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Directors’ Remuneration Report continued 

Deferral into shares 
The bonus amount up to 100% of base salary is paid in cash. The excess above 100% of base salary is paid in the form of deferred shares. 
The shares are released after two years subject to the executive director remaining in service with the Group, and carry the right to receive 
a payment in lieu of dividend between award and release. Both the cash and share elements are subject to malus and claw back 
provisions, as set out above. 

Overview for the year ended 31 March 2018 

  Awards are linked to stretching 

financial targets set at the start of 
the year against key metrics: 
  Group profit – measures the underlying 

profit generated by the total business and 
whether management is converting growth 
into profit effectively 

  Food & Beverage Solutions volume – 

measures whether management is growing 
the Food & Beverage Solutions segment 
  Group operating cash flow – provides a 
focus on managing working capital and 
converting profit into cash effectively. 

    Bonus awards reflect strong underlying financial performance 
  13% increase in adjusted profit before tax at constant currency with profit growth 

in all businesses 

  8% increase in Food & Beverage Solutions profit1 to £137 million, with good 

volume and New Products momentum 

  5% increase in Sucralose profit1 to £55 million 
  30% increase in Primary Products profit1 to £166 million, 11% profit1 growth in 

main business, Commodities £24 million higher 

  7% increase in earnings per share2 at constant currency 
  £53 million higher Group statutory profit before tax with improved trading and 

lower exceptional costs 

  Net debt £60 million lower, with adjusted free cash flow £22 million higher at  

£196 million. 

1  Adjusted operating profit, percentage change in constant currency.  
2  Adjusted diluted earnings per share from continuing operations. 

Annual bonus for the year ended 31 March 2018 (audited) 
The table below provides further information on each metric, the targets set at the start of the year and actual performance for the year.  

Bonus objective 

  Profitability 

  Growth 

  Cash management 

  Adjusted profit before tax 

  Food & Beverage Solutions volume    Adjusted operating cash flow 

  Adjusted profit before tax, 
exceptional items, amortisation and 
net retirement benefit interest 

  Measures the underlying profit 
performance of the total business  

  Volume targets are set relative to 
prior year performance  

  Adjusted group operating cash flow, 
based on the average of half-year and 
full-year figures 

  Measures whether management is 
growing the Food & Beverage 
Solutions business  

  Measures effective management of 
working capital and effective 
conversion of profit into cash  

Metric 

Definition 

Rationale 

Threshold 

Target 

Stretch 

  £282m 

  £297m 

  £310m 

Actual performance1 

  £319m 

  Equal to prior year 

  +4% vs prior year 

  +5% vs prior year 

  +3% vs prior year 

  £261m 

  £281m 

  £301m 

  £321m 

1  Bonus targets are set and actual performance is assessed at constant (budget) exchange rates, reflecting consistent practice with prior years.  

The Committee also considers the Group’s safety and overall financial performance to ensure that the results are a true reflection of  
the underlying strength and performance of the Group. On the basis of these performance outcomes, annual bonus awards of 72% of 
maximum, equivalent to 126% of base salary, were awarded by the Committee to the Chief Executive (Javed Ahmed) and the Chief 
Financial Officer (Nick Hampton) for the year ended 31 March 2018. No discretion has been exercised by the Committee in relation to  
these awards. 

The bonus amount up to 100% of base salary is paid in cash and the balance is paid in the form of deferred shares as described above.  

Bonus arrangements for the coming year 
This overall framework will be retained for the year ahead (the profit metric will be aligned with our corporate reporting, no longer adjusted for 
retirement benefit interest); the overall bonus framework gives the greatest weighting to the Group profit metric, and retains the requirement 
that a minimum level of profit must be achieved before any bonus is payable regardless of performance against other metrics. 

The Board considers that bonus targets for the year ahead are commercially sensitive because they may reveal information about the 
business plan that may damage our competitive advantage, and accordingly does not disclose these on a prospective basis. However,  
we continue our practice of reporting targets in full, and the level of performance actually achieved, for the year just ended. 

As noted in my introductory statement, the Committee expects to review our current remuneration arrangements during the year ahead to 
ensure these support the business priorities established by Nick Hampton, Chief Executive. At this stage, we expect any changes to be 
within the scope of our existing Policy, but we will consult with shareholders in respect of any material changes that are proposed for the 
subsequent financial year, as appropriate, later in the year.  

82  Tate & Lyle PLC Annual Report 2018
82 
Tate & Lyle PLC Annual Report 2018 

 
 
 
 
 
 
 
 
 
Long-term incentive – Performance Share Plan (PSP) 

Overview 
The PSP provides a share-based incentive to closely align executive directors’ and senior executives’ interests with the strategy and with 
the interests of shareholders over the long term. It is therefore an important component of the overall package.  

Maximum award level 
Since the 2010 AGM, awards to executive directors and other senior executives have been granted at the discretion of the Committee, with 
flexibility for the Committee to make awards of up to 300% of base salary where necessary to ensure market competitiveness, while taking 
into account Group performance. Individual awards made in any year are considered by the Committee on a case-by-case basis.  

Performance conditions for awards made in 2015 
The release of awards depends on the Group’s performance during the three-year performance period beginning on 1 April in the year of 
the award. For awards made in the years 2010 to 2015 (inclusive), the performance conditions comprised two elements, explained in the 
table below. These metrics were selected following the review and consultation with shareholders at that time, as they represented key 
drivers of shareholder value creation for the Group as a whole. 

Metric 

Definition 

  Earnings per share (EPS) 

  Return on capital employed (ROCE) 

  Compound annual growth rate (CAGR) of the Group’s 
adjusted diluted EPS from continuing operations over the 
performance period 

  Adjusted ROCE on continuing operations achieved at the 
end of the three-year performance period1, 2 

Weighting 

  50% of the award depends on this metric 

  50% of the award depends on this metric 

Vesting schedule    EPS performance (CAGR) 

  Vesting outcome  
(% of maximum) 

  ROCE performance 

  Vesting outcome  
(% of maximum) 

  Below 6% 

  6% 

  Nil 

  15% 

  Below 12.6% 

  12.6% 

  Nil 

  15% 

  Between 6% and 15% 

  On a straight line between 
15% and 100% 

  Between 12.6% and 15.6% 

  On a straight line between 

15% and 100% 

  At or above 15% 

  100% 

  At or above 15.6% 

  100% 

1  The ROCE outcome may be adjusted downward in the event of an asset impairment (adding this back into capital employed); this is to encourage a prudent investment 

strategy. In these circumstances, the ROCE figure for PSP purposes can be significantly lower than would otherwise be reported. 

2  ROCE performance for awards made in 2015 is assessed on the basis of proportionate consolidation of joint ventures, consistent with the basis on which targets were 

set for these awards prior to their grant.  

Before any shares are released, the Committee must also be satisfied that the level of vesting determined by performance against these 
targets is justified by the broader underlying financial performance of the Group. 

2015 PSP awards vesting by reference to the period ended 31 March 2018 (audited) 
PSP awards made in 2015 were dependent on EPS growth and ROCE targets as described above, with each condition applicable to half of 
the award. Performance against these conditions and the vesting outcome is indicated in the table below. 

Performance condition 

  Threshold 

  Stretch 

Performance 
outcome 

  Combined vesting outcome 

Adjusted Group ROCE1 on continuing 
operations (50%) 

Adjusted Group EPS CAGR from 
continuing operations (50%) 

  12.6% 

  15.6%1 

17.5% 

  6.0% 

  15.0% 

16.1% 

As EPS and ROCE performance outcomes are 
each above the corresponding ‘stretch’ levels,  
the PSP awards made in 2015 will vest in full 

  ROCE performance is shown under proportionate accounting consistent with the basis on which the targets for the 2015 award were established. 

The performance period applicable to 2015 awards is 1 April 2015 to 31 March 2018. Over this period, the business has maintained clear 
principles in relation to the disciplined use of capital, and ROCE performance of 17.5% (under proportionate accounting) will result in this 
element being paid at stretch. Over the same period, the earnings per share performance of 16.1% will result in 100% of the total award 
being permitted to vest. No discretion has been exercised by the Committee in relation to this outcome. 

In confirming the vesting outcome, the Committee also considered the broader underlying financial performance of the Group over the 
performance period, including the impact of impairments, to ensure that vesting results based on these performance outcomes are 
consistent with a broader view of the financial health and performance of the business. 

www.tateandlyle.com  83 
www.tateandlyle.com  83

Strategic ReportGovernanceFinancial StatementsUseful Information 
 
 
 
 
 
 
 
Directors’ Remuneration Report continued 

Performance conditions for awards made in 2016 and 2017 
The Performance framework was reviewed in 2016 to ensure continued alignment with the Group strategy and long-term growth plans following 
the structural changes in the business in 2015. The metrics adopted aligned the PSP with our strategic priorities to deliver long-term value by: 

  Incentivising overall growth in the value of the Group and above-market growth in our higher value Food & Beverage Solutions business 

(half the award relates to Group and Food & Beverage Solutions profit growth metrics) 

  Incentivising the maintenance of a strong balance sheet and the efficient deployment of Group capital (a ROCE metric applies to half the award). 

Appropriate threshold and stretch targets for each of these metrics were considered carefully by the Committee taking into account a 
number of reference points, described in summary below. Overall, performance at these levels requires our Food & Beverage Solutions 
(and Sucralose) and Primary Products (PP) businesses to perform strongly in their respective markets. 

We consulted with a broad group of our largest shareholders on these proposals, which were met with high levels of support during that 
consultation, and were strongly endorsed by shareholders at the 2016 AGM. 
 See pages 74 and 75 of our 2016 Annual Report for more details. 

Metrics for Awards 
since 2016 (weighting) 

  Rationale for metric 

Target range 
(threshold-stretch) 

  Rationale for target ranges 

F&B Solutions adjusted 
operating profit (25%) 

  Consistent with the  
F&B Solutions growth-
led business strategy 
and investment case 

Group adjusted profit 
before tax (25%) 

  Key performance 
metric to drive 
sustainable long-term 
profitable growth 

  8% – 13% p.a. three-
year compound growth 

    Targets above-market F&B Solutions growth and significant 

New Product sales  

  Value generative in the context of global market growth of  

4-5% and our historic operating profit growth trend of c. 7%. 

  5% – 10% p.a. 
three-year compound 
growth 

    Targets are consistent with execution of Group strategy: 
steady earnings from PP as described in 2016, with 
profitable F&B Solutions growth ahead of the market 

  Targets aligned with our long-term plan and the realities of 
our operating model (without growth investment in PP, and 
recognising US sweetener market is in structural decline). 

Group adjusted ROCE 
(50%) 

  Drives efficient 
investment for value-
added returns from the 
total business 

  12% – 16% in the final 
year of the three-year 
performance period 

    Reflects geographic footprint (post exit from European  

PP business) 

  Incentivises ROCE performance in excess of our cost of 

capital and progression over time. 

Financial underpin 

  Before any shares are released, the Committee must also be satisfied that the level of vesting determined by 
performance against these targets is justified by the broader underlying financial performance of the Group. 

Recognising the importance of the dividend to our investors, the Committee retains a specific discretion to reduce PSP 
vesting if dividends paid by the Group over the performance period do not conform with our stated dividend policy. 

Note: Food & Beverage Solutions metrics relate to the reportable segment. 

Targets are set and performance is assessed at reported exchange rates.  

The level of vesting at threshold is limited to 15% of the maximum for executive directors. 

The Committee reviews the appropriateness of metrics and targets ahead of the grant of awards in any year to ensure they remain 
sufficiently stretching. 

As noted in my introductory statement, we do not propose any changes to our arrangements for the year ahead. During the coming year, 
the Committee expects to review our remuneration arrangements to ensure they support the business priorities established with Nick 
Hampton’s succession as Chief Executive. At this stage, we expect any changes to be within the scope of our existing Policy, and we will 
consult with shareholders, as appropriate, later in the year in respect of any changes that are proposed for the subsequent financial year 
(ending 31 March 2020). 

Post-vesting holding period  
For awards made in 2016 and subsequently, executive directors are required to hold shares for a two-year period after the end of the 
three-year performance period (i.e. the combination of performance and holding period is five years in total). This holding period sits 
alongside the existing personal shareholding requirements and claw back/malus provisions, and demonstrates a strong long-term 
alignment with shareholder interests. 

Malus and claw back provisions 
Awards made under the PSP from 1 April 2013 are subject to malus and claw back provisions for a period following the vesting date and 
extending to the fifth anniversary following the date of grant. During this period, the Committee may determine that an award will lapse 
wholly or in part (or may require that a participant shall repay up to 100% of the value of any award that has vested by virtue of 
performance), in the event of circumstances including the following: material misstatement of financial results; misconduct which 
justifies, or could justify, summary dismissal of the participant; or if information emerges which would have affected the value of the 
original award that was granted to a participant, or the level at which the performance conditions were judged to have been satisfied. 

84  Tate & Lyle PLC Annual Report 2018
84 
Tate & Lyle PLC Annual Report 2018 

 
 
Executive director changes during the year 

Nick Hampton – appointed Chief Executive 
As announced on 16 January 2018, Nick will receive an annual salary of £665,000 from 1 April 2018, subject to annual review. His pension 
allowance remains at 25% of salary, reflecting the contractual commitment made on appointment in 2014 (and representing a reduction 
against the established policy for the CEO role of 35% of salary). His maximum level of award under the annual bonus and PSP as a 
percentage of salary are not changing from those applicable to his role as CFO. Target bonus opportunity is 75% of salary (consistent with 
our Policy for the CEO role). These arrangements provide fixed compensation that is circa 15% lower than the previous CEO. 

Imran Nawaz – appointed Chief Financial Officer 
Imran Nawaz was appointed Chief Financial Officer with effect from 1 August 2018 and his remuneration details were provided on the 
announcement of his appointment on 17 April 2018. He will receive an annual salary of £470,000. He will receive a company contribution  
to his pension plan of 20% of base salary (being a reduction against the established policy level of 25% for the Chief Financial Officer role). 
He will also be eligible for a bonus under Tate & Lyle’s discretionary bonus scheme (50% of salary at target and a maximum opportunity of 
175% of salary), with bonus participation in the financial year ending 31 March 2019 being on a time pro-rated basis. Imran will be eligible 
to participate in the PSP with annual awards at up to 300% of base salary, subject to performance conditions over a three-year period.  

Consistent with our shareholder-approved Policy on the terms of directors’ appointment, we have made provision to compensate Imran 
for specific short-term and long-term incentives given up by him as a consequence of him leaving his former employer. As announced, 
these compensatory awards comprised a one-off Restricted Stock Award (RSA) of £800,000 worth of shares in Tate & Lyle PLC (subject to 
employment and subject to achievement of individual business performance conditions); and we have agreed that in 2018, he will receive a 
PSP award at 300% of his full annual salary subject to normal PSP performance conditions. 

The RSA and 2018 PSP awards will be subject to forfeiture/repayment if he ceases to be employed in the first 36 months of employment 
due to his resignation or dismissal for cause. 

Imran will receive practical relocation assistance including a taxable allowance of £200,000 (gross; being £106,000 estimated net) within  
a 12-month period following appointment in line with the Company’s relocation policy – to mitigate the many expenses expected to be 
incurred on relocation from Zurich, including stamp duty and equivalent home sale and purchase fees, and taxes and estate agency fees. 

Remuneration Policy scenarios for the year ahead 
The overall impact of these executive director appointments, and the reduction in pension provision against policy levels and the operation 
for our incentive plans for the year ahead, is that the total compensation opportunity for each of these roles has reduced year-on-year. The 
charts below illustrate the value that may be delivered from each element of the package under different performance scenarios for the 
year ending 31 March 2019. 

  Chief Executive (£000s) – Nick Hampton 

Chief Financial Officer (£000s) – Imran Nawaz1 

£848

£1 210

£2 345

£4 007

XX%

50%

29%

21%

XX%

43%

21%

36%

5%

25%

70%

100%

Total
£4m

£3m

£2m

£1m

£0m

Total
£4m

£3m

£2m

£1m

£0m

£577

£818

£1 517

£2 810

50%

29%

21%

XX%

XX%

4%

26%

70%

100%

47%

15%
38%

Below 
threshold

Threshold

Target

Stretch

Below 
threshold

Threshold

Target

Stretch

   Base and benefits  Annual bonus  Performance Share Plan 

1  Imran Nawaz will join the Company on 1 August 2018; the illustration shows the full annualised value of the core remuneration package for comparison. 

Javed Ahmed – retires as Chief Executive 
As announced on 16 January 2018, Javed Ahmed retired as Chief Executive and ceased employment with the Company on 1 April 2018. 
Arrangements relating to his departure were disclosed at the time and are set out on page 87. 

www.tateandlyle.com  85 
www.tateandlyle.com  85

Strategic ReportGovernanceFinancial StatementsUseful Information 
 
 
 
 
 
 
 
 
 
 
 
 
Directors’ Remuneration Report continued 

Other audited disclosures  

Single figure table (audited) 

£000s 
Year ended 31 March 

Salary/fees 
2018 

2017   

Chairman 

Benefits1 
2018 

  Annual bonus 

  Share awards 

Pension 

Total 

2017   

20182 

2017   

2018 

2017   

2018 

2017   

2018 

2017 

Dr Gerry Murphy 

350 

88   

– 

–   

– 

–   

– 

–   

– 

–   

350 

88 

Executive directors 

Javed Ahmed3 

Nick Hampton4 
Non-executive 
directors6 

Paul Forman 

Lars Frederiksen 

Douglas Hurt 

Anne Minto 

Dr Ajai Puri 

Sybella Stanley 

Former directors7 

Sir Peter Gershon 

William Camp 

Liz Airey 

Jeanne Johns 

721 

526 

721   

513   

41 

13 

42   

13   

908 

1 009    1 7505 

1 215  

662 

808    1 4445 

1 676  

252 

131 

252   

3 672 

3 239 

128   

2 776 

3 138 

66 

66 

95 

80 

91 

66 

– 

– 

22 

46 

65   

65   

84   

78   

89   

65   

334   

76   

72   

28   

– 

– 

– 

– 

– 

– 

– 

– 

– 

– 

–   

–   

–   

–   

–   

–   

–   

–   

–   

–   

– 

– 

– 

– 

– 

– 

– 

– 

– 

– 

–   

–   

–   

–   

–   

–   

–   

–   

–   

–   

– 

– 

– 

– 

– 

– 

– 

– 

– 

– 

–   

–   

–   

–   

–   

–   

–   

–   

–   

–   

– 

– 

– 

– 

– 

– 

– 

– 

– 

– 

–   

–   

–   

–   

–   

–   

–   

–   

–   

–   

66 

66 

95 

80 

91 

66 

– 

– 

22 

46 

65 

65 

84 

78 

89 

65 

334 

76 

72 

28 

Totals 

2 129 

2 278   

54 

55   

1 570 

1 817   

3 194 

2 891   

383 

380   

7 330 

 7 421 

1  Benefits for executive directors include health insurance and car allowance. 
2  Bonus includes the value of deferred shares (based on the average share price over the period 1 January – 31 March 2018). The cash bonus award to Javed Ahmed was 

£721,000 and the cash bonus award to Nick Hampton was £526,000. 

3  Javed Ahmed retired as Chief Executive following the end of the financial year on 1 April 2018 (see page 87). 
4  Nick Hampton served as Chief Financial Officer during the year, and was appointed Chief Executive following the end of the financial year on 1 April 2018 (see page 85). 
5  This is the PSP Award made in 2015. PSP awards outcomes are discussed on page 83, and the value is included in the table above based on a share price of £5.98, 

being the closing share price on 21 May 2018 when the Remuneration Committee determined performance conditions were met. For Nick Hampton, this also includes 
the value from SAYE awards on release from the 2014 SAYE scheme. 

6  In accordance with the Group’s expenses policies, non-executive directors receive reimbursement for their reasonable expenses for attending Board meetings.  

In instances where those costs are treated by HMRC as taxable benefits, the Group also meets the associated tax cost to the non-executive director through a PAYE 
settlement agreement with HMRC. Amounts are minimal and do not show in the table after rounding.  

7  William Camp stepped down as Director on 31 March 2017 and Sir Peter Gershon stepped down as Chairman on 31 March 2017. Liz Airey stepped down as a Director 

on 27 July 2017. Jeanne Johns stepped down as a Director on 31 October 2017.  

Total pension entitlements (audited) 
Directors participate in arrangements that are defined contribution in nature. Contributions made to or in lieu of pension in respect of  
each director during the year are shown in the single figure table, and are equivalent to 35% of salary for Javed Ahmed as Chief Executive 
and 25% for Nick Hampton as Chief Financial Officer, reflecting contracts on appointment. Nick Hampton was appointed Chief Executive  
effective 1 April 2018 and his pension contribution will remain at 25% of salary. 

86  Tate & Lyle PLC Annual Report 2018
86 
Tate & Lyle PLC Annual Report 2018 

 
 
 
 
 
 
 
 
   
 
   
 
   
 
   
 
   
 
 
 
 
 
   
 
   
 
   
 
   
 
   
 
 
 
 
 
 
   
 
   
 
   
 
   
 
   
 
 
 
 
 
 
 
 
 
 
   
 
   
 
   
 
   
 
   
 
 
 
 
 
 
 
 
 
   
 
   
 
   
 
   
 
   
 
 
 
 
 
Payments to past directors (audited) 
As announced on 16 January 2018, Javed Ahmed retired as Chief Executive and ceased employment with the Group on 1 April 2018. His 
salary and other benefits all ceased with effect from this date.  

As previously announced, and in keeping with our shareholder approved policy, the Committee determined that Javed would retain: 

  An entitlement to bonus in relation to the year ending 31 March 2018, which was determined and will be paid in due course in line with 

full year performance (as described on page 82)  

  Deferred bonus awards, which were earned based on performance in the relevant year, may be released at the end of the relevant 

deferral period, in accordance with the applicable Scheme rules 

  Rights to previously granted awards under the PSP, which remain subject to the relevant performance criteria, and may vest on the 

normal vesting dates, on a time pro-rated basis reflecting the proportion of the three-year vesting period during which he was 
employed, in accordance with the applicable Scheme rules. 

The Committee has not exercised any discretion in relation to the assessment of any performance conditions or the timing of vesting,  
or the basis on which relevant awards will be pro-rated. 

Payments for loss of office 
There have been no other payments to past directors other than as disclosed in this Report. No loss of office payments have been made 
during the year. 

Share awards made during the year ended 31 March 2018 (audited)  

Javed 
Ahmed  

  Award 
  Group Bonus 

Plan (31 March 
2017) 

Type of 
award 
  Nil cost 
option 

  Date of grant 
  23 May 2017 

Number of 
shares 
  39 850 

Face value of 
award 
  £288 4021 

Performance 
conditions 
  None2 

Performance 
period 
  Two-year 
deferral 

% of 
vesting at 
threshold 

  n/a 

  Performance 
Share Plan3 

  Nil cost 
option 

  16 August 
2017 

  298 875 

  £2 163 018 

Nick 
Hampton 

  Group Bonus 

Plan (31 March 
2017) 

  Nil cost 
option 

  23 May 2017 

  40 739 

  £294 8361 

  Performance 
Share Plan3 

  Nil cost 
option 

  16 August 
2017 

  217 855 

  £1 576 660 

  Sharesave 
Scheme5 

  Savings-
related 
options 

  4 December 
2017 

  3 243 

  £17 998 

  25% F&B Solutions 
adjusted operating 
profit; 25% Group 
adjusted profit; 
50% adjusted 
ROCE4 
  None2 

  25% F&B Solutions 
adjusted operating 
profit; 25% Group 
adjusted profit; 
50% adjusted 
ROCE4 
  Continued 
employment 
(SAYE) 

  15% 

  Three financial 
years ending 
31 March 2020 
plus two-year 
holding period 

  n/a 

  15% 

  Two-year 
deferral 

  Three financial 
years ending 
31 March 2020 
plus two-year 
holding period 

  Three years 
ending  
1 March 2021 

  n/a 

1  Deferred shares are granted under the annual bonus plan (as described on page 82). The full value of these awards has been previously disclosed for each Director in 
the single figure’ table in last year’s Annual Report for the year ended 31 March 2017 and is similarly included in the 2017 figure in the single figure table on page 86 of 
this Report. The share allocation was made during the year ending 31 March 2018, and shown in the table above, based on the average share price over the last three 
months of the preceding financial year, being 723.72 pence per share for the 2017 award.  

2  Deferred bonus awards were subject to performance conditions in the year ending 31 March 2017, and remain subject to continued employment in accordance with the 

Scheme rules. 

3  Under the terms of the plan approved by shareholders, the number of shares comprising an award in any year is calculated based on the average share price over the 
last three months of the preceding financial year, being 723.72 pence per share for the 2017 award. In 2017, the Committee approved awards of 300% of salary for the 
Chief Executive and 300% of salary for the Chief Financial Officer, which is within our approved Remuneration Policy. 

4  Performance conditions applicable to PSP awards made in 2017 are described on page 83. 
5  Savings-related share options are options granted under the HMRC-approved Sharesave Plan. Options are granted on the same terms to all participating employees, 
are not subject to performance conditions, and are normally exercisable during the six-month period following the end of the relevant three- or five-year savings 
contract. The exercise price per share for these shares under option is 555.00 pence, reflecting a 20% discount to market value as permitted under HMRC rules, and is 
applicable to all participants. 

www.tateandlyle.com  87 
www.tateandlyle.com  87

Strategic ReportGovernanceFinancial StatementsUseful Information 
 
 
 
 
 
 
 
 
 
 
 
 
Directors’ Remuneration Report continued 

Historic awards under all-employee schemes (audited)  
The table below sets out the current position of options to subscribe for ordinary shares of the Company that were granted to executive 
directors in the years prior to the current reporting year. 

Savings-related share options are options granted under the HMRC-approved Sharesave Plan. Options are granted on the same terms to 
all participating employees, are not subject to performance conditions, and are normally exercisable during the six-month period following 
the end of the relevant three- or five-year savings contract. The exercise price reflects a 20% discount to market value as permitted under 
HMRC rules, and is applicable to all participants. 

Javed Ahmed 
Savings-related options 2014 
Nick Hampton 
Savings-related options 2014 

As at  
1 April 2017 

(number)   
5 941   

Options 
vested 
during year 

Options 
exercised 
during year 

Options 
lapsed 
during year 

(number)   
–   

(number)   
–   

(number)   
–   

As at  
31 March 
2018 

(number)   
5 941   

3 529   

3 529   

3 529   

–   

–   

Exercise 
price 
Exercise 
(pence)   
period 
510.00    01/03/20 to 
31/08/20 

510.00    01/03/18 to 
31/08/18 

Share awards made in prior years (audited)  
The table below sets out the current position of share-based awards made to executive directors. 

As at  
31 March 
2017 

(number)   

Awards 
vested 
during year 

Awards 
lapsed 
during year 

Awards 
exercised 
during year 

(number)   

(number)   

(number)   

As at  
31 March 
2018 

(number)   

Market 
price on 
date 
awards 
granted 
(pence)   

Market 
price on 
date 
awards 
exercised 

(pence)6   

Vesting date 

Javed Ahmed 
Share-incentive 
arrangements on 
recruitment: 
Compensatory Award A1 
Performance Share Plan2, 3:   
2013 
2014 
20154 
2016 
Group Bonus Plan 
2016 

Nick Hampton 
Share incentive 
arrangements on 
recruitment: 
2015 Restricted Share 
Award5 
Performance Share Plan2, 3:   
20154 
2016 
Group Bonus Plan: 
2016 

419 403   

–   

–   

419 403   

–   

444.90   

661.60   

01/10/11 

29 148   
305 584   
292 595   
374 124   

–   
152 792   
–   
–   

–   
152 792   
–   
–   

29 148   
152 792   
–   
–   

–   
–   
292 595   
374 124   

817.50   
707.83   
616.04   
578.15   

726.97   
726.97   

15/06/16 
15/06/17 
–    After 31/03/18 
–    After 31/03/19 

42 742   

–   

–   

–   

42 742   

578.15   

–   

25/05/2018 

121 781   

121 781   

–   

121 781   

–   

574.80   

726.97   

15/06/17 

241 251   
266 064   

29 368   

–   
–   

–   

–   
–   

–   

–   
–   

241 251   
266 064   

616.04   
578.15   

–    After 31/03/18 
–    After 31/03/19 

–   

29 368   

578.15   

–   

25/05/2018 

1  This award, to compensate Javed Ahmed for certain long-term incentives given up by him as a consequence of leaving his former employer, was not subject to 

performance conditions. The shares were available to exercise from 1 October 2011, being the second anniversary of Javed Ahmed joining the Group.  

2  The three-year performance period for these awards began on the first day of the financial year in which the award was granted. 
3  The performance conditions for PSP awards made in 2013, 2014 and 2015 are 50% adjusted diluted EPS and 50% adjusted ROCE, as described in this Report.  

The performance conditions for the PSP awards made in 2016 are 25% Food & Beverage Solutions adjusted operating profit; 25% Group adjusted profit; 50% adjusted 
ROCE (as described on page 84). 

4  The PSP award made in 2015 will vest at 100%, following the Committee’s assessment of performance conditions (as described on page 83). 
5  This award, as described on page 71 of the 2015 Annual Report, was made to compensate Mr Hampton for incentives forfeited with his previous employer. 
6  These awards are structured as nil cost options; awards were exercised with a nil exercise price. 

88  Tate & Lyle PLC Annual Report 2018
88 
Tate & Lyle PLC Annual Report 2018 

   
 
 
   
   
   
   
   
   
 
 
   
   
   
   
   
   
   
 
   
   
   
   
   
   
   
 
 
   
   
   
   
   
   
   
 
 
   
   
   
   
   
   
   
 
 
 
 
 
 
   
   
   
   
   
   
   
 
 
 
 
   
   
   
   
   
   
   
 
 
   
   
   
   
   
   
   
 
 
   
   
   
   
   
   
   
 
 
   
   
   
   
   
   
   
 
 
 
 
   
   
   
   
   
   
   
 
 
 
 
Statement of Directors’ shareholding and share interests (audited) 

Personal share ownership requirements (policy on executive share ownership)  
The Committee and executive management believe that personal investment in Company shares is an important part of our overall 
remuneration framework. Material personal investment in Company shares serves to strengthen the long-term alignment of interests 
between senior executives and shareholders. 

Our executive shareholding requirements are more demanding and extend to a greater number of senior executives in the Group when 
compared with similar UK-listed companies. 

  The Chief Executive has a target share ownership requirement of four times base salary. At 31 March 2018, Javed Ahmed held shares  

in accordance with this policy with a value just under 30 times base salary 

  The Chief Financial Officer has a target shareholding of three times base salary, to be achieved within five years of appointment.  

Nick Hampton joined the Group in September 2014, and at 31 March 2018, he held shares in accordance with the policy with a value  
of just under three times base salary as Chief Financial Officer 

  Other Executive Committee members are subject to the share ownership policy, with target holdings at three times salary 
  This policy extends to a broader group of executives who have senior leadership roles within the Group. The shareholding target for this 

group is equal to their base salary. 

Under the shareholding policy, the value of shareholdings is assessed net of tax, at the prevailing share price, and executives are expected 
to reach the required level of shareholding within five years of appointment. The Committee monitors progress against the share 
ownership requirements annually. 

Directors’ interests (audited)  
The interests held by each person who was a Director during the financial year in the ordinary shares of 25 pence each in the Company  
are shown below. All these interests are beneficially held and no Director had interests in any other class of shares. The table also 
summarises the interests in shares held through the Company’s various share plans. 

Chairman 
Dr Gerry Murphy 
Executive directors 
Javed Ahmed 
Nick Hampton 
Non-executive directors 
Paul Forman 
Lars Frederiksen 
Douglas Hurt 
Anne Minto 
Dr Ajai Puri 
Sybella Stanley 
Former directors 
Liz Airey5 
Jeanne Johns5 

Interest in 

Nil cost options 
– conditional on 

shares1   

performance2   

Shares – not 
conditional on 
performance3   

Options – not 
conditional on 
performance4   

Total as at  
31 March 2018   

Total as at  
31 March 2017 

20 000   

–   

–   

–   

20 000   

10 000 

3 431 568   
190 032   

965 594   
725 170   

82 592   
70 107   

5 941   
3 243   

4 485 695   
988 552   

4 568 387 
784 154 

10 000   
15 000   
10 000   
8 600   
10 018   
4 983   

26 000   
4 000   

–   
–   
–   
–   
–   
–   

–   
–   

–   
–   
–   
–   
–   
–   

–   
–   

–   
–   
–   
–   
–   
–   

–   
–   

10 000   
15 000   
10 000   
8 600   
10 018   
4 983   

26 000   
4 000   

10 000 
15 000 
10 000 
8 600 
10 018 
3 983 

26 000 
– 

1  Includes shares owned by connected persons. 
2  Awards under the PSP. These awards were made as options with a nil exercise price. 
3  Deferred share awards made under the Group Bonus Plan. 
4  These are HMRC-approved Sharesave Plan awards. 
5  As at the date they ceased to be a Director. 

There were no changes in Directors’ interests in the period from 1 April 2018 to 23 May 2018. 

On behalf of the Board 

Anne Minto OBE 
Chair of the Remuneration Committee 

23 May 2018 

www.tateandlyle.com  89 
www.tateandlyle.com  89

Strategic ReportGovernanceFinancial StatementsUseful Information 
   
 
   
   
   
   
   
 
 
 
   
   
   
   
   
 
 
 
 
   
   
   
   
   
 
 
 
 
 
 
 
 
   
   
   
   
   
 
 
 
 
Directors’ Report  

About the Directors’ Report 

The Directors’ Report comprises the 
Governance section from pages 52 to 71, 
the Directors’ Report on pages 90 and 91 
and the Useful Information section from 
pages 177 to inside back cover. Other 
information that is relevant to the 
Directors’ Report, and which is 
incorporated by reference into the 
Directors’ Report, is disclosed as follows: 

  Likely future developments of  
the Company (throughout the 
Strategic Report) 

  Human rights (page 42) 
  Greenhouse gas emissions (pages 48 

and 49) 

  Relationship with employees (pages 

42 to 44) 

  Financial instruments (Note 29) 
  Post balance sheet events (Note 35). 

Results and dividend 
A review of the consolidated Group’s results 
can be found on the inside front cover to 
page 51.  

An interim dividend of 8.4 pence per ordinary 
share was paid on 5 January 2018. The 
Directors recommend a final dividend of  
20.3 pence per ordinary share to be paid  
on 1 August 2018 to shareholders on the 
register on 22 June 2018, subject to approval 
at the 2018 Annual General Meeting (AGM). 
The total dividend for the year is 28.7 pence 
per ordinary share (2017 – 28.0 pence).  

The Trustees of the Tate & Lyle PLC 
Employee Benefit Trust (the EBT) have 
waived their right to receive dividends over 
their total holding of 4,788,306 ordinary 
shares as at 31 March 2018. 

Research and development 
The Group spent £35 million  
(2017 – £37 million) on research  
and development during the year. 

Articles of Association 
The Articles of Association set out the 
internal regulation of the Company and 
cover such matters as the rights of 
shareholders, the appointment or removal 
of Directors, and the conduct of the Board 
and general meetings. Copies are available 
on request and are displayed on the 
Company’s website, www.tateandlyle.com.  

In accordance with the Articles of Association, 
Directors can be appointed or removed by the 
Board or by shareholders in general meeting. 
Amendments to the Articles of Association 
have to be approved by at least 75% of those 
voting in person or by proxy at a general 
meeting of the Company. Subject to UK 

90 
Tate & Lyle PLC Annual Report 2018 
90  Tate & Lyle PLC Annual Report 2018

company law and the Articles of Association, 
the Directors may exercise all the powers of 
the Company, and may delegate authorities to 
committees, and may delegate day-to-day 
management and decision making to 
individual executive directors. Details of the 
Board Committees can be found on pages 66 
to 71 and on page 79. 

Share capital 
As at 31 March 2018, the Company had 
nominal issued ordinary and preference 
share capital of £119 million comprising 
£117 million in ordinary shares, including 
£0.6 million in treasury shares and  
£2 million in preference shares.  

To satisfy obligations under employee share 
plans, the Company issued 52,068 ordinary 
shares during the year and reissued 1,010,461 
ordinary shares from treasury. The Company 
issued 2,646 shares during the period from 1 
April 2018 to 23 May 2018. Further information 
about share capital is in Note 22. Information 
about options granted under the Company’s 
employee share plans is in Note 31.  

The Company was given authority at the 2017 
AGM to make market purchases of up to 
46,468,572 of its own ordinary shares. The 
Company made no purchases of its own 
ordinary shares during the year ended  
31 March 2018, however the EBT purchased  
3.9 million ordinary shares in the year. This 
authority will expire at the 2018 AGM and 
approval will be sought from shareholders for 
a similar authority to be given for a further year. 

Restrictions on holding shares 
There are no restrictions on the transfer of 
ordinary and preference shares in the 
capital of the Company.  

No limitations are placed on the holding of 
shares and no share class carries special 
rights of control of the Company. There are 
no restrictions on voting rights other than 

those outlined in ‘Shareholders’ rights’  
on preference shares. The Company is  
not aware of any agreements between 
shareholders that may restrict the transfer 
or exercise of voting rights. 

Shareholders’ rights 
Holders of ordinary shares have the rights 
accorded to them under UK company law, 
including the rights to receive the Company’s 
annual report and accounts, attend and speak 
at general meetings, appoint proxies and 
exercise voting rights.  

Holders of preference shares have limited 
voting rights and may not vote on: the disposal 
of surplus profits after the dividend on the 
preference shares has been provided for; the 
election of Directors or their remuneration; 
any agreement between the Directors and the 
Company; or the alteration of the Articles of 
Association dealing with any such matters. 
Further details regarding the rights and 
obligations attached to share classes are 
contained in the Articles of Association which 
are available on the Company’s website, 
www.tateandlyle.com. 

Change of control 
At 31 March 2018, the Group had a 
committed bank facility of US$800 million 
with a number of relationship banks which 
contains change of control clauses. The 
Group also had £200 million of Guaranteed 
Notes and US$400 million of Private 
Placement Notes which contain change of 
control provisions. In aggregate, this 
financing is considered significant to the 
Group and in the event of a takeover (change 
of control) of the Company, these contracts 
may be cancelled, become immediately 
payable or be subject to acceleration.  

All the Company’s share plans contain 
provisions relating to a change of control. 
Further information is set out in the 
Directors’ Remuneration Policy. 

Disclosure table pursuant to Listing Rule LR 9.8.4C 
In accordance with LR 9.8.4C, the table below sets out the location of the information 
required to be disclosed, where applicable. 

Applicable sub-paragraph within LR 9.8.4 
(1) 
(2) 
(4) 
(5) 
(6) 
(7) 
(8) 
(9) 
(10) 
(11) 
(12) 
(13) 
(14) 

  Interest capitalised by the Group  
  Unaudited financial information  
  Long-term incentive scheme only involving a Director  
  Directors’ waivers of emoluments 
  Directors’ waivers of future emoluments  
  Non pro-rata allotments for cash (issuer)  
  Non pro-rata allotments for cash (major subsidiaries)  
  Listed company is a subsidiary of another company  
  Contracts of significance involving a Director  
  Contracts of significance involving a controlling shareholder  
  Waivers of dividends  
  Waivers of future dividends  
  Agreement with a controlling shareholder  

  Page(s) 
  127 
  None 
  85 and 88 
  None 
  Not applicable 
  90 
  None 
  Not applicable 
  None 
  Not applicable 
  90 
  90 
  Not applicable 

   
 
 
 
 
DTR Rule 5 disclosure 
As at 31 March 2018, the Company had 
been notified under Rule 5 of the Disclosure 
and Transparency Rules of the following 
holdings of voting rights in its shares: 

Black Rock, Inc.1 
Ameriprise  
Financial, Inc. 
Standard Life  
Aberdeen plc 
The Capital Group 
Companies, Inc. 
Artemis Investment 
Management LLP1 
AXA S.A.1 
Invesco Limited1 
Schroders plc1 
Barclays Global 
Investors1 

Number  
of shares2   

%  
 held2 
  46 514 801     9.97  

  23 767 456     5.10  

  23 463 001     5.04  

  23 129 245     4.96  

  23 045 106     4.94  
  22 890 148     4.98  
  23 111 061     4.95  
  23 098 654     4.95  

  17 568 133     3.59  

1  Notification was made over 12 months ago; as 
permitted under Rule 5, shareholders are not 
required to notify us of subsequent changes 
within certain ranges. 

2  As at the date in the notification to the Company. 

In the period from 1 April 2018 to 23 May 
2018, there have been no changes,  
notified to the Company, to the holdings  
as disclosed above. 

Political donations 
Again this year, in line with the Group’s 
policy, no political donations were made  
in the European Union (EU). Outside the  
EU, the Group’s US business made 
contributions during the year totalling 
US$26,200 (£18,700) (2017 – US$22,000; 
£17,000) to state political party committees 
or political action committees, and to the 
campaign committees of state or local 
candidates affiliated to the major parties.  
In all, nine separate donations were made, 
the largest being US$10,000 and the 
smallest US$500. 

US$12,700 (£9,000) (2017 – US$17,450; 
£13,000) was also contributed by the Tate & 
Lyle Political Action Committee (PAC). Eight 
separate donations were made, the largest 
being of US$3,000 and the smallest US$500. 
The PAC is funded entirely by US employees. 
Employee contributions are entirely voluntary 
and no pressure is placed on US employees to 
participate. No funds are provided to the  
PAC by Tate & Lyle but under US law, an 
employee-funded PAC must bear the  
name of the employing company. 

i

S
t
r
a
t
e
g
c
R
e
p
o
r
t

G
o
v
e
r
n
a
n
c
e

i

F
n
a
n
c
a
l

i

S
t
a
t
e
m
e
n
t
s

U
s
e
f
u
l

I

n
f
o
r
m
a
t
i
o
n

Directors’ Statement of Responsibilities 
The Directors are responsible for preparing 
the Annual Report, the Directors’ 
Remuneration Report and the Financial 
Statements in accordance with applicable 
law and regulation.  

The Directors are responsible for the 
maintenance and integrity of the Company’s 
website. Legislation in the UK governing the 
preparation and dissemination of financial 
statements may differ from legislation in 
other jurisdictions. 

Company law requires the Directors to 
prepare financial statements for each 
financial year. Under that law, the Directors 
have prepared the Group Financial 
Statements in accordance with 
International Financial Reporting Standards 
(IFRSs) as adopted by the EU, and Company 
Financial Statements in accordance with 
UK GAAP (United Kingdom Accounting 
Standards, comprising FRS 101 ‘Reduced 
Disclosure Framework’ and applicable law). 
Under company law the Directors must not 
approve the financial statements unless 
they are satisfied that they give a true and 
fair view of the state of affairs of the 
Company and the Group and of the profit or 
loss of the Group for that year.  

In preparing these financial statements,  
the Directors are required to: 

  Select suitable accounting policies and 

then apply them consistently 

  Make judgements and accounting 
estimates that are reasonable  
and prudent 

  State whether applicable IFRSs as 

adopted by the EU have been followed for 
the Group Financial Statements and 
United Kingdom Accounting Standards, 
comprising FRS 101, have been followed 
for the Company Financial Statements, 
subject to any material departures 
disclosed and explained in the  
Financial Statements 

  Prepare the Financial Statements on the 

going concern basis unless it is 
inappropriate to presume that the 
Company will continue in business. 

The Directors are responsible for keeping 
adequate accounting records that are 
sufficient to show and explain the Group 
and Company’s transactions and disclose 
with reasonable accuracy at any time the 
financial position of the Company and the 
Group. These records should enable them 
to ensure that the financial statements and 
the Directors’ Remuneration Report comply 
with the Companies Act 2006 and, as 
regards the Group Financial Statements, 
Article 4 of the IAS Regulation. The 
Directors are also responsible for 
safeguarding the assets of the Company 
and the Group and hence for taking 
reasonable steps for the prevention and 
detection of fraud and other irregularities. 

Each of the Directors, whose names and 
functions are listed on page 52, confirms that, 
to the best of his or her knowledge: 

  The Annual Report, taken as a whole, is fair, 
balanced and understandable and provides 
the information necessary for shareholders 
to assess the Company’s and the Group’s 
position and performance, business model 
and strategy 

  The Group Financial Statements, which 
have been prepared in accordance with 
IFRSs as adopted by the EU, give a true 
and fair view of the assets, liabilities, 
financial position and profit of the Group 

  The Company Financial Statements, 

which have been prepared in accordance 
with UK GAAP (United Kingdom 
Accounting Standards, comprising FRS 
101 ‘Reduced Disclosure Framework’ 
and applicable law) give a true and fair 
view of the assets, liabilities, financial 
position and profit of the Company  
  The Strategic Report and the Directors’ 

Report include a fair review of the 
development and performance of the 
business and the position of the Group 
and the Company, together with a 
description of the principal risks and 
uncertainties that it faces. 

Disclosure of information  
to auditors 
So far as each Director is aware, there is no 
relevant audit information of which the 
Company’s auditors are unaware; and he or 
she has taken all the steps that he or she 
ought to have taken as a Director in order to 
make himself or herself aware of any 
relevant audit information and to establish 
that the Group and Company’s auditors are 
aware of that information.  

The Directors’ Report on pages 52 to 71, 
pages 90 and 91and pages 177 to the  
inside back cover and the Directors’ 
Remuneration Report from pages 72 to 89 
of this Annual Report were approved by  
the Directors on 23 May 2018.  

On behalf of the Board 

Claire-Marie O’Grady 
Company Secretary 

23 May 2018 

www.tateandlyle.com 
91 
www.tateandlyle.com  91

Strategic ReportGovernanceFinancial StatementsUseful Information 
 
 
 
 
 
 
 
 
 
   
 
Independent Auditors’ Report to the Members of Tate & Lyle PLC 

Report on the audit of the financial statements 

Opinion 
In our opinion: 

•  Tate & Lyle PLC’s Group financial statements and Parent Company financial statements (the ‘financial statements’) give a true and fair 
view of the state of the Group’s and of the Parent Company’s affairs as at 31 March 2018 and of the Group’s profit and cash flows for the 
year then ended; 

•  the Group financial statements have been properly prepared in accordance with IFRSs as adopted by the European Union; 
•  the Parent Company financial statements have been properly prepared in accordance with United Kingdom Generally Accepted 

Accounting Practice (United Kingdom Accounting Standards, comprising FRS 101 ‘Reduced Disclosure Framework’, and applicable 
law); and 

•  the financial statements have been prepared in accordance with the requirements of the Companies Act 2006 and, as regards the Group 

financial statements, Article 4 of the IAS Regulation. 

We have audited the financial statements, included within the Annual Report, which comprise: the Consolidated Statements of Financial 
Position as at 31 March 2018; the Parent Company Balance Sheet as at 31 March 2018, the Consolidated Income Statement and 
Consolidated Statement of Comprehensive Income, the Consolidated Statement of Cash Flows, and the Consolidated and Parent Company 
Statements of Changes in Equity for the year then ended; and the notes to the Consolidated and Parent Company financial statements, 
which include a description of the significant accounting policies. 

Our opinion is consistent with our reporting to the Audit Committee.  

Basis for opinion 
We conducted our audit in accordance with International Standards on Auditing (UK) (‘ISAs (UK)’) and applicable law. Our responsibilities 
under ISAs (UK) are further described in the Auditors’ responsibilities for the audit of the financial statements section of our report. We 
believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion. 

Independence 
We remained independent of the Group in accordance with the ethical requirements that are relevant to our audit of the financial 
statements in the UK, which includes the FRC’s Ethical Standard, as applicable to listed public interest entities, and we have fulfilled our 
other ethical responsibilities in accordance with these requirements. 

To the best of our knowledge and belief, we declare that non-audit services prohibited by the FRC’s Ethical Standard were not provided to 
the Group or the Parent Company. 

Other than those disclosed in Note 9 to the financial statements, we have provided no non-audit services to the Group or the Parent 
Company in the period from 1 April 2017 to 31 March 2018. 

Our audit approach 
Context 
The context of our audit was set by the Group’s major activities in the year ended 31 March 2018 (‘FY18’). FY18 involved few significant 
business changes, although as a result of the Food Systems business being fully integrated into Food & Beverage Solutions, the business 
revised its allocation of goodwill to the CGUs. The goodwill associated with Biovelop, the Group’s oat business in Sweden, continues to be 
sensitive to reasonably possible changes in assumptions. As such we have retained goodwill and intangible asset impairment as a key 
audit matter. 

Our other key audit matters have been further refined to reflect certain developments in the Group during FY18.  

.

92  Tate & Lyle PLC Annual Report 2018
92 
Tate & Lyle PLC Annual Report 2018 

Overview 

Materiality 
•  Overall Group materiality: £14.7 million (2017 – £12 million), based on 5% of profit before tax 

from continuing operations adding back the Group’s share of tax of joint ventures and 
associates and exceptional items, which is our defined profit measure. 

•  Overall Parent Company materiality: £3.4 million (2017 – £1.6 million), based on 5% of profit 

before tax from continuing operations excluding dividends received.  

Audit scope 
•  Our audit included full-scope audits of six reporting components (Tate & Lyle PLC, Tate & Lyle 
International Finance, the Primary Products business in the US, the Food & Beverage Solutions 
business in the US, the US Sucralose business, and G.C. Hahn Limited, a Company in Wales) 
with specified audit procedures performed at a further five reporting components  
(Tate & Lyle Services Slovakia, Tate & Lyle Insurance Gibraltar, the Brazil Primary Products 
business, the Brazil Food & Beverage Solutions business and the US Tax Group). We also 
performed testing at the Global Shared Services Centre (GSS) in Poland in support of these 
component audits. 

Materiality

Audit scope

•  Taken together, the components at which audit work was performed accounted for 84% of 

consolidated sales and 63% of our profit measure (as defined above). This percentage is calculated 
on an absolute basis, which aggregates component profits and losses, ignoring sign convention. 
Adjusting further to remove group recharges our work accounted for 81% of our profit measure. 
•  Our audit covered all components that individually contributed more than 10% of consolidated 

sales and our profit measure (as defined above). 

•  The Group engagement team performed the audit of the standalone Parent Company financial 
statements, for which work was performed by the Group engagement team as well as at the 
GSS in Poland. 

Areas of 
focus

Areas of focus 
•  Commodity risk (Group). 
•  Complex tax accounting and uncertain tax positions (Group). 
•  Retirement benefit obligations and assets (Group). 
•  Goodwill and intangible asset impairment (Group). 
•  Investments in subsidiaries (Parent). 

Consolidated sales

Profit1

Profit2

i

S
t
r
a
t
e
g
c
R
e
p
o
r
t

G
o
v
e
r
n
a
n
c
e

i

F
n
a
n
c
i
a
l
S
t
a
t
e
m
e
n
t
s

U
s
e
f
u
l

I

n
f
o
r
m
a
t
i
o
n

1  Reporting 

 components: 84%

2  Other 

 components: 16%

1  Reporting 

 components: 63%

2  Other 

 components: 37%

1  Reporting 

 components: 81%

2  Other 

 components: 19%

1  As defined above.

2  Profit, as defined above, further adjusted for recharges.

The scope of our audit 
As part of designing our audit, we determined materiality and assessed the risks of material misstatement in the financial statements.  
In particular, we looked at where the Directors made subjective judgements, for example in respect of significant accounting estimates 
that involved making assumptions and considering future events that are inherently uncertain.  

We gained an understanding of the legal and regulatory framework applicable to the Group and the industry in which it operates, and 
considered the risk of acts by the Group which were contrary to applicable laws and regulations, including fraud. We designed audit 
procedures at Group and significant component level to respond to the risk, recognising that the risk of not detecting a material 
misstatement due to fraud is higher than the risk of not detecting one resulting from error, as fraud may involve deliberate concealment 
by, for example, forgery or intentional misrepresentations, or through collusion. We focused on laws and regulations that could give rise to 
a material misstatement in the Group and Parent Company financial statements, including, but not limited to, the Companies Act 2006, the 
Listing Rules, Pensions legislation, UK tax legislation and equivalent local laws and regulations applicable to significant component teams. 
Our tests included, but were not limited to, discussions with in-house legal counsel and inspection of underlying support and calculations 
where applicable. There are inherent limitations in the audit procedures described above and the further removed non-compliance with 
laws and regulations is from the events and transactions reflected in the financial statements, the less likely we would become aware of it. 

We did not identify any key audit matters relating to irregularities, including fraud. As in all of our audits we also addressed the risk of 
management override of internal controls, including testing journals and evaluating whether there was evidence of bias by the Directors 
that represented a risk of material misstatement due to fraud.

www.tateandlyle.com  93
www.tateandlyle.com  93 

Strategic ReportGovernanceFinancial StatementsUseful Information 
 
 
 
 
 
 
 
 
 
 
 
Independent Auditors’ Report to the Members of Tate & Lyle PLC 
continued 

Key audit matters 
Key audit matters are those matters that, in the auditors’ professional judgement, were of most significance in the audit of the financial 
statements of the current period and include the most significant assessed risks of material misstatement (whether or not due to fraud) 
identified by the auditors, including those which had the greatest effect on: the overall audit strategy; the allocation of resources in the 
audit; and directing the efforts of the engagement team. These matters, and any comments we make on the results of our procedures 
thereon, were addressed in the context of our audit of the financial statements as a whole, and in forming our opinion thereon, and we do 
not provide a separate opinion on these matters. This is not a complete list of all risks identified by our audit.  

Key audit matter 

  How our audit addressed the key audit matter 

Commodity risk (Group) 
Refer to Notes 2, 28 and 29 in the Group financial statements. 
The Group’s accounting policy is to mark-to-market at each balance 
sheet date its commodity positions, including its forward sales and 
purchase contracts with customers and grain suppliers. In addition, 
certain commodity raw material inventories are measured at net 
realisable value. The Group manages the commodity price risk on 
sales and purchase contracts by taking long and short positions and 
through the use of derivative financial instruments, primarily futures 
and options contracts. 
This was a key audit matter due to the complexity of the calculations 
and the judgement involved in the valuation of certain commodities 
positions, most notably co-products that do not have an actively 
traded futures market. These co-products include corn gluten feed, 
corn gluten meal and corn oil. Additionally, basis adjustments are 
made to certain commodity valuations to reflect market conditions, 
which necessitate further management judgement. 
The fair values of commodities pricing contracts as at 31 March 
2018 were assets of £22 million and liabilities of £11 million. 

We understood and evaluated management’s process for 
managing the commodity price risk inherent within its commodity 
positions and compared it with management’s underlying risk 
management and accounting policies. No matters were identified 
that would indicate that the risk management and accounting 
policies were not being followed. 
We obtained management’s forward pricing sheet for commodities 
used in its mark-to-market calculations. For those commodities 
with an actively traded market, we assessed the consistency of the 
forward prices with those published by the Chicago Mercantile 
Exchange. For those commodities where an active futures market 
does not exist (principally co-products) and for the basis 
adjustments made, we understood and challenged management’s 
methodology for determining the valuations, including the inputs 
and assumptions used. To further assess the reasonableness of 
the forward prices estimated by management, we performed trend 
analyses against similar market or exchange traded commodities 
and compared certain ratios of co-product prices against 
historical ratios. 
In addition to testing the forward price estimates, we audited the 
calculations of the fair value and associated unrealised gains 
and losses on the commodity based positions. We found that 
management’s forward price estimates and the calculations of  
fair value of positions were reasonable and supported by market 
observable data, where appropriate. 
Where management had calculated values by reference to non-
market observable data, we found that these were within 
acceptable ranges. 
For derivative financial instruments, which were used to manage 
the commodity price risk, we independently confirmed these 
positions with the counterparty and recalculated the fair value  
of the positions held. We found that the fair values of these 
derivative financial instruments were supported by the 
confirmations and recalculations. 

94  Tate & Lyle PLC Annual Report 2018
94 
Tate & Lyle PLC Annual Report 2018 

 
 
Key audit matter 

  How our audit addressed the key audit matter 

Complex tax accounting and uncertain tax positions (Group) 
Refer to Notes 2 and 12 in the Group financial statements. 
The nature of the Group’s multinational and cross-border 
operations exposes it to complicated tax regulations. This requires 
management to exercise judgement in determining the appropriate 
amount of tax to provide in respect of tax obligations in a number of 
jurisdictions. In addition, certain financing arrangements that the 
Group has entered into, while not uncommon or unduly aggressive, 
have been previously subject to enquiry by tax authorities. Changes 
in management’s estimates of the likely result of enquiries by tax 
authorities could materially affect the quantum of tax provisions 
recognised in the Group financial statements. At 31 March 2018 the 
Group had centrally held provisions for uncertain tax positions of 
£30 million (2017 – £34 million). There have also been changes in 
tax law in the US that have impacted the Group’s current and 
deferred tax balances at 31 March 2018. The most significant 
impact has been in respect of the US Tax Cuts and Jobs Act (‘US 
Tax Reform’) which was substantively enacted before the year-end. 
Some of the changes are complex and there are a number of areas 
of uncertainty relating both to the manner in which the law will 
apply and to the accounting in certain areas.  

Retirement benefit obligations and assets (Group) 
Refer to Notes 2 and 30 in the Group financial statements. 
The Group has significant retirement benefit obligations in the UK 
and the US, including unfunded retirement medical plans in the US. 
At 31 March 2018 the present value of these obligations was  
£1,612 million (2017 – £1,769 million) offset by plan assets at  
fair value of £1,630 million (2017 – £1,630 million) in respect of 
funded schemes. 
These retirement benefit obligations were determined based on a 
number of actuarial assumptions and calculations, which were subject 
to significant judgement and estimate. Changes in these assumptions 
can have a material impact on the quantum of obligations recorded in 
the consolidated statement of financial position.  
During FY18 an additional lump sum payment of £56 million was 
made to reduce the deficit in the US pension scheme. 

In conjunction with our UK, US, and international tax and transfer 
pricing specialists, we evaluated and challenged management’s 
judgements in respect of estimates of tax exposures and 
contingencies, in order to assess the adequacy of the Group’s tax 
provisions. This included obtaining a detailed understanding of the 
Group’s key technical tax matters and the related risks, including 
business and legislative developments. 
We recalculated management’s valuation of its tax provisions and 
determined whether the calculations were in line with the Group’s 
methodology and principles, and whether they had been applied on 
a basis consistent with previous years. We also examined 
management’s analysis of its financing arrangements and 
considered recent correspondence with the tax authorities and 
third party tax advisors. From the evidence obtained, we concluded 
that the level of provisioning was acceptable. 
Additionally, we assessed the appropriateness of judgements and 
estimates, as they pertain to taxation matters and concluded they 
were appropriate. 
We have assessed management’s treatment of changes arising 
from US Tax Reform with help from our UK and US tax specialists 
and consider the judgements made, including the classification of 
the impact of the changes as exceptional, to be appropriate. 

We understood and evaluated the assumptions used by the Group’s 
actuaries and management in calculating the retirement benefit 
obligations for the defined benefit pension plans in the UK and the 
US and the unfunded retirement medical scheme in the US. 
In conjunction with our pension specialists, we challenged the 
actuarial assumptions by comparing these against benchmark 
ranges based on the market conditions and expectations at  
31 March 2018. Based on our review of the assumptions, in each 
case we found that the actuarial assumptions used were reasonable 
and sat within our acceptable range and, where appropriate, were 
applied on a basis consistent with previous years. 
In addition, we independently confirmed the pension assets held by 
the UK and US schemes with the third-party custodians and fund 
managers. We also performed an independent assessment of the 
asset valuations and concluded that they were appropriate. 
We considered it appropriate to classify the additional lump sum 
payment as exceptional as it is non-recurring and material. 

i

S
t
r
a
t
e
g
c
R
e
p
o
r
t

G
o
v
e
r
n
a
n
c
e

i

F
n
a
n
c
i
a
l
S
t
a
t
e
m
e
n
t
s

U
s
e
f
u
l

I

n
f
o
r
m
a
t
i
o
n

www.tateandlyle.com  95
www.tateandlyle.com  95 

Strategic ReportGovernanceFinancial StatementsUseful Information 
 
 
 
 
 
 
 
 
 
 
 
 
Independent Auditors’ Report to the Members of Tate & Lyle PLC 
continued 

Key audit matter 

  How our audit addressed the key audit matter 

Goodwill and intangible asset impairment (Group) 
Refer to Notes 2 and 19 in the Group financial statements. 
At 31 March 2018 the Group had a net balance of £204 million of 
goodwill (2017 – £212 million) spread across multiple geographies 
and relating to multiple cash generating units (‘CGUs’). In addition, 
the Group had £156 million of intangible assets (2017 –£189 million) 
comprising patents and other intellectual property, capitalised 
development expenses and other acquired intangible assets. 
The carrying values of goodwill and intangible assets are contingent 
on future cash flows and there is a risk that the assets will be 
impaired if these cash flows do not meet the Group’s expectations. 
The impairment reviews performed by the Group contained a 
number of judgements and estimates including revenue growth, 
the success of market and capacity expansion, profit margin, cash 
conversion, terminal values and discount rates. Changes in these 
assumptions could lead to an impairment to the carrying value of 
intangible assets and goodwill. During the year, the Group had re-
evaluated the allocation of Goodwill to the CGUs and reduced the 
number of CGUs triggered by the Group reorganisation whereby  
the Food Systems business has been fully integrated into the  
Food & Beverage Solutions segment.  

We obtained the Group’s annual impairment analyses and tested 
the reasonableness of key assumptions, including profit and cash 
flow growth or decline, terminal values and the selection of 
discount rates.  
We performed our own independent sensitivity calculations to 
quantify downside changes to management’s models required to 
result in impairment. 
With the exception of Biovelop, there is no reasonably possible 
change in one or more of the key assumptions used in the 
impairment tests for goodwill and other intangible assets that 
would give rise to an impairment loss during the coming year.  
Our work surrounding the assessment of Biovelop involved 
analysing the validity of the key assumption for the valorisation  
of its co-products. Incorporating this into the model, it remains 
highly sensitive to a reasonably possible change in assumptions, 
and as such, a disclosure has been made within the Group’s 
financial statements (Note 19), together with a sensitivity  
analysis performed. 

Investments in subsidiaries (Parent) 
Refer to Notes 1 and 4 in the Parent Company financial statements. 
The Parent Company holds direct investments in Group 
subsidiaries. This is the entity's principal activity and therefore  
a key audit matter. At 31 March 2018, the Parent Company had 
investments in subsidiary undertakings of £1,037 million  
(2017 – £1,028 million). 

We obtained the details of the Parent Company’s investments in 
subsidiaries on the balance sheet and compared them to the 
Parent Company’s share of the subsidiaries’ net assets. As a result 
of our work, which leveraged the procedures performed over the 
goodwill and intangible asset impairment models described above, 
we determined that the impairment charges and reversals recognised 
during the year were appropriate and that the carrying values of the 
assets recognised on the balance sheet were supportable. 

How we tailored the audit scope 
We tailored the scope of our audit to ensure that we performed enough work to be able to give an opinion on the financial statements as a 
whole, taking into account the structure of the Group and the Parent Company, the accounting processes and controls, and the industry in 
which they operate.  

The Group is structured across three reportable segments; Food & Beverage Solutions, Sucralose and Primary Products, with a central 
support function. The Group financial statements are a consolidation of the Group’s reporting units, spread across the three reportable 
segments, which comprise the Group’s operating businesses and centralised functions covering more than 250 individual components. 

In establishing the overall approach to the Group audit, we determined the type of work that needed to be performed at the reporting units 
by us, as the Group engagement team, or component auditors from other PwC network firms operating under our instructions. Where the 
work was performed by component auditors, we determined the level of involvement we needed to have in the audit work at those 
components, in order to be able to conclude whether sufficient appropriate audit evidence had been obtained, as a basis for our opinion on 
the Group financial statements as a whole. This involvement included oversight visits and review of working papers at the GSS in Poland, 
and the Group’s two financially significant components in the US (the US Primary Products business and the US Food & Beverage 
Solutions business). We also attended the clearance meetings for these components. In addition, we met with management in Brazil, 
Sweden and the UK, and the non-PwC firm audit team for the Group’s joint venture in Mexico, and reviewed the audit work they performed. 

The Parent Company operates as a single entity. Work on the audit was performed by both the Group audit team and our component team 
at the GSS in Poland. All work was overseen by the Group audit team. Members of the Group audit team conducted a site visit to the GSS in 
Poland to discuss the work performed by those auditors. 

96  Tate & Lyle PLC Annual Report 2018
96 
Tate & Lyle PLC Annual Report 2018 

 
 
 
 
i

S
t
r
a
t
e
g
c
R
e
p
o
r
t

G
o
v
e
r
n
a
n
c
e

i

F
n
a
n
c
i
a
l
S
t
a
t
e
m
e
n
t
s

U
s
e
f
u
l

I

n
f
o
r
m
a
t
i
o
n

Materiality 
The scope of our audit was influenced by our application of materiality. We set certain quantitative thresholds for materiality. These, 
together with qualitative considerations, helped us to determine the scope of our audit and the nature, timing and extent of our audit 
procedures on the individual financial statement line items and disclosures and in evaluating the effect of misstatements, both individually 
and in aggregate on the financial statements as a whole.  

Based on our professional judgement, we determined materiality for the financial statements as a whole as follows: 

 Group financial statements 

  Parent Company financial statements 

Overall materiality 

 £14.7 million (2017 – £12.0 million). 

  £3·4 million (2017 – £1.6 million). 

How we determined it 

Rationale for  
benchmark applied 

5% of profit before tax from continuing operations  
(£286 million) adding back the Group’s share of tax of 
joint ventures and associates (£12 million) and 
exceptional items (£2 million). 

The Group’s principal measure of earnings is adjusted 
profit before tax from continuing operations, which 
excludes exceptional items, amortisation of acquired 
intangible assets and net retirement benefit interest 
from profit before tax. The Group adjusts for 
exceptional items as it believes that doing so is 
necessary to provide an understanding of financial 
performance. We have not used adjusted profit before 
tax, as defined above, as our benchmark since the 
amortisation of acquired intangible assets and net 
retirement benefit interest are recurring items. 

  5% of result before tax adding back the receipt of 
intercompany dividends. 

  The Company’s principal measure of earnings is 
profit before tax. 

For each component in the scope of our Group audit, we allocated a materiality that is less than our overall Group materiality. The range of 
materiality allocated across components was between £1 million and £11 million. Certain components were audited to a local statutory 
audit materiality that was also less than our overall Group materiality. 

We agreed with the Audit Committee that we would report to them misstatements identified during our audit above £750,000 (Group audit) 
(2017 – £500,000) and £340,000 (Parent Company audit) (2017 – £160,000) as well as misstatements below those amounts that, in our view, 
warranted reporting for qualitative reasons. 

Going concern 
In accordance with ISAs (UK) we report as follows: 

Reporting obligation 

  Outcome 

We are required to report if we have anything material to add or draw 
attention to in respect of the directors’ statement in the financial 
statements about whether the Directors considered it appropriate to 
adopt the going concern basis of accounting in preparing the 
financial statements and the Directors’ identification of any material 
uncertainties to the Group’s and the Parent Company’s ability to 
continue as a going concern over a period of at least 12 months from 
the date of approval of the financial statements. 

We have nothing material to add or to draw attention to. However, 
because not all future events or conditions can be predicted, this 
statement is not a guarantee as to the Group’s and Parent 
Company’s ability to continue as a going concern. 

We are required to report if the directors’ statement relating to 
Going Concern in accordance with Listing Rule 9.8.6R(3) is 
materially inconsistent with our knowledge obtained in the audit. 

We have nothing to report. 

www.tateandlyle.com  97
www.tateandlyle.com  97 

Strategic ReportGovernanceFinancial StatementsUseful Information 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Independent Auditors’ Report to the Members of Tate & Lyle PLC 
continued 

Reporting on other information  
The other information comprises all of the information in the Annual Report other than the financial statements and our auditors’ report 
thereon. The Directors are responsible for the other information. Our opinion on the financial statements does not cover the other 
information and, accordingly, we do not express an audit opinion or, except to the extent otherwise explicitly stated in this report, any form 
of assurance thereon.  

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider 
whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit, or otherwise 
appears to be materially misstated. If we identify an apparent material inconsistency or material misstatement, we are required to perform 
procedures to conclude whether there is a material misstatement of the financial statements or a material misstatement of the other 
information. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are 
required to report that fact. We have nothing to report based on these responsibilities. 

With respect to the Strategic Report and Directors’ Report, we also considered whether the disclosures required by the UK Companies Act 
2006 have been included.  

Based on the responsibilities described above and our work undertaken in the course of the audit, the Companies Act 2006 (CA06),  
ISAs (UK) and the Listing Rules of the Financial Conduct Authority (FCA) require us also to report certain opinions and matters as 
described below (required by ISAs (UK) unless otherwise stated). 

Strategic Report and Directors’ Report 
In our opinion, based on the work undertaken in the course of the audit, the information given in the Strategic Report and Directors’ Report 
for the year ended 31 March 2018 is consistent with the financial statements and has been prepared in accordance with applicable legal 
requirements. (CA06) 

In light of the knowledge and understanding of the Group and Parent Company and their environment obtained in the course of the audit, 
we did not identify any material misstatements in the Strategic Report and Directors’ Report. (CA06) 

The Directors’ assessment of the prospects of the Group and of the principal risks that would threaten the solvency or liquidity of 
the Group 
We have nothing material to add or draw attention to regarding: 

•  The Directors’ confirmation on page 39 of the Annual Report that they have carried out a robust assessment of the principal risks facing 

the Group, including those that would threaten its business model, future performance, solvency or liquidity. 

•  The disclosures in the Annual Report that describe those risks and explain how they are being managed or mitigated. 
•  The Directors’ explanation on page 39 of the Annual Report as to how they have assessed the prospects of the Group, over what period 

they have done so and why they consider that period to be appropriate, and their statement as to whether they have a reasonable 
expectation that the Group will be able to continue in operation and meet its liabilities as they fall due over the period of their 
assessment, including any related disclosures drawing attention to any necessary qualifications or assumptions. 

We have nothing to report having performed a review of the directors’ statement that they have carried out a robust assessment of the 
principal risks facing the Group and statement in relation to the longer-term viability of the Group. Our review was substantially less in 
scope than an audit and only consisted of making inquiries and considering the Directors’ process supporting their statements; checking 
that the statements are in alignment with the relevant provisions of the UK Corporate Governance Code (the ’Code’); and considering 
whether the statements are consistent with the knowledge and understanding of the Group and Parent Company and their environment 
obtained in the course of the audit. (Listing Rules) 

Other Code Provisions 
We have nothing to report in respect of our responsibility to report when:  
•  The statement given by the Directors, on page 91, that they consider the Annual Report taken as a whole to be fair, balanced and 

understandable, and provides the information necessary for the members to assess the Group’s and Parent Company’s position and 
performance, business model and strategy is materially inconsistent with our knowledge of the Group and Parent Company obtained in 
the course of performing our audit. 

•  The section of the Annual Report on page 68 describing the work of the Audit Committee does not appropriately address matters 

communicated by us to the Audit Committee. 

•  The directors’ statement relating to the Parent Company’s compliance with the Code does not properly disclose a departure from a 

relevant provision of the Code specified, under the Listing Rules, for review by the auditors. 

Directors’ Remuneration 
In our opinion, the part of the Directors’ Remuneration Report to be audited has been properly prepared in accordance with the Companies 
Act 2006. (CA06)

98  Tate & Lyle PLC Annual Report 2018
98 
Tate & Lyle PLC Annual Report 2018 

Responsibilities for the financial statements and the audit 
Responsibilities of the Directors for the financial statements 
As explained more fully in the Directors’ Statement of Responsibilities, the Directors are responsible for the preparation of the financial 
statements in accordance with the applicable framework and for being satisfied that they give a true and fair view. The Directors are also 
responsible for such internal control as they determine is necessary to enable the preparation of financial statements that are free from 
material misstatement, whether due to fraud or error. 

In preparing the financial statements, the Directors are responsible for assessing the Group’s and the Parent Company’s ability to 
continue as a going concern, disclosing as applicable, matters related to going concern and using the going concern basis of accounting 
unless the Directors either intend to liquidate the Group or the Parent Company or to cease operations, or have no realistic alternative but 
to do so. 

Auditors’ responsibilities for the audit of the financial statements 
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material 
misstatement, whether due to fraud or error, and to issue an auditors’ report that includes our opinion. Reasonable assurance is a high 
level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement 
when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could 
reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.  

A further description of our responsibilities for the audit of the financial statements is located on the FRC’s website at: 
www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditors’ report. 

Use of this report 
This report, including the opinions, has been prepared for and only for the Parent Company’s members as a body in accordance with 
Chapter 3 of Part 16 of the Companies Act 2006 and for no other purpose. We do not, in giving these opinions, accept or assume 
responsibility for any other purpose or to any other person to whom this report is shown or into whose hands it may come save where 
expressly agreed by our prior consent in writing. 

Other required reporting 

Companies Act 2006 reporting 
Under the Companies Act 2006 we are required to report to you if, in our opinion: 

•  we have not received all the information and explanations we require for our audit; or 
•  adequate accounting records have not been kept by the Parent Company, or returns adequate for our audit have not been received from 

branches not visited by us; or 

•  certain disclosures of directors’ remuneration specified by law are not made; or 
•  the Parent Company financial statements and the part of the Directors’ Remuneration Report to be audited are not in agreement with 

the accounting records and returns.  

We have no exceptions to report arising from this responsibility. 

Appointment 
Following the recommendation of the Audit Committee, we were appointed by the members on 24 January 1990 to audit the financial 
statements for the year ended 29 September 1990 and subsequent financial periods. The period of total uninterrupted engagement is  
28 years, covering the years ended 29 September 1990 to 31 March 2018. 

i

S
t
r
a
t
e
g
c
R
e
p
o
r
t

G
o
v
e
r
n
a
n
c
e

i

F
n
a
n
c
i
a
l
S
t
a
t
e
m
e
n
t
s

U
s
e
f
u
l

I

n
f
o
r
m
a
t
i
o
n

John Waters (Senior Statutory Auditor) 
for and on behalf of PricewaterhouseCoopers LLP 
Chartered Accountants and Statutory Auditors 

London 

23 May 2018 

www.tateandlyle.com  99
www.tateandlyle.com  99 

Strategic ReportGovernanceFinancial StatementsUseful Information 
 
 
 
 
 
 
 
 
 
 
 
Consolidated Income Statement 

Continuing operations 

Sales 

Operating profit 

Finance income 

Finance expense 

Share of profit after tax of joint ventures and associates 

Profit before tax 

Income tax (expense)/credit 

Profit for the year – continuing operations 

Profit for the year – discontinued operations 

Profit for the year – total operations 

Notes   

5   

6   

11   

11   

21   

12   

8   

Profit for the years presented from total operations is entirely attributable to owners of the Company. 

Earnings per share 

Continuing operations: 

– basic 

– diluted 

Total operations: 

– basic 

– diluted 

Analysis of adjusted profit for the year – continuing operations 

Profit before tax – continuing operations 

Adjusted for: 

Net (gain)/loss on exceptional items 

Amortisation of acquired intangible assets 

Net retirement benefit interest 

Adjusted profit before tax – continuing operations 

Adjusted income tax expense – continuing operations 

Adjusted profit for the year – continuing operations 

13   

13   

7   

19   

11, 30   

4   

4, 12   

4   

Year ended 31 March 

2018 

£m   

2017 
£m 

2 710   

2 753 

290   

2   

(34)   

28   

286   

(23)  

263   

2   

265   

233 

2 

(34) 

32 

233 

22 

255 

1 

256 

Pence   

Pence 

57.0p   

56.1p   

57.4p   

56.5p   

£m   

286   

(2)  

12   

5   

301   

(66)  

235   

55.0p 

54.2p 

55.2p 

54.4p 

£m 

233 

19 

12 

7 

271 

(49) 

222 

100  Tate & Lyle PLC Annual Report 2018
100  Tate & Lyle PLC Annual Report 2018 

   
   
   
 
   
   
 
 
 
 
 
 
 
   
 
 
   
 
 
   
 
 
   
   
 
 
   
 
   
 
 
   
 
   
 
   
 
 
   
 
   
 
 
   
   
 
 
   
 
   
 
   
   
 
 
 
 
 
 
 
 
Consolidated Statement of Comprehensive Income 

Profit for the year 

Other comprehensive income/(expense) 

Items that have been/may be reclassified to profit or loss: 

Fair value gain on cash flow hedges 

Fair value (gain)/loss on cash flow hedges transferred to the income statement 

Reclassified and reported in the income statement in respect of  

available-for-sale financial assets 

Fair value gain on available-for-sale financial assets 

(Loss)/gain on currency translation of foreign operations 

Fair value gain/(loss) on net investment hedges 

Share of other comprehensive (expense)/income of joint ventures and  

associates 

Amounts transferred to the income statement upon disposal of subsidiary 

Amounts transferred to the income statement upon disposal of associate 

Tax effect of the above items 

Items that will not be reclassified to profit or loss: 

Re-measurement of retirement benefit plans: 

– actual return higher than interest on plan assets 

– net actuarial gain/(loss) on retirement benefit obligations 

Tax effect of the above items 

Total other comprehensive (expense)/income 

Total comprehensive income 

Analysed by: 

– continuing operations 

– discontinued operations 

Total comprehensive income 

Total comprehensive income is entirely attributable to owners of the Company.

Notes   

23   

23   

23   

23   

23   

23   

21, 23   

23, 34   

21, 23   

12, 23   

30   

30   

12   

i

S
t
r
a
t
e
g
c
R
e
p
o
r
t

G
o
v
e
r
n
a
n
c
e

i

F
n
a
n
c
i
a
l
S
t
a
t
e
m
e
n
t
s

U
s
e
f
u
l

I

n
f
o
r
m
a
t
i
o
n

Year ended 31 March 

2018 

£m   

265   

2017 
£m 

256 

–   

(4)  

–   

3   

(122)  

39   

(9)  

–   

(1)  

–   

(94)  

2   

41   

(33)  

10   

(84)   

181   

179   

2   

181   

1 

4 

(1) 

– 

185 

(69) 

7 

(1) 

– 

– 

126 

179 

(106) 

(30) 

43 

169 

425 

425 

– 

425 

www.tateandlyle.com  101
www.tateandlyle.com  101 

Strategic ReportGovernanceFinancial StatementsUseful Information 
 
 
 
 
 
 
   
   
   
 
   
 
 
   
   
 
 
   
   
 
 
 
   
   
 
 
   
   
 
 
 
 
   
  
 
 
 
 
 
 
   
   
 
 
 
 
 
 
 
   
 
   
   
 
 
   
   
 
 
 
 
 
 
   
 
   
 
   
 
 
   
   
 
 
   
   
 
 
   
 
   
 
   
Consolidated Statement of Financial Position 

ASSETS 
Non-current assets 
Goodwill and other intangible assets 
Property, plant and equipment 
Investments in joint ventures 
Investments in associates 
Available-for-sale financial assets 
Derivative financial instruments 
Deferred tax assets 
Trade and other receivables 
Retirement benefit surplus 

Current assets 
Inventories 
Trade and other receivables 
Current tax assets 
Derivative financial instruments 
Cash and cash equivalents 

TOTAL ASSETS 

EQUITY  
Capital and reserves 
Share capital  
Share premium 
Capital redemption reserve 
Other reserves 
Retained earnings 
Equity attributable to owners of the Company 
TOTAL EQUITY 

LIABILITIES 
Non-current liabilities 
Trade and other payables 
Borrowings 
Derivative financial instruments 
Deferred tax liabilities 
Retirement benefit deficit 
Provisions for other liabilities and charges 

Current liabilities 
Trade and other payables 
Current tax liabilities 
Borrowings and bank overdrafts 
Derivative financial instruments 
Provisions for other liabilities and charges 

TOTAL LIABILITIES 

TOTAL EQUITY AND LIABILITIES 

Notes   

2018 

£m   

At 31 March 

2017 
£m 

19   
20   
21   
21   
18   
28   
12   
17   
30   

15   
17   
12   
28   
16   

22   
22   

23   

24   
25   
28   
12   
30   
32   

24   
12   
25   
28   
32   

360   
965   
85   
–   
37   
8   
7   
3   
178   
1 643   

419   
294   
1   
24   
190   
928   
2 571   

117   
406   
8   
159   
677   
1 367   
1 367   

10   
554   
21   
42   
160   
15   
802   

312   
57   
16   
12   
5   
402   
1 204   
2 571   

401 
1 061 
92 
4 
30 
15 
22 
1 
120 
1 746 

441 
291 
1 
31 
261 

1 025 
2 771 

117 
406 
8 
253 
548 

1 332 
1 332 

10 
604 
37 
25 
259 
17 
952 

315 
57 
88 
17 
10 
487 

1 439 
2 771 

The notes on pages 105 to 168 form part of these financial statements. The consolidated financial statements on pages 100 to 168 were 
approved by the Board of Directors on 23 May 2018 and signed on its behalf by:  

Nick Hampton  
Director 

102  Tate & Lyle PLC Annual Report 2018
102  Tate & Lyle PLC Annual Report 2018 

   
   
   
   
 
   
   
 
 
   
   
 
 
 
 
 
 
 
 
 
 
 
 
   
 
   
   
 
 
 
 
 
 
 
 
   
 
   
 
   
   
 
 
   
   
 
 
 
 
   
 
 
   
 
   
 
   
 
   
   
 
 
   
   
 
 
 
 
 
 
 
 
 
   
 
   
   
 
 
 
 
 
 
 
 
   
 
   
 
   
Consolidated Statement of Cash Flows 

Cash flows from operating activities 

Profit before tax from continuing operations 

Adjustments for: 
–  depreciation of property, plant and equipment 
–  amortisation of intangible assets 
–  share-based payments 
–  exceptional income statement items 
–  net finance expense 
–  share of profit after tax of joint ventures and associates 
Net retirement benefit obligations, comprising: 

–   Accelerated US defined benefit schemes contribution (exceptional cash flows) 
–   Underlying funding 

Changes in working capital and other non-cash movements 

Cash generated from continuing operations 

Net income tax paid, comprising: 

–  Cash tax benefit on accelerated contribution (exceptional cash flows) 
–  Net underlying income tax paid 

Interest paid 

Cash used in discontinued operations 

Net cash generated from operating activities 

Cash flows from investing activities  

Purchase of property, plant and equipment 

Purchase of intangible assets 

Disposal of property, plant and equipment 

Cash adjustment in respect of previous acquisitions 

Disposal of businesses, net of cash disposed 

Disposal of associates 

Purchase of available-for-sale financial assets 

Disposal of available-for-sale financial assets 

Interest received 

Dividends received from joint ventures and associates 

Net cash used in investing activities 

Cash flows from financing activities 

Purchase of own shares to trust or treasury  

Cash inflow from additional borrowings 

Cash outflow from repayment of borrowings 

Repayment of capital element of finance leases 

Dividends paid to the owners of the Company 

Net cash used in financing activities 

Notes   

20   

19   

31   

7   

11   

21   

7   

26   

7   

8   

34   

34   

18   

21   

22   

14   

i

S
t
r
a
t
e
g
c
R
e
p
o
r
t

G
o
v
e
r
n
a
n
c
e

i

F
n
a
n
c
i
a
l
S
t
a
t
e
m
e
n
t
s

U
s
e
f
u
l

I

n
f
o
r
m
a
t
i
o
n

Year ended 31 March 

2018 
£m    

286   

114   

40   

15   

(4)  

32   

(28)  

(94)  

(56)  

(38)  

(36)  

325   

(11)  

20   

(31)  

(27)  

(1)  

286   

(111)  

(20)  

–   

–   

–   

5   

(8)  

4   

2   

26   

2017 
£m  

233 

109 

40 

21 

(5) 

32 

(32) 

(36) 

– 

(36) 

4 

366 

(35) 

– 

(35) 

(30) 

(3) 

298 

(127) 

(26) 

2 

3 

3 

– 

(4) 

4 

2 

29 

(102)  

(114) 

(27)  

4   

(77)  

(1)  

(131)  

(232)  

(18) 

66 

(189) 

(1) 

(130) 

(272) 

Net decrease in cash and cash equivalents 

27   

(48)  

(88) 

Cash and cash equivalents 

Balance at beginning of year 

Net decrease in cash and cash equivalents 

Currency translation differences 

Balance at end of year 

27   

27   

16   

261   

(48)  

(23)  

190   

317 

(88) 

32 

261 

A reconciliation of the movement in cash and cash equivalents to the movement in net debt is presented in Note 27.  

www.tateandlyle.com  103
www.tateandlyle.com  103 

Strategic ReportGovernanceFinancial StatementsUseful Information 
 
 
 
 
 
 
   
   
   
 
   
   
 
 
   
 
   
   
 
 
 
 
 
 
 
 
   
 
 
     
 
 
 
   
 
   
 
 
   
 
   
 
 
   
 
   
   
 
 
   
 
   
 
   
 
   
 
 
 
 
   
 
   
 
 
   
 
   
   
 
 
 
   
 
   
 
   
 
 
   
 
   
   
   
 
 
   
   
 
 
   
 
 
 
Consolidated Statement of Changes in Equity 

Other 
reserves 

Retained 
earnings 

Attributable 
 to the 
owners  
of the  
Company 

Non- 
controlling 
interests 
(NCI) 

£m   

370   

£m   

1 028   

£m   

1   

£m   

127   

–   

126   

126   

–   

–   

–   

–   

–   

253   

–   

(94)  

(94)  

–   

–   

–   

159   

256   

43   

299   

24   

(18)  

3   

–   

(130)   

548   

265   

10   

275   

12   

(27)  

(131)  

677   

256   

169   

425   

24   

(18)  

3   

–   

(130)  

1 332   

265   

(84)  

181  

12   

(27)  

(131)  

1 367   

 Notes   

14   

14   

Total 
equity 
£m 

1 029 

256 

169 

425 

24 

(18) 

3 

(1) 

(130) 

1 332 

265 

(84) 

181 

12 

(27) 

(131) 

1 367 

–   

–   

–   

–   

–   

–   

(1)  

–   

–   

–   

–   

–   

–   

–   

–   

–   

Year ended 31 March 

2018 
Pence   

2017 
Pence 

8.4   

20.3   

28.7   

8.4   

19.8   

28.2   

8.2 

19.8 

28.0 

8.2 

19.8 

28.0 

Share capital 
and share 
premium 

Capital 
redemption 
reserve 

£m   

523   

£m   

8   

–   

–   

–   

–   

–   

–   

–   

–   

523   

–   

–   

–   

–   

–   

–   

523   

–   

–   

–   

–   

–   

–   

–   

–   

8   

–   

–   

–   

–   

–   

–   

8   

At 1 April 2016 

Year ended 31 March 2017: 

Profit for the year – total operations 

Other comprehensive income 

Total comprehensive income 

Share-based payments, net of tax 

Purchase of own shares to trust or treasury 

Derecognition of put option on NCI 

Movement on NCI 

Dividends paid (Note 14) 

At 31 March 2017 

Year ended 31 March 2018: 

Profit for the year – total operations 

Other comprehensive (expense)/income 

Total comprehensive (expense)/income 

Share-based payments, net of tax 

Purchase of own shares to trust or treasury 

Dividends paid (Note 14) 

At 31 March 2018 

Dividends on ordinary shares (pence per share) 

In respect of the financial year: 
–  interim  
–  final  

Paid in the financial year: 
–  interim – in respect of the financial year 
–  final – in respect of the previous financial year 

104  Tate & Lyle PLC Annual Report 2018
104  Tate & Lyle PLC Annual Report 2018 

   
 
 
   
   
   
   
   
   
 
 
 
 
 
 
 
 
 
 
 
   
   
   
   
   
   
 
 
 
 
 
 
 
 
 
 
   
   
   
   
   
   
 
   
   
   
   
   
   
 
   
   
   
 
   
   
   
   
    
 
 
   
   
   
   
   
 
   
   
   
   
   
 
 
   
   
   
   
   
 
   
   
   
   
   
 
 
   
   
   
   
 
   
   
   
   
 
 
   
   
   
   
   
Notes to the Consolidated Financial Statements 

i

S
t
r
a
t
e
g
c
R
e
p
o
r
t

G
o
v
e
r
n
a
n
c
e

i

F
n
a
n
c
i
a
l
S
t
a
t
e
m
e
n
t
s

U
s
e
f
u
l

I

n
f
o
r
m
a
t
i
o
n

1. Basis of preparation 
Description of business  
Tate & Lyle PLC (the Company) is a public limited company 
incorporated in the United Kingdom and registered in England.  
The Company’s ordinary shares are listed on the London  
Stock Exchange. 

The Company and its subsidiaries (together ‘the Group’) provide 
ingredients and solutions to the food, beverage and other 
industries. The Group operates from numerous production  
facilities around the world.  

The Group’s continuing operations comprise three reportable 
segments: Food & Beverage Solutions, Sucralose and Primary 
Products. Segment information is presented in Note 5.  

Accounting period  
The Group’s annual financial statements are drawn up to 31 March. 
These financial statements cover the year ended 31 March 2018 
with comparative financials for the year ended 31 March 2017.  

Basis of accounting  
The consolidated financial statements on pages 100 to 168 have 
been prepared in accordance with International Financial Reporting 
Standards (IFRS) and related interpretations as adopted for use in 
the European Union and those parts of the Companies Act 2006 
that are applicable to companies reporting under IFRS.  

The Directors are satisfied that the Group has adequate resources 
to continue to operate for a period not less than 12 months  
from the date of approval of the financial statements and that  
there are no material uncertainties around their assessment. 
Accordingly, the Directors continue to adopt the going concern 
basis of accounting.  

The Group’s principal accounting policies have been consistently 
applied throughout the year and are set out in Note 2 and Note 3.  

Functional and presentation currency  
The consolidated financial statements are presented in pounds sterling, 
which is also the Company’s functional currency. All amounts are 
rounded to the nearest million, unless otherwise indicated.  

Accounting standards adopted during the year  
In the current year, the Group has adopted, with effect from  
1 April 2017, new or revised accounting standards as set out below: 

•  IAS 7 Disclosure Initiative 
•  IAS 12 Recognition of Deferred Tax Assets for Unrealised Losses 
•  Annual Improvements to IFRSs 2014-2016 cycle. 

The adoption of these amendments has had no material effect on 
the Group’s financial statements. 

Use of alternative performance measures  
The Group also presents alternative performance measures, 
including adjusted operating profit, adjusted profit before tax, 
adjusted earnings per share, adjusted operating cash flow  
and adjusted free cash flow, which are used for internal 
performance analysis and incentive compensation arrangements 
for employees. 

These measures are presented because they provide investors with 
additional information about the performance of the business which 
the Directors consider to be valuable. For the years presented, 
alternative performance measures exclude, where relevant: 

•  Exceptional items (excluded as they relate to events which are 

unlikely to recur, are outside the normal course of business and 
therefore merit separate disclosure in order to provide a better 
understanding of the Group's underlying financial performance)  
•  Amortisation of acquired intangible assets (costs associated with 
amounts recognised through acquisition accounting that impact 
earnings compared to organic investments)  

•  Net retirement benefit interest (accounting charges or credits 
which are not linked to the underlying performance of the 
business. The amounts excluded reflect the net interest cost of 
post-retirement benefit plans substantially closed to future 
accrual); and 

•  Tax on the above items and tax items that themselves meet these 
definitions. For tax items to be treated as exceptional, amounts 
must be material and their treatment as exceptional enable a better 
understanding of the Group’s underlying financial performance. 

Alternative performance measures reported by the Group are not 
defined terms under IFRS and may therefore not be comparable 
with similarly-titled measures reported by other companies.  

Reconciliations of the alternative performance measures to the 
most directly comparable IFRS measures are presented in Note 4.  

Following the improved funding status of the Group’s pension 
schemes, the Group no longer intends to exclude net retirement 
benefit interest from its alternative performance measures from 
the beginning of the 2019 financial year as the size of this 
adjustment is no longer expected to be material. 

Changes in constant currency 
Where changes in constant currency are presented, they are 
calculated by retranslating current year results at prior year 
exchange rates. Reconciliations of the movement in constant 
currency have been included in the additional information within 
this document. 

2. Principal accounting policies requiring 
significant judgements and estimates 
In preparing these consolidated financial statements, management 
has made judgements and used estimates and assumptions in 
establishing the reported amounts of assets, liabilities, income and 
expense under the Group’s accounting policies. Judgements are 
based on the best evidence available to management. Estimates 
are based on factors including historical experience and 
expectations of future events, corroborated with external 
information where possible. Judgements and estimates and their 
underlying assumptions are reviewed and updated on an ongoing 
basis, with any revisions being recognised prospectively. However, 
given the inherent uncertainty of such estimates, the actual results 
might differ significantly from the anticipated ones.  

The accounting policies and information about the accounting 
estimates and judgements made in applying these accounting policies 
that have the most significant effect on the amounts recognised in the 
consolidated financial statements are set out below.  

www.tateandlyle.com  105
www.tateandlyle.com  105 

Strategic ReportGovernanceFinancial StatementsUseful Information 
 
 
 
 
 
 
 
 
Notes to the Consolidated Financial Statements continued 

2. Principal accounting policies requiring 
significant judgements and estimates continued 
Fair value measurement  
(This accounting policy applies principally to Available-for-sale 
financial assets; Derivatives and hedge accounting; Financial 
instruments – fair value and risk management; and Retirement 
benefit obligations – see Notes 18, 28, 29, and 30)  

A number of the Group’s accounting policies and disclosures 
require the measurement of fair value for either financial or non-
financial assets and liabilities. Examples of the former include 
loans, interest rate swaps and commodity contracts; examples of 
the latter include intangible assets and property, plant and 
equipment acquired in a business combination.  

Fair value is the amount of money, or other consideration, expected 
to be exchanged for an asset or a liability in an arm’s length 
transaction. When measuring fair value, the Group takes into 
account the characteristics of the asset or liability and uses 
observable market data, such as prices quoted on a recognised 
exchange, to the greatest extent possible. Where such data is not 
available, the Group has an established framework in place that 
deals with setting, monitoring and evaluating non-observable 
inputs, including the respective classification of the fair value 
measurements. Such unobservable inputs are based on 
management’s own assessment of market and other conditions 
currently prevailing or expected to prevail.  

Fair value measurements are categorised into three different levels 
based on the degree to which the inputs used to arrive at the fair 
value of the assets and liabilities are observable and the significance 
of the inputs to the fair value measurement in its entirety, as follows:  

•  Level 1 inputs are quoted prices (unadjusted) in active markets 
for identical assets or liabilities that the entity can assess at the 
measurement date. The prices of equity shares or bonds quoted 
on the London Stock Exchange are examples of Level 1 inputs  

•  Level 2 inputs are those, other than quoted prices included in 
Level 1, that are observable either directly or indirectly. Most 
interest rate swaps fall in this category as their prices are 
referenced to a published rate curve, but it is not price specific  
to the swap itself 

•  Level 3 inputs are unobservable inputs. The Group generally 

classifies assets or liabilities as Level 3 when their fair value is 
determined using unobservable inputs that individually, or when 
aggregated with other unobservable inputs, represent more than 
10% of the fair value of the observable inputs of the assets or 
liabilities. This would include expected future cash flows from 
budgets and forecasts the entity has made. Certain elements of the 
Group’s commodity contract portfolio also fall into this category, as 
their values include significant management-derived assumptions.  

For assets and liabilities that are recognised in the financial 
statements at fair value on a recurring basis, the Group determines 
whether transfers have occurred between levels in the hierarchy by 
re-assessing categorisation (based on the lowest level of input that 
is significant to the fair value measurement as a whole) at the end 
of the reporting period. 

Key sources of estimation uncertainty  
Corn and co-product inventories held in the US business are 
measured at net realisable value since they are considered to be 
agricultural produce after harvest. The Group uses financial 
instruments (mainly forward contracts) to manage price risk within 
its US business, by hedging the contracted amount of corn when 
any business division enters into a finished good sales contract.  

106  Tate & Lyle PLC Annual Report 2018
106  Tate & Lyle PLC Annual Report 2018 

The elements of the Group’s US net corn position are accounted for 
as follows:  

•  Contracts for the physical purchase of corn in respect of 

corresponding committed sales of finished goods are marked to 
market in accordance with IAS 39 with any gains or losses 
recognised in the income statement  

•  Contracts for the sale of corn and corn based products are 

marked to market in accordance with IAS 39 with any gains or 
losses recognised in the income statement  

•  Corn inventories are measured at net realisable value in 

accordance with IAS 2.3, with any gains or losses recognised in 
the income statement  

•  Financial instruments (futures and options) are carried at fair 
value with any gains or losses recognised immediately in the 
income statement.  

Although the Group manages corn price risk by entering into 
offsetting ‘back-to-back’ corn positions, there is still underlying 
price risk on the basis cost that must be paid for delivery of the corn 
to its plants. This basis is the difference in price between that at 
which a farmer will sell and the price on the Chicago Mercantile 
Exchange (CME), and is typically driven by local supply, demand and 
logistics factors, requiring estimation for valuation purposes.  

The production of finished goods from corn also results in the 
production of three co-products (corn gluten feed, corn gluten 
meal and corn oil). The price risk associated with these co-
products cannot readily be hedged as there are no actively traded 
markets for these commodities. Whilst the Group actively manages 
its overall co-product positions in the US, the Group can hold either 
a net long or short position for each co-product based on the 
volume of co-products made, bought (or short sold) and forward 
sold at any point in time. These positions are measured at fair value 
at each reporting date, with gains and losses recognised in the 
income statement.  

Management exercises significant judgement in deriving these fair 
values, which involves estimating the basis and the price at which 
the Group will purchase or sell these co-product positions in the 
future. These inputs are classified as unobservable, and are derived 
by in-house experts, with reference to sources such as: the 
expected supply and demand for corn and substitute products, 
expectations of weather conditions, and historical published  
co-product pricing levels over a period of up to three months from 
the balance sheet date.  

Whilst it is possible to model the sensitivity of profit to changes in 
any one of the key assumptions, it is important to note that, due to 
the complexity and interdependence of related assumptions, the 
overall (net) impact in reality is likely to be different. 

The accounting for corn and co-product positions can 
create significant volatility in the Group’s income statement, 
although the use of such contracts is critical to the business as it 
effectively limits the Group’s exposure to fluctuating market prices.  

Whilst it is not practical to quantify all elements included in fair 
value measurements, the Group discloses sensitivity analysis on 
the key areas of judgement (price of co-products and basis) and the 
carrying amounts impacted by estimation uncertainty in Note 29. 
Full details of the valuation technique are also included in Note 29. 

Corn and co-product positions in Europe are measured and carried 
at the lower of cost and net realisable value, since the European 
business does not currently have the potential to hedge corn price 
risk on a similar basis to the US. 

Taxation  
(This accounting policy principally applies to Income taxes – see 
Note 12)  

Taxable profit differs from accounting profit because it excludes 
certain items of income and expense that are recognised in the 
financial statements but are treated differently for tax purposes.  

Current tax is the amount of tax expected to be payable or receivable 
on the taxable profit or loss for the current period. This amount is 
then amended for any adjustments in respect of prior periods. 
Current tax is calculated using tax rates that have been written into 
law (‘enacted’) or irrevocably announced/committed by the respective 
government (‘substantively enacted’) at the period-end date.  

Current tax receivable (assets) and payable (liabilities) are offset 
only when there is a legal right to settle them net and the entity 
intends to do so. This is generally true when the taxes are levied by 
the same tax authority.  

Because of the differences between accounting and taxable profits 
and losses reported in each period, temporary differences arise on 
the amount certain assets and liabilities are carried at for accounting 
purposes and their respective tax values. Deferred tax is the amount 
of tax payable or recoverable on these temporary differences.  

Deferred tax liabilities arise where the carrying amount of an asset 
is higher than its tax value (more tax deduction has been taken). 
This can happen where the Group invests in capital assets, as 
governments often encourage investment by allowing tax 
depreciation to be recognised faster than accounting depreciation. 
This reduces the tax value of the asset relative to its accounting 
carrying amount. Deferred tax liabilities are generally provided on 
all taxable temporary differences. The periods over which such 
temporary differences reverse will vary depending on the life of the 
related asset or liability.  

Deferred tax assets arise where the carrying amount of an asset is 
lower than the tax value (less tax benefit has been taken). This can 
happen where the Group has trading losses, which cannot be offset 
in the current period but can be carried forward. Deferred tax assets 
are recognised only where the Group considers it probable that it 
will be able to obtain the benefit of them in the future (for example, 
use such losses by offsetting them against future taxable profits).  

Taxable temporary differences can also arise on investments in 
foreign subsidiaries and associates, and interests in joint ventures. 
Where the Group is able to control the reversal of these differences 
and it is probable that these will not reverse in the foreseeable 
future, then no deferred tax is provided.  

Deferred tax is calculated using the enacted or substantively 
enacted rates that are expected to apply when the asset is realised 
or the liability is settled.  

Similar to current taxes, deferred tax assets and liabilities are 
offset only when there is a legal right to settle them net and the 
entity intends to do so. This normally requires both assets and 
liabilities to have arisen in the same country. 

Income tax expense reported in the financial statements comprises 
current tax as well as the effects of changes in deferred tax assets 
and liabilities. Tax expenses/credits are generally recognised in the 
same place as the items to which they relate. For example, the tax 
associated with a gain on disposal is recognised in the income 
statement, in line with the gain on disposal. Equally, the tax 
associated with pension obligation actuarial gains and losses is 
recognised in other comprehensive income, in line with the 
actuarial gains and losses.  

i

S
t
r
a
t
e
g
c
R
e
p
o
r
t

G
o
v
e
r
n
a
n
c
e

i

F
n
a
n
c
i
a
l
S
t
a
t
e
m
e
n
t
s

U
s
e
f
u
l

I

n
f
o
r
m
a
t
i
o
n

Key sources of estimation uncertainty  
The Group operates in a large number of countries around the 
world. Uncertainties exist in relation to the interpretation of 
complex tax legislation, changes in tax laws, and the amount and 
timing of future taxable income. In some jurisdictions, agreeing tax 
liabilities with local tax authorities can take several years. This 
could necessitate future adjustments to taxable income and 
expense already recorded.  

At the period-end date, tax liabilities and assets are based on 
management’s best judgements around the application of the tax 
regulations and management’s estimate of the future amounts that 
will be settled. Management considers tax exposures individually, 
and arrives at judgements with support from experienced tax 
professionals and external advisors. There is, however, a risk that 
the Group’s judgements are challenged by the tax authorities, 
resulting in a different tax payable or recoverable from the amounts 
that have been provided.  

Deferred tax assets are recognised for unused tax losses only to 
the extent that it is probable that taxable profit will be available 
against which the losses can be utilised. Management judgement  
is required to determine the amount of deferred tax that should be 
recognised, dependent on the anticipated timing and quantum of 
future taxable profit. This amount includes UK deferred tax assets 
based on the level of brought-forward losses it expects to utilise in 
the future. This amount is dependent on key judgements relating  
to the size, duration and interest rate of the Group’s internal 
financing arrangements.  

The main uncertainties impacting taxation arise from potential 
changes to legislation. Firstly, the OECD’s Base Erosion and Profit 
Shifting (BEPS) project has been one of the most significant 
multilateral initiatives in recent years for modifying international tax 
rules. As these recommendations continue to evolve and are 
adopted into local tax legislation over the coming years, this may 
continue to impact the Group’s effective tax rate. Secondly, on  
22 December 2017 the United States enacted the Tax Cuts and Jobs 
Act (‘US Tax Reforms’). As well as reducing the headline rate of 
corporation tax in the US, it introduced a number of incentives for 
companies to invest in the US and other changes to broaden the tax 
base in the US. Whilst guidance will continue to emerge, 
management has exercised judgement in the application of the US 
Tax Reforms which has had a material impact on the Group’s 
statutory effective tax rate.  

The Group’s operating model involves cross-border supply of 
significant volumes of goods into numerous end markets, and the 
provision of services from one jurisdiction to another. There is a 
risk that different tax authorities could seek to assess higher profits 
(or lower costs) to activities being undertaken in their jurisdiction, 
potentially leading to higher total tax payable by the Group.  

Retirement benefit plans  
(This accounting policy principally applies to Retirement benefit 
obligations – see Note 30)  

The Group operates both defined contribution and defined benefit 
pension plans principally in the UK and the US and unfunded 
retirement medical plans in the US.  

www.tateandlyle.com  107
www.tateandlyle.com  107 

Strategic ReportGovernanceFinancial StatementsUseful Information 
 
 
 
 
 
 
 
 
 
Notes to the Consolidated Financial Statements continued 

2. Principal accounting policies requiring 
significant judgements and estimates continued 
Retirement benefit plans continued 
a) Defined benefit plans  
For accounting purposes a valuation of each of the defined benefit 
plans is carried out annually at 31 March using independent 
qualified actuaries. Benefit obligations are measured using the 
projected unit credit method and are discounted using the market 
yields on high-quality corporate bonds denominated in the same 
currency as, and of similar duration to, the benefit obligations. Plan 
assets are measured at their fair value at the period-end date. 
Where a plan holds a qualifying insurance policy, the fair value of 
the policy is deemed to be equivalent to the present value of the 
related benefit obligations.  

A deficit or surplus is recognised on each plan, representing the 
difference between the present value of the benefit obligation and 
the fair value of the plan assets. Where a plan is in surplus, the 
surplus recognised is limited to the present value of any amounts 
that the Group expects to recover by way of refunds or a reduction 
in future contributions.  

The costs of the defined benefit plan that are recognised in the 
income statement include the current service cost, any past service 
cost and the interest on the net deficit or surplus. Gains or losses 
on curtailments or settlements of the plans are recognised in the 
income statement in the period in which the curtailment or 
settlement occurs. Plan administration costs incurred by the Group 
are also recognised in the income statement.  

Current service cost represents the increase in the present value 
of the benefit obligation due to benefits accrued during the period, 
less employee contributions. Past service cost represents the 
change in the present value of the benefit obligation that arises 
from benefit changes that are applied retrospectively to benefits 
accrued in previous years. Any past service cost is recognised in 
full in the period in which the benefit changes are made.  

Interest on the net deficit or surplus is calculated by applying the 
discount rate that is used in measuring the present value of the 
benefit obligation to the deficit or surplus.  

Re-measurements of the deficit or surplus are recognised in other 
comprehensive income. Re-measurements comprise differences 
between the actual return on plan assets (less asset management 
expenses) and the interest on the plan assets and actuarial gains 
and losses. Actuarial gains and losses represent the effect of 
changes in the actuarial assumptions made in measuring the 
present value of the benefit obligation and experience differences 
between those assumptions and actual outcomes. Actuarial gains 
and losses are recognised in full in the period in which they occur.  

b) Defined contribution plans  
Contributions made by the Group to defined contribution pension 
schemes are recognised in the income statement in the period in 
which they fall due. 

Key sources of estimation uncertainty  
At 31 March 2018, the present value of the benefit obligations of the 
plans was £1,612 million (2017 – £1,769 million), including  
£63 million (2017 – £76 million) in respect of the unfunded medical 
plans. The present value of the benefit obligations is based on 
actuarial estimates of the future benefits that will be payable to the 
members of the plans. As such, the benefit obligations are based 
on a number of assumptions, changes to which could have a 
material impact on the reported amounts.  

108  Tate & Lyle PLC Annual Report 2018
108  Tate & Lyle PLC Annual Report 2018 

The present value of the benefit obligations is most sensitive to the 
discount rate applied to the benefit obligations, assumed life 
expectancies, and expected future price inflation rates. Whilst the 
Group establishes the assumptions on a consistent basis reflecting 
advice from qualified actuaries, based on published indices and other 
actuarial data, management must apply judgement in selecting the 
most appropriate value from within an acceptable range.  

Changes in the assumptions used in determining the present value 
of the benefit obligations will have an impact on the Group’s income 
statement through their effect on the service cost and the interest 
on the net deficit or surplus in the plans. However, most of the impact 
of such changes, together with fluctuations in the actual return on 
the plan assets, will be reflected in other comprehensive income.  

Impairment of non-financial assets  
(This accounting policy principally applies to Goodwill and other 
intangible assets; and Property, plant and equipment – see Notes 
19 and 20)  

Property, plant and equipment and intangible assets are reviewed 
for impairment whenever any events or changes in circumstances 
indicate that their carrying amounts may not be recoverable.  

If such an indication exists, then the recoverable amount of the asset 
is estimated. In addition, goodwill is tested for impairment annually.  

An asset is impaired to the extent that its carrying amount exceeds 
its recoverable amount. An asset’s recoverable amount represents 
the higher of the benefit which the entity expects to derive from the 
asset over its life, discounted to present value (value in use) and the 
net price for which the entity can sell the asset in the open market 
(fair value less costs of disposal). The discount rate used for the 
value in use calculation is a pre-tax rate that reflects the risks 
specific to the asset or groups of assets tested.  

For the purpose of impairment testing, assets are grouped together 
into the smallest group of assets which has cash inflows that are 
largely independent of the cash inflows from other assets or groups 
of assets. This could also be a single asset. Goodwill does not 
generate cash inflows independently and is, therefore, tested for 
impairment at the level of the Cash Generating Unit (‘CGU’) or 
group of CGUs to which it is allocated. Note 19 shows the allocation 
of material elements of goodwill to CGUs for impairment testing 
purposes. When goodwill is tested for impairment and the carrying 
amount of the CGU or group of CGUs to which it is allocated 
exceeds its recoverable amount, the impairment is allocated first to 
reduce the carrying amount of the goodwill and then pro-rata to the 
other non-financial assets belonging to the CGU or group of CGUs 
on the basis of their respective carrying amounts.  

Impairment losses are recognised in the income statement. 
Impairment losses recognised in previous periods for assets other 
than goodwill are reversed if there has been a change in the 
estimates used to determine the asset’s recoverable amount. Such 
reversals are limited to the carrying amount of the asset had no 
impairment been recognised in previous periods. Impairment 
losses recognised in respect of goodwill cannot be reversed. 

Asset impairments have the potential to significantly impact 
operating profit. In order to determine whether impairments 
are required, the Group estimates the recoverable amount of the 
asset. This calculation is usually based on projecting future cash 
flows over a five-year period and using a terminal value to 
incorporate expectations of growth thereafter. A discount factor is 
applied to obtain a present value (‘value in use’). The ‘fair value less 
costs of disposal’ of an asset may be used where this results in an 
amount in excess of ‘value in use’.  

i

S
t
r
a
t
e
g
c
R
e
p
o
r
t

G
o
v
e
r
n
a
n
c
e

i

F
n
a
n
c
i
a
l
S
t
a
t
e
m
e
n
t
s

U
s
e
f
u
l

I

n
f
o
r
m
a
t
i
o
n

Key sources of estimation uncertainty  
Estimated future cash flows for impairment calculations are based 
on management’s expectations of future volumes and margins 
based on plans and best estimates of the productivity of the assets 
in their current condition. Future cash flows exclude benefits from 
major expansion projects requiring future capital expenditure 
where that expenditure has not been approved and committed on 
the dates the assets are tested except where a fair value less costs 
of disposal model is used. These estimates are particularly 
significant for Tate & Lyle Sweden AB where the amount of 
headroom is relatively small.  

Future cash flows are discounted using a discount rate appropriate 
for the CGU being tested. The discount rate is impacted by 
estimates of interest rates, equity returns and market and country-
related risks. The Group’s weighted average cost of capital, which is 
used as the initial reference point for the discount rate before any 
asset-specific adjustments are made, is reviewed on a regular 
basis. If the cash flow or discount rate assumptions were to change 
because of market conditions, the recoverable amount could be 
different and could result in an asset impairment being increased 
or, excepting goodwill, reversed, in part or in full, at a future date. 

Critical accounting judgement 
In respect of Tate & Lyle Sweden AB (formerly ’Biovelop’), the 
Group’s Oat Beta Glucan plant, the impairment test resulted in a 
low level of headroom compared to the carrying value. The 
recoverable amount is dependent on the ability to commercialise 
certain co-product streams which remain under development. 
Management has been required to exercise significant judgement 
in determining the value of future cash flows associated with these 
co-product sales.  

3. Other principal accounting policies  
The consolidated financial statements have been prepared under 
the historical cost convention, modified in respect of the revaluation 
to fair value of available-for-sale financial assets, derivative 
financial instruments, certain inventories, assets classified as held 
for sale, assets held by defined benefit pension plans and intangible 
and tangible assets acquired in a business combination.  

Basis of consolidation  
a) Business combinations  
A business combination is a transaction or other event in which the 
Group obtains control over a business. Business combinations are 
accounted for using the acquisition method, the key elements of 
which are set out below.  

Identifiable assets and liabilities of the acquired business are 
generally measured at their fair value at the acquisition date. 
Retirement benefit obligations and deferred tax assets and 
liabilities are measured in accordance with the Group’s 
accounting policies.  

Consideration transferred represents the sum of the fair values 
at the acquisition date of the assets given, liabilities incurred or 
assumed and equity instruments issued by the Group in exchange 
for control over the acquired business. Acquisition-related costs 
are charged to the income statement in the period in which they 
are incurred. 

Any non-controlling interest in the acquired business is measured 
either at fair value or at the non-controlling interest’s proportionate 
share of the identifiable assets and liabilities of the business.  

Put options written by the Group over non-controlling interests are 
initially recognised as a liability measured at the present value of 
the exercise price with a corresponding charge directly to equity. 
Subsequently, the liability is measured at the present value of the 
expected redemption amount and re-measured in accordance 
with IAS 39 (at amortised cost), with changes recognised in the 
income statement.  

Goodwill arising in a business combination represents the excess 
of the sum of the consideration transferred, the amount of any non-
controlling interest in the acquired business and, where a business 
combination is achieved in stages, the fair value at the acquisition 
date of the Group’s previously held equity interest, over the net total 
of the identifiable assets and liabilities of the acquired business at 
the acquisition date. Any re-measurement gain or loss on the 
previously held equity interest is recognised in the income 
statement. Any shortfall, or negative goodwill, is recognised 
immediately as a gain in the income statement.  

Changes in the Group’s ownership interest in a subsidiary that 
do not result in a loss of control are accounted for within equity. 
Any gain or loss upon loss of control is recognised in the 
income statement.  

b) Subsidiaries  
Subsidiaries are all entities (including structured entities) over 
which the Group has control. The Group controls an entity when the 
Group is exposed to, or has rights to, variable returns from its 
involvement with the entity and has the ability to affect those 
returns through its power over the entity. Subsidiaries are 
consolidated from the date on which the Group obtains control. 
They are deconsolidated from the date that control ceases.  

A non-controlling interest in a subsidiary represents the share of 
the net assets of the subsidiary that is attributable to the equity 
interest in the subsidiary that is not owned by the Group.  

The Group’s income and expenses, assets and liabilities and cash 
flows include those of each of its subsidiaries from the date on 
which the Company obtains control until such time as control is 
lost. Inter-company transactions, balances and unrealised gains or 
losses on transactions between Group companies are eliminated.  

c) Equity accounted investments  
An associate is an entity over which the Group has significant 
influence. Significant influence is the power to participate in 
financial and operating policy decisions but not to control or jointly 
control them.  

A joint venture is an entity or a contractual arrangement under 
which the Group and other parties undertake activities that are 
subject to joint control, whereby the Group has rights to the net 
assets of the arrangement rather than to the arrangement’s assets 
or obligations for its liabilities.  

Interests in associates and joint ventures (together ‘Equity 
accounted investments’) are accounted for under the equity 
method. They are initially recognised at cost, which includes 
transaction costs. Subsequently, the Group’s share of the profit or 
loss, other comprehensive income and net assets are shown on 
one line of the relevant primary financial statements, until the date 
on which significant influence or joint control ceases. 

www.tateandlyle.com  109
www.tateandlyle.com  109 

Strategic ReportGovernanceFinancial StatementsUseful Information 
 
 
 
 
 
 
 
 
 
 
Notes to the Consolidated Financial Statements continued 

3. Other principal accounting policies continued 
Basis of consolidation continued 
c) Equity accounted investments continued 
Losses of an equity accounted investment in excess of the Group’s 
interest in the entity are not recognised, except to the extent that 
the Group has incurred obligations or made payments on behalf of 
the investment.  

Unrealised profits or losses on transactions between the Group and 
its equity accounted investments are eliminated to the extent of the 
Group’s interest. Losses are, however, recognised in full where 
they represent a reduction in the net realisable value of a current 
asset or an impairment loss. 

Discontinued operations  
(see Note 8)  

An operation is classified as discontinued if it is a component of the 
Group that: (i) has been disposed of, or meets the criteria to be 
classified as held for sale; and (ii) represents a separate major line 
of business or geographic area of operations or will be disposed of 
as part of a single co-ordinated plan to dispose of a separate major 
line of business or geographic area of operations.  

The results, assets and liabilities and cash flows of discontinued 
operations are presented separately from those of continuing 
operations.  

Discontinued operations comprised the following: 

Eaststarch / Morocco 
During the year ended 31 March 2018, the Group reached a 
settlement with the Moroccan tax authorities over historical tax 
matters relating to the Group’s former corn wet mill in Casablanca, 
Morocco. This resulted in a net credit of £2 million.  

Discontinued operations in the comparative year also related to the 
Group’s Moroccan subsidiary.  

Foreign currency translation  
(This accounting policy applies to all transactions and net assets in 
foreign currencies)  

At entity level, transactions in foreign currencies are translated into 
the entity’s functional currency at the exchange rate ruling at the 
date of the transaction. Monetary assets and liabilities denominated 
in foreign currencies are translated at the exchange rate ruling at 
the period-end date. Currency translation differences arising at 
entity level are recognised in the income statement.  

The consolidated financial statements are presented in pounds 
sterling. On consolidation, the results of foreign operations are 
translated into pounds sterling at the average rate of exchange for 
the period and their assets and liabilities are translated into pounds 
sterling at the exchange rate ruling at the period-end date. 
Currency translation differences arising on consolidation are 
recognised in other comprehensive income and taken to the 
currency translation reserve.  

Goodwill and fair value adjustments arising on the acquisition of a 
foreign operation are treated as assets and liabilities of the foreign 
operation and translated accordingly.  

When a foreign operation is sold, the gain or loss on disposal 
recognised in the income statement is determined after taking into 
account the recycling of cumulative currency translation 
differences arising on consolidation of the operation subsequent to 
the adoption of IFRS.  

In the cash flow statement, the cash flows of foreign operations 
are translated into pounds sterling at the average exchange rate for 
the period.  

Revenue recognition  
(This accounting policy relates to Notes 5 and 6)  

a) Sales of goods and services  
Revenue comprises the fair value of consideration receivable in the 
ordinary course of business, net of value added and sales taxes, 
rebates and discounts and after eliminating sales within the Group. 
Sales are recognised at the point or points at which the Group has 
performed its obligations in connection with the contractual terms 
of the sales agreement, primarily at the point of delivering to the 
customer, and at which time, in exchange it obtains the right to 
consideration. Discounts mainly comprise volume-driven rebates. 
The Group accrues for discounts against agreed customer terms 
reflecting latest expectations of amounts likely to fall due under  
the terms of the customer contract, subsequently adjusted for 
actual performance.  

Where amounts are paid to customers in advance in order to obtain 
commercial rights, the resultant asset is amortised against 
revenue in accordance with performance under the agreement. 

b) Interest income  
Interest income is recognised on a time proportion basis using the 
effective interest rate method.  

c) Dividend income  
Dividend income is recognised when the right to receive payment  
is established.  

Exceptional items  
(This accounting policy principally relates to Note 7)  

Exceptional items comprise items of income, expense and cash 
flow, including tax items, that are: material in amount, relate to 
events which are unlikely to recur, are outside the normal course of 
business and therefore merit separate disclosure in order to 
provide a better understanding of the Group's underlying financial 
performance. Examples of events that give rise to the disclosure of 
material items of income, expense and cash flow as exceptional 
items include, but are not limited to: impairment events; significant 
business transformation activities; disposals of operations or 
significant individual assets; litigation claims by or against the 
Group; and restructuring of components of the Group’s operations. 

For tax items to be treated as exceptional, amounts must be 
material and their treatment as exceptional enable a better 
understanding of the Group’s underlying financial performance. 

All material amounts relating to exceptional items in the Group’s 
financial statements are classified on a consistent basis across 
accounting periods. 

Goodwill and other intangible assets  
(see Note 19) 

a) Goodwill  
Goodwill arising in a business combination is recognised as an 
intangible asset and is allocated to the CGU or group of CGUs that is 
expected to benefit from the synergies of the business combination. 
Goodwill is not amortised but is tested for impairment annually.  

Goodwill is carried at cost less any recognised impairment losses.  

b) Intangible assets other than goodwill  
Intangible assets other than goodwill are stated at cost less 
accumulated amortisation and any recognised impairment losses.  

110  Tate & Lyle PLC Annual Report 2018
110  Tate & Lyle PLC Annual Report 2018 

i

S
t
r
a
t
e
g
c
R
e
p
o
r
t

G
o
v
e
r
n
a
n
c
e

i

F
n
a
n
c
i
a
l
S
t
a
t
e
m
e
n
t
s

U
s
e
f
u
l

I

n
f
o
r
m
a
t
i
o
n

c) Intangible assets acquired in business combinations  
An intangible resource acquired in a business combination is 
recognised as an intangible asset at its fair value at the date 
of acquisition, if it is separable from the acquired business or arises 
from contractual or legal rights. Acquired intangible assets, for 
example, patents and customer relationships, are amortised on a 
straight-line basis over the periods of their expected benefit to the 
Group, which range from three to 15 years. 

d) Other intangible assets  
Other intangible assets mainly comprise certain capitalised costs 
relating to product development, marketing, computer software 
and the global IS/IT system.  

Costs incurred on the development, design and testing of new or 
improved products are capitalised only when the technical and 
commercial feasibility of the product has been established and 
prior to the product going into full production. Research and other 
related expenditures are charged to the income statement in the 
period in which they are incurred.  

Other intangible assets are amortised on a straight-line basis over 
the periods of their expected benefit to the Group, which are in the 
range of three to ten years. Capitalised costs in respect of the core 
global IS/IT system are being amortised over a period of five to 
seven years. 

Residual values and useful lives are reviewed at each period-end 
date and adjusted as appropriate, with any resulting changes 
recognised in the income statement prospectively. 

Property, plant and equipment  
(see Note 20)  

Land and buildings mainly comprise manufacturing sites, 
application laboratories and administrative facilities. Plant and 
machinery mainly comprise equipment used in the manufacturing 
and operating process. Assets in the course of construction 
comprise property, plant and equipment which is in the process of 
being completed and not ready for use.  

Property, plant and equipment is stated at historical cost less 
accumulated depreciation and impairment. Historical cost includes 
expenditure that is directly attributable to the acquisition of the 
items. Subsequent costs are included in the asset’s carrying 
amount or recognised as a separate asset, as appropriate, only 
when it is probable that future economic benefits associated with 
the expenditure will flow to the Group and the cost of the item can 
be measured reliably. All repairs and maintenance expenditures 
are charged to the income statement during the period in which 
they are incurred.  

Depreciation is calculated using the straight-line method to 
allocate the cost of each asset to its residual value over its useful 
economic life as follows:  

Freehold land  

Freehold buildings 

Leasehold property 

Plant and machinery 

No depreciation 

20 to 50 years 

Period of the lease 

3 to 28 years 

Residual values and useful lives are reviewed at each period-end 
date and adjusted as appropriate, with any resulting changes 
recognised in the income statement prospectively.  

Gains and losses on disposals are determined by comparing the 
disposal proceeds with the carrying amount and are included in the 
income statement.  

Leased assets  
(see Notes 20, 25, 29 and 33)  

Leases of property, plant and equipment where the Group assumes 
substantially all the risks and rewards of ownership are classified 
as finance leases. Assets held under finance leases are capitalised 
at the lower of the fair value of the leased asset and the present 
value of the minimum lease payments. The corresponding lease 
commitments, net of finance charges, are included in liabilities. 
Leasing payments are analysed between capital and interest 
components so that the interest element is charged to the income 
statement over the period of the lease at a constant rate of interest.  

Depreciation on assets held under finance leases is charged to the 
income statement, on a straight-line basis over the shorter of the 
lease term and their useful life.  

All other leases are treated as operating leases. The total amount 
payable under the operating lease, including lease incentives and 
guaranteed lease increases, is spread over the lease period on a 
straight-line basis. Where termination or extension options are 
available to the Group, management considers whether it is 
reasonably certain of exercising these options in determining the 
lease period.  

Inventories  
(see Note 15)  

Corn and co-product inventories held in the US business are 
measured at net realisable value since they are considered to be 
agricultural produce after harvest, in accordance with IAS 2.3. 
Gains and losses are recognised in the income statement.  

All other inventories are carried at the lower of cost and net 
realisable value. Cost comprises direct materials and, where 
applicable, direct labour costs and those overheads that have been 
incurred in bringing the inventories to their present location and 
condition and is calculated using the ‘first in/first out’ or ‘weighted 
average’ methods, appropriate to the materials and production 
processes involved. Net realisable value represents the estimated 
selling price less all estimated costs to completion and costs to be 
incurred in marketing, selling and distribution.  

Provisions are made for any slow moving, obsolete or defective 
inventories.  

Financial instruments  
(see Notes 16, 17, 18, 24, 25, 28 and 29)  

a) Trade receivables  
Trade receivables are initially recognised at fair value, which is 
generally the same as the invoiced amount, and subsequently 
measured at amortised cost, or their recoverable amount. Trade 
receivables are predominantly short-term and so the effects of 
time-value of money are not considered material.  

Where there is objective evidence that the Group will not be  
able to collect all amounts due according to the original terms  
of the receivable, the receivable is considered to be impaired. 
Significant financial difficulties of the debtor, probability that  
the debtor will enter bankruptcy or financial reorganisation, and 
default or delinquency in payments are considered to be objective 
evidence of impairment. The amount of the impairment, and 
related provision, is the difference between the receivable’s  
original value and the present value of the estimated future  
cash flows, discounted at the original effective interest rate. 

www.tateandlyle.com  111
www.tateandlyle.com  111 

Strategic ReportGovernanceFinancial StatementsUseful Information 
 
 
 
 
 
 
 
Notes to the Consolidated Financial Statements continued 

3. Other principal accounting policies continued 
Financial instruments continued 
a) Trade receivables continued 
The impairment is recognised in the income statement 
immediately, and the provision is netted against the value of the 
receivable. When a trade receivable is deemed uncollectable, it is 
written off against the related provision.  

Subsequent recoveries of amounts previously written off are 
credited against operating expenses in the income statement in the 
period in which they are recovered.  

b) Trade payables  
Trade payables are predominantly short-term and are initially 
recognised at fair value, which is generally the invoice amount. The 
effects of time-value of money are not considered material.  

c) Cash and cash equivalents  
Cash and cash equivalents include cash in hand, deposits held at 
call with banks and other short-term highly liquid investments with 
original maturities of three months or less and, for the purposes of 
the cash flow statement only, bank overdrafts where the legal right 
of offset exists. 

d) Available-for-sale financial assets  
Equity instruments held by the Group are generally available-for-
sale and are carried at fair value, with movements in fair value 
recognised in other comprehensive income. The Group does not 
trade equity instruments and does not manage them on a fair value 
basis. Where fair value cannot be reliably measured, the assets are 
carried at cost.  

Cumulative fair value gains or losses on an asset are recycled 
through the income statement when the asset is disposed or 
impaired. A significant or prolonged decline in the fair value of a 
security below its cost is considered as an indicator that the 
securities are impaired. Impairments are recognised in the income 
statement. Impairment losses recognised in profit or loss for an 
investment in an available-for-sale equity instrument are not 
reversed through profit or loss. However, if the fair value of an 
impaired available-for-sale debt security subsequently increases 
and the increase can be related objectively to an event occurring 
after the impairment loss was recognised, then the impairment is 
reversed through profit or loss.  

e) Borrowings  
Borrowings are initially measured at fair value, net of transaction 
costs incurred, which is generally the amount of proceeds received. 
Borrowings are subsequently measured at amortised cost using 
the effective interest rate method, whereby the net proceeds are 
gradually increased to the amount that will be ultimately settled 
using a constant rate of interest. This constant rate of return is 
used to calculate the amount recognised as interest expense in the 
income statement.  

As explained under ‘Hedge accounting’ (see below), the carrying 
amount of a borrowing may be adjusted where it is a hedged 
liability in a fair value hedge.  

Borrowings are classified as current liabilities unless the Group 
has an unconditional right to defer settlement of the liability for at 
least 12 months after the period-end date.  

Dividends on preference shares that are classified as a liability are 
recognised in the income statement as interest expense.  

f) Derivative financial instruments  
The Group uses derivative financial instruments to reduce its 
exposure to commodity price, currency exchange rate and interest 
rate movements. The Group does not hold or issue derivatives for 
speculative purposes.  

All derivative financial instruments held by the Group are 
recognised as assets or liabilities measured at their fair values at 
the period-end date. As explained under ‘Hedge accounting’ 
below, unless and to the extent that a derivative is in a designated 
and effective cash flow or net investment hedging relationship, fair 
value gains and losses on derivatives are recognised in the 
income statement.  

Derivative financial instruments that are not in a designated 
hedging relationship are classified as held for trading.  

g) Embedded derivatives  
Some contracts may include features that are similar to and expose 
the Group to the same risks as standalone derivatives. Where such 
an embedded derivative is not closely related to the host contract 
and where the host contract itself is not already recognised at fair 
value, the embedded derivative is separated from the host contract 
and accounted as a standalone derivative. The hedge accounting 
principles described below equally apply to embedded derivatives.  

h) Offsetting financial instruments  
Financial assets and financial liabilities are offset and the net 
amount presented in the statement of financial position only where 
there is a legally enforceable right to offset them and the Group 
intends to either settle them on a net basis or realise the asset and 
settle the liability simultaneously.  

Hedge accounting  
(see Notes 28 and 29)  

As described in Note 29, the Group uses derivatives to mitigate risk. 
In many cases, the changes in the fair value of the derivatives are 
recognised before the hedged risk affects the Group income 
statement. For example, when the Group takes out a forward 
foreign currency contract to fix the exchange rate on committed or 
highly probable future sales in a foreign currency, changes in the 
fair value of the forward foreign exchange contract will be 
recognised in the income statement immediately, whereas the 
future sale will not affect the income statement until it is made. 
This creates a mismatch in the timing of recognition for 
compensating gains and losses. Hedge accounting seeks to 
mitigate this mismatch by applying specific accounting rules, if 
strict criteria are met, to the items that create the exposure to risk 
and the items used to manage that risk.  

A hedging relationship principally consists of two items: the hedged 
item and the hedging instrument. The hedged item is the 
transaction or balance that exposes the Group to a risk that can be 
identified and the hedging instrument is the transaction or balance 
that is used to manage the risk. In the above example, the contract 
to sell goods at a future date in a foreign currency gives rise to 
foreign currency transaction exposure for the Group. As exchange 
rates change, the eventual proceeds from the future sale when 
expressed in the entity’s functional currency will also change, 
creating risk. This is the hedged item. In this example, the foreign 
currency exchange contract the Group takes out locks in a known 
functional currency value for its foreign currency cash receipt and 
therefore eliminates the volatility in cash flows on the sale. The 
forward currency exchange contract is the hedging instrument.  

112  Tate & Lyle PLC Annual Report 2018
112  Tate & Lyle PLC Annual Report 2018 

 
 
i

S
t
r
a
t
e
g
c
R
e
p
o
r
t

G
o
v
e
r
n
a
n
c
e

i

F
n
a
n
c
i
a
l
S
t
a
t
e
m
e
n
t
s

U
s
e
f
u
l

I

n
f
o
r
m
a
t
i
o
n

For a hedging relationship to qualify for hedge accounting, it must be 
documented at inception together with the Group’s risk management 
objective and strategy for initiating the hedge. The hedge must both be 
expected to be highly effective in offsetting the changes in cash flows or 
fair value attributed to the hedged risk and actually be highly effective in 
doing so. This relationship is demonstrated by matching the terms of 
hedging instruments very closely to the hedged items, or where the 
Group uses more complex arrangements, by the use of statistical 
methods that show the relationship between the hedging pairs.  

There are three hedging models that apply to different types  
of transactions.  

a) Cash flow hedges  
Hedging relationships are classified as cash flow hedges where the 
hedging instrument hedges exposure to variability in cash flows 
that are attributable either to a particular risk associated with a 
recognised asset or liability (such as interest payments on variable 
rate debt), a highly probable forecast transaction (such as 
commodity purchases) or the foreign currency risk in a firm 
commitment (such as the purchase of an item of equipment). 

Where a hedging relationship is classified as a cash flow hedge, to 
the extent that the hedge is effective, changes in the fair value of 
the hedging instrument are recognised in other comprehensive 
income rather than in the income statement. When the hedged 
item affects the income statement, the cumulative fair value gain or 
loss recognised in other comprehensive income is transferred to 
the income statement. When a hedged firm commitment results in 
the recognition of a non-current asset, the initial carrying amount 
of the asset is adjusted for the cumulative fair value gain or loss.  

If the hedging instrument expires or is sold, or if the hedging 
relationship no longer meets the conditions for hedge accounting, 
the cumulative fair value gain or loss remains in equity until the 
forecast transaction is recognised in the income statement. If a 
hedged forecast transaction is no longer expected to occur, the 
cumulative fair value gain or loss is immediately transferred to the 
income statement.  

b) Net investment hedges  
A net investment hedge is the hedge of the currency exposure on the 
retranslation of the Group’s net investment in a foreign operation.  

Net investment hedges are accounted for similarly to cash flow 
hedges. Changes in the fair value of the hedging instrument are, to 
the extent that the hedge is effective, recognised in other 
comprehensive income.  

In the event that the foreign operation is disposed of, the cumulative 
fair value gain or loss recognised in other comprehensive income is 
transferred to the income statement where it is included in the gain 
or loss on disposal of the foreign operation.  

c) Fair value hedges  
Hedging relationships are classified as fair value hedges where the 
hedging instrument hedges the exposure to changes in the fair 
value of a recognised asset or liability that is attributable to a 
particular risk (such as the fair value of fixed rate debt).  

Where the hedging relationship is classified as a fair value hedge, 
the carrying amount of the hedged asset or liability is adjusted by 
the change in its fair value attributable to the hedged risk only and 
the resulting gain or loss is recognised in the income statement 
where, to the extent that the hedge is effective, it offsets the fair 
value gain or loss on the hedging instrument. 

Share-based payments  
(see Note 31)  

The Company operates share-based compensation plans  
under which it grants awards over its ordinary shares to its own 
employees and to those of its subsidiaries. All of the awards 
granted under the existing plans are classified as equity-settled 
awards. The Group recognises a compensation expense based on 
the fair value of the awards measured at the grant date using the 
Black-Scholes option pricing model. Fair value is not subsequently 
re-measured unless relevant conditions attaching to the award  
are modified.  

Fair value reflects any market performance conditions and all non-
vesting conditions. Adjustments are made to the compensation 
expense to reflect actual and expected forfeitures due to failure to 
satisfy service conditions or non-market performance conditions.  

The resulting compensation expense is recognised in the income 
statement on a straight-line basis over the vesting period and a 
corresponding credit is recognised in equity. In the event of the 
cancellation of an award, whether by the Group or a participating 
employee, the compensation expense that would have been 
recognised over the remainder of the vesting period is recognised 
immediately in the income statement.  

Provisions and contingent liabilities  
(see Note 32)  

A provision is a liability of uncertain timing or amount that is 
recognised when: 1) the Group has a present obligation (legal or 
constructive) as a result of a past event; 2) it is more likely than not 
that a payment will be required to settle the obligation; and 3) the 
amount can be reliably estimated.  

Where a payment is not probable, or the amount of the obligation 
cannot be measured with sufficient certainty, a contingent liability 
is disclosed.  

Contingent liabilities are also disclosed if a possible obligation 
arises from past events, but its existence will be confirmed only by 
the occurrence or non-occurrence of uncertain future events.  

Provisions are determined by discounting the expected future 
payments using a pre-tax discount rate that reflects current 
market assessments of the time value of money and, where 
appropriate, the risks specific to the liability. The unwinding of 
any discount is recognised in the income statement within 
finance expense. The impact of discounting is not material 
to the Group. 

Provision is made for restructuring costs when a detailed formal 
plan for the restructuring has been determined and the plan has 
been communicated to those affected by it. Gains from the 
expected disposal of assets are not taken into account in 
measuring restructuring provisions. Future operating losses  
are not provided for.  

Provisions are recognised for onerous contracts to the extent  
that the benefits expected to be derived from a contract are lower 
than the unavoidable cost to the Group of meeting its obligations 
under the contract. Before establishing the amount of the provision, 
any impairment losses on assets associated with the contract  
are recognised.  

www.tateandlyle.com  113
www.tateandlyle.com  113 

Strategic ReportGovernanceFinancial StatementsUseful Information 
 
 
 
 
 
 
 
 
 
 
Notes to the Consolidated Financial Statements continued 

3. Other principal accounting policies continued 
Assets held for sale  
(see Note 8)  

An asset or group of assets is classified as held for sale if its 
carrying amount will be principally recovered through a sale 
transaction rather than through continuing use in the business and 
the following conditions are met: 

•  it is available for immediate sale in its present condition  
•  management has committed to, and has initiated, a plan to sell 

the asset; and  

•  the sale is expected to complete within 12 months of the balance 

sheet date, and must be highly probable. 

Assets that are classified as held for sale are measured at the 
lower of their carrying amount when they were classified as held 
for sale and their fair value less costs to sell. Any impairment loss 
on a disposal group is allocated first to goodwill and then, on a  
pro-rata basis, to the remaining assets and liabilities other than 
inventories, financial instruments, investment property, employee 
benefits and deferred tax assets, which continue to be measured in 
accordance with the relevant Group accounting policies. 

Impairment on the initial recognition of held for sale assets, and 
gains or losses on subsequent re-measurement, are recognised in 
the income statement. 

Once classified as held for sale, property, plant and equipment and 
intangible assets are no longer depreciated or amortised. Equity 
accounted investments are no longer equity accounted when 
classified as held for sale.  

Accounting standards issued but not yet adopted  
The following new standards have been issued and are relevant to 
the Group, but were not effective for the financial year beginning  
1 April 2017, and have not been adopted early: 

a) IFRS 15 Revenue from Contracts with Customers (effective 
for the year ending 31 March 2019) 
The Group has undertaken a review of its commercial 
arrangements across all significant revenue streams and 
geographies including assessing the timing of revenue recognition 
as well as focusing on the accounting for principal and agency 
relationships, consignment stocks and discounts provided. As a 
result of the review, the Group has concluded that the adoption of 
IFRS 15 is not expected to have a material impact on reported 
revenue or revenue growth rates. 

b) IFRS 9 Financial Instruments (effective for the year ending 
31 March 2019) 
The Group has reviewed the key areas of IFRS 9 and its activities in 
these areas to ensure full compliance upon adoption. The Group 
has concluded that the adoption of IFRS 9 will not have a material 
impact on its consolidated results or financial position.  

The review focused on all three aspects of IFRS 9: 

Classification and measurement 
The Group expects to continue measuring at fair value all financial 
assets currently held at fair value. The Group intends to apply the 
option to present fair value changes in Other Comprehensive 
Income (OCI) for those equity shares currently held as available-
for-sale (AFS) and which are intended to be held for the foreseeable 
future. All other assets held as AFS are expected to be measured at 
fair value through profit or loss. Any amounts held in OCI related to 
those other assets will be reclassified to retained earnings, the 
quantum of which is expected to be immaterial. Trade receivables 
and other receivables are held to collect the principal amount in 
line with the contractual arrangements. As such, the Group has 
concluded that they meet the criteria for amortised cost 
measurement under IFRS 9. This is consistent with the current 
basis of accounting. 

Impairment  
The Group will apply the simplified approach and record lifetime 
expected losses on all trade receivables. The loss allowance to be 
recognised is not expected to be material.  

Hedge accounting 
The Group determined that all existing hedge relationships that are 
currently designated in effective hedging relationships will continue 
to qualify for hedge accounting under IFRS 9. As IFRS 9 does not 
change the general principles of how an entity accounts for 
effective hedges, applying the hedging requirements of IFRS 9 is 
not expected to have a significant impact on the Group’s financial 
statements. 

c) IFRS 16 Leases (effective for the year ending 31 March 2020) 
The standard eliminates the classification of leases as 
either operating or finance leases and introduces a single 
accounting model, requiring the recognition of substantially  
all current operating lease commitments on the statement of 
financial position.  

The Group is in the process of performing an impact assessment by 
assessing all existing leases against the guidance contained in 
IFRS 16. Material judgements and estimates are required in 
identifying and accounting for leases and determining the discount 
rate, as well as choosing the transition methodology. The Group is 
continuing to assess the impact of these judgements and 
estimates, and based on current information, expects a material 
increase in both property, plant and equipment and associated 
lease obligations. A quantification of the impact upon adoption will 
be included in the 31 March 2019 financial statements. 

d) IFRIC 23 Uncertainty over Income Tax Treatments (effective 
for the year ending 31 March 2020, subject to EU endorsement) 
The interpretation is to be applied to the determination of taxable 
profit (tax loss), tax bases, unused tax losses, unused tax credits 
and tax rates, when there is uncertainty over income tax treatments 
under IAS 12. The financial impact of this, together with any other 
implications of this interpretation, will be assessed during the 2019 
financial year. 

No other new standards, new interpretations or amendments 
to standards or interpretations have been published which 
are expected to have a significant impact on the Group’s 
financial statements. 

114  Tate & Lyle PLC Annual Report 2018
114  Tate & Lyle PLC Annual Report 2018 

 
4. Reconciliation of alternative performance measures 
Income statement measures 
For the reasons set out in Note 1, the Group presents alternative performance measures including adjusted operating profit, adjusted 
profit before tax and adjusted earnings per share.  

For the years presented, these alternative performance measures exclude, where relevant: 

•  exceptional items  
•  the amortisation of acquired intangible assets 
•  net retirement benefit interest 
•  tax on the above items and tax items that themselves meet these definitions.  

Following the improved funding status of the Group’s pension schemes, the Group no longer intends to exclude net retirement benefit 
interest from its alternative performance measures from the beginning of the 2019 financial year as the size of this adjustment is no longer 
expected to be material. 

The following table shows the reconciliation of the key income statement alternative performance measures to the most directly 
comparable measures reported in accordance with IFRS: 

£m unless otherwise stated 

Continuing operations 

Sales 

Operating profit 

Net finance expense 

Share of profit after tax of joint ventures and 
associates  

Profit before tax 

Income tax (expense)/credit 

Profit for the year 

Basic earnings per share (pence) 

Diluted earnings per share (pence) 

Effective tax rate expense/(credit) % 

Year ended 31 March 2018   

Year ended 31 March 2017 

IFRS 
reported 

Adjusting 
items 

Adjusted 
reported   

IFRS 
reported   

Adjusting 

items   

Adjusted 
reported 

2 710   

290   

(32)  

28   

286   

(23)  

263   

57.0p   

56.1p   

8.1%   

–   

10   

5   

–   

15   

(43)  

(28)  

(6.1p)  

(6.0p)  

2 710   

2 753   

300   

(27)  

28   

301   

(66)  

235   

50.9p   

50.1p   

21.9%   

233   

(32)   

32   

233   

22   

255   

55.0p   

54.2p   

(9.6%)   

–   

31   

7   

–   

38   

(71)   

(33)  

(7.2p)  

(7.1p)  

2 753 

264 

(25) 

32 

271 

(49) 

222 

47.8p 

47.1p 

18.2% 

The following table shows the reconciliation of the adjusting items impacting adjusted profit for the year in the current and comparative year: 

i

S
t
r
a
t
e
g
c
R
e
p
o
r
t

G
o
v
e
r
n
a
n
c
e

i

F
n
a
n
c
i
a
l
S
t
a
t
e
m
e
n
t
s

U
s
e
f
u
l

I

n
f
o
r
m
a
t
i
o
n

Continuing operations 

Exceptional (gain)/loss in operating profit 

Amortisation of acquired intangible assets 

Total excluded from adjusted operating profit 

Net retirement benefit interest 

Total excluded from adjusted profit before tax 

Tax credit on adjusting items 

Exceptional tax credits 

Total excluded from adjusted profit for the year 

Notes   

7   

19   

11   

12   

7, 12   

Year ended 31 March 

2018 

£m   

2017 
£m 

(2)  

12   

10   

5   

15   

(5)  

(38)  

(28)  

19 

12 

31 

7 

38 

(6) 

(65) 

(33) 

Cash flow alternative performance measures 

The Group also presents two alternative cash flow measures which are defined as follows: 

a)  Adjusted free cash flow represents cash generated from continuing operations, after net interest and tax paid, and capital 

expenditure and excluding the impact of exceptional items.  

b)  Adjusted operating cash flow is defined as adjusted free cash flow from continuing operations, adding back net interest and tax 

paid, retirement cash contributions, and excluding derivative and margin call movements within working capital. 

www.tateandlyle.com  115
www.tateandlyle.com  115 

Strategic ReportGovernanceFinancial StatementsUseful Information 
 
 
 
 
 
 
 
   
 
 
   
 
 
 
 
   
   
   
   
   
 
 
 
 
 
 
 
 
 
 
 
   
   
   
 
 
   
   
 
 
 
 
   
   
 
   
  
  
   
   
 
 
   
  
  
 
   
  
  
 
   
  
  
   
 
   
  
  
 
  
  
   
 
  
  
 
  
  
 
  
   
 
 
 
Notes to the Consolidated Financial Statements continued 

4. Reconciliation of alternative performance measures continued 
Cash flow alternative performance measures continued 
The following table shows the reconciliation of these cash flow alternative performance measures: 

Adjusted operating profit from continuing operations 

Adjusted for: 

Depreciation and adjusted amortisation 

Share-based payments charge 

Changes in working capital and other non-cash movements 

Net retirement benefit obligations 

Less: accelerated US defined benefit schemes contribution (exceptional cash flows)   

Net retirement benefit obligations: underlying funding 

Capital expenditure 

Net interest and tax paid 

Less: cash tax benefit on accelerated contribution (exceptional cash flows) 

Net interest and tax paid: underlying 

Adjusted free cash flow 

Add back: net interest and tax paid (excluding exceptional cash flows) 

Add back: net retirement underlying cash contributions 

Less: derivatives and margin call movements within changes in working capital 

Adjusted operating cash flow 

Year ended 31 March 

2018 

£m   

300   

142   

15   

(36)  

(94)  

56   

(38)  

(131)  

(36)  

(20)  

(56)  

196   

56   

44   

3   

299   

2017 

£m 

264 

137 

21 

4 

(36) 

– 

(36) 

(153) 

(63) 

– 

(63) 

174 

63 

42 

(6) 

273 

Other performance measures 
The Group presents certain financial measures as defined in its external financial covenants as well as return on capital employed (ROCE) 
as Key Performance Indicators. Net debt to EBITDA and interest cover are defined under the Group’s financial covenants and are required 
to be reported on a proportionate consolidation basis. For financial covenant purposes these ratios are calculated based on the accounting 
standards that applied for the 2014 financial year, with new accounting standards adopted by the Group subsequent to 1 April 2014 
disregarded. Net debt is calculated using average currency exchange rates. Average invested operating capital represents the average  
at the beginning and end of the year of goodwill and other intangible assets, property, plant and equipment, working capital, provisions, 
non-debt derivatives and other assets. All ratios are calculated based on unrounded figures in £ million. The following tables present the 
calculation of these alternative measures: 

Calculation of net debt to EBITDA ratio – on a financial covenant basis 

Net debt  

Further adjustments set out in financial covenants: 

to reflect use of average exchange rates in translating net debt and proportionate 
consolidation 

Net debt – on a financial covenant basis 

Adjusted operating profit 

Further adjustments set out in financial covenants: 

to reflect proportionate consolidation 

to exclude charges for share-based payments 

to add back depreciation and adjusted amortisation 

deduction for other finance costs 

Pre-exceptional EBITDA – on a financial covenant basis 

Net debt to EBITDA ratio (times) 

116  Tate & Lyle PLC Annual Report 2018
116  Tate & Lyle PLC Annual Report 2018 

Note   

2018 

£m   

31 March 

2017 
£m 

27   

392   

452 

25   

417   

300   

44   

15   

142   

(2)  

499   

0.8   

(13) 

439 

264 

48 

21 

137 

– 

470 

0.9 

 
 
   
 
 
   
 
   
 
   
   
 
 
   
 
   
 
   
 
   
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
 
   
 
 
 
   
   
 
 
 
   
   
 
 
   
 
   
 
 
   
   
 
 
   
 
   
   
 
 
   
 
   
 
   
 
   
 
   
 
   
 
 
 
i

S
t
r
a
t
e
g
c
R
e
p
o
r
t

G
o
v
e
r
n
a
n
c
e

i

F
n
a
n
c
i
a
l
S
t
a
t
e
m
e
n
t
s

U
s
e
f
u
l

I

n
f
o
r
m
a
t
i
o
n

4. Reconciliation of alternative performance measures continued 
Other performance measures continued 

Calculation of interest cover ratio – on a financial covenant basis 

Adjusted operating profit 

Further adjustments set out in financial covenants: 

to reflect proportionate consolidation 

to exclude charges for share-based payments 

deduction for other finance costs 

2018 

£m   

300   

39   

15   

(2)  

 31 March 

2017 
£m 

264 

43 

21 

– 

Operating profit before exceptional items and amortisation of intangible assets 

– on a financial covenant basis 

352   

328 

Adjusted net finance expense 

Less: Other finance costs 

Further adjustments set out in financial covenants: 

to reflect proportionate consolidation and other adjustments 

Net finance expense – on a financial covenant basis 

Interest cover ratio (times) 

Calculation of return on capital employed 

Adjusted operating profit 

Add back amortisation on acquired intangible assets 

Profit before interest, tax and exceptional items from continuing operations for ROCE    

Goodwill and other intangible assets 

Property, plant and equipment 

Working capital, provisions and non-debt derivatives 

Other 

Invested operating capital of continuing operations 

Average invested operating capital 

Return on capital employed (ROCE) %  

25 

– 

(1) 

24 

13.9 

31 March 

2016 
£m 

390 

926 

323 

29 

1 668 

27   

(2)  

(1)  

24   

14.6   

2017 

£m   

264   

(12)  

252   

401   

1 061   

394   

–   

1 856   

1 762   

14.3   

2018 

£m   

300   

(12)  

288   

360   

965   

385   

–   

1 710   

1 783   

16.2   

5. Segment information 
Segment information is presented on a basis consistent with the information presented to the Board (the designated Chief Operating 
Decision Maker) for the purposes of allocating resources within the Group and assessing the performance of the Group’s businesses.  
As described on page 37, continuing operations now comprise three reportable segments: Food & Beverage Solutions, Sucralose (which 
together made up the Speciality Food Ingredients segment in the prior year) and Primary Products (Bulk Ingredients segment in the prior 
year). This change was made to reflect the different economic characteristics of these products, and reflects the way in which information 
on the Group’s performance is presented to the Board. Central, which comprises central costs including head office, treasury and re-
insurance activities, does not meet the definition of an operating segment under IFRS 8 ‘Operating Segments’ but is included in order to be 
consistent with the presentation of segment information presented to the Board. The segments are served by a single manufacturing 
network, and receive services from a number of global support functions. The segmental allocation of costs is performed using standard 
product costs to allocate all direct costs (including manufacturing facility-based depreciation) and allocation keys for all indirect costs 
(including share-based payments and amortisation) consistently applied over time. 

www.tateandlyle.com  117
www.tateandlyle.com  117 

Strategic ReportGovernanceFinancial StatementsUseful Information 
 
 
 
 
 
 
 
 
 
   
 
 
   
 
   
   
 
 
   
 
   
   
 
 
   
 
   
 
   
 
   
   
 
 
   
 
 
   
   
 
 
   
 
   
 
   
   
 
 
   
 
   
 
   
 
 
 
   
 
 
 
   
   
 
 
 
 
 
 
 
 
   
  
 
 
 
 
 
 
 
 
 
 
 
 
Notes to the Consolidated Financial Statements continued 

5. Segment information continued 
The Board uses adjusted operating profit as the measure of the profitability of the Group’s businesses. Adjusted operating profit is, 
therefore, the measure of segment profit presented in the Group’s segment disclosures. Adjusted operating profit represents operating 
profit before specific items that are considered to hinder comparison of the trading performance of the Group’s businesses year on year. 
During the years presented, the items excluded from operating profit in arriving at adjusted operating profit were the amortisation of 
acquired intangible assets and exceptional items. The segmental classification of exceptional items is detailed in Note 7. 

An analysis of total assets and total liabilities by operating segment is not presented to the Board but it does receive segmental analysis of 
net working capital (inventories, trade and other receivables, less trade and other payables). Accordingly, the amounts presented for 
segment assets and segment liabilities in the tables below represent those assets and liabilities that comprise elements of net working 
capital. The segmental split of working capital allocates raw material and co-product inventories, and associated payables, based on the 
segmental split of primary capacity. Other payables, work in progress and finished goods inventories and receivables are allocated based 
on the products to which they relate. The segment results were as follows:  

a) Segment sales 

Food & Beverage Solutions 

Sucralose 

Primary Products 

Sales – continuing operations 

Sales – discontinued operations 

Sales – total operations 

Note   

8   

Year ended 31 March 

2018 

£m   

850   

146   

1 714   

2 710   

–   

2 710   

2017* 
£m  

834* 

162* 

1 757  

2 753  

3  

2 756  

*  Restated to reflect the change in reportable segments made in the 2018 financial year.  

If the above segmental information were presented on a basis consistent with the prior year, Food & Beverage Solutions and Sucralose 
would be combined as Speciality Food Ingredients to show sales for the year ended 31 March 2018 of £996 million (2017 – £996 million). 
Primary Products was renamed from Bulk Ingredients in the year. 

b) Segment results 
Adjusted operating profit, as defined in Notes 1 and 4, is the measure of profitability of the Group’s businesses used by the Board as it is 
considered to be the best measure to compare the results over time.  

Year ended 31 March 

Notes   

7   
19   

11   
11   
21   

2018 

£m   

137   
55   
166   
(58)  
300   

2   
(12)  
290   
2   
(34)  
28   
286   
–   
286   

2017* 
£m  

129* 

52* 

129  

(46)  

264  

(19)  

(12)  

233  

2  

(34)  

32  

233  

1  

234  

Food & Beverage Solutions 

Sucralose 

Primary Products 

Central 
Adjusted operating profit – continuing operations 

Adjusting items: 
– exceptional items 

– amortisation of acquired intangible assets 

Operating profit – continuing operations 

Finance income 

Finance expense 

Share of profit after tax of joint ventures and associates 

Profit before tax – continuing operations 

Profit before tax – discontinued operations 

Profit before tax – total operations 

*  Restated to reflect the change in reportable segments made in the 2018 financial year. 

118  Tate & Lyle PLC Annual Report 2018
118  Tate & Lyle PLC Annual Report 2018 

 
 
   
 
 
 
   
 
   
 
   
 
   
 
 
   
   
   
   
 
   
 
   
 
   
 
   
 
   
 
   
   
 
 
 
 
   
 
 
 
 
   
 
   
 
   
 
 
 
 
 
 
 
i

S
t
r
a
t
e
g
c
R
e
p
o
r
t

G
o
v
e
r
n
a
n
c
e

i

F
n
a
n
c
i
a
l
S
t
a
t
e
m
e
n
t
s

U
s
e
f
u
l

I

n
f
o
r
m
a
t
i
o
n

5. Segment information continued 

Adjusted operating margin 

Food & Beverage Solutions 

Sucralose 

Primary Products 

Central 

Total – continuing operations 

Year ended 31 March 

2018 

%   

2017* 
£m  

16.1%   

37.7%   

9.7%   

n/a   

11.1%   

15.5%* 

32.1%* 

7.3%  

n/a  

9.6%  

*  Restated to reflect the change in reportable segments made in the 2018 financial year.  

If the above segmental information were presented on a basis consistent with the prior year, Food & Beverage Solutions and Sucralose 
would be combined as Speciality Food Ingredients to show adjusted operating profit for the year ended 31 March 2018 of £192 million  
(2017 – £181 million) and an adjusted operating margin of 19.3% (2017 – 18.2%). Primary Products was renamed from Bulk Ingredients in 
the year. 

c) Segment assets/(liabilities) 
Segment assets and segment liabilities include net working capital (inventories, trade and other receivables, less trade and other 
payables). An analysis of total assets and total liabilities by operating segment is not presented to the Board. 

Net working capital 

Food & Beverage Solutions 

Sucralose 

Primary Products 

Central 

Group working capital – continuing and total operations 

Other assets/(liabilities)  

Group assets/(liabilities) 

Net working capital 

Food & Beverage Solutions 

Sucralose 

Primary Products 

Central 

Group working capital – continuing and total operations 

Other assets/(liabilities)  

Group assets/(liabilities) 

Assets 
£m 

Liabilities 
£m 

287   

62   

357   

10   

716   

1 855   

2 571   

At 31 March 2018 

Net 
£m 

154 

53 

212 

(25) 

394 

973 

(133)  

(9)  

(145)  

(35)  

(322)  

(882)  

(1 204)  

1 367 

At 31 March 2017* 

Assets  

£m    

Liabilities  

£m    

307*   

64*   

349    

13    

733    

2 038    

2 771    

(122)*  

(7)*  

(146)   

(50)   

(325)   

(1 114)   

(1 439)   

Net  
£m  

185* 

57* 

203  

(37)  

408  

924  

1 332  

*  Restated to reflect the change in reportable segments made in the 2018 financial year.  

If the above segmental information were presented on a basis consistent with the prior year, Food & Beverage Solutions and Sucralose 
would be combined as Speciality Food Ingredients to show net working capital assets of £349 million (2017 – £371 million) and net working 
capital liabilities of £142 million (2017 – £129 million). Primary Products was renamed from Bulk Ingredients in the year. 

www.tateandlyle.com  119
www.tateandlyle.com  119 

Strategic ReportGovernanceFinancial StatementsUseful Information 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
   
 
 
 
 
 
 
 
 
 
   
   
   
   
 
   
   
 
 
 
 
 
 
 
 
 
 
Notes to the Consolidated Financial Statements continued 

5. Segment information continued 
d) Other information – depreciation 

Food & Beverage Solutions  

Sucralose 

Primary Products 

Central 

Depreciation – continuing operations 

Depreciation – total operations 

Year ended 31 March 

2018 
 £m   

38   

9   

66   

1   

114   

114   

2017* 
£m  

36* 

9* 

63  

1  

109  

109  

*  Restated to reflect the change in reportable segments made in the 2018 financial year.  

If the above segmental information were presented on a basis consistent with the prior year, Food & Beverage Solutions and Sucralose 
would be combined as Speciality Food Ingredients to show depreciation of £47 million (2017 – £45 million). Primary Products was renamed 
from Bulk Ingredients in the year. 

e) Other information – amortisation  

Food & Beverage Solutions  

Sucralose 

Primary Products 

Central 

Amortisation – continuing operations 

Amortisation – total operations 

Year ended 31 March 

2018 

£m   

30   

–   

9   

1   

40   

40   

2017* 
£m  

30* 

–* 

9  

1  

40  

40  

*  Restated to reflect the change in reportable segments made in the 2018 financial year.  

If the above segmental information were presented on a basis consistent with the prior year, Food & Beverage Solutions and Sucralose 
would be combined as Speciality Food Ingredients to show amortisation of £30 million (2017 – £30 million). Primary Products was renamed 
from Bulk Ingredients in the year. 

f) Other information – share-based payments 

Food & Beverage Solutions 

Sucralose 

Primary Products 

Central 

Share-based payments – continuing operations 

Share-based payments – total operations  

Year ended 31 March 

2018 

£m   

3   

1   

4   

7   

15   

15   

2017* 
£m  

6* 

1* 

6  

8  

21  

21  

*  Restated to reflect the change in reportable segments made in the 2018 financial year.  

If the above segmental information were presented on a basis consistent with the prior year, Food & Beverage Solutions and  Sucralose 
would be combined as Speciality Food Ingredients to show share-based payments of £4 million (2017 – £7 million). Primary Products was 
renamed from Bulk Ingredients in the year. 

120  Tate & Lyle PLC Annual Report 2018
120  Tate & Lyle PLC Annual Report 2018 

   
   
 
 
 
 
 
 
   
   
 
 
 
 
 
 
   
   
 
 
 
 
 
 
 
 
 
 
 
 
 
i

S
t
r
a
t
e
g
c
R
e
p
o
r
t

G
o
v
e
r
n
a
n
c
e

i

F
n
a
n
c
i
a
l
S
t
a
t
e
m
e
n
t
s

U
s
e
f
u
l

I

n
f
o
r
m
a
t
i
o
n

5. Segment information continued 
g) Other information – capital investment 
Capital investment comprises the cost of acquisition of businesses and capital expenditure on property, plant and equipment, intangible 
assets (including amounts accrued) and investments. Capital investment is allocated based on the product(s) to which the investment 
relates. Where capital expenditure relates to plant sustaining or cost reduction projects, the cost is allocated based on the segmental split 
of the product mix by plant. 

Food & Beverage Solutions 

Sucralose 

Primary Products 

Central 

Capital investment – continuing operations 

Capital investment – total operations  

Year ended 31 March 

2018 

£m   

51   

4   

67   

19   

141   

141   

2017* 
£m  

60* 

6* 

73  

19  

158  

158  

*  Restated to reflect the change in reportable segments made in the 2018 financial year.  

If the above segmental information were presented on a basis consistent with the prior year, Food & Beverage Solutions and Sucralose 
would be combined as Speciality Food Ingredients to show capital investment of £55 million (2017 – £66 million). Primary Products was 
renamed from Bulk Ingredients in the year. 

h) Geographical information – sales by destination 

United Kingdom 

United States 

Other European countries 

Rest of the world 

Sales – continuing operations 

Sales – discontinued operations 

Sales – total operations  

i) Geographical information – sales by origin 

United Kingdom 

United States 

Other European countries 

Rest of the world 

Sales – continuing operations 

Sales – discontinued operations 

Sales – total operations  

Note   

8   

Note   

8   

Year ended 31 March 

2018 

£m   

39   

1 902   

312   

457   

2 710   

–   

2 710   

2017 
£m 

34 

2 057 

306 

356 

2 753 

3 

2 756 

Year ended 31 March 

2018 

£m   

45   

2 128   

342   

195   

2 710   

–   

2 710   

2017 
£m 

37 

2 173 

335 

208 

2 753 

3 

2 756 

j) Concentration of revenue 
During the year ended 31 March 2018, no customer contributed more than 10% of the Group’s external sales from continuing operations 
(2017 – no customer contributed more than 10%). 

www.tateandlyle.com  121
www.tateandlyle.com  121 

Strategic ReportGovernanceFinancial StatementsUseful Information 
 
 
 
 
 
 
 
   
   
 
 
 
 
 
 
   
   
   
 
   
 
   
 
   
 
   
 
   
 
 
   
   
   
   
 
   
 
   
 
   
 
   
 
   
 
 
   
 
 
 
 
Notes to the Consolidated Financial Statements continued 

5. Segment information continued 
k) Geographical information – location of non-current assets 
The Parent Company is based in the United Kingdom. The location of non-current assets, other than financial instruments, deferred tax 
assets and retirement benefits are as follows:  

United Kingdom 

United States 

Other European countries 

Rest of the world 

Non-current assets 

6. Operating profit 
Analysis of operating expenses by nature: 

Continuing operations 

External sales 

Operating expenses 

Cost of inventories (included in cost of sales) 

Staff costs (of which £151 million (2017 – £153 million) was included in cost  

of sales) 

Depreciation of property, plant and equipment: 
–  owned assets (of which £104 million (2017 – £99 million) was included in cost  

of sales) 

–  leased assets (included in cost of sales) 
Exceptional (gain)/loss 

Amortisation of intangible assets: 
–  acquired intangible assets 
–  other intangible assets 
Operating lease rentals 

Impairment of trade receivables 

Impairment of intangible assets (non-exceptional items) 

Other operating expenses 

Total operating expenses 

Operating profit 

2018 

£m   

17   

965   

331   

100   

1 413   

At 31 March 

2017 
£m 

20 

1 088 

343 

108 

1 559 

Year ended 31 March 

2018 

£m   

2 710   

2017 
£m 

2 753 

1 362   

1 449 

Notes   

10   

336   

328 

20   

20   

7   

19   

19   

17   

19   

113   

1   

(2)  

12   

28   

35   

1   

1   

533   

2 420   

290   

106 

3 

19 

12 

28 

32 

5 

5 

533 

2 520 

233 

Research and development expenditure totalling £35 million (2017 – £37 million) was included within amounts above. 

122  Tate & Lyle PLC Annual Report 2018
122  Tate & Lyle PLC Annual Report 2018 

   
   
   
 
 
 
 
 
   
   
 
 
   
 
   
   
 
 
   
 
 
   
   
 
 
 
 
 
   
   
 
 
 
 
   
 
 
 
   
 
   
 
   
 
 
i

S
t
r
a
t
e
g
c
R
e
p
o
r
t

G
o
v
e
r
n
a
n
c
e

i

F
n
a
n
c
i
a
l
S
t
a
t
e
m
e
n
t
s

U
s
e
f
u
l

I

n
f
o
r
m
a
t
i
o
n

7. Exceptional items 
Exceptional items recognised in arriving at operating profit were as follows:  

Continuing operations 

Tate & Lyle Ventures gain on disposals 

Business re-alignment – impairment, restructuring and other net costs 

Asset impairments and related costs 

US retirement benefit obligation settlement gain 

Exceptional items – continuing operations 

Discontinued operations 

Business re-alignment – Eaststarch / Morocco disposals 

Exceptional items – discontinued operations 

Exceptional items – total operations 

Footnotes   

Year ended 31 March 

2018 

£m   

2017 
£m 

(a)  

(b)  

(c)  

(d)  

(e)  

2   

–   

–   

–   

2   

–   

–   

2   

3 

(5) 

(26) 

9 

(19) 

1 

1 

(18) 

In addition, the following exceptional tax items were recognised in the current and comparative year: 

Continuing operations 

US tax adjustments 

UK tax adjustments 

Exceptional tax credit – continuing operations 

Discontinued operations 

Moroccan tax matters 

Exceptional tax credit – discontinued operations 

Exceptional tax credit – total operations 

Footnotes   

Year ended 31 March 

2018 

£m   

2017 
£m 

(f)  

(g)  

(h)  

36   

2   

38   

2   

2   

40   

31 

34 

65 

– 

– 

65 

Continuing operations – within operating profit 
a) 

In the year ended 31 March 2018, the Group recognised a £2 million cash gain, in respect of the disposal of an investment held 
as part of its venture fund portfolio, previously classified as an available-for-sale financial asset. This gain was classified within 
central costs. 

In the year ended 31 March 2017, the Group recognised a £3 million cash gain, primarily in respect of deferred consideration 
received following disposal of part of its venture fund portfolio. This profit was classified within central costs. 

b) 

In the year ended 31 March 2018, the Group paid cash of £2 million to utilise remaining provisions in respect of the business 
re-alignment of Sucralose and its European operations, but recognised no charges in this respect during the year. 

In the year ended 31 March 2017, the Group recognised a net £5 million charge (£6 million of cash costs offset by a £1 million 
non-cash credit) in respect of the business re-alignment of Sucralose and its European operations. Cash payments in respect 
of this re-alignment were £21 million. The net £5 million charge was recognised within the Sucralose segment.  

c) 

In the year ended 31 March 2017, the Group recognised a net £13 million exceptional charge in respect of its Brazilian Food 
Systems business, Gemacom Tech Indústria E Comércio S.A. reflecting a partial impairment of goodwill offset by lower contingent 
consideration now expected to fall due. The net charge was recognised within the Food & Beverage Solutions segment.  

In the year ended 31 March 2017, the Group recognised a £7 million charge for the disposal of its equity interest in  
Jiangsu Tate & Lyle Howbetter Food Co., Ltd, its Food Systems subsidiary in China. Cash payments for costs totalled  
£3 million. This charge was recognised within the Food & Beverage Solutions segment. 

Also recognised in the year ended 31 March 2017 was a non-cash charge of £6 million in respect of the impairment of certain 
redundant assets at our Decatur facility in the US. The charge was recognised within the Primary Products segment. 

d) 

In the year ended 31 March 2017, the Group recognised a £9 million non-cash gain in respect of the settlement of certain 
elements of its US retirement benefit plan obligations. The exceptional gain was recognised within the Primary Products 
segment (£6 million) and the Food & Beverage Solutions segment (£3 million). 

There was no net tax on continuing exceptional items in either the current or comparative year. Tax credits/charges on exceptional items 
are only recognised to the extent that gains/losses incurred are expected to result in tax recoverable/payable in the future. 

www.tateandlyle.com  123
www.tateandlyle.com  123 

Strategic ReportGovernanceFinancial StatementsUseful Information 
 
 
 
 
 
 
 
   
   
   
 
   
   
 
 
 
 
 
 
  
 
 
  
   
 
 
  
   
 
 
 
   
 
   
   
   
   
 
   
   
 
 
 
 
  
 
 
  
   
 
 
  
   
 
 
 
   
 
   
Notes to the Consolidated Financial Statements continued 

7. Exceptional items continued 
Discontinued operations – within operating profit 
e)  On 1 June 2016, the Group completed the sale of its corn wet mill in Casablanca, Morocco to ADM, receiving gross cash 
proceeds of £4 million. In the year ended 31 March 2017, following completion of this disposal, the Group recognised a  
£1 million exceptional gain resulting from the recycling of cumulative foreign exchange translation gains from reserves to the 
income statement. This non-cash gain was recognised within the Primary Products segment.  

There was no tax on discontinued exceptional items in either the current or comparative year. 

Continuing operations – exceptional taxation items  
f) 

In the year ended 31 March 2018, the Group recognised an exceptional tax credit of £36 million, principally reflecting the 
revaluation downwards of net US deferred tax liabilities following the reduction in the US federal corporation tax rate from  
1 January 2018. US deferred tax liabilities primarily comprise amounts arising from accelerated tax depreciation on assets. 

In the year ended 31 March 2017, following the transfer at fair value of its sucralose intellectual property assets from the UK to 
the US, the Group recognised an exceptional deferred tax credit of £31 million, reflecting the anticipated future tax benefits. 

g) 

In the year ended 31 March 2018, two significant changes drove an exceptional net credit of £2 million resulting from the 
increase in UK deferred tax assets:  

i.  UK legislation to limit to 50% the utilisation of brought-forward losses was enacted during the second half of the 2018 

financial year, resulting in a £16 million write down of the previous deferred tax asset recognised in relation to the Group’s 
internal financing arrangements. 

ii.  Anticipated changes to the Group’s internal financing arrangements, enabled by amendments to US tax legislation, led to 

the recognition of an increase in the deferred tax asset of £18 million. 

In the year ended 31 March 2017, following changes in UK tax legislation arising from the OECD’s Base Erosion and Profit 
Shifting project and changes to the internal financing arrangements we use to fund our international businesses, the Group 
recognised an exceptional deferred tax credit of £34 million, reflecting previously unrecognised tax losses in the UK, which, 
based on enacted legislation at the time, were expected to be utilised against future UK taxable profits. 

Discontinued operations – exceptional taxation items  
h) 

In the year ended 31 March 2018, the Group recognised an exceptional tax gain of £2 million following settlement with the 
Moroccan tax authorities of historical matters relating to the Group’s former Moroccan subsidiary. The Group made a payment 
of £1 million in respect of this matter during the 2018 financial year. This subsidiary was sold, as part of a broader transaction, 
to ADM on 1 June 2016. 

Exceptional cash flows 
Net cash outflows on exceptional items were as follows: 

Continuing operations 

Business re-alignment – impairment, restructuring and other net costs 

Asset impairment and related costs 

Net cash outflows – exceptional items 

Income statement (gain)/loss – included in profit before tax 

Adjustment for exceptional income statement items – per statement of cash flows  

Footnotes   

(b)  

(c)  

Accelerated US defined benefit schemes contribution (exceptional cash flows) 

Cash tax benefit on accelerated contribution (exceptional cash flows) 

Adjustment for exceptional cash flows 

(i)   

Year ended 31 March 

2018 

£m   

(2)  

–   

(2)  

(2)  

(4)  

(56)  

20   

(36)  

2017 
£m 

(21) 

(3) 

(24) 

19 

(5) 

– 

– 

– 

i) 

In the year ended 31 March 2018, the Group made an accelerated cash contribution of £56 million into the US defined benefit 
pension schemes against which the Group received a cash tax benefit of £20 million leading to an overall cash outflow of  
£36 million. This cash contribution was incremental to the ongoing annual scheme payments. 

In addition, in the year ended 31 March 2018, there were exceptional cash flows relating to the sale of assets from the Group’s venture fund 
portfolio totalling £2 million (2017 – £2 million) recognised within cash from investing activities. 

124  Tate & Lyle PLC Annual Report 2018
124  Tate & Lyle PLC Annual Report 2018 

   
   
 
 
 
 
   
 
   
 
   
 
 
   
  
 
 
   
 
   
 
 
 
 
 
i

S
t
r
a
t
e
g
c
R
e
p
o
r
t

G
o
v
e
r
n
a
n
c
e

i

F
n
a
n
c
i
a
l
S
t
a
t
e
m
e
n
t
s

U
s
e
f
u
l

I

n
f
o
r
m
a
t
i
o
n

8. Discontinued operations 
The discontinued operations of the Group are disclosed and discussed further in Note 3. 

The results of the discontinued operations which have been included in the Consolidated income statement were as follows: 

Discontinued operations – Eaststarch / Morocco  

Sales 

Operating profit including exceptional items 

Profit for the year – discontinued operations 

Notes   

5   

Year ended 31 March 

2018 
£m 

–   

–   

2   

2017 
£m 

3 

1 

1 

Basic and diluted earnings per share (pence) – discontinued operations 

13   

0.4p   

0.2p 

During the year ended 31 March 2018, the Group recognised an exceptional tax gain of £2 million following settlement with the Moroccan 
tax authorities of historical matters relating to the Group’s former Moroccan subsidiary. The Group made a payment of £1 million in 
respect of this matter during the 2018 financial year. This subsidiary was sold, as part of a broader transaction, to ADM on 1 June 2016. 

In the year ended 31 March 2017, the Group received gross cash proceeds of £4 million in relation to this sale to ADM and recognised a  
£1 million exceptional gain (see Note 7). 

The results of the discontinued operations which have been included in the consolidated statement of cash flows were as follows: 

Discontinued operations – Eaststarch / Morocco 

Profit before tax from discontinued operations 

Adjustment for: 
Exceptional items and changes in working capital 

Cash used in discontinued operations 

9. Auditors’ remuneration 
Fees payable to the Company’s external auditors, PricewaterhouseCoopers LLP, and its associates were as follows: 

Fees payable for the audit of the Company and consolidated financial statements 

Fees payable for other services: 

– the audit of the Company’s subsidiaries 

– audit-related assurance services 

– other non-audit services 

Fees in respect of the audit of the Group’s pension schemes 

Total 

Year ended 31 March 

2018 
£m 

–   

(1) 

(1)  

2017 
£m 

1 

(4) 

(3) 

Year ended 31 March 

 2018 

£m   

0.7   

1.6   

0.1   

–   

2.4   

0.1   

2.5   

2017 
£m 

0.7 

1.7 

0.1 

0.1 

2.6 

0.1 

2.7 

The audit and non-audit fees related to joint ventures payable to PricewaterhouseCoopers LLP and its associates, excluded from the table 
above, were £0.1 million (2017 – £0.1 million) and £nil (2017 – £nil) respectively. 

www.tateandlyle.com  125
www.tateandlyle.com  125 

Strategic ReportGovernanceFinancial StatementsUseful Information 
 
 
 
 
 
 
 
   
   
 
 
 
 
   
 
   
 
   
   
 
 
 
 
 
   
 
   
 
 
   
   
   
 
 
   
 
 
 
 
 
 
 
 
 
 
Notes to the Consolidated Financial Statements continued 

10. Staff costs 
Staff costs were as follows: 

Wages and salaries 

Social security costs 

Other pension costs: 

– defined benefit pension schemes 

– defined contribution pension schemes 

Retirement medical benefits 

Share-based payments 

Total 

Year ended 31 March 

2018 

£m   

282   

25   

3   

10   

1   

15   

336   

2017 
£m 

275 

22 

2 

7 

1 

21 

328 

The average number of people employed by the Company and its subsidiaries, including part-time employees, is set out below: 

By reportable segment 

Continuing operations 

Food & Beverage Solutions 

Sucralose** 

Primary Products 

Central 

Total 

Year ended 31 March 

2018   

2017* 

1 811   

90   

1 754   

534   

4 189   

1 843* 

88* 

1 731  

489  

4 151  

*  Restated to reflect the change in reportable segments made in the 2018 financial year. 

** The Food & Beverage Solutions division operates with a single commercial team. It is not practicable to split this team between the two segments comprising this 

division, and therefore the entire headcount of this team has been included within the Food & Beverage Solutions segment.  

In the year ended 31 March 2018, there were no employees (2017 – average number of employees – 15) within discontinued operations.  

At 31 March 2018, the Group employed 4,192 (2017 – 4,146) people all within continuing operations. The Group’s three reportable segments 
are supported by Global Operations, which is responsible for running the Group’s manufacturing facilities. The Group allocates the 
headcount of the Global Operations team to segments based on the split of primary capacity at each location. Central includes shared-
service employees who perform activities for the whole Group, including the Food & Beverage Solutions, Sucralose and Primary Products 
segments.  

Key management compensation 

Salaries and short-term employee benefits 

Retirement benefits 

Share-based payments 

Total 

Year ended 31 March 

2018 

£m   

10   

1   

6   

17   

2017 
£m 

11 

1 

9 

21 

Key management is represented by the Executive Committee and the Company’s Directors. Remuneration details of the Company’s 
Directors are given in the Directors’ Remuneration Report on pages 72 to 89. Members of the Executive Committee are identified on  
pages 16 and 17. The aggregate gains made by the Directors on the exercise of share options were £7 million (2017 – £4 million).  

126  Tate & Lyle PLC Annual Report 2018
126  Tate & Lyle PLC Annual Report 2018 

   
   
 
 
 
   
 
 
 
 
 
 
   
 
 
   
 
 
 
 
 
 
   
   
 
 
 
 
 
 
i

S
t
r
a
t
e
g
c
R
e
p
o
r
t

G
o
v
e
r
n
a
n
c
e

i

F
n
a
n
c
i
a
l
S
t
a
t
e
m
e
n
t
s

U
s
e
f
u
l

I

n
f
o
r
m
a
t
i
o
n

11. Finance income and expense 

Continuing operations 

Net finance expense 

Interest payable on bank and other borrowings 

Fair value hedges:  

– fair value loss on interest rate derivatives 

– fair value adjustment of hedged borrowings 

Finance lease interest 

Net retirement benefit interest 

Unwinding of discount on liabilities 

Finance expense 

Finance income 

Net finance expense 

Reconciliation to adjusted net finance expense 

Net finance expense 

Net retirement benefit interest 

Adjusted net finance expense – continuing operations 

Note   

Year ended 31 March 

2018 
£m 

2017 
£m 

(27)  

(6)  

6   

(1)  

(5)  

(1)  

(34)  

2   

(32)  

£m   

(32)  

5   

(27)  

(25) 

(4) 

4 

(1) 

(7) 

(1) 

(34) 

2 

(32) 

£m 

(32) 

7 

(25) 

30   

Notes   

30   

4   

Finance expense is shown net of borrowing costs capitalised within property, plant and equipment of £nil (2017 – £2 million) at a 
capitalisation rate of 3.9% (2017 – 3.8%). 

Interest payable on other borrowings includes £0.2 million (2017 – £0.2 million) of dividends in respect of the Group’s 6.5% cumulative 
preference shares. Finance income and finance expense relate wholly to continuing operations. 

12. Income taxes 
Analysis of charge for the year – continuing operations 

Continuing operations 

Current tax: 

– United Kingdom 

– Overseas 

Deferred tax:  

Credit for the year 

Income tax (expense)/credit – continuing operations 

Year ended 31 March 

2018 

£m   

2017 
£m  

(9)   

(45)  

(54)  

31   

(23)  

– 

(23) 

(23) 

45 

22 

For the years ended 31 March 2018 and 31 March 2017, there were no adjustments in respect of previous years for current or deferred tax. 

Reconciliation to adjusted income tax expense  

Income tax (expense)/credit 

Taxation on exceptional items, amortisation of acquired intangibles and  

net retirement benefit interest 

Exceptional US tax credit 

Exceptional UK tax credit 

Adjusted income tax expense – continuing operations 

Notes   

7   

7   

4   

£m   

(23)  

(5)  

(36)  

(2)  

(66)  

£m 

22 

(6) 

(31) 

(34) 

(49) 

The Group’s adjusted effective tax rate on continuing operations, calculated on the basis of the adjusted income tax expense of £66 million 
(2017 – £49 million) as a proportion of adjusted profit before tax of £301 million (2017 – £271 million) was 21.9% (2017 – 18.2%). 

The Group’s statutory effective tax rate on continuing operations, calculated on the basis of the reported income tax expense of £23 million 
(2017 – credit of £22 million) as a proportion of profit before tax of £286 million (2017 – £233 million) was 8.1% (2017 – credit of 9.6%). 

www.tateandlyle.com  127
www.tateandlyle.com  127 

Strategic ReportGovernanceFinancial StatementsUseful Information 
 
 
 
 
 
 
 
 
 
   
 
 
 
   
   
 
 
   
 
   
   
 
 
   
 
   
 
   
 
 
   
 
   
 
   
 
   
 
 
   
   
 
 
 
   
 
 
   
 
 
   
 
 
 
 
 
 
   
 
 
 
 
 
   
 
   
   
 
 
   
 
 
 
 
 
Notes to the Consolidated Financial Statements continued 

12. Income taxes continued 
In the year to 31 March 2018, the Group recognised exceptional tax gains totalling £38 million, comprising two items: firstly, a credit of  
£36 million predominantly reflecting the revaluation downwards of net US deferred tax liabilities following the reduction in the US federal 
tax rate; and secondly a net credit of £2 million following an increase in UK deferred tax assets. This resulted from: changes to UK 
legislation limiting to 50% the utilisation of brought-forward losses, resulting in a £16 million write down of the previous deferred tax asset; 
and anticipated changes to the Group’s internal financing arrangements, enabled by amendments to US tax legislation, resulting in an 
increase of £18 million in the deferred tax asset. In the comparative year, the Group recognised tax credits totalling £65 million. Further 
details can be found in Note 7.  

The Group’s adjusted income tax charge of £66 million (2017 – £49 million) is stated before the exceptional tax credits above, and the tax 
impact of the adjustments made between reported and adjusted profit before tax (being adjustments for amortisation of acquired 
intangibles, exceptional items in operating profit and net retirement benefit interest). The adjusted effective tax rate increased as a result 
of changes to the UK tax legislation and consequent changes to our internal financing arrangements and an increase in profits from the 
US, a jurisdiction with higher rates of corporation tax during the year. 

The standard rate of corporation tax in the UK reduced from 20% to 19% with effect from 1 April 2017 and is expected to reduce from  
19% to 17% with effect from 1 April 2020. The Group tax charge in future years is expected to benefit modestly from US Tax Reforms, 
which came into effect from 1 January 2018. Further changes in tax legislation in the jurisdictions in which the Group operates could have 
a material impact on the Group’s tax charge and/or the amount of deferred tax recognised in future accounting periods. 

The Group recognised a tax charge in the UK in the year of £9 million (2017 – £nil), as current year taxable income exceeded costs, 
together with brought-forward losses. The remaining UK losses have been treated as partially recoverable in future periods, as reflected in 
the deferred tax asset booked for the year (see page 130). 

At 31 March 2018, the carrying value of current tax assets totalled £1 million (2017 – £1 million) and the carrying value of the current tax 
liabilities totalled £57 million (2017 – £57 million). 

An analysis of tax charged or credited on adjusting items and exceptional tax items within continuing operations is set out below: 

Year ended 31 March 2018 

Year ended 31 March 2017 

Notes   

Pre-tax 

£m   

Tax (charge)/ 
credit 
£m 

Pre-tax 

£m   

Tax (charge)/  
credit 
£m 

Exceptional items 

Tate & Lyle Ventures disposal gain 

Business re-alignment – impairment,  

restructuring and other net costs 

Asset reversals/(impairments) and related costs 

US retirement benefit obligation settlement gain 

Exceptional items 

Amortisation of acquired intangibles 

Net retirement benefit interest 

Adjusting items 

Exceptional deferred tax items 

Exceptional US tax credit 

Exceptional UK tax credit 

4   

Exceptional deferred tax items 

4, 7   

2   

–   

–   

–   

2   

(12)  

(5)  

(15)  

–   

–   

–   

Total – continuing operations 

4   

(15)  

–   

–   

–   

–   

–   

3   

2   

5   

36   

2   

38   

43   

3   

(5)  

(26)  

9   

(19)  

(12)  

(7)  

(38)  

–   

–   

–   

(38)  

– 

1 

2 

(3) 

– 

3 

3 

6 

31 

34 

65 

71 

128  Tate & Lyle PLC Annual Report 2018
128  Tate & Lyle PLC Annual Report 2018 

   
   
 
   
 
 
   
   
   
   
 
 
   
 
   
  
   
   
 
 
   
 
   
 
   
 
   
 
 
   
   
   
  
 
 
   
 
   
 
 
 
   
   
   
   
 
 
   
   
   
   
 
 
   
 
   
 
 
 
   
  
   
   
 
 
 
 
 
 
i

S
t
r
a
t
e
g
c
R
e
p
o
r
t

G
o
v
e
r
n
a
n
c
e

i

F
n
a
n
c
i
a
l
S
t
a
t
e
m
e
n
t
s

U
s
e
f
u
l

I

n
f
o
r
m
a
t
i
o
n

12. Income taxes continued 
Reconciliation of the effective tax rate  
As the Group’s head office and parent company are domiciled in the UK, the Group uses the UK corporation tax rate to reference its 
effective tax rate, notwithstanding that only a small proportion of the Group’s business is in the UK. The tax on the Group’s profit before tax 
differs from the standard rate of corporation tax in the UK as follows: 

Year ended 31 March 

Profit before tax 

Less share of profit after tax of joint ventures and associates 

Parent Company and subsidiaries’ profit before tax 

Corporation tax charge thereon at 19% (2017 – 20%) 

Adjusted for the effects of: 

– non-deductible expenses and other permanent items 

– impairment of assets not deductible 

– sale of investments not taxable 

– manufacturing credits1 

– losses not currently treated as being recoverable in future periods2 

– losses previously considered irrecoverable, now expected to be recoverable 

– exceptional tax credits3 

– tax rates above the UK rate applied on overseas earnings4 

Total tax (charge)/credit – continuing operations 

1  The Group benefits from certain tax incentives available to manufacturing companies.  

2018 

£m   

286   

(28)  

258   

(49)  

(2)  

–   

–   

1   

(2)  

–   

38   

(9)  

(23)  

2017 
£m 

233 

(32) 

201 

(40) 

– 

(5) 

1 

6 

(4) 

3 

65 

(4) 

22 

2  The Group incurs expenses in jurisdictions where it does not currently expect to be able to recover these amounts against future taxable profits. This has the effect of 

increasing the Group’s overall effective tax rate.  

3  Changes in UK and US tax legislation led to exceptional tax credits totalling £38 million which included a £3 million current tax charge (See Note 7).  

4  The Group is subject to tax rates in the jurisdictions in which it operates which are above the UK corporation tax rate (the Group’s reference rate) leading to an increase 

in total tax charge. The Group’s tax rate is favourably impacted by its internal financing arrangements which involve borrowing by its operations from the UK, the 
interest on which has the effect of reducing the amount of tax payable. This financing benefit was materially reduced following UK legislation changes.  

Key factors impacting the sustainability of the effective tax rate:  
1. Tax Reforms  
US Tax Reforms, effective 1 January 2018, have reduced the US federal tax rate from 35% to 21%. Further changes to tax legislation, in the 
US or in other jurisdictions in which the Group operates, could materially impact the effective tax rate in the future.  

The Group operates internal financing arrangements which involve borrowing by our operations from the UK, the interest on which has the 
effect of reducing the amount of tax payable. These arrangements could be affected by further tax reforms in future periods impacting the 
Group’s effective tax rate. 

2. The timing of recognising tax benefits from brought-forward losses in the UK  
Legislative changes in the UK have been enacted which restrict the utilisation of brought-forward losses by 50% which has led to a 
significant taxation charge in the Group’s income statement. The extent of UK taxable profits utilised in subsequent years may be subject 
to variability, impacting the Group's tax charge. 

3. Material changes in the geographic mix of profits  
The Group’s effective tax rate is sensitive to the geographic mix of profits and reflects a combination of higher rates in certain jurisdictions 
such as the US, lower effective rates in the UK due to the availability of losses and rates that lie somewhere in between. If the geographic 
mix of profits were to change materially, through changes in the composition of the Group’s business or changes in performance, our tax 
rate could change materially.  

www.tateandlyle.com  129
www.tateandlyle.com  129 

Strategic ReportGovernanceFinancial StatementsUseful Information 
 
 
 
 
 
 
 
   
   
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
Notes to the Consolidated Financial Statements continued 

12. Income taxes continued 
Key factors impacting the sustainability of the effective tax rate continued:  
4. Resolution of tax judgements arising from current or future tax issues  
At any one time, the Group can be subject to a number of challenges by tax authorities in the jurisdictions in which it operates. The 
outcome of these challenges is inherently uncertain, potentially resulting in a different tax charge from the amounts initially provided. 

At 31 March 2018, the Group carried a central provision in current tax payables in respect of uncertain tax positions within its continuing 
operations totalling £29 million (2017 – £34 million). Based on all substantively enacted legislation, the Group believes that no reasonably 
possible change in assumptions would lead to a material change in this number. 

Exceptional tax credits 
In the year ended 31 March 2018, the Group recognised exceptional tax credits totalling £38 million (2017 – £65 million) in respect of recent 
changes to UK and US tax legislation and the Group’s internal financing arrangements. Further details can be found in Note 7. 

Deferred tax 
Deferred tax is calculated on differences between the accounting value of assets and liabilities and their respective tax values. 

The movements in deferred tax assets and liabilities during the year were as follows: 

At 1 April 2016 

(Charged)/credited to the income statement 

underlying 

exceptional 

Charged to other comprehensive income 

Credited directly to equity 

Currency translation differences 

At 31 March 2017 

(Charged)/credited to the income statement 

underlying 

exceptional 

Charged to other comprehensive income 

Charged directly to equity 

Currency translation differences 

At 31 March 2018 

Capital 
allowances in 
excess of 
depreciation 

Retirement 
benefit 
obligations 

£m   

(134)  

(11)  

–   

–   

–   

(24)  

(169)  

(2)  

52   

–   

–   

18   

(101)  

£m   

83   

(6)  

–   

(30)   

–   

17   

64   

4   

1   

(60)  

–   

(9)  

–   

Share- 
based  
payments 

£m   

2   

2   

–   

–   

3   

–   

7   

–   

–   

–   

(3)  

–   

4   

Tax losses 
£m 

6   

–   

34   

–   

–   

–   

40   

(5)  

(4)  

–   

–   

(1)  

30   

Other1 

£m   

25   

(5)  

31   

–   

–   

4   

55   

(7)  

(8)  

–   

–   

(8)  

32   

Total 
£m 

(18) 

(20) 

65 

(30) 

3 

(3) 

(3) 

(10) 

41 

(60) 

(3) 

– 

(35) 

1  During the prior year the Group rationalised ownership of its Sucralose IP to align it with the underlying US manufacturing base. This resulted in the recognition of a 
deferred tax asset of £31 million. Other deferred tax items include temporary differences arising from accounting provisions, where the timing of the tax deduction is 
different from the timing of accounting recognition, and business combinations.  

Deferred tax assets and liabilities are offset where there is a legally enforceable right of offset and there is an intention to net settle the 
balances. After taking these offsets into account, the net position of £35 million liability (2017 – £3 million liability) is presented as a  
£7 million deferred tax asset (2017 – £22 million asset) and a £42 million deferred tax liability (2017 – £25 million liability) in the Group’s 
statement of financial position.  

Other than changes as a result of US Tax Reforms (see previous page), changes in enacted tax rates had no effect on the amount of 
deferred tax charged to the income statement and other comprehensive income or equity. There was no impact from the imposition of new 
taxes. No deferred tax assets have been recognised in respect of tax losses of £556 million (2017 – £508 million) as there is uncertainty as 
to whether taxable profits against which these assets may be recovered, will be available. No unrelieved tax losses expired under current 
tax legislation in the year ended 31 March 2018.  

The total deferred tax on unremitted earnings is £1 million (2017 – £3 million) of which £nil (2017 – £2 million) has been recognised. The 
Group has not recognised the full amount as it is able to control the timing of the reversal of certain of these temporary differences and it 
is not probable that they will reverse in the foreseeable future. 

130  Tate & Lyle PLC Annual Report 2018
130  Tate & Lyle PLC Annual Report 2018 

   
 
 
 
  
  
   
   
  
 
 
 
 
 
 
 
 
  
  
   
   
  
 
 
 
 
 
 
 
 
i

S
t
r
a
t
e
g
c
R
e
p
o
r
t

G
o
v
e
r
n
a
n
c
e

i

F
n
a
n
c
i
a
l
S
t
a
t
e
m
e
n
t
s

U
s
e
f
u
l

I

n
f
o
r
m
a
t
i
o
n

12. Income taxes continued 
Discontinued operations 
An exceptional income tax credit of £2 million was recognised in the year ended 31 March 2018 (2017 – £nil) in respect of discontinued 
operations (see Note 8). This credit related to historical tax matters at the Moroccan facility, which the Group sold to ADM during the  
2017 financial year. 

Tax on other comprehensive income  
The following table sets out the tax arising on components of other comprehensive income: 

Retirement benefit obligations  

Deferred tax credit relating to components of other comprehensive income 

Retirement benefit obligations  

Current tax charge relating to components of other comprehensive income 

Total tax on other comprehensive income 

Year ended 31 March 

2018 
£m 

(60)  

(60)  

27   

27   

(33)  

2017 
£m 

(30) 

(30) 

– 

– 

(30) 

Tax on items recognised directly in equity  
A deferred tax charge of £3 million, in relation to share-based payments, was recognised directly in equity (2017 – £3 million credit). 

13. Earnings per share 
Basic earnings per share is calculated by dividing the profit attributable to owners of the Company by the weighted average number of 
ordinary shares in issue during the year, excluding an average of 6 million shares (2017 – 4 million shares) held by the Company and the 
Employee Benefit Trust to satisfy awards made under the Group’s share-based incentive plans. 

Diluted earnings per share is calculated by adjusting the weighted average number of ordinary shares in issue assuming conversion of 
potentially dilutive ordinary shares, reflecting vesting assumptions on employee share plans, as well as the profit attributable to owners of 
the Company for any proceeds on such conversions. Potentially dilutive ordinary shares arise from awards made under the Group’s share-
based incentive plans. Where the vesting of these awards is contingent on satisfying a service or performance condition, the number of 
potentially dilutive ordinary shares is calculated based on the status of the condition at the end of the period. Potentially dilutive ordinary 
shares are dilutive only when the average market price of the Company’s ordinary shares during the year exceeds their exercise price 
(options) or issue price (other awards). Otherwise, the effect of exercising such options or awards would be to increase the earnings per 
share rather than to dilute. The greater any such excess, the greater the dilutive effect. The average market price of the Company’s 
ordinary shares during the year was 676p (2017 – 695p). The dilutive effect of share-based incentives was 7.7 million shares  
(2017 – 7.1 million shares). 

Profit attributable to owners of the 

Company (£ million) 

Weighted average number of ordinary shares 

(million) – basic 

Basic earnings per share (pence) 

Weighted average number of ordinary shares 

(million) – diluted 

Diluted earnings per share (pence) 

Year ended 31 March 2018   

Year ended 31 March 2017 

Continuing 
operations   

Discontinued 

Total 

operations   

operations   

Continuing 
operations   

Discontinued 

operations   

Total 
operations 

263   

2   

265   

255   

1   

256 

462.3   

57.0p   

462.3   

0.4p   

462.3   

57.4p   

464.1   

55.0p   

464.1   

0.2p   

464.1 

55.2p 

470.0   

56.1p   

470.0   

0.4p   

470.0   

56.5p   

471.2   

54.2p   

471.2   

0.2p   

471.2 

54.4p 

www.tateandlyle.com  131
www.tateandlyle.com  131 

Strategic ReportGovernanceFinancial StatementsUseful Information 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
   
   
 
   
   
   
   
   
 
 
 
   
   
   
   
   
 
 
 
 
 
   
   
   
   
   
 
 
   
   
   
   
   
 
 
 
 
 
Notes to the Consolidated Financial Statements continued 

13. Earnings per share continued 
Adjusted earnings per share 
A reconciliation between profit attributable to owners of the Company from continuing operations and the equivalent adjusted metric, 
together with the resulting adjusted earnings per share metrics can be found below: 

Continuing operations 

Profit attributable to owners of the Company  

Adjusting items: 

– exceptional (gain)/loss  

– amortisation of acquired intangible assets  

– net retirement benefit interest  

– tax effect of the above adjustments 

– exceptional tax credits 

Adjusted profit attributable to owners of the Company  

Notes   

7   

19   

11, 30   

12   

7, 12   

4   

Year ended 31 March 

2018 

£m   

263   

(2)  

12   

5   

(5)  

(38)  

235   

2017 
£m 

255 

19 

12 

7 

(6) 

(65) 

222 

Adjusted basic earnings per share (pence) – continuing operations 

Adjusted diluted earnings per share (pence) – continuing operations 

50.9p   

50.1p   

47.8p 

47.1p 

14. Dividends on ordinary shares 
Dividends on ordinary shares in respect of the financial year: 

Per ordinary share: 

– interim dividend paid 

– final dividend proposed 

Total dividend 

  Year ended 31 March 

2018 
Pence   

8.4   

20.3   

28.7   

2017 
Pence 

8.2 

19.8 

28.0 

The Directors propose a final dividend for the financial year of 20.3p per ordinary share that, subject to approval by shareholders, will be 
paid on 1 August 2018 to shareholders who are on the Register of Members on 22 June 2018. 

Dividends on ordinary shares paid in the financial year: 

Final dividend paid relating to the prior financial year  

Interim dividend paid relating to the financial year 

Total dividend paid 

Year ended 31 March 

2018 

£m   

92   

39   

131   

2017 
£m 

92 

38 

130 

Based on the number of ordinary shares outstanding at 31 March 2018 and the proposed amount, the final dividend for the financial year is 
expected to amount to £94 million. 

15. Inventories 

Raw materials and consumables 

Work in progress 

Finished goods 

Total 

2018 

£m   

201   

17   

201   

419   

At 31 March 

2017 
£m 

206 

19 

216 

441 

Finished goods inventories of £1 million (2017 – £4 million) are carried at net realisable value, this being lower than cost. Agricultural 
produce after harvest of £103 million (2017 – £103 million) is carried at net realisable value. During the year ended 31 March 2018, the 
Group recognised a write down of inventories totalling £3 million (2017 – £6 million), which relates to the normal course of business and is 
included in the cost of inventories.  

132  Tate & Lyle PLC Annual Report 2018
132  Tate & Lyle PLC Annual Report 2018 

   
   
 
 
   
 
   
   
 
 
 
 
 
 
 
 
 
   
   
 
 
   
 
   
   
   
 
   
 
 
 
 
   
   
 
 
 
   
 
   
 
 
 
 
 
16. Cash and cash equivalents 

Cash and cash equivalents 

Total 

The carrying amount of cash and cash equivalents was denominated in the following currencies: 

US dollar 

Euro 

Sterling 

Other 

Total  

17. Trade and other receivables 

Trade receivables 

Less provision for doubtful debts 

Trade receivables – net 

Prepayments and accrued income 

Margin deposits 

Other receivables 

Total 

The amounts above do not include non-current other receivables of £3 million (2017 – £1 million).  

The carrying amount of trade and other receivables was denominated in the following currencies: 

US dollar 

Euro 

Sterling 

Other 

Total 

i

S
t
r
a
t
e
g
c
R
e
p
o
r
t

G
o
v
e
r
n
a
n
c
e

i

F
n
a
n
c
i
a
l
S
t
a
t
e
m
e
n
t
s

U
s
e
f
u
l

I

n
f
o
r
m
a
t
i
o
n

2018 

£m   

190   

190   

2018 
£m 

161   

16   

4   

9   

190   

2018 

£m   

280   

(14)  

266   

16   

1   

11   

294   

2018 

£m   

201   

40   

14   

42   

297   

At 31 March 

2017 
£m 

261 

261 

At 31 March 

2017 
£m 

226 

12 

2 

21 

261 

At 31 March 

2017 
£m 

264 

(14) 

250 

15 

3 

23 

291 

At 31 March 

2017 
£m 

184 

46 

12 

50 

292 

During the year, the Group recognised impairments or write offs of receivables totalling £1 million (2017 – £5 million). At 31 March 2018, 
trade receivables of £18 million (2017 – £7 million) were past due but not impaired because they were considered to be collectible. The 
ageing analysis of these trade receivables was as follows: 

Up to 30 days past due 

1–3 months past due 

Over 3 months past due 

Total 

2018 

£m   

14   

3   

1   

18   

At 31 March 

2017 
£m 

6 

1 

– 

7 

Trade receivables are not generally interest-bearing but interest may be charged to customers on overdue amounts. 

www.tateandlyle.com  133
www.tateandlyle.com  133 

Strategic ReportGovernanceFinancial StatementsUseful Information 
 
 
 
 
 
 
 
   
 
   
 
 
   
 
 
 
 
 
 
 
 
 
   
 
   
 
 
 
 
 
 
 
   
 
   
 
 
 
 
 
   
 
   
 
 
 
 
 
 
Notes to the Consolidated Financial Statements continued 

18. Available-for-sale financial assets 
Available-for-sale financial assets comprise £37 million (2017 – £30 million) of unlisted securities. These available-for-sale financial assets 
are carried at cost where fair value cannot be reliably measured.  

At 1 April 2016 

Year ended 31 March 2017: 

Additions 

Disposals 

Re-measurement of non-qualified deferred compensation arrangements 

Currency translation differences 

At 31 March 2017 

Year ended 31 March 2018: 

Additions 

Revaluations 

Disposals 

Impairment 

Re-measurement of non-qualified deferred compensation arrangements 

Currency translation differences 

At 31 March 2018 

The carrying value of available-for-sale financial assets was denominated in the following currencies: 

US dollar 

Sterling 

Euro 

Total 

Presented in the statement of financial position as follows: 

Non-current assets 

Current assets 

Total 

Note   

30   

30   

2018 

£m   

31   

2   

4   

37   

2018 

£m   

37   

–   

37   

£m 

23 

4 

(2) 

2 

3 

30 

8 

3 

(2) 

(1) 

2 

(3) 

37 

At 31 March 

2017 
£m 

25 

2 

3 

30 

At 31 March 

2017 
£m 

30 

– 

30 

134  Tate & Lyle PLC Annual Report 2018
134  Tate & Lyle PLC Annual Report 2018 

   
 
   
 
   
 
 
   
 
   
 
 
   
 
   
 
   
 
 
   
 
   
 
   
 
   
 
 
   
 
   
   
 
   
 
 
 
 
   
 
   
 
 
 
 
 
19. Goodwill and other intangible assets 

Cost 

At 1 April 2017 

Additions at cost 

Currency translation differences 

At 31 March 2018 

Accumulated amortisation and impairment 

At 1 April 2017 

Impairment charge 

Amortisation charge 

Currency translation differences 

At 31 March 2018 

Net book value at 31 March 2018 

Cost 

At 1 April 2016 

Re-measurement of acquisition 

Additions at cost 

Disposals and write offs 

Currency translation differences 

At 31 March 2017 

Accumulated amortisation and impairment 

At 1 April 2016 

Impairment charge 

Disposals and write offs 

Amortisation charge 

Currency translation differences 

At 31 March 2017  

Net book value at 31 March 2017 

Goodwill 
The carrying amount of goodwill is allocated as follows: 

Allocated by geographical area 

United States 

Europe 

Allocated by reportable segment 

Food & Beverage Solutions 

Primary Products 

Total 

i

S
t
r
a
t
e
g
c
R
e
p
o
r
t

G
o
v
e
r
n
a
n
c
e

i

F
n
a
n
c
i
a
l
S
t
a
t
e
m
e
n
t
s

U
s
e
f
u
l

I

n
f
o
r
m
a
t
i
o
n

Goodwill 

£m   

Patents and 
other IP 

Other acquired 
intangibles 

Total acquired 
intangibles 

£m   

£m   

£m   

Other  
intangible 
assets 

£m   

229   

–   

(11)  

218   

17   

–   

–   

(3)  

14   

204   

41   

–   

(1)  

40   

37   

–   

1   

–   

38   

2   

166   

–   

(1)  

165   

112   

–   

11   

(3)  

120   

45   

436   

–   

(13)  

423   

166   

–   

12   

(6)  

172   

251   

254   

20   

(20)  

254   

123   

1   

28   

(7)  

145   

109   

Total 
£m 

690 

20 

(33) 

677 

289 

1 

40 

(13) 

317 

360 

204   

40   

150   

394   

204   

598 

1   

–   

(2)  

26   

229   

–   

18   

(2)  

–   

1   

17   

212   

–   

–   

–   

1   

41   

35   

–   

–   

2   

–   

37   

4   

–   

–   

–   

16   

166   

91   

–   

–   

10   

11   

112   

54   

1   

–   

(2)   

43   

436   

126   

18   

(2)  

12   

12   

166   

270   

–   

26   

(1)   

25   

1 

26 

(3) 

68 

254   

690 

82   

5   

–   

28   

8   

123   

131   

208 

23 

(2) 

40 

20 

289 

401 

2018 

£m   

72   

109   

181   

21   

2   

23   

204   

At 31 March 

2017 
£m 

74 

– 

74 

136 

2 

138 

212 

www.tateandlyle.com  135
www.tateandlyle.com  135 

Strategic ReportGovernanceFinancial StatementsUseful Information 
 
 
 
 
 
 
 
   
 
   
   
   
   
   
 
 
 
 
 
 
   
   
   
   
   
 
 
 
 
 
 
 
 
   
   
   
   
   
 
 
 
 
 
 
 
 
   
   
   
   
   
 
 
 
 
 
 
 
 
   
 
   
 
     
 
 
 
 
 
   
 
 
 
 
 
 
 
 
Notes to the Consolidated Financial Statements continued 

19. Goodwill and other intangible assets continued 
(i) Impairment tests carried out during the year  
The Group operates principally as an integrated manufacturing network in the United States and Europe, with a large amount of 
interdependency between plants servicing both the Food & Beverage Solutions and Primary Products segments. Goodwill is therefore 
tested for impairment on a geographical basis, except where it can be allocated to a specific CGU. During the year, the Group has 
integrated its Food Systems business into the core Speciality Food Ingredients business (now together Food & Beverage Solutions) to drive 
synergies in commercial strategy, commercial organisation and enabling infrastructure and organisation. As a result of this  
re-organisation, management considers that goodwill in relation to Food Systems businesses should no longer be tested separately but 
should be tested at a geographical level.  

A description of the impairment tests conducted in relation to the most significant goodwill amounts are set out as follows. In each case, 
the recoverable amount was calculated based on value in use, with the exception of the European business, the Latin American Food & 
Beverage Solutions operations and Tate & Lyle Sweden AB. Value in use was calculated based on budgets and plans covering the next five 
years that have been reviewed by the Board. Cash flows were projected during the five-year period based on budgeted operating profit and 
management’s expectations of market developments. Beyond the five-year plan, cash flows were generally assumed to grow at the  
long-term growth rate for the relevant geographical markets based on forecasts included in industry reports. Cash flows were discounted 
using pre-tax rates that are based on the Group’s weighted average cost of capital adjusted, where appropriate, to reflect differences 
between the risk profile of the geographical areas or CGUs concerned and that of the Group as a whole. 

Goodwill allocated by geographical area  
United States  
Goodwill allocated to the US operations of £72 million (2017 – £74 million which related to single ingredient operations only) relates 
predominantly to the Staley acquisition in 1988. The key assumptions in the model are derived from the Group’s Annual Operating Plan for 
2019 and Board-reviewed five-year plan, which includes mid-single digit volume growth in Food & Beverage Solutions and flat volumes in 
Primary Products. Operating profit is assumed to increase by low-single digits for both Food & Beverage Solutions and Primary Products, 
based on management’s long-term expectations. Based on the risk profile of the assets tested, cash flows were discounted using a pre-
tax rate of 8.9% (2017 – 8.8%). Significant headroom exists and management concluded that no impairment is required. 

Europe 
Goodwill of £109 million is allocated to the European operations. At 31 March 2017, goodwill totalled £106 million being £63 million relating 
to the European Food Systems CGU incorporating G.C. Hahn and Company and Cesalpinia Foods and £43 million relating to the  
Tate & Lyle Boleraz s.r.o. CGU. Both CGUs were tested separately in 2017. The key assumptions in the model are derived from the Group’s 
Annual Operating Plan for 2019 and Board-reviewed five-year plan which assumes expansion beyond normal maintenance capital 
expenditure. Accordingly, the recoverable amount was determined based on fair value less costs of disposal. The fair value was 
determined based on a discounted cash flow model using a post-tax discount rate and cash inflows and outflows from future expansion. 
Cash flows from 2019 onwards are expected to grow at a double-digit compound annual rate over the subsequent four years reflecting the 
growth derived from the expansion. Cash flows were discounted using a post-tax rate of 7.1%. Management concluded that no impairment 
is required. 

Goodwill allocated by reportable segment  
Food & Beverage Solutions 
Goodwill of £6 million is allocated to the Latin American Food & Beverage Solutions operations (2017 – £7 million) relating to Tate & Lyle 
Gemacom Tech Indústria E Comércio S.A. which was tested separately in 2017. The impairment model assumes expansion beyond normal 
maintenance capital expenditure and the recoverable amount therefore was calculated based on fair value less costs of disposal. The fair 
value was determined based on a discounted cash flow model using a post-tax discount rate and cash inflows and outflows from future 
expansion. The model assumes a return to profitability over the first two years with volume and contribution margin growth in low-double 
digits over the five years. The long-term growth rate is assumed to be 5% thereafter, reflecting the growth expectations for this market. 
Cash flows were discounted using a post-tax rate of 11.7% (2017 – 12% post-tax). Management concluded that no impairment is required.  

In 2017, management recognised an impairment charge of £16 million within other expenses as an exceptional item in relation to the 
Gemacom CGU. Refer to Note 7 for further details.  

Goodwill of £9 million (2017 – £10 million) allocated to the Food & Beverage Solutions segment relates to the acquisition of Tate & Lyle 
Sweden AB (formerly ’Biovelop’), the Oat Beta Glucan plant, in the 2014 financial year. The key assumptions in the model are derived from 
the Group’s Annual Operating Plan for 2019, and the model projects material operating profit growth as commercialisation of a key  
co-product stream is achieved. Management concluded, based on the fair value less cost of disposal model used, that no impairment is 
required. Cash flows were discounted using a post-tax rate of 7.0% (2017 – 7.1%). Long-term growth rate is assumed to be 1% (2017 – 0%) 
thereafter, reflecting the future growth potential of the market. However, this calculation resulted in a low level of headroom compared 
with the carrying value. The amount of headroom was particularly sensitive to the discount rate, the pricing of the PrOateinTM main product 
and sales volumes and prices of co-products. Reasonably possible changes in each of these assumptions individually, being changes in 
excess of an increase in the discount rate of 6bps, a reduction in pricing of PrOateinTM sold of 100bps, a reduction in volumes of  
co-products sold in years two to five of 90bps or a reduction in pricing of co-products sold of 100bps would lead to an impairment. 
Management considers the value of co-product revenues within the model to be an area of significant judgement. Refer to Note 2 for 
further details. 

There are no other individually material elements of goodwill allocated to the Food & Beverage Solutions, Sucralose or Primary Products 
reportable segments. 

136  Tate & Lyle PLC Annual Report 2018
136  Tate & Lyle PLC Annual Report 2018 

 
i

S
t
r
a
t
e
g
c
R
e
p
o
r
t

G
o
v
e
r
n
a
n
c
e

i

F
n
a
n
c
i
a
l
S
t
a
t
e
m
e
n
t
s

U
s
e
f
u
l

I

n
f
o
r
m
a
t
i
o
n

19. Goodwill and other intangible assets continued 
(ii) Possibility of impairment in the near future  
Management considers that, with the exception of Tate & Lyle Sweden AB, there is no reasonably possible change in one or more of the 
key assumptions used in the impairment tests for goodwill and other intangible assets that would give rise to an impairment loss during 
the coming year. 

20. Property, plant and equipment 

Cost 

At 1 April 2017 

Additions at cost 

Transfers on completion 

Disposals and write offs 

Currency translation differences 

At 31 March 2018 

Accumulated depreciation and impairment 

At 1 April 2017 

Depreciation charge 

Disposals and write offs 

Currency translation differences 

At 31 March 2018 

Net book value at 31 March 2018 

Including assets held under finance leases 

Cost 

At 1 April 2016 

Additions at cost 

Transfers on completion 

Disposals and write offs1 

Currency translation differences 

At 31 March 2017  

Accumulated depreciation and impairment 

At 1 April 2016 

Depreciation charge 

Impairment charge 

Disposals and write offs1 

Currency translation differences 

At 31 March 2017 

Net book value at 31 March 2017 

Including assets held under finance leases 

Land 
and buildings 

£m   

Plant and 
machinery 

£m   

Assets in the 
course of 
construction  
£m   

569   

5   

43   

(4)  

(57)  

556   

289   

14   

(3)  

(30)  

270   

286   

–   

485   

1   

43   

(30)   

70   

569   

265   

14   

3   

(30)   

37   

289   

280   

–   

2 433   

4   

111   

(18)  

(252)  

2 278   

1 729   

100   

(17)  

(187)  

1 625   

653   

8   

2 142   

5   

199   

(249)   

336   

2 433   

1 633   

95   

4   

(247)   

244   

1 729   

704   

10   

77   

104   

(154)  

(1)  

–   

26   

–   

–   

–   

–   

–   

26   

–   

222   

122   

(242)  

(25)  

–   

77   

25   

–   

–   

(25)   

–   

–   

77   

–   

Total 
£m  

3 079 

113 

– 

(23) 

(309) 

2 860 

2 018 

114 

(20) 

(217) 

1 895 

965 

8 

2 849 

128 

– 

(304) 

406 

3 079 

1 923 

109 

7 

(302) 

281 

2 018 

1 061 

10 

1  In the year ended 31 March 2017, the formerly impaired assets at the Singapore plant were decommissioned and removed from the fixed asset register. 

Impairment reviews  
Management conducted impairment reviews of property, plant and equipment during the year and concluded that there were no 
impairments. During the prior year, the Group recognised an impairment charge of £6 million in respect of the impairment of certain 
redundant assets at the Decatur facility in the US (see Note 7). As part of the impairment and deconsolidation of the Group's equity interest 
in Jiangsu Tate & Lyle Howbetter Food Co., Ltd, the Group recognised a £1 million charge (see Note 7).  

www.tateandlyle.com  137
www.tateandlyle.com  137 

Strategic ReportGovernanceFinancial StatementsUseful Information 
 
 
 
 
 
 
 
   
   
 
   
   
   
   
 
 
   
 
   
 
   
 
   
 
   
 
   
 
   
   
   
   
 
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
   
   
   
 
 
   
 
   
 
   
 
   
 
   
 
   
 
   
   
   
   
 
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
 
Notes to the Consolidated Financial Statements continued 

21. Equity accounted investments 
The amounts recognised in the Consolidated income statement are as follows: 

Joint ventures – continuing operations 

Total operations 

The amounts recognised in the Consolidated statement of financial position are as follows: 

Associates  

Joint ventures 

  Year ended 31 March 

2018 

£m   

28   

28   

2018 

£m   

–   

85   

2017 
£m 

32 

32 

At 31 March 

2017 
£m 

4 

92 

Associates 
On 2 November 2017, the Group completed the sale of its 33.3% share in an associated undertaking, the Tapioca Development 
Corporation. This was the Group’s only associate and was accounted for under the equity method. The associate had share capital 
consisting solely of ordinary shares, which were held directly by the Group, and the country of incorporation or registration is also its 
principal place of business. Tapioca Development Corporation is a private company, based in Thailand, and there is no quoted market price 
available for its shares. 

This sale resulted in cash proceeds of £5 million and resulted in a profit on disposal of £2 million, after recycling of cumulative foreign 
exchange translation gains of £1 million from reserves to the income statement upon disposal. 

In the opinion of the Directors, this former associate was not considered to be material to the Group and there are no contingent liabilities 
relating to the Group’s previously held interest in the associate.  

The investment in the associate as at 31 March 2018 was £nil (2017 – £4 million). During the years ended 31 March 2018 and 31 March 
2017, other than the gain on disposal, the Group recognised no net profit in its consolidated income statement and received no dividends 
from its associate.  

Joint ventures  
In the opinion of the Directors, the Group’s material joint ventures, which are accounted for under the equity method, are Almidones 
Mexicanos SA (Almex) and DuPont Tate & Lyle Bio Products Company, LLC (Bio-PDO) (see Note 38). The joint ventures have share capital 
consisting solely of ordinary shares, which are held directly by the Group (and its joint venture partners) and are private companies. No 
quoted market price is available for their shares. There are no contingent liabilities relating to the Group’s interest in the joint ventures.  

The movements in the carrying value of the Group’s investment in joint ventures are summarised as follows: 

Investments in joint ventures 

At 1 April 2017 

Share of profit after tax of joint ventures – total operations 

Other comprehensive expense (including exchange) 

Dividends paid 

At 31 March 2018 

At 1 April 2016 

Share of profit after tax of joint ventures – total operations 

Other comprehensive income (including exchange) 

Dividends 

At 31 March 2017 

Note   

23   

Note   

23   

£m 

92 

28 

(9) 

(26) 

85 

£m 

82 

32 

7 

(29) 

92 

Set out below is the summarised financial information for each material joint venture accounted for using the equity method.  

The information reflects the amounts presented in the financial statements of the joint ventures (and not the Group’s share of those 
amounts) adjusted for differences in accounting policies between the Group and the joint ventures to make it consistent with the Group’s 
accounting policies. 

138  Tate & Lyle PLC Annual Report 2018
138  Tate & Lyle PLC Annual Report 2018 

   
   
   
   
 
   
  
   
   
 
   
 
 
 
 
   
 
   
 
 
   
 
   
   
   
 
   
 
   
 
   
 
 
   
 
   
 
 
21. Equity accounted investments continued 
Income Statement 

Year ended 31 March 2018 

Bio-PDO 
£m 

Other 
£m 

Sales 

Depreciation and amortisation 

Other expense 

Profit before tax 

Income tax expense 

Profit for the year from total operations 

Other comprehensive expense 

Total comprehensive income 

Dividends 

Sales 

Depreciation and amortisation 

Other expense 

Profit before tax 

Income tax expense 

Profit for the year from total operations 

Other comprehensive income 

Total comprehensive income 

Dividends 

Statement of Financial Position 

Assets 

Non-current assets 

Cash and cash equivalents 

Other current assets 

Liabilities 

Other non-current liabilities 

Current borrowings 

Other current liabilities 

Net assets 

Almex 
£m 

627   

(2)  

(564)   

61   

(17)  

44   

(12)  

32   

(53)  

Almex 

£m   

618   

(2)   

(546)   

70   

(20)   

50   

5   

55   

(33)   

97   

(7)  

(71)   

19   

(7)  

12   

(4)   

8   

–   

Bio-PDO 

£m   

90   

(7)  

(65)  

18   

(4)  

14   

10   

24   

(24)  

i

S
t
r
a
t
e
g
c
R
e
p
o
r
t

G
o
v
e
r
n
a
n
c
e

i

F
n
a
n
c
i
a
l
S
t
a
t
e
m
e
n
t
s

U
s
e
f
u
l

I

n
f
o
r
m
a
t
i
o
n

Total  
£m 

724 

(9) 

(635) 

80 

(24) 

56 

(17) 

39 

(53) 

–   

–   

– 

–   

–   

–   

(1)   

(1)   

–   

Year ended 31 March 2017 

Other 

£m   

–   

–   

–   

–   

–   

–   

(1)  

(1)  

–   

Total  
£m 

708 

(9) 

(611) 

88 

(24) 

64 

14 

78 

(57) 

At 31 March 2018 

Almex  
£m 

Bio-PDO 
£m 

Other  
£m 

43   

2   

161   

206   

4   

47   

57   

108   

98   

46   

27   

20   

93   

–   

–   

21   

21   

72   

–   

–   

–   

–   

–   

–   

–   

–   

–   

Total 
£m 

89 

29 

181 

299 

4 

47 

78 

129 

170 

www.tateandlyle.com  139
www.tateandlyle.com  139 

Strategic ReportGovernanceFinancial StatementsUseful Information 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
   
   
 
 
 
 
 
 
 
   
   
   
 
 
 
 
 
 
 
 
 
Notes to the Consolidated Financial Statements continued 

21. Equity accounted investments continued 
Statement of Financial Position 

At 31 March 2017 

Total  
£m 

99 

17 

169 

285 

4 

22 

75 

101 

184 

Total 
£m 

184 

56 

(17) 

(53) 

170 

85 

85 

Total 
£m 

163 

64 

14 

(57) 

184 

92 

92 

Assets 

Non-current assets 

Cash and cash equivalents 

Other current assets 

Liabilities 

Other non-current liabilities 

Current borrowings 

Other current liabilities 

Net assets 

Almex  
£m   

Bio-PDO 

£m   

Other  
£m   

45   

7   

155   

207   

4   

22   

62   

88   

119   

53   

10   

14   

77   

–   

–   

13   

13   

64   

1   

–   

–   

1   

–   

–   

–   

–   

1   

Reconciliation of the summarised financial information presented to the carrying amount of the Group’s interest in joint ventures: 

Reconciliation of summarised financial information 

Almex 
£m 

119   

44   

(12)  

(53)  

98   

50%   

49   

49   

Almex 
£m 

97   

50   

5   

(33)   

119   

50%   

59   

59   

Bio-PDO 
£m 

Other 
£m 

64   

12   

(4)  

–   

72   

50%   

36   

36   

Bio-PDO 
£m 

64   

14   

10   

(24)  

64   

50%   

32   

32   

1   

–   

(1)  

–   

–   

50%   

–   

–   

Other 
£m 

2   

–   

(1)  

–   

1   

50%   

1   

1   

Opening net assets at 1 April 2017 

Profit for the year from total operations 

Other comprehensive expense 

Dividends 

Closing net assets at 31 March 2018 

Interest in joint venture (%) 

Interest in joint venture at share 

Carrying value at 31 March 2018 

Opening net assets at 1 April 2016 

Profit for the year from total operations 

Other comprehensive income/(expense) 

Dividends 

Closing net assets at 31 March 2017 

Interest in joint venture (%) 

Interest in joint venture at share 

Carrying value at 31 March 2017 

140  Tate & Lyle PLC Annual Report 2018
140  Tate & Lyle PLC Annual Report 2018 

   
   
   
   
   
   
   
 
   
   
   
   
 
 
   
 
   
 
   
 
 
   
 
   
   
   
   
 
 
   
 
   
 
   
 
 
   
 
   
   
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
22. Share capital and share premium 

At 31 March 2018 and 31 March 2017 

Ordinary share 
capital 

£m   

117   

Share 
premium 

£m   

406   

Total 
£m 

523 

Ordinary shares carry the right to participate in dividends and each share entitles the holder to one vote on matters requiring shareholder 
approval. 

Allotted, called up and fully paid equity share capital 

At 1 April 

Allotted under share option schemes 

At 31 March 

Year ended 31 March 2018   

Year ended 31 March 2017 

Number of   
shares* 

Cost 
£m 

Number  
of shares* 

468 256 866    

117   

468 235 944    

52 068    

–   

20 922    

468 308 934    

117   

468 256 866    

Cost 
£m 

117 

– 

117 

*  The nominal value of each share is 25 pence. 
Own shares 
Own shares represent the Company’s ordinary shares that are acquired to meet the Group’s expected obligations under share-based 
incentive arrangements (see Note 31). Own shares are held either by the Company in treasury or by an Employee Benefit Trust (EBT) that 
was established by the Company. 

Movements in own shares held were as follows: 

Year ended 31 March 2018   

Year ended 31 March 2017 

At 1 April 

Purchased in the market: 

– into treasury 

– into the EBT 

Transferred to EBT* 

Transferred to employees: 

– from treasury 

– from the EBT 

At 31 March 

Number  
of shares 

5 529 597   

–   

3 900 000   

–   

(1 010 461)  

(1 068 438)  

7 350 698   

Cost 

£m   

37   

Number  
of shares   

4 161 942   

–   

27   

–   

(6)  

(6)  

52   

2 000 000   

541 110   

15 572   

(230 619)   

(958 408)   

5 529 597   

Cost 
£m 

28 

14 

4 

– 

(2) 

(7) 

37 

*  Shares held for the benefit of untraceable shareholders and bearer warrant holders transferred to the trust at nil cost. 

Treasury shares 

Shares held in the EBT 

Total  

Number  
of shares 

2 562 392   

4 788 306   

7 350 698   

At 31 March 2018   

Market  
value 
£m 

% of outstanding 

share capital   

14   

26   

40   

0.6   

1.0   

1.6   

Number  
of shares   

3 572 853   

1 956 744   

5 529 597   

At 31 March 2017 

Market  
value 

£m   

% of outstanding 
share capital 

27   

15   

42   

0.8 

0.4 

1.2 

www.tateandlyle.com  141
www.tateandlyle.com  141 

Strategic ReportGovernanceFinancial StatementsUseful Information 
   
 
   
 
 
 
 
 
 
 
 
   
   
 
 
 
   
   
   
 
 
 
 
 
   
   
   
 
 
 
 
   
 
 
 
   
 
 
 
 
 
 
 
Notes to the Consolidated Financial Statements continued 

23. Other reserves 

At 1 April 2016 

Other comprehensive income/(expense): 

Cash flow hedges: 

– fair value gain in the year 

– reclassified and reported in the income statement  

in the year 

Available-for-sale financial assets: 

– reclassified and reported in the income statement  

in the year 

Currency translation differences: 

– gain on currency translation of foreign operations 

– fair value loss on net investment hedges 

Share of other comprehensive income of joint ventures 

Items transferred to income statement on disposal of subsidiary 

At 31 March 2017 

Other comprehensive (expense)/income: 

Cash flow hedges: 

– reclassified and reported in the income statement  

in the year 

Available-for-sale financial assets: 

– fair value gain in the year 

Currency translation differences: 

– loss on currency translation of foreign operations 

– fair value gain on net investment hedges 

Share of other comprehensive expense of joint ventures 

Items transferred to income statement on disposal of associate 

At 31 March 2018 

Hedging reserve 

Currency 
translation reserve 

Other reserves 

£m   

(2)   

1   

4   

–   

–   

–   

–   

–   

3   

(4)  

–   

–   

–   

–   

–   

(1)  

£m   

30   

–   

–   

–   

185   

(69)   

7   

(1)  

152   

–   

–   

(122)  

39   

(9)  

(1)  

59   

£m   

99   

–   

–   

(1)   

–   

– 

–   

–   

98   

–   

3   

–   

–   

–   

–   

101   

Total 
£m 

127 

1 

4 

(1) 

185 

(69) 

7 

(1) 

253 

(4) 

3 

(122) 

39 

(9) 

(1) 

159 

For the years ended 31 March 2018 and 31 March 2017, there was no tax effect on the above movements in reserves. 

24. Trade and other payables 

Current payables 

Trade payables 

Social security 

Accruals and deferred income 

Other payables 

Total 

The above amounts do not include non-current other payables of £10 million (2017 – £10 million). 

2018 

£m   

192   

7   

91   

22   

312   

At 31 March 

2017 
£m 

185 

6 

107 

17 

315 

142  Tate & Lyle PLC Annual Report 2018
142  Tate & Lyle PLC Annual Report 2018 

   
 
 
   
   
   
 
 
   
   
   
 
 
 
 
   
   
   
 
 
 
   
   
   
 
 
 
 
 
 
 
 
   
   
   
 
 
   
   
   
 
 
 
   
   
   
 
 
 
   
   
   
 
 
 
 
 
 
   
 
   
 
   
 
 
 
 
 
 
 
 
24. Trade and other payables continued 
The carrying amount of trade and other payables was denominated in the following currencies: 

US Dollar 

Euro 

Sterling 

Other  

Total 

25. Borrowings 
Non-current borrowings 

2,394,000 6.5% cumulative preference shares of £1 each 

Industrial Revenue Bonds 2023–2036 (US$70,100,000) 

US Private Placement 2023-2027 (US$400,000,000) 

6.75% Guaranteed Notes 2019 (£200,000,000) 

Total loan notes 

Other bank loans 

Total other bank loans 

Other borrowings 

Obligations under finance leases 

Total obligations under lease obligations 

Total non-current borrowings 

Current borrowings 

US commercial paper 

Short-term loans 

Unsecured bank overdrafts 

Total loan notes and overdrafts 

Other borrowings 

Obligations under finance leases 

Total current borrowings 

i

S
t
r
a
t
e
g
c
R
e
p
o
r
t

G
o
v
e
r
n
a
n
c
e

i

F
n
a
n
c
i
a
l
S
t
a
t
e
m
e
n
t
s

U
s
e
f
u
l

I

n
f
o
r
m
a
t
i
o
n

2018 

£m   

220   

43   

29   

30   

322   

2018 

£m   

2   

50   

285   

207   

544   

–   

–   

10   

10   

554   

2018 

£m   

–   

13   

1   

14   

2   

16   

At 31 March 

2017 
£m 

242 

22 

32 

29 

325 

At 31 March 

2017 
£m 

2 

56 

319 

212 

589 

1 

1 

14 

14 

604 

At 31 March 

2017 
£m 

70 

16 

1 

87 

1 

88 

Included within borrowings are £150 million (2017 – £150 million) of borrowings subject to fair value hedges, the amortised cost of which 
has been increased by £7 million (2017 – £13 million) in the tables above. 

Lease liabilities are effectively secured as the rights to the leased asset revert to the lessor in the event of default. There are no other 
securities on borrowings.  

www.tateandlyle.com  143
www.tateandlyle.com  143 

Strategic ReportGovernanceFinancial StatementsUseful Information 
 
 
 
 
 
 
 
   
 
   
 
 
 
 
 
   
 
   
 
 
 
 
 
 
 
 
   
 
 
 
 
   
 
   
 
 
 
 
 
   
 
 
 
 
 
Notes to the Consolidated Financial Statements continued 

25. Borrowings continued 
Current borrowings continued 
Taking into account the Group’s interest rate and cross currency swap contracts, the effective interest rates of its borrowings are as follows: 

$25m 3.83% US Private Placement Notes 2023 

$180m 4.06% US Private Placement Notes 2025 

$100m 4.16% US Private Placement Notes 2027 

$95m US Private Placement FRN1 2023 

2,394,000 6.5% cumulative preference shares of £1 each 

Industrial Revenue Bonds 2023–2036 (US$70,100,000) 

6.75% Guaranteed Notes 2019 (£200,000,000) 

  Year ended 31 March  

2018   

3.8%   

4.1%   

4.2%   

3.1%   

6.5%   

1.1%   

5.4%   

2017 

3.8% 

4.1% 

4.2% 

2.4% 

6.5% 

0.7% 

5.2% 

1  Floating rate note based on US six-month LIBOR + 1.47%. 
Short-term loans and overdrafts 
Short-term loans mature within the next 12 months and overdrafts are repayable on demand. Both short-term loans and bank overdrafts 
are arranged at floating rates of interest and expose the Group to cash flow interest rate risk. 

Credit facilities and arrangements 
Tate & Lyle International Finance PLC holds a US$800 million five-year committed revolving credit facility with a core of highly rated banks 
which matures between July 2020 and July 2021. At 31 March 2018, the facility had a value of £570 million (2017 – £638 million) and was 
undrawn. The facility incurs commitment fees at market rates prevailing when the facility was arranged. The lenders have the right, but 
not the obligation, to cancel their commitments in the event of specified events of default. In addition, the Group has substantial 
uncommitted facilities. 

Finance lease commitments 
Amounts payable under finance lease commitments are as follows: 

Within one year 

Between one and five years 

After five years 

Total 

Less future finance charges 

Present value of minimum lease payments 

2018   

Present value  
of minimum  
lease payments 

£m   

2   

9   

1   

12   

Minimum lease 
payments 
£m 

3   

10   

1   

14   

(2)  

12   

Minimum lease 
payments  
£m   

1   

12   

5   

18   

(3)  

15   

At 31 March 

2017 

Present value  
of minimum  
lease payments 
£m 

1 

10 

4 

15 

26. Change in working capital and other non-cash movements 

Continuing operations 

(Increase)/decrease in inventories 

(Increase)/decrease in receivables 

Increase/(decrease) in payables 

Increase in derivative financial instruments (excluding debt-related derivatives) 

Decrease in provisions for other liabilities and charges 

Change in working capital 

Other non-cash movements 

Change in working capital and other non-cash movements 

  Year ended 31 March 

2018 
£m 

(8)  

(41)  

19   

(6)  

(2)  

(38)  

2   

(36)  

2017 
£m 

13 

35 

(47) 

(4) 

(2) 

(5) 

9 

4 

144  Tate & Lyle PLC Annual Report 2018
144  Tate & Lyle PLC Annual Report 2018 

   
   
 
 
 
 
 
 
 
   
 
   
 
   
 
 
   
 
 
 
 
 
 
   
 
 
   
 
   
 
 
 
 
 
 
 
 
 
 
 
 
27. Net debt 
Reconciliation of the decrease in cash and cash equivalents to the movement in net debt: 

  Year ended 31 March 

Net decrease in cash and cash equivalents 

Net decrease in borrowings* 

Decrease in net debt resulting from cash flows 

Fair value and other movements 

Currency translation differences 

Decrease/(increase) in net debt in the year 

Net debt at beginning of the year 

Net debt at end of year 

2018 
£m 

(48)  

74   

26   

(1)  

35   

60   

(452)  

(392)  

*  Net change in borrowings includes repayments of capital elements of finance leases of £1 million (2017 - £1 million).  

Movements in the Group’s net debt were as follows: 

At 1 April 2016 

(Increase)/decrease resulting from cash flows 

Fair value and other movements 

Reclassification 

Currency translation differences 

At 31 March 2017 

(Increase)/decrease resulting from cash flows 

Fair value and other movements 

Reclassification 

Currency translation differences 

At 31 March 2018 

Cash and cash 
equivalents  
£m   

317   

(88)  

–   

–   

32   

261   

(48)  

–   

–   

(23)  

190   

Borrowings and finance leases   

Current 

£m   

(200)  

124   

4   

(2)  

(14)  

(88)  

74   

(2)  

(3)  

3   

(16)  

Non-current 

£m   

(556)  

–   

2   

2   

(52)  

(604)  

–   

6   

3   

41   

(554)  

Debt-related 
derivatives 

£m   

5   

–   

(3)  

–   

(23)  

(21)  

–   

(5)  

–   

14   

(12)  

2017 
£m 

(88) 

124 

36 

3 

(57) 

(18) 

(434) 

(452) 

Total  
£m 

(434) 

36 

3 

– 

(57) 

(452) 

26 

(1) 

– 

35 

(392) 

At 31 March 2018, total liabilities arising from financing activities were £582 million (2017 – £713 million). 

Debt-related derivative financial instruments represent the net fair value of currency and interest rate swaps that are used to manage the 
currency and interest rate profile of the Group’s net debt. At 31 March 2018, the net fair value of these derivatives comprised assets of  
£10 million (2017 – £17 million) and liabilities of £22 million (2017 – £38 million).  

Net debt is denominated in the following currencies: 

i

S
t
r
a
t
e
g
c
R
e
p
o
r
t

G
o
v
e
r
n
a
n
c
e

i

F
n
a
n
c
i
a
l
S
t
a
t
e
m
e
n
t
s

U
s
e
f
u
l

I

n
f
o
r
m
a
t
i
o
n

US dollar 

Euro 

Sterling 

Other 

Total 

2018 

£m   

(276)  

(36)  

(56)  

(24)  

(392)  

At 31 March 

2017 
£m 

(347) 

(41) 

(46) 

(18) 

(452) 

www.tateandlyle.com  145
www.tateandlyle.com  145 

Strategic ReportGovernanceFinancial StatementsUseful Information 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
   
   
 
   
 
 
 
 
 
 
 
 
 
 
 
   
 
   
 
 
 
 
 
 
 
Notes to the Consolidated Financial Statements continued 

28. Derivatives and hedge accounting 

Non-current derivative financial instruments used to manage the 
Group’s net debt profile 

Currency swaps 

Interest rate swaps 

Current derivative financial instruments used to manage the 
Group’s net debt profile 

Currency swaps 

Interest rate swaps 

Total derivative financial instruments used to manage  
the Group’s net debt profile 

Other current derivative financial instruments 

Commodity pricing contracts: 

– cash flow hedges 

– held for trading 

Total other derivative financial instruments 

Total derivative financial instruments 

Presented in the statement of financial position as follows: 

Non-current derivative financial instruments 

Current derivative financial instruments 

 At 31 March 2018   

At 31 March 2017 

Assets 
£m 

Liabilities 

£m   

Assets 

£m   

Liabilities 
£m 

1   

7   

8   

–   

2   

2   

(21)  

–   

(21)  

(1)  

–   

(1)  

2   

13   

15   

–   

2   

2   

(37) 

– 

(37) 

(1) 

– 

(1) 

10   

(22)  

17   

(38) 

–   

22   

22   

32   

8   

24   

32   

(2)  

(9)  

(11)  

(33)  

(21)  

(12)  

(33)  

3   

26   

29   

46   

15   

31   

46   

(1) 

(15) 

(16) 

(54) 

(37) 

(17) 

(54) 

The ineffectiveness recognised in profit or loss in the current period arising from net investment hedges was £1 million gain (2017 – £nil). 
The ineffectiveness recognised in profit or loss in the current and prior periods arising from fair value and cash flow hedges was not material. 

Cash flow hedges 
The Group employs commodity pricing contracts to hedge cash flow risk associated with forecast transactions. Gains and losses 
recognised in the hedging reserve in equity (see Note 23) on commodity pricing contracts at 31 March 2018 are expected to be reclassified 
to the income statement at various future dates. 
Fair value hedges 
The Group employs interest rate swap contracts to hedge interest rate risks associated with its borrowings. The notional principal 
amounts of the outstanding interest rate swap contracts applied in fair value hedging relationships as of 31 March 2018 were  
£150 million (2017 – £150 million). 

Net investment hedges  
The Group employs currency swap contracts to hedge the currency risk associated with its net investments in subsidiaries located 
primarily in the US and Europe. The notional principal amounts of the outstanding currency swap contracts applied in net investment 
hedging relationships as of 31 March 2018 were £169 million (2017 – £182 million). Within net investment hedging gains/losses, a fair value 
gain of £14 million (2017 – £21 million loss) on translation of the currency swap contracts to pounds sterling at the period-end date was 
recognised in the currency translation reserve in shareholders’ equity (see Note 23).  

In addition, at 31 March 2018, of the Group’s liabilities, a total of £163 million (2017 – £188 million) are designated as hedges of the net 
investments in foreign operations. 

146  Tate & Lyle PLC Annual Report 2018
146  Tate & Lyle PLC Annual Report 2018 

   
 
 
   
 
 
   
   
   
 
 
 
 
 
 
   
   
   
 
 
 
 
 
 
 
   
   
   
 
 
   
   
   
 
 
 
 
 
 
   
   
   
 
 
 
 
 
 
i

S
t
r
a
t
e
g
c
R
e
p
o
r
t

G
o
v
e
r
n
a
n
c
e

i

F
n
a
n
c
i
a
l
S
t
a
t
e
m
e
n
t
s

U
s
e
f
u
l

I

n
f
o
r
m
a
t
i
o
n

29. Financial instruments – fair value and risk management  
Financial instruments by category 
Set out below is a comparison by category of carrying values and fair values of all the Group’s financial assets and financial liabilities as at 
31 March 2018 and 31 March 2017. 

Available-for-sale financial assets  

Trade and other receivables 

Cash and cash equivalents 

Derivative financial instruments 
– assets 

Borrowings 

Derivative financial instruments 
– liabilities 

Trade and other payables 

Total 

Available-for-sale financial assets 

Trade and other receivables 

Cash and cash equivalents 

Derivative financial instruments  
– assets 

Borrowings 

Derivative financial instruments  
– liabilities 

Trade and other payables 

Total 

Amortised 
cost/cash 
£m 

Derivatives in 
a hedging 
relationship 
£m 

Derivatives 
held for 
trading 
£m 

Available-for-
sale financial 
assets 
£m 

Total carrying 
value 
£m 

Notes   

Fair value 
£m 

At 31 March 2018 

18   

17   

16   

28   

25   

28   

24   

Notes   

18   

17   

16   

28   

25   

28   

24   

–   

281   

190   

–   

(570)  

–   

(315)  

(414)  

–   

–   

–   

10   

–   

(24)  

–   

(14)  

–   

–   

–   

22   

–   

(9)  

–   

13   

37   

–   

–   

–   

–   

–   

–   

37   

37   

281   

190   

32   

(570)  

(33)  

(315)  

(378)  

37 

281 

190 

32 

(576) 

(33) 

(315) 

(384) 

At 31 March 2017 

Amortised 
cost/cash 

Derivatives in a 
hedging 
relationship 

Derivatives 
held for  
trading 

Available-for-
sale financial 
assets 

Total carrying 
value 

£m   

–   

277   

261   

–   

(692)  

–   

(319)  

(473)   

£m   

£m   

–   

–   

–   

20   

–   

(39)   

–   

(19)  

–   

–   

–   

26   

–   

(15)  

–   

11   

£m   

30   

–   

–   

–   

–   

–   

–   

30   

£m   

30   

277   

261   

46   

(692)   

(54)   

(319)   

(451)   

Fair value 
£m 

30 

277 

261 

46 

(712) 

(54) 

(319) 

(471) 

Trade and other receivables presented above excludes £16 million (2017 – £15 million) relating to prepayments. Trade and other payables 
presented above excludes £7 million (2017 – £6 million) relating to social security.  

Borrowings with a carrying value of £207 million (2017 – £212 million) relate to listed bonds with a fair value of £217 million  
(2017 –£229 million) according to quoted market prices and are categorised as Level 1 for fair value measurement. Borrowings with a 
carrying value of £285 million (2017 – £319 million) relate to US Private Placement Notes with a fair value of £281 million  
(2017 – £322 million) according to broker dealer quotations and are categorised as Level 3 for fair value measurement. The remaining 
borrowings have a fair value measured by discounted estimated cash flows with an applicable market quoted yield and are categorised  
as Level 2 for fair value measurement.  

www.tateandlyle.com  147
www.tateandlyle.com  147 

Strategic ReportGovernanceFinancial StatementsUseful Information 
 
 
 
 
 
 
 
   
   
   
   
   
   
   
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
   
   
   
   
   
 
   
   
   
   
   
   
   
 
 
 
 
 
 
 
 
   
 
 
Notes to the Consolidated Financial Statements continued 

29. Financial instruments – fair value and risk management continued 
Fair value hierarchy  
The following tables illustrate the Group’s financial assets and liabilities measured at fair value at 31 March 2018 and 31 March 2017 (refer 
to Note 2 for a description of the three levels of fair value measurement): 

Notes   

Level 1 
£m 

Level 2 
£m 

Level 3 
£m 

Total 
 £m 

At 31 March 2018 

18   

28   

28   

28   

28   

28   

–   

–   

–   

5   

5   

–   

(5)  

(5)  

–   

1   

9   

6   

16   

(22)  

(1)  

(23)  

37   

–   

–   

11   

48   

–   

(5)  

(5)  

37 

1 

9 

22 

69 

(22) 

(11) 

(33) 

Notes   

Level 1 

£m   

Level 2 

£m   

Level 3 

£m   

Total 
£m 

At 31 March 2017 

18   

28   

28   

28   

28   

28   

–   

–   

–   

7   

7   

– 

(6)   

(6)   

–   

2   

15   

1   

18   

(38)   

(7)   

(45)   

30   

–   

–   

21   

51   

– 

(3)   

(3)   

30 

2 

15 

29 

76 

(38) 

(16) 

(54) 

Assets at fair value 

Available-for-sale financial assets 

Derivative financial instruments: 

– currency swaps 

– interest rate swaps 

– commodity pricing contracts 

Assets at fair value 

Liabilities at fair value 

Derivative financial instruments: 

– currency swaps 

– commodity pricing contracts 

Liabilities at fair value 

Assets at fair value 

Available-for-sale financial assets 

Derivative financial instruments: 

– currency swaps 

– interest rate swaps 

– commodity pricing contracts 

Assets at fair value 

Liabilities at fair value 

Derivative financial instruments: 

– currency swaps 

– commodity pricing contracts 

Liabilities at fair value 

148  Tate & Lyle PLC Annual Report 2018
148  Tate & Lyle PLC Annual Report 2018 

   
   
 
 
 
 
 
 
   
 
 
 
 
   
   
   
   
 
 
 
   
   
   
   
 
 
 
 
 
   
 
 
   
   
   
   
 
 
   
   
   
   
 
 
   
   
   
   
 
 
 
 
   
 
 
   
   
   
   
 
   
   
 
 
 
 
 
 
   
 
   
   
   
   
 
 
 
   
   
   
   
 
 
 
 
 
   
 
 
   
   
   
   
 
 
   
   
   
   
 
 
   
   
   
   
 
 
 
 
 
 
   
 
 
i

S
t
r
a
t
e
g
c
R
e
p
o
r
t

G
o
v
e
r
n
a
n
c
e

i

F
n
a
n
c
i
a
l
S
t
a
t
e
m
e
n
t
s

U
s
e
f
u
l

I

n
f
o
r
m
a
t
i
o
n

29. Financial instruments – fair value and risk management continued 
Financial instruments measured at fair value 
The following table shows the methodology used to measure Level 3 fair values. The table isolates the unobservable inputs; however, the 
full impact on the Group’s income statement is described within the price risk management section. 

Type 

  Valuation technique 

  Significant unobservable inputs 

Written commodity contract 

  Based on the Group’s own 

assessment of the 
commodity, supply and 
demand, as well as 
expected pricing. 

  1. Price of co-product 
positions (refer to fair 
value measurement 
section in Note 2).  
2. Basis (refer to fair value 
measurement section in 
Note 2). 

Sensitivity of the fair value measurement in 
reasonable changes to inputs 

  1. 10% increase/(decrease) in the price of 

the co-products would result in a net 
increase/(decrease) in fair value of  
£3 million (2017 – £nil) in respect of  
Level 3 financial instruments.  
2. 10% increase/(decrease) in the cost of 
basis would result in a net increase/ 
(decrease) in fair value of £2 million  
(2017 – £2 million) in respect of Level 3 
financial instruments. 

In addition to the above, the Group’s available-for-sale financial assets are sensitive to a number of market and non-market factors.  

The following table reconciles the movement in the Group’s net financial instruments classified in Level 3 of the fair value hierarchy: 

Commodity pricing 
contracts –  
assets 

Commodity pricing 
contracts – 
liabilities 

Available-for- 
sale financial 
assets 

Other financial 
liability 

At 1 April 2016 

Total gains/(losses): 

– in operating profit 

– in other comprehensive income 

Re-measurement of non-qualified deferred 

compensation arrangements 

Purchases 

Settlements 

At 31 March 2017  

Total gains/(losses): 

– in operating profit 

Re-measurement of non-qualified deferred 

compensation arrangements 

Purchases 

Settlements 

At 31 March 2018 

£m   

38   

21   

–   

–   

–   

(38)   

21   

11   

–   

–   

(21)  

11   

£m   

(4)  

(3)  

–   

–   

–   

4   

(3)  

(5)  

–   

–   

3   

(5)  

£m   

23   

–   

3   

2   

4   

(2)  

30   

(1)  

2   

8   

(2)  

37   

£m   

(2)   

3   

(1)  

–   

–   

–   

–   

–   

–   

–   

–   

–   

Total 
£m 

55 

21 

2 

2 

4 

(36) 

48 

5 

2 

8 

(20) 

43 

Management of financial risk 
The key financial risks faced by the Group are credit risk, liquidity risk and market risks, which include interest rate risk, foreign exchange 
risk and certain commodity price risks. The Board regularly reviews these risks and approves written policies covering the use of financial 
instruments to manage these risks and sets overall risk limits. The derivative financial instruments approved by the Board of  
Tate & Lyle PLC to manage financial risks include swaps, both interest rate and currency, swaptions, caps, forward rate agreements, 
foreign exchange and commodity forward contracts and options, and commodity futures.  

The Chief Financial Officer retains overall responsibility for management of financial risk for the Group. Most of the Group’s financing, 
interest rate and foreign exchange risk are managed through the Group treasury company, Tate & Lyle International Finance PLC, whose 
operations are directed by its board. Tate & Lyle International Finance PLC arranges funding and manages interest rate, foreign exchange 
and bank counterparty risks within limits approved by the Board of Tate & Lyle PLC.  

Commodity price risks are managed through divisional commodity trading functions in the US and Europe. These functions are  
controlled by divisional management who are responsible for ratifying general strategy and overseeing performance on a monthly  
basis. The performance of the commodity trading function is monitored against its ability to match the Group’s needs for raw materials 
with purchase contracts, as well as the Group’s output of co-products with sales contracts. Commodity price contracts are categorised as 
being held either for trading or for hedging price exposures. The Group applies a limited level of hedge accounting to its economic price 
exposure hedges. 

www.tateandlyle.com  149
www.tateandlyle.com  149 

Strategic ReportGovernanceFinancial StatementsUseful Information 
 
 
 
 
 
 
 
 
   
 
 
   
   
   
   
 
 
 
 
   
   
   
   
 
 
 
 
 
 
   
   
   
   
 
 
 
   
   
   
   
 
 
 
 
 
 
Notes to the Consolidated Financial Statements continued 

29. Financial instruments – fair value and risk management continued 
Market risks 
Foreign exchange management  
The Group operates internationally and is exposed to foreign exchange risks arising from commercial transactions (transaction exposure), 
and from recognised assets, liabilities and investments in foreign operations (translation exposure).  

Transaction exposure  
The Group’s policy requires subsidiaries to hedge transactional currency exposures against their functional currency once the transaction 
is committed or highly probable, mainly through the use of forward foreign exchange contracts, although exceptions can be approved by 
the Chief Financial Officer. The amounts deferred in equity from derivative financial instruments designated as cash flow hedges are 
released to the income statement or statement of financial position and offset against the movement in underlying transactions only when 
the forecast transactions affect the income statement or statement of financial position respectively.  

Translation exposure  
The Group manages the foreign exchange exposure to net investments in overseas operations, particularly in the US and Europe,  
by borrowing principally in US dollars, which provide a partial match for the Group’s major foreign currency assets. The Group also 
manages some of its foreign exchange exposure to net investments in foreign operations through the use of currency swap contracts and 
other liabilities. The amount deferred in equity from the hedging instruments designated as net investment hedges is offset against the 
foreign currency translation effect of the net investment in foreign operations, and is released to the income statement upon disposal of 
those investments.  

The following table illustrates only the Group’s sensitivity to the fluctuation of the Group’s major currencies against sterling on its income 
statement and other components of equity, assuming that each exchange rate moves in isolation. The income statement impact is due to 
changes in the fair value of monetary assets and liabilities including non-designated foreign currency derivatives. The equity impact for 
foreign exchange sensitivity relates to derivative and non-derivative financial instruments hedging the Group’s net investments in its 
European and US operations. 

Sterling/US dollar 10% change  

Sterling/euro 10% change 

 At 31 March 2018   

At 31 March 2017 

Income  
statement -/+ 
£m 

1   

1   

Equity -/+ 

Income  
statement -/+ 

£m   

27   

5   

£m   

–   

1   

Equity -/+ 
£m 

31 

5 

Interest rate management  
The Group has an exposure to interest rate risk, arising principally from changes in US dollar, sterling and euro interest rates. This risk is 
managed by fixing or capping portions of debt using interest rate derivatives to achieve a target level of fixed/floating rate net debt, which 
aims to optimise net finance expense and reduce volatility in reported earnings. The Group’s policy is that between 30% and 75% of Group 
net debt is fixed for more than one year and that no interest rates are fixed for more than 12 years. At 31 March 2018, the longest term of 
any fixed rate debt held by the Group was until October 2027 (2017 – October 2027). The proportion of net debt managed by the Group’s 
treasury function at 31 March 2018 that was fixed or capped for more than one year was 68% (2017 – 65%).  

The Group considers a 100 basis point change in interest rates a reasonably possible change except where rates are less than 100 basis 
points. In these instances it is assumed that the interest rates increase by 100 basis points and decrease to zero for the purpose of 
performing the sensitivity analysis. The impact is calculated with reference to the gross debt and cash held as at 31 March 2018 assuming 
that other variables remain unchanged.  

As at 31 March 2018, if interest rates increased by 100 basis points, Group profit before tax would decrease by £2 million (2017 – £2 million).  
If interest rates decreased by 100 basis points, or less where applicable, Group profit before tax would increase by £1 million  
(2017 – £1 million increase). 

Price risk management 
The Group participates mainly in four markets: food and beverage; industrial ingredients; pharmaceutical and personal care; and animal 
feed. Food and beverage and industrial ingredients markets are the most significant. All ingredients are produced from renewable crops, 
predominantly corn.  

The Group is exposed to movements in the future prices of commodities in those domestic and international markets where the Group 
buys and sells corn (and related co-products) and energy for production. Commodity futures, forwards and options are used where 
available to hedge inventories and the costs of raw materials for unpriced and prospective contracts not covered by forward product sales. 
Some of the contracts are used to hedge co-product pricing, for which there is no active market. The pricing is established by the Group, 
based on a number of inputs, as discussed on page 106. Due to the seasonality of corn production, at certain points in time throughout the 
year, the exposure to commodity pricing contracts may be higher.  

As at 31 March 2018, a 50% increase/decrease in the price of corn will result in a decrease/increase to the income statement of  
£3 million (2017 – £3 million) and related decrease/increase in other components of equity of £1 million (2017 – £nil). 

150  Tate & Lyle PLC Annual Report 2018
150  Tate & Lyle PLC Annual Report 2018 

   
 
 
   
 
 
 
 
 
 
i

S
t
r
a
t
e
g
c
R
e
p
o
r
t

G
o
v
e
r
n
a
n
c
e

i

F
n
a
n
c
i
a
l
S
t
a
t
e
m
e
n
t
s

U
s
e
f
u
l

I

n
f
o
r
m
a
t
i
o
n

29. Financial instruments – fair value and risk management continued 
Credit risk management 
Counterparty credit risk arises from the placing of deposits and entering into derivative financial instrument contracts with banks and 
financial institutions, as well as credit exposures inherent within the Group’s outstanding receivables.  

The Group manages credit risk by entering into financial instrument contracts substantially with investment grade counterparties 
approved by the Board.  

The Board has approved maximum counterparty exposure limits for specified banks and financial institutions based on the long-term 
credit ratings of Standard & Poor’s and Moody’s. Trading limits assigned to commercial customers are based on ratings from Dun & 
Bradstreet and Credit Risk Monitor. In cases where published financial ratings are not available or inconclusive, credit application, 
reference checking, and obtaining of customers’ financial information such as liquidity and turnover ratio, are required to evaluate 
customers’ credit worthiness. 

Analysis of maximum credit exposure 
Counterparties’ positions are monitored on a regular basis to ensure that they are within the approved limits and there are no significant 
concentrations of credit risks.  

The Group’s trade receivables are short term in nature and are largely comprised of amounts receivable from business customers. 
Concentrations of credit risk with respect to trade receivables are limited, with our customer base including large, unrelated and 
internationally dispersed customers. 

The Group considers its maximum exposure to credit risk at the year-end date is the carrying value of each class of financial assets as 
disclosed under financial instruments by category on page 147. 

Analysis of amounts set-off 
The Group does not offset financial assets and liabilities in its statement of financial position as the Group has no intention to net settle, 
except as described below. 

Derivative assets and liabilities of £9 million (2017 – £17 million) could be offset under an enforceable master netting agreement. Amounts 
which do not meet the criteria for offsetting in the statement of financial position but could be settled net in certain circumstances 
principally relate to derivative transactions under International Swaps and Derivatives Association (ISDA) agreements where each party 
has the option to settle amounts on a net basis in the event of default of the other party. 

Liquidity risk management 
The Group manages its exposure to liquidity risk and ensures maximum flexibility in meeting changing business needs by maintaining 
access to a wide range of funding sources, including capital markets and bank borrowings. Capital market issues outstanding at  
31 March 2018 are listed in Note 25.  

At the year end, the Group held cash and cash equivalents of £190 million (2017 – £261 million) and had committed undrawn facilities of 
£570 million (2017 – £638 million). These resources are maintained to provide liquidity back-up and to meet the projected maximum cash 
outflow from debt repayment, capital expenditure and seasonal working capital needs foreseen for at least a year into the future at any  
one time. 

The Group has a core committed bank facility of US$800 million, of which US$80 million matures in 2020 and US$720 million in 2021. This 
facility is unsecured and contains financial covenants for the Group that the interest cover ratio should not be less than 2.5 times and the 
multiple of net debt to EBITDA, as defined in our financial covenants, should not be greater than 3.5 times. Refer to Note 4 for the 
calculation of these measures for financial covenant purposes. The Group monitors compliance against all its financial obligations and it is 
Group policy to manage the consolidated statement of financial position so as to operate well within these covenanted restrictions. In both 
the current and comparative reporting periods, the Group complied with its financial covenants at all measurement points. The majority of 
the Group’s borrowings are raised through the Group treasury company, Tate & Lyle International Finance PLC, and are then on-lent to 
the business units on an arm’s length basis.  

Current Group policy is to ensure that, after taking into account the total of undrawn committed facilities, no more than 10% of gross debt 
matures within 12 months and at least 35% matures beyond 2.5 years. At 31 March 2018, after taking account of undrawn committed 
facilities, the Group was compliant with the policy. The average maturity of the Group’s gross debt was 5.4 years (2017 – 6.2 years), taking 
account of undrawn committed facilities.  

www.tateandlyle.com  151
www.tateandlyle.com  151 

Strategic ReportGovernanceFinancial StatementsUseful Information 
 
 
 
 
 
 
 
 
 
Notes to the Consolidated Financial Statements continued 

29. Financial instruments – fair value and risk management continued 
The table below analyses the undiscounted cash flows related to the Group’s non-derivative financial liabilities and derivative assets and 
liabilities. 

Liquidity analysis 

Borrowings including finance leases 

Interest on borrowings 

Trade and other payables 

Derivative contracts: 

– receipts 

– payments 

Commodity pricing contracts 

Liquidity analysis 

Borrowings including finance leases 

Interest on borrowings 

Trade and other payables 

Derivative contracts: 

– receipts 

– payments 

Commodity pricing contracts 

< 1 year 
£m 

1 – 5 years 
£m 

(8)  

(25)  

(305)  

113   

(110)  

1   

< 1 year 

£m   

(79)   

(26)   

(315)   

107   

(105)   

3   

(210)  

(63)  

(10)  

166   

(183)  

–   

1 – 5 years 

£m   

(212)  

(79)  

(10)  

179   

(206)  

(1)  

At 31 March 2018 

> 5 years 
£m 

(339) 

(38) 

– 

– 

– 

– 

At 31 March 2017 

> 5 years 
£m 

(383) 

(54) 

– 

– 

– 

– 

Included in borrowings are £2,394,000 of 6.5% cumulative preference shares. Only one year’s worth of interest payable on these shares is 
included in the less than one year category. 

Derivative contracts include currency swaps, forward exchange contracts and interest rate swaps. Commodity pricing contracts included 
above represent options and futures. Commodity pricing contracts classified within Level 2 and Level 3 of fair value measurement are not 
included in the liquidity analysis above as they are not settled for cash. 

Financial assets and liabilities denominated in currencies other than pounds sterling are translated to pounds sterling using year-end 
exchange rates. 

Capital risk management 
The Group’s primary objectives in managing its capital are to safeguard the business as a going concern; to maintain the dividend policy; to 
maintain sufficient financial flexibility to undertake its investment plans; and to retain an investment-grade credit rating which enables 
access to debt capital markets. The Group’s financial profile and level of financial risk is assessed on a regular basis in the light of changes 
to the economic conditions, business environment, the Group’s business profile and the risk characteristics of its businesses.  

Tate & Lyle PLC has contractual relationships with Moody’s and Standard & Poor’s (S&P) for the provision of credit ratings.  
At 31 March 2018, the long-term credit rating from Moody’s was Baa2 (stable outlook) (2017 – Baa2) and from S&P was BBB  
(stable outlook) (2017 – BBB).  

The Group regards its total capital as follows: 

Net debt 

Equity attributable to owners of the Company 

Total capital 

Note   

27   

2018 

£m   

392   

1 367   

1 759   

At 31 March 

2017 
£m 

452 

1 332 

1 784 

The Board has set two ongoing key performance indicators (KPIs) to measure the Group’s financial strength. The target levels for these 
financial KPIs are that the ratio of net debt/EBITDA should not exceed two times and interest cover should exceed five times. These ratios 
are calculated on the same basis as the external financial covenants noted above. The ratios for these KPIs were: 

Net debt/EBITDA 

Interest cover 

152  Tate & Lyle PLC Annual Report 2018
152  Tate & Lyle PLC Annual Report 2018 

Note   

4   

4   

year ended 31 March 

2018 
Times   

0.8   

14.6   

2017 
Times 

0.9 

13.9 

 
 
 
 
 
 
 
 
 
 
 
 
 
   
   
 
 
 
 
 
 
   
   
 
 
 
   
   
 
 
 
 
 
   
   
 
 
 
 
   
   
   
 
 
 
 
 
   
 
   
   
   
 
 
 
 
 
i

S
t
r
a
t
e
g
c
R
e
p
o
r
t

G
o
v
e
r
n
a
n
c
e

i

F
n
a
n
c
i
a
l
S
t
a
t
e
m
e
n
t
s

U
s
e
f
u
l

I

n
f
o
r
m
a
t
i
o
n

30. Retirement benefit obligations 
a) Plan information 
(i) Pensions 
The Group operates a number of defined benefit pension plans, principally in the UK and the US. Generally, the pension benefits provided 
under these plans are determined based on the pensionable salary and period of pensionable service of the individual members. Most of 
the plans are funded and the plan assets held separately from those of the Group in funds that are under the control of trustees. The 
extent of the powers of the trustees, in particular in respect of funding and investment strategy, varies and is dependent on local 
regulations and the rules of each plan.  

Payments made by the Group to the plans principally comprise funding contributions agreed with the trustees that are determined in 
accordance with local regulations to ensure that appropriate funding levels are maintained and funding deficits are eliminated over a 
reasonable period of time. All of the significant defined benefit pension plans operated by the Group are closed to new entrants and to 
future accrual.  

The Group operates defined contribution pension plans in a number of countries. Contributions payable by the Group to these plans during 
the year amounted to £10 million (2017 – £7 million). 

(ii) Other benefits 
The Group’s subsidiaries in the US provide unfunded retirement medical plans to the majority of their employees. Such plans provide 
financial assistance in meeting various costs including medical, dental and prescription drugs. Employees are required to contribute to  
the cost of benefits received under the plans. The Group meets the remaining costs of providing these benefits in the period in which they 
are incurred. 

b) Movement in net defined benefit asset/(liability) 
(i) Analysis of net defined benefit asset/(liability) 

At 31 March 2018   

At 31 March 2017 

Benefit obligations: 

Funded plans 

Unfunded plans 

Fair value of plan assets 

Net surplus/(deficit) 

Presented in the statement of financial position as: 

Retirement benefit surplus 

Retirement benefit deficit 

Net defined benefit asset/(liability) reconciliation: 

At 1 April 2016 

Year ended 31 March 2017 

– net increase in the benefit obligation 

– net increase in the fair value of plan assets 

At 31 March 2017 

Year ended 31 March 2018 

– net decrease in the benefit obligation 

– net change in the fair value of plan assets 

At 31 March 2018 

Pensions 
£m 

Medical 
benefits 

£m   

Total 

£m   

Pensions 

£m   

Medical 
benefits 

£m   

(1 493)  

(56)  

(1 549)  

1 630   

81   

178   

(97)  

81   

–   

(63)  

(63)  

–   

(63)  

–   

(63)  

(63)  

(1 493)  

(1 630)   

(119)  

(1 612)  

1 630   

18   

(63)   

(1 693)   

1 630   

(63)   

178   

(160)  

18   

120   

(183)   

(63)   

–   

(76)   

(76)   

– 

(76)   

–   

(76)   

(76)   

Pensions 

£m   

(142)  

Medical 
benefits 

£m   

(66)   

(125)   

204   

(63)   

144   

–   

81   

(10)   

–   

(76)   

13   

–   

(63)  

Total 
£m 

(1 630) 

(139) 

(1 769) 

1 630 

(139) 

120 

(259) 

(139) 

Total 
£m 

(208) 

(135) 

204 

(139) 

157 

– 

18 

www.tateandlyle.com  153
www.tateandlyle.com  153 

Strategic ReportGovernanceFinancial StatementsUseful Information 
 
 
 
 
 
 
 
   
   
 
 
   
   
   
   
   
 
 
 
 
 
 
 
 
 
 
   
   
   
   
   
 
 
   
   
   
   
   
 
 
 
 
 
   
 
 
   
   
 
   
   
   
 
   
   
   
   
   
 
 
   
   
   
 
   
   
   
 
   
   
   
 
   
   
   
   
   
 
 
   
   
   
 
   
   
   
 
   
   
   
 
 
Notes to the Consolidated Financial Statements continued 

30. Retirement benefit obligations continued 
(ii) Analysis of movements in the benefit obligation 

Pension benefits   

UK 
£m   

US 
£m   

Other 

£m   

Total 

£m   

(985)   

(568)   

(15)   

(1 568)   

Medical 
benefits 

£m   

(66)   

Total 
£m 

(1 634) 

–   

(3)   

(33)   

(177)   

53   

12   

(112)   

51   

–   

–   

(2)   

(99)   

–   

–   

(23)   

16   

10   

(19)   

7   

69   

9   

–   

(83)   

(21)   

(2)   

–   

–   

–   

–   

–   

–   

–   

–   

(2)   

(1)   

(5)   

(2)   

(3)   

(56)   

(161)   

63 

(7)   

(105)   

120   

9 

(2)   

(86)   

(125)   

(1 084)   

(589)   

(20)   

(1 693)   

–   

(26)  

25   

23   

(8)  

40   

60   

–   

2   

76   

–   

(21)  

–   

4   

(6)  

(2)  

31   

–   

63   

71   

(3)  

–   

–   

–   

–   

–   

–   

(2)  

2   

(3)  

(3)  

(47)  

25   

27   

(14)  

38   

91   

(2)  

67   

144   

(1)   

–   

(2)   

(2)   

1   

–   

(1)   

4   

–   

–   

(10)   

(10)   

(76)   

(1)  

(2)  

–   

–   

3   

3   

5   

–   

8   

13   

(63)  

(3) 

(3) 

(58) 

(163) 

64 

(7) 

(106) 

124 

9 

(2) 

(96) 

(135) 

(1 769) 

(4) 

(49) 

25 

27 

(11) 

41 

96 

(2) 

75 

157 

(1 612) 

Total 
£m 

76 

77 

236 

399 

At 31 March 2018 

(1 008)  

(518)  

(23)  

(1 549)  

At 31 March 2018, the benefits payment expected by the plans over the next ten years were as follows: 

UK 
£m 

41   

41   

125   

216   

31   

32   

97   

162   

Pension benefits   

US 
£m 

Other 
£m 

Total 
£m 

Medical 
benefits 
£m 

72   

73   

222   

378   

4   

4   

14   

21   

–   

–   

–   

–   

–   

423   

322   

745   

43   

788 

At 1 April 2016 

Year ended 31 March 2017 

Service cost – current 

Plan administration costs 

Interest on benefit obligation 

Actuarial gains/(losses): 

– changes in financial assumptions 

– changes in demographic assumptions 

– experience against assumptions 

Net actuarial (loss)/gain 

Benefits paid 

Settlement gain (see Note 7) 

Re-measurement of non-qualified deferred 

compensation arrangements (see Note 18) 

Currency translation differences 

Increase in the benefit obligation 

At 31 March 2017 

Year ended 31 March 2018 

Service cost – current 

Interest on benefit obligation 

Actuarial gains/(losses): 

– changes in financial assumptions 

– changes in demographic assumptions 

– experience against assumptions 

Net actuarial gain/(loss) 

Benefits paid 

Re-measurement of non-qualified deferred 

compensation arrangements (see Note 18) 

Currency translation differences 

Decrease/(increase) in the benefit obligation 

Benefit payments: 

– within 12 months 

– between 1 to 2 years 

– between 3 to 5 years 

– between 6 to 10 years 

Total expected benefit payments  

over the next ten years 

154  Tate & Lyle PLC Annual Report 2018
154  Tate & Lyle PLC Annual Report 2018 

   
   
   
   
 
   
 
 
   
   
   
   
   
 
 
 
 
 
   
   
   
   
   
 
 
 
 
 
 
 
 
 
 
   
   
   
   
   
 
 
 
 
 
 
   
   
   
   
   
 
 
 
 
   
   
   
   
   
 
 
 
 
 
 
 
   
  
  
  
  
 
 
 
 
 
   
   
   
   
 
   
 
 
 
 
 
 
   
   
   
   
   
 
 
 
 
 
 
   
   
   
   
   
 
 
 
 
i

S
t
r
a
t
e
g
c
R
e
p
o
r
t

G
o
v
e
r
n
a
n
c
e

i

F
n
a
n
c
i
a
l
S
t
a
t
e
m
e
n
t
s

U
s
e
f
u
l

I

n
f
o
r
m
a
t
i
o
n

30. Retirement benefit obligations continued 

In the UK, scheme members can elect to forego a portion of their future pension benefits, in return for a lump sum payment, or a transfer 
out to other arrangements. These amounts are excluded from future benefit projections. 

The £157 million improvement was driven by a reduction in the deficit of the US schemes largely as a result of foreign exchange 
movements from the weakening of the US dollar and by cash contributions. In addition to regular cash contributions of £44 million in the 
year, the Group made an accelerated gross cash contribution to the US schemes of £56 million, in light of an opportunity to fund the 
schemes while taking advantage of a higher US tax deduction. 

The pension benefits paid in respect of US plans were higher in the financial year ended 31 March 2017 compared to the current financial 
year due to the settlement made by some deferred members during the prior year which resulted in the recognition of a £9 million 
exceptional gain (see Note 7d). 

At 31 March 2018, the weighted average duration of the significant defined benefit obligations was as follows: 

Pension plans: 

– UK 

– US 

Medical benefits 

Duration 

16 years 

11 years 

10 years 

Assumptions 
For accounting purposes, the benefit obligation of each plan has been calculated in accordance with IAS 19 based on data gathered for the 
most recent actuarial valuation and by applying assumptions made by the Group on the advice of independent actuaries. Note that for the 
UK defined benefit pension plan these ’best estimate’ IAS 19 assumptions are different to the more prudent assumptions used for funding 
valuation purposes. For the US defined benefit pension plan, the funding valuation assumptions are identical to the IAS 19 assumptions.  

The principal assumptions used in calculating the benefit obligation were as follows: 

Inflation rate 

Expected rate of salary increases 

Expected rate of pension increases: 

– deferred pensions 

– pensions in payment 

Discount rate 

At 31 March 2018   

At 31 March 2017 

UK 

2.2%/3.2%   

n/a   

2.2%   

3.1%   

2.6%   

US   

2.5%   

3.5%   

n/a   

n/a   

4.0%   

UK   

2.3%/3.3%   

n/a   

2.3%   

3.1%   

2.4%   

US 

2.5% 

3.5% 

n/a 

n/a 

4.0% 

Assumptions regarding future mortality rates of members of the Group’s pension plans are based on published statistics and take into 
account the profile of the plan members. On this basis, the average life expectancies assumed for members of the plans are  
as follows: 

Male aged 65 now 

Male aged 65 in 20 years’ time 

Female aged 65 now 

Female aged 65 in 20 years’ time 

At 31 March 2018   

At 31 March 2017 

UK 

US   

UK   

US 

21.4 years   

20.8 years   

21.6 years   

20.9 years 

23.2 years   

22.4 years   

23.7 years   

22.5 years 

23.5 years   

22.7 years   

23.8 years   

22.9 years 

25.3 years   

24.3 years   

26.1 years   

24.5 years 

Shorter longevity assumptions are used for members who retire on grounds of ill health. 

www.tateandlyle.com  155
www.tateandlyle.com  155 

Strategic ReportGovernanceFinancial StatementsUseful Information 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
   
   
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Notes to the Consolidated Financial Statements continued 

30. Retirement benefit obligations continued 
Medical benefits 
Principal assumptions used in calculating the benefit obligation are medical cost inflation and the discount rate applied to the expected 
benefit payments. The Group has assumed medical cost inflation at 7.5% per annum (2017 – 8.0%), grading down to 5% by 2023, and used 
a discount rate of 3.9% (2017 – 3.9%).  

At 31 March 2018, the sensitivity of the net surplus/(deficit) on the plans to changes in the principal assumptions was as follows (assuming 
in each case that the other assumptions are unchanged): 

Pension plans 

Inflation rate* 

Life expectancy 

Discount rate 

Medical benefits 

Medical cost inflation 

Discount rate 

Increase/(decrease) in obligation 

Change in 

Increase in 

assumptions +/-   

surplus/(deficit)    

Decrease in 
surplus/(deficit) 

50 bp   

1 year   

50 bp   

50 bp   

50 bp   

58   

68   

(102)  

2   

(3)  

(55) 

(70) 

115 

(2) 

3 

*  Inflation rate sensitivity covers the inflation assumption, expected rate of salary increases assumption and expected rate of pensions in payment increases assumption. 

UK 
£m 

1 018   

34   

164   

22   

(51)   

–   

169   

1 187   

28   

(9)  

22   

(1)  

(60)  

–   

(20)  

1 167   

US 
£m 

408   

17   

15   

16   

(69)   

56   

35   

443   

16   

11   

69   

(1)  

(27)  

(48)  

20   

463   

Total 
£m 

1 426 

51 

179 

38 

(120) 

56 

204 

1 630 

44 

2 

91 

(2) 

(87) 

(48) 

– 

1 630 

(iii) Analysis of movements in the plan assets 

At 1 April 2016 

Year ended 31 March 2017 

Interest on plan assets 

Actual return higher than interest on plan assets 

Employer’s contributions 

Benefits paid 

Currency translation differences 

Increase in fair value of plan assets 

At 31 March 2017 

Year ended 31 March 2018 

Interest on plan assets 

Actual return (lower)/higher than interest on plan assets 

Employer’s contributions 

Plan administration costs 

Benefits paid 

Currency translation differences 

(Decrease)/increase in fair value of plan assets 

At 31 March 2018 

156  Tate & Lyle PLC Annual Report 2018
156  Tate & Lyle PLC Annual Report 2018 

   
   
   
 
   
   
 
 
 
 
 
   
   
 
 
 
 
 
 
 
 
 
   
   
 
 
 
 
 
 
 
 
 
   
   
 
 
 
 
 
 
 
 
 
 
 
 
i

S
t
r
a
t
e
g
c
R
e
p
o
r
t

G
o
v
e
r
n
a
n
c
e

i

F
n
a
n
c
i
a
l
S
t
a
t
e
m
e
n
t
s

U
s
e
f
u
l

I

n
f
o
r
m
a
t
i
o
n

30. Retirement benefit obligations continued 
Analysis of plan assets 

Equities – quoted 

Corporate bonds – quoted 

Government bonds – quoted 

Investment funds – quoted 

Derivatives – quoted 

Cash 

Property – unquoted 

Investment funds – unquoted 

Derivatives – unquoted 

Insurance policies – unquoted 

Year ended 31 March 2018   

Year ended 31 March 2017 

UK 
£m 

79   

162   

811   

205   

(383)  

15   

–   

1   

15   

262   

1 167   

US 
£m 

–   

331   

128   

–   

–   

–   

–   

–   

–   

4   

463   

Total 

£m   

79   

493   

939   

205   

(383)  

15   

–   

1   

15   

266   

1 630   

UK 
£m   

150   

138   

795   

182   

(395)  

20   

–   

1   

18   

278   

1 187   

US 
£m   

110   

254   

53   

–   

–   

–   

22   

–   

–   

4   

443   

Total 
£m 

260 

392 

848 

182 

(395) 

20 

22 

1 

18 

282 

1 630 

The fair value of the insurance policies is deemed to be equivalent to the present value of the related benefit obligation.  

The Group also paid an additional £5 million (2017 – £4 million) into the US unfunded retirement medical plans and £4 million  
(2017 – £4 million) into the US unfunded pension plans to meet the cost of providing benefits in the financial year. 

Plan assets do not include any direct investments in securities issued by the Group or any property occupied by or other assets  
used by the Group. Assets are classified as quoted only if they have a quoted market price in an active market as defined by  
IFRS 13 Fair Value Measurement. All other assets are classified as unquoted. 

Where a plan is in surplus, the surplus recognised is limited to the present value of any amounts that the Group expects to recover 
by way of refunds or a reduction in future contributions. The Group considers that it has an unconditional right to the surplus  
relating to the UK plan as the scheme rules state that any surplus should be returned to the Group in the event that there are  
no members left in the pension scheme. 

c) Mitigation of risk 
The defined benefit pension plans expose the Group to actuarial risks such as interest rate, longevity, inflation and investment risk.  

The Group encourages the trustees of the plans to adopt an investment policy that seeks to mitigate these risks, which involves investing a 
significant proportion of the plan assets in liability-driven investment portfolios that mitigate interest rate, inflation and investment risks. 
The Group seeks to ensure that, as far as practicable, the investment portfolios of the funded plans are invested in long-term fixed interest 
securities with maturities and in currencies that match the expected future benefit payments as they fall due. 

At 31 March 2018, £266 million (2017 – £282 million) of the benefit obligation was fully matched by qualifying insurance policies that also 
mitigate longevity and investment risks. The UK plans also maintain a portfolio of return-seeking investments, principally in the form of 
equities and investment funds, whilst the US funded plans are principally comprised of fixed interest securities since all equity and real 
estate assets were sold following the accelerated contribution payment. 

In the UK, interest rate derivatives are used to achieve close matching where matching fixed-interest securities are not available in the 
market. At 31 March 2018 the ratio of non-insured liabilities under the main UK plan which had been hedged for both interest rate and 
inflation rate risks was 87%. For interest rate purposes it is the economic liability risk which is hedged rather than the IAS 19 accounting 
liability risk, i.e. the hedging is linked to movements in government bond yields rather than high quality AA corporate bond yields. The 
economic liability risk is hedged in this way as it impacts the funding position which, in turn, drives the Company’s cash contribution 
requirements. Most of the inflation risk for the Group arises in the UK since deferred pensions and pensions in payment in the US do not 
attract inflation increases. Inflation risk is mitigated by holding index-linked government bonds and corporate bonds and, in the UK, 
inflation derivatives. 

d) Funding of the plans 
As required by local regulations, actuarial valuations of the US pension plans are carried out each year and those of the UK pension plans 
are carried out at least every three years. The main UK scheme triennial valuation as at 31 March 2016 was concluded during the prior 
year, with agreed core funding contributions maintained at £12 million per year, and the Group also committing to extend the 
supplementary contributions payable into the secured funding account of £6 million per year until 31 March 2023. This funding is payable 
to the trustees on certain triggering events such as underperformance of the Scheme’s investments or a deterioration in the strength of 
the Group’s financial covenant. The Group will continue to fund the UK plan administration costs. 

During the year ending 31 March 2019, the Group expects to contribute approximately £26 million to its defined benefit pension plans and 
to pay approximately £4 million in relation to retirement medical benefits. 

www.tateandlyle.com  157
www.tateandlyle.com  157 

Strategic ReportGovernanceFinancial StatementsUseful Information 
 
 
 
 
 
 
 
   
 
 
   
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Notes to the Consolidated Financial Statements continued 

31. Share-based payments 
The Company operates share-based incentive arrangements for the executive directors, senior executives and other eligible employees 
under which awards and options are granted over the Company’s ordinary shares. All of the arrangements under which awards and 
options were outstanding during the 2018 and 2017 financial years are classified as equity-settled. During the year, the compensation 
expense recognised in profit or loss in respect of share-based incentives was £15 million (2017 – £21 million). Other than the Sharesave 
Plan, all option awards have a nil exercise price. The following arrangements existed during the period:  

a) Performance Share Plan 
The Group’s principal ongoing share-based incentive arrangement is the Performance Share Plan (PSP). Participation in the PSP is 
restricted to the executive directors and other senior executives. Awards made under the PSP normally vest provided the participant 
remains in the Group’s employment until the end of the performance period, and are subject to the satisfaction of performance conditions.  

The conditions applicable to PSP awards made from 1 April 2016 relate to the achievement of the Group adjusted return on capital 
employed (ROCE) and adjusted profit targets. Up to 50% of each award vests dependent on the Group’s adjusted ROCE from continuing 
operations reaching specified levels at the end of the performance period. Up to 25% of each award vests dependent on the compound 
annual growth in the Group’s adjusted profit before tax with the remaining 25% from compound annual growth of the Food & Beverage 
Solutions adjusted operating profit. 

The conditions applicable to PSP awards made prior to 31 March 2016 relate to the achievement of earnings per share (EPS) and ROCE 
targets. Up to 50% of each award vests dependent on the compound annual growth rate of the Group’s adjusted diluted EPS from 
continuing operations reaching specified levels over the performance period. Up to 50% of each award vests dependent on the Group’s 
adjusted ROCE from continuing operations reaching specified levels at the end of the performance period.  

The performance period is the period of three financial years beginning with the financial year in which the award is granted.  

b) Group Bonus Plan – deferred element  
Bonuses earned under the Group Bonus Plan (GBP) are normally paid in cash up to 100% of the base salary of the participating executive. 
Any excess above 100% of base salary is paid in the form of deferred shares that are released after two years subject to the executive 
remaining in the Group’s employment. During the vesting period, payments in lieu of dividends are made in relation to the deferred shares.  

c) Sharesave Plan  
Options are granted from time to time under the Company’s Sharesave Plan, which is open to all employees in the UK. It offers eligible 
employees the option to buy shares in the Company after a period of three or five years funded from the proceeds of a savings contract to 
which they contribute on a monthly basis. The exercise price reflects a discount to market value of up to 20%. 

d) Restricted Share Awards  
The Company has made a Restricted Share Award (RSA) to a number of eligible employees. Awards made normally vest provided the 
participant remains in the Group’s employment during the performance period and other conditions, specific to the individual awards,  
are met.  

e) Conditional Share Award  
During the prior year, the Company made a Conditional Share Award (CSA) to eligible employees. Up to 50% of each award vested 
dependent on adjusted Group profit after tax on continuing operations for the year ended 31 March 2017. Up to 50% of each award vested 
dependent on the Group’s adjusted ROCE from continuing operations as at 31 March 2017. The award vested as soon as practicable after 
31 March 2017, although, some employees were subject to an additional retention period ending 31 March 2018. The vesting level of the 
awards may be reduced in other circumstances specified at award.  

Further information for these awards made in relation to executive directors (a, b and c only) are set out in the Directors’ Remuneration 
Report on pages 72 to 89. 

Movements in the year  
Movements in the awards outstanding during the year were as follows: 

Outstanding at 1 April 

Granted 

Exercised 

Lapsed 

Outstanding at 31 March 

Exercisable at 31 March 

2018   

2017 

Awards  
(number) 

Weighted average 
exercise price 

(pence)   

Awards  
(number)   

Weighted average 
exercise price 
(pence) 

12 435 492   

4 262 759   

(2 130 967)  

(3 453 377)  

11 113 907   

485 268   

10p   

15p   

13p   

5p   

13p   

17p   

10 607 961   

5 875 352   

(1 209 949)  

(2 837 872)  

12 435 492   

603 939   

10p 

6p 

10p 

5p 

10p 

3p 

The weighted average market price of the Company’s ordinary shares on the dates on which awards were exercised during the year was 
704p (2017 – 684p). 

158  Tate & Lyle PLC Annual Report 2018
158  Tate & Lyle PLC Annual Report 2018 

   
 
 
   
   
 
 
 
 
 
 
 
 
31. Share-based payments continued 
Awards granted in the year  
During the year, PSP awards were granted over 3,807,789 shares (2017 – 4,177,420 shares), RSAs were granted over 124,011 shares  
(2017 – nil), no CSAs were granted (2017 – 1,474,000 shares), the deferred element of GBP awards were granted over 216,727 shares  
(2017 – 161,503 shares) and Sharesave options were granted over 114,232 shares (2017 – 62,429 shares). The compensation expense 
recognised in relation to these awards is based on the fair value of the awards at their respective grant dates. The weighted average fair 
values of the awards granted during the year and the principal assumptions made in measuring those fair values were as follows: 

Fair value at grant date 

Exercise price 

Principal assumptions: 

Share price on grant date 

Expected life of the awards 

Risk-free interest rate 

Dividend yield on the Company’s shares 

Volatility of the Company’s shares 

Year ended 31 March 2018   

Year ended 31 March 2017 

PSP 

Sharesave 

627p   

–   

133p   

555p   

687p   

684p   

3 years    3.3/5.3 years   

–    0.62%/0.86%   

4.08%   

n/a   

4.12%   

25%   

CSA   

n/a   

–   

n/a   

n/a   

–   

n/a   

n/a   

PSP   

Sharesave   

662p   

–   

102p   

597p   

CSA 

582p 

– 

722p   

667p   

621p 

3 years   

3.3/5.3 years   

0.9/1.9 years 

–   

0.37%/0.76%   

3.87%   

n/a   

4.20%   

25%   

– 

4.51% 

n/a 

In addition, 216,727 deferred shares issued under the Group Bonus Plan during the year have an expected life of 2.0 years with a fair value 
at the grant date of 795p (2017 – 614p). RSAs of 124,011 (2017 – nil) were granted, with employment related conditions and expected life of 
the award, specific to each individual grant. 

The fair value of the awards was measured using the Black-Scholes option pricing formula, taking into account factors such as  
non-transferability, exercise restrictions and behavioural considerations. 

Expected volatility was based on the historical volatility of the market price of the Company’s shares over the expected life of the awards.  

Awards outstanding at the end of the year 
The range of exercise prices and the weighted average remaining contractual life of the awards outstanding at the end of the year were  
as follows: 

i

S
t
r
a
t
e
g
c
R
e
p
o
r
t

G
o
v
e
r
n
a
n
c
e

i

F
n
a
n
c
i
a
l
S
t
a
t
e
m
e
n
t
s

U
s
e
f
u
l

I

n
f
o
r
m
a
t
i
o
n

Exercise price 

Nil 

400p to 799p 

Total 

At 31 March 2018   

Weighted average 
contractual life  

(months)   

46.7   

33.8   

46.4   

Awards 
(number) 

10 853 697   

260 210   

11 113 907   

At 31 March 2017 

Weighted average 
contractual life 
(months) 

44.9 

32.1 

44.7 

Awards 
(number)   

12 207 008   

228 484   

12 435 492   

www.tateandlyle.com  159
www.tateandlyle.com  159 

Strategic ReportGovernanceFinancial StatementsUseful Information 
 
 
 
 
 
 
 
   
 
 
   
   
 
 
 
 
 
   
   
   
   
   
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
Notes to the Consolidated Financial Statements continued 

32. Provisions and contingent liabilities 
Provisions 

Insurance 
provisions 

Restructuring and 
closure provisions 

Other provisions 

At 1 April 2016 

Year ended 31 March 2017 

Provided in the year 

Released in the year 

Utilised in the year 

Exchange and other movements 

At 31 March 2017 

Year ended 31 March 2018 

Provided in the year 

Released in the year 

Utilised in the year 

Exchange and other movements 

At 31 March 2018 

Provisions are expected to be utilised as follows: 

– within one year 

– after more than one year 

Total 

£m   

12   

1   

(1)   

(5)   

2   

9   

2   

–   

(3)  

(1)  

7   

£m   

14   

3   

(1)  

(14)  

1   

3   

–   

–   

(2)  

(1)  

–   

£m   

10   

3   

–   

–   

2   

15   

1   

(1)  

(1)  

(1)  

13   

2018  
£m   

5   

15   

20   

Total 
£m 

36 

7 

(2) 

(19) 

5 

27 

3 

(1) 

(6) 

(3) 

20 

At 31 March 

2017  
£m 

10 

17 

27 

Provisions primarily relate to Group legal matters, previously disposed businesses and insurance provisions representing amounts 
provided by the Group’s captive insurance subsidiary in respect of the expected level of insurance claims. All provisions are expected to be 
utilised within five years.  

The difference between the carrying value and the discounted present value was not material in either year. 

Contingent liabilities  
Passaic River  
The Group remains subject to a legal case arising from the notification in 2007 by the U.S. Environmental Protection Agency (USEPA) that 
it, along with approximately 70+ others, is a potentially responsible party (PRP) for a 17 mile section of the northern New Jersey Passaic 
River, a major ‘Superfund’ site. In March 2016, the USEPA issued its Record of Decision (ROD) on the likely cost for the remediation of the 
lower eight-mile section of the river (the most contaminated). Whilst the Group will continue to vigorously defend itself in this matter, in 
light of the publication of the ROD, the Group has maintained a provision of £6 million in respect of this. The Group continues to be unable 
to estimate a reasonably possible range of loss in respect of the remaining nine-mile section of the river and therefore has not recognised 
a provision for this section.  

Other claims  
The Group is subject to claims and litigation generally arising in the ordinary course of its business, some of which are for substantial 
amounts. All such actions are strenuously defended but provision is made for liabilities that are considered likely to arise on the basis of 
current information and legal advice. While there is always uncertainty as to the outcome of any claim or litigation, it is not expected that 
the claims and litigation existing at 31 March 2018 will have a material adverse effect on the Group’s financial position. 

160  Tate & Lyle PLC Annual Report 2018
160  Tate & Lyle PLC Annual Report 2018 

   
 
 
   
   
   
 
 
 
 
 
 
 
   
   
   
 
 
 
 
 
 
 
   
   
  
  
  
  
  
  
 
 
33. Commitments 
Capital commitments 

Total commitments for the purchase of property, plant and equipment 

In addition, commitments in respect of retirement benefit obligations are detailed in Note 30. 

2018 

£m   

26   

At 31 March 

2017 
£m 

25 

Operating lease arrangements  
Operating lease payments represent rentals payable by the Group for certain of its land, buildings, plant and equipment. Certain operating 
lease agreements allow for renewal at the end of the original term at the option of the Group.  

At the year-end date, the Group has outstanding commitments under non-cancellable operating leases which fall due as follows: 

Within one year 

Between one year and five years 

After five years 

Total 

2018 

£m   

35   

106   

133   

274   

At 31 March 

2017 
£m 

34 

116 

168 

318 

34. Acquisitions and disposals 
Completion of Tapioca Development Corporation disposal in the 2018 financial year 
On 2 November 2017, the Group completed the sale of its 33.3% share in an associated undertaking, the Tapioca Development 
Corporation. This sale resulted in cash proceeds of £5 million and resulted in a profit on disposal of £2 million, after recycling of 
cumulative foreign exchange translation gains of £1 million from reserves to the income statement upon disposal. 

Completion of Moroccan disposal in the 2017 financial year 
On 1 June 2016, the Group completed the sale of its corn wet mill in Casablanca, Morocco to ADM, receiving gross cash proceeds of  
£4 million, a net £3 million after cash disposed. In the year ended 31 March 2017, the Group recognised a £1 million exceptional gain 
resulting from the recycling of cumulative foreign exchange translation gains from reserves to the income statement upon disposal of the 
investment. Refer to Note 7 for details on the settlement reached with the Moroccan tax authorities in respect of historical tax matters 
relating to this entity. 

Completion of Howbetter disposal in the 2017 financial year 
On 23 December 2016, the Group completed the disposal of Jiangsu Tate & Lyle Howbetter Food Co., Ltd, its Food Systems subsidiary in 
China, recognising a £7 million operating exceptional charge (within other expenses) in respect of impairing and deconsolidating the entity 
prior to disposal, and the associated costs of exiting (see Note 7). 

35. Events after the balance sheet date 
On 23 May 2018, the Group entered into an agreement to acquire a 15% equity holding in Sweet Green Fields, one of the largest privately 
held, fully integrated global stevia ingredient companies. Under the terms of the agreement, the Group has an option to acquire the 
remaining 85% share in due course. 

i

S
t
r
a
t
e
g
c
R
e
p
o
r
t

G
o
v
e
r
n
a
n
c
e

i

F
n
a
n
c
i
a
l
S
t
a
t
e
m
e
n
t
s

U
s
e
f
u
l

I

n
f
o
r
m
a
t
i
o
n

www.tateandlyle.com  161
www.tateandlyle.com  161 

Strategic ReportGovernanceFinancial StatementsUseful Information 
 
 
 
 
 
 
 
   
   
   
 
   
   
   
 
 
 
 
 
 
 
Notes to the Consolidated Financial Statements continued 

36. Related party disclosure 
Identity of related parties 
The Group has related party relationships with its joint ventures and associates, the Group’s pension schemes and with key management, 
being its Directors and executive officers. No related party transaction with close family members of the Group’s key management 
occurred in the current or comparative year. 

Subsidiaries, joint ventures and associates  
Transactions entered into by the Company, Tate & Lyle PLC, with subsidiaries and between subsidiaries as well as the resultant balances 
of receivables and payables are eliminated on consolidation and are not required to be disclosed. Transactions and balances with and 
between joint ventures are as shown below. There are no such transactions with associates. 

In the year ended 31 March 2018, the Group disposed of its 33.3% interest in Tapioca Development Corporation, a company based in 
Thailand, its only associate. See Notes 21 and 34. 

In the year ended 31 March 2017, the Group disposed of, and therefore ceased to have related party transactions with two of its 
subsidiaries. The Group disposed of its equity interest in Jiangsu Tate & Lyle Howbetter Food Co., Ltd, its Food Systems business in China. 
The Group also completed the disposal of its interest in its corn wet mill in Casablanca, Morocco.  

There were no other material changes in related parties or in the nature of related party transactions during the year. 

Sales of goods and services 

– to joint ventures 

Purchases of goods and services 

– from joint ventures 

Receivables 

– due from joint ventures 

Payables 

– due to joint ventures 

Year ended 31 March 

2018 

£m   

147   

–   

2018 

£m   

20   

–   

2017 
£m 

133 

– 

At 31 March 

2017 
£m 

24 

– 

The Group had no material related party transactions containing unusual commercial terms in the current or prior year. 

Key management compensation is disclosed in Note 10. There were no other related party transactions with key management. 

37. Currency exchange rates 
The principal exchange rates used to translate the results, assets and liabilities and cash flows of the Group’s foreign operations into 
pounds sterling were as follows: 

Year ended 31 March 

2018 
£1 = 

1.33   

1.13   

2018 
£1 =   

1.40   

1.14   

2017 
£1 =  

1.30 

1.19 

At 31 March 

2017 
£1 =  

1.25 

1.17 

Average rate 

US dollar 

Euro 

Year-end rate 

US dollar 

Euro 

162  Tate & Lyle PLC Annual Report 2018
162  Tate & Lyle PLC Annual Report 2018 

   
   
 
   
 
 
 
   
 
 
 
 
   
 
   
   
   
 
   
 
 
 
   
 
 
   
 
 
 
 
   
   
 
   
   
 
 
 
 
 
i

S
t
r
a
t
e
g
c
R
e
p
o
r
t

G
o
v
e
r
n
a
n
c
e

i

F
n
a
n
c
i
a
l
S
t
a
t
e
m
e
n
t
s

U
s
e
f
u
l

I

n
f
o
r
m
a
t
i
o
n

38. Full listing of subsidiaries, joint ventures and associates  
Subsidiaries based in the United Kingdom1 

Astaxanthin Manufacturing Limited 

Cesalpinia (UK) Limited 

G.C. Hahn and Company Limited 

Hahntech International Limited 

Harvey Steel Sugars Limited2 

Histonpark Limited 

    Type of business 

  Dormant 

  Dormant 

Food & Beverage 
Solutions 
production 

  Dormant 

  Dormant 

  Dormant 

Robinson Milling Systems (Tewkesbury) Limited 

  Dormant 

T.L.S.S. Pension Nominees Limited 

  Dormant 

Tate & Lyle Export Holdings Limited2 

  Holding company 

Tate & Lyle Group Services Limited 

  Holding company 

Tate & Lyle Holdings Americas Limited 

  Holding company 

Tate & Lyle Holdings Limited 

  Holding company 

Tate & Lyle Industrial Holdings Limited2 

  Dormant 

Tate & Lyle Industries Limited 

Tate & Lyle International Finance PLC2 

  Holding company 

In-house treasury 
company 

Tate & Lyle Investments (Gulf States) Limited 

  Dormant 

Tate & Lyle Investments America Limited 

  Holding company 

Tate & Lyle Investments Brazil Limited 

  Holding company 

Tate & Lyle Investments Limited2 

  Holding company 

Tate & Lyle L.P. 

Tate & Lyle Overseas Limited 

Investment 
partnership 

  Dormant 

Tate & Lyle Pension Trust Limited2 

  Pension company 

Tate & Lyle Share Shop Limited2 

  Non-trading 

Tate & Lyle Technology Limited2 

  Holding company 

Tate & Lyle UK Limited2 

Tate & Lyle Ventures II LP 

  Non-trading 

Investment 
partnership 

Tate & Lyle Ventures Limited2 

  Holding company 

Tate & Lyle Ventures LP 

Investment 
partnership 

Percentage of 
ordinary shares 
attributable to  
 Tate & Lyle PLC   

Percentage of 
preference 
shares 
attributable to  

 Tate & Lyle PLC    Registered address 

100   

100   

100   

100   

100   

100   

100   

100   

100   

100   

100   

100   

100   

100   

100   

100   

100   

100   

100   

100   

100   

100   

100   

100   

100   

100   

100   

100   

–    1 Kingsway, London WC2B 6AT, United Kingdom 

–    1 Kingsway, London WC2B 6AT, United Kingdom 

– 

1 Kingsway, London WC2B 6AT, United Kingdom 

–    1 Kingsway, London WC2B 6AT, United Kingdom 

–    1 Kingsway, London WC2B 6AT, United Kingdom 

–    1 Kingsway, London WC2B 6AT, United Kingdom 

100    1 Kingsway, London WC2B 6AT, United Kingdom 

–    1 Kingsway, London WC2B 6AT, United Kingdom 

–    1 Kingsway, London WC2B 6AT, United Kingdom 

–    1 Kingsway, London WC2B 6AT, United Kingdom 

–    1 Kingsway, London WC2B 6AT, United Kingdom 

100    1 Kingsway, London WC2B 6AT, United Kingdom 

–    1 Kingsway, London WC2B 6AT, United Kingdom 

–    1 Kingsway, London WC2B 6AT, United Kingdom 

– 

1 Kingsway, London WC2B 6AT, United Kingdom 

–    1 Kingsway, London WC2B 6AT, United Kingdom 

100    1 Kingsway, London WC2B 6AT, United Kingdom 

–    1 Kingsway, London WC2B 6AT, United Kingdom 

100    1 Kingsway, London WC2B 6AT, United Kingdom 

– 

1209 North Orange Street, Wilmington, Delaware 
19801, United States 

–    1 Kingsway, London WC2B 6AT, United Kingdom 

–    1 Kingsway, London WC2B 6AT, United Kingdom 

–    1 Kingsway, London WC2B 6AT, United Kingdom 

–    1 Kingsway, London WC2B 6AT, United Kingdom 

–    1 Kingsway, London WC2B 6AT, United Kingdom 

– 

1 Kingsway, London WC2B 6AT, United Kingdom 

–    1 Kingsway, London WC2B 6AT, United Kingdom 

– 

1 Kingsway, London WC2B 6AT, United Kingdom 

1  Registered in England and Wales, except Tate & Lyle L.P. which is registered in Delaware, USA. 

2  Direct subsidiaries of Tate & Lyle PLC. 

www.tateandlyle.com  163
www.tateandlyle.com  163 

Strategic ReportGovernanceFinancial StatementsUseful Information 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Notes to the Consolidated Financial Statements continued 

38. Full listing of subsidiaries, joint ventures and associates continued 
Subsidiaries operating overseas 

Percentage of 
ordinary shares 
attributable to 
 Tate & Lyle PLC   

Percentage of 
preference 
shares 
attributable to 
Tate & Lyle PLC 

Registered address 

Country of incorporation 
or registration 

  Company 

  Type of business 

Argentina 

  Tate & Lyle Argentina SA1 

  Food & Beverage Solutions 

Australia 

  Tate & Lyle ANZ Pty Limited 

distribution and sales support 

  Food & Beverage Solutions 
production and distribution 

Belgium 

  Tate & Lyle Services 

  Internal service provider and 

(Belgium) N.V.2 

sales support 

Bermuda 

  Tate & Lyle Management & 

  Reinsurance 

Finance Limited 

Brazil 

  Tate & Lyle Brasil S.A.1 

  Citric acid production and 

Food & Beverage Solutions 
distribution 

  G.C. Hahn & Co. do Brasil 

  Dormant 

Estabilizantes e Tecnologia 
para Alimentos Ltda.1 

  Tate & Lyle Gemacom Tech 
Indústria e Comércio S.A.1 

  Food & Beverage Solutions 

production and support 

100   

100   

100   

100   

100   

100   

93   

Canada 

  Tate & Lyle Ingredients 

  Food & Beverage Solutions 

100   

Canada Limited 

sales support 

Chile 

China 

  Tate & Lyle Chile 
Commercial Ltda 

  Tate & Lyle Trading 
(Shanghai) Co. Ltd1 

  Food & Beverage Solutions 

distribution and sales support 

  Food & Beverage Solutions 

distribution and sales support 

100   

100   

  Food & Beverage Solutions 

100   

sales 

  G.C. Hahn & Co. Food 
Stabiliser Business 
(Shanghai) Ltd1 

  Tate & Lyle Food Ingredients 
(Nantong) Company Limited1 

  Polydextrose production 

100   

–    New & Hi-Tech Industrial 

–    San Martín 140, 14th Floor, City 
of Buenos Aires, Argentina 

–    Building 2, 1425 Boundary Road, 
Wacol QLD 4076, Australia 

–    Industrielaan 4 box 10/1, 9320 

Aalst, Belgium 

–    Canon's Court, 22 Victoria 

Street, Hamilton, Bermuda 

–    Santa Rosa do Viterbo, State of 

São Paulo, Fazenda Amália, São 
Paulo, 14270-000, Brazil 

–    Rua Sapetuba Nº 211, CEP:- 
005510-001- Vila Pirajussara, 
Estado de São Paulo, Brazil 

–    No. 380, Distrito Industrial, City 
of Juiz de Fora, State of Minas 
Gerais at Rua B, 36092-050, 
Brazil 

–    Suite 400, Phoenix Square, 371 
Queen Street, Fredericton NB 
E3B 4Y9, Canada 

–    Isidora Goyenechea 2800, Piso 
43, Las Condes, Santiago, Chile 

–    16F, Building C, Headquarters 
Park Phase 2, 1582 Gumei 
Road, Shanghai, 200233, China 

–    16F, Building C, Headquarters 
Park Phase 2, 1582 Gumei 
Road, Shanghai, 200233, China 

Development District, Rudong 
county, Nantong city, China 
226400 

–    Calle 11 #100-121 Of 309, Cali, 

Colombia 

–    Donji Banovec 15, Koprivnica, 

48000, Croatia 

–    Ostravská 169, 339 01 Klatovy IV, 

Czech Republic 

–    87 Street 9, Maadi , Cairo, Egypt 

–    76, rue du Maréchal Lyautey, 
78100 Saint Germain En Laye, 
France 

–    2 Avenue de L'Horizon, 59650 
Villeneuve-D'Ascq, France 

Colombia 

  Tate & Lyle Colombia S.A.S.1    Food & Beverage Solutions 

Croatia 

  G.C. Hahn & Co. d.o.o. Za 
distribuciju stabilizacionih 
sistema 

distribution and sales support 

  Food & Beverage Solutions 

sales 

Czech Republic 

  G.C. Hahn & Co. stabilizacni 

  Food & Beverage Solutions 

Egypt 

France 

technika, s.r.o. 

sales 

  Tate & Lyle Egypt LLC 

  Dormant 

  G.C. Hahn & Cie. SARL 

  Food & Beverage Solutions 

sales 

100   

100   

100   

100   

100   

  Tate & Lyle Ingredients 

  Research and development 

100   

France S.A.S. 

centre and Food & Beverage 
Solutions sales support 

164  Tate & Lyle PLC Annual Report 2018
164  Tate & Lyle PLC Annual Report 2018 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
38. Full listing of subsidiaries, joint ventures and associates continued 
Subsidiaries operating overseas continued 

Country of incorporation 
or registration 

  Company 

Germany 

  G.C. Hahn & Co. 

Stabilisierungstechnik 
GmbH 

  Type of business 

  Food & Beverage Solutions 
research and development 
and sales support 

  G.C. Hahn & Co. 

  Holding company 

Cooperationsgesellschaft 
mbH 

  Tate & Lyle Germany GmbH 

  Food & Beverage Solutions 

Gibraltar 

  Tate & Lyle Insurance 
(Gibraltar) Limited 

sales support 

  Reinsurance 

Greece 

  Tate & Lyle Greece A.E. 

  Food & Beverage Solutions 

sales support 

India 

  Tate & Lyle Investments 

  Dormant 

(India) Private Ltd 

Israel 

  Tate & Lyle Israel Limited 

  Dormant 

  Gamtal Foods Ltd 

  Dormant 

Italy 

  Tate & Lyle Italia S.P.A. 

  Food & Beverage Solutions 

production and 
 sales support 

Percentage of 
ordinary shares 
attributable to 
 Tate & Lyle PLC 

Percentage of 
preference 
shares 
attributable to 
Tate & Lyle PLC 

Registered address 

100   

100   

100   

100   

95   

100   

100   

65   

100   

–    Roggenhorster Strasse 31, 
23556, Lübeck, Germany 

–    Roggenhorster Strasse 31, 
23556, Lübeck, Germany 

–    Roggenhorster Strasse 31, 
23556, Lübeck, Germany 

–    Suite 913, Europort, Gibraltar 

–    54248 Thessaloniki, K. 
Papadaki 69, Greece 

–    C-367, Defense Colony, New 

Delhi, 110 024, India 

–    16 Hatidhar st Ra'annana, 
Raanana, 4088, Israel 

–    7 Anatot, Tel Aviv Jaffa, 

6908007, Israel 

–    Via Verdi, 1-Ossona, Milano, 

Italy 

Japan 

  Tate & Lyle Japan KK 

  Food & Beverage Solutions 

100   

–    2F Oak Minami-Azabu Building, 

i

S
t
r
a
t
e
g
c
R
e
p
o
r
t

G
o
v
e
r
n
a
n
c
e

i

F
n
a
n
c
i
a
l
S
t
a
t
e
m
e
n
t
s

U
s
e
f
u
l

I

n
f
o
r
m
a
t
i
o
n

distribution 

Lithuania 

  UAB G.C. Hahn & Co. 

  Food & Beverage Solutions 

sales 

Mexico 

  Tate & Lyle México, S. de 

  Food & Beverage Solutions 

R.L. de C.V.1 

distribution and sales support 

  Mexama, S.A. de C.V.1 

  Non-trading 

100   

100   

65   

  Talo Services de Mexico, 

  Internal service provider 

100   

S.C.1 

Morocco 

  T&L Casablanca S.A.R.L. 

  Food & Beverage Solutions 

100   

sales support 

Netherlands 

  Nederlandse Glucose 

  Holding company 

Industrie B.V. 

  Tate & Lyle Netherlands 

  Primary Products and Food & 

B.V. 

Beverage Solutions 
production 

Poland 

  G.C. Hahn & Co. Technika 
stabilizowania Sp.z o.o. 

  Food & Beverage Solutions 

sales 

  Tate & Lyle Global Shared 

  Internal service provider 

Services Sp.z o.o. 

  Tate & Lyle Poland  

  Dormant 

Sp.z o.o. 

100   

100   

100   

100   

100   

3-19-23 Minami-Azabu, 
Minato-ku, Tokyo, Japan 

–    E. Simkunaites Str. 10, Vilnius, 

LT04130, Lithuania 

–    piso 2, Av. Universidad 749, 
Col del Valle Sur, Ciudad de 
Mexico , 03100, México 

–    Calle lago de tequesquitengo , 
No 111 Col. Cuahutemoc C.P. 
62430 , Morelos, México 

–    piso 2, Av. Universidad 749, 
Col del Valle Sur, Ciudad de 
Mexico , 03100, México 

–    22, Rue du Parc, Casa Théâtre 
Centre, Anfa, Casablanca, 
Morocco 

100    1541 KA, Koog aan de Zaan, 
Lagedijk 5, The Netherlands 

–    1541 KA, Koog aan de Zaan, 
Lagedijk 5, The Netherlands 

–    Sterlinga 8A, 91425, Łódź, 

Poland 

–    Sterlinga 8A, 91425, Łódź, 

Poland 

–    Sterlinga 8A, 91425, Łódź, 

Poland 

www.tateandlyle.com  165
www.tateandlyle.com  165 

Strategic ReportGovernanceFinancial StatementsUseful Information 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Notes to the Consolidated Financial Statements continued 

38. Full listing of subsidiaries, joint ventures and associates continued 
Subsidiaries operating overseas continued 

Country of incorporation 
or registration 

  Company 

Russian Federation    Tate & Lyle CIS LLC1 

  Type of business 

  Food & Beverage 
Solutions sales 

Percentage of 
ordinary shares 
attributable to 
Tate & Lyle PLC   

Percentage of 
preference 
shares 
attributable to 
Tate & Lyle PLC 

Registered address 

100   

–    Leninskaya Sloboda,26, Area 2, Room 

100, 115280, Moscow, Russian 
Federation 

Singapore 

  Tate & Lyle Asia Pacific 

  Food & Beverage 

100   

–    3 Biopolis Drive, #05-11 Synapse, 

Pte. Ltd. 

Solutions sales and 
ASPAC regional head 
office 

  Tate & Lyle Singapore 

  Sucralose production (now 

Pte Ltd 

decommissioned) 

  Tate & Lyle Singapore 

  Holding company 

Holdings Pte Ltd 

Slovakia 

  Tate & Lyle Boleraz s.r.o.    Primary Products and 

Food & Beverage 
Solutions production 

  Tate & Lyle Slovakia, 

  Internal service provider 

s.r.o. 

  Tate and Lyle South 
Africa Proprietary 
Limited 

  Food & Beverage 

Solutions production and 
distribution 

South Africa 

Singapore 138623 

–    One Marina Boulevard #28-00 

Singapore 018989 

–    One Marina Boulevard #28-00 

Singapore 018989 

–    Boleraz 114, 91908 Boleraz, Slovakia 

–    Boleraz 114, 91908 Boleraz, Slovakia 

–    1 Gravel Drive, Kya Sands Business 
Park, Kya Sands, 2163, South Africa 

100   

100   

100   

100   

100   

Spain 

  G.C. Hahn Estabilizantes 

y Tecnologia para 
Alimentos 

  Food & Beverage 
Solutions sales 

100   

–    Av. Valencia, 15, 46171, Casinos 

Valencia, Spain 

  Ebromyl S.L. 

  Dormant 

  Talan Iberica SA 

  Dormant 

Sweden 

  Tate & Lyle Sweden AB 

  Oat protein and Beta 
Glucan production 

Turkey 

  Tate and Lyle Turkey 

  Food & Beverage 

Gıda Hizmetleri Anonim 
Şirketi 

Solutions sales support 

Ukraine 

  PII G.C. Hahn & Co. Kiev1    Food & Beverage 

Solutions sales 

United Arab 
Emirates 

  Tate & Lyle DMCC 

  Food & Beverage 

Solutions sales support 

USA 

  Staley Holdings LLC 

  Holding company 

  Tate & Lyle Custom 
Ingredients LLC 

  Food & Beverage 

Solutions production 

  Tate & Lyle Finance LLC 

  In-house finance 

  TLHUS, Inc. 

  Holding company 

  Tate & Lyle Ingredients 

  Primary Products and 

Americas LLC 

Food & Beverage 
Solutions production 

  Tate & Lyle Sucralose 

  Sucralose production 

LLC 

  TLI Holding LLC 

  In-house finance 

166  Tate & Lyle PLC Annual Report 2018
166  Tate & Lyle PLC Annual Report 2018 

100   

100   

100   

100   

100   

100   

100   

100   

100   

100   

100   

100   

100   

–    Paseo Independencia, 6- PLT 3, 50004, 

Zaragoza, Zaragoza, Spain 

–    28 Raimundo Fernández Villaverde, 

28003, Madrid, Spain 

–    Älvåsvägen 1, 610 20, Kimstad, Sweden 

–    Esentepe Mah., Büyükdere Cad. , 193 

Plaza Kat: 2 193 / 235A14 Şişli, İstanbul, 
Turkey 

–    Mala Olexandriwka, Zentralna-Str. 2-B, 

Borispol, 08320KIEW, UKRAINE 

–    Cluster X, Tower X3, Office n. 3805., 

Jumeira Lake Towers, Dubai, United 
Arab Emirates 

–    1209 North Orange Street, Wilmington, 

Delaware 19801, United States 

–    1209 North Orange Street, Wilmington, 

Delaware 19801, United States 

–    1209 North Orange Street, Wilmington, 

Delaware 19801, United States 

–    1209 North Orange Street, Wilmington, 

Delaware 19801, United States 

–    1209 North Orange Street, Wilmington, 

Delaware 19801, United States 

–    1209 North Orange Street, Wilmington, 

Delaware 19801, United States 

–    1209 North Orange Street, Wilmington, 

Delaware 19801, United States 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
   
 
   
     
38. Full listing of subsidiaries, joint ventures and associates continued 
Subsidiaries operating overseas continued 

Country of incorporation 
or registration 

  Company 

  Type of business 

Percentage of 
ordinary shares 
attributable to 
Tate & Lyle PLC 

Percentage of 
preference 
shares 
attributable to 
Tate & Lyle PLC 

Registered address 

  Tate & Lyle Domestic 

  Internal service provider 

100   

–    1209 North Orange Street, 

International  
Sales Corporation 

Wilmington, Delaware 19801, 
United States 

  Tate & Lyle Grain, Inc. 

  Grain products 

100   

–    1209 North Orange Street, 

Wilmington, Delaware 19801, 
United States 

  Tate & Lyle Malic Acid 

  Dormant 

100   

–    1209 North Orange Street, 

LLC 

Wilmington, Delaware 19801, 
United States 

  Tate & Lyle Sugar 

  Holding company 

100   

–    1209 North Orange Street, 

Holdings, Inc. 

Wilmington, Delaware 19801, 
United States 

  Tate & Lyle Americas 

  Internal service provider 

100   

–    1209 North Orange Street, 

LLC 

Wilmington, Delaware 19801, 
United States 

  Tate & Lyle Citric Acid 

  Citric acid production 

100   

–    1209 North Orange Street, 

LLC 

  Staley International Inc. 

  Cereal sweeteners and 

  G. C. Hahn USA LLC 

  Dormant 

starches 

100   

100   

Wilmington, Delaware 19801, 
United States 

–    208 So. LaSalle Street, Suite 814, 
Chicago, IL 560604, United States 

–    1209 North Orange Street, 

Wilmington, Delaware 19801, 
United States 

1  Non-coterminous year-end. 

2  Direct subsidiaries of Tate & Lyle PLC. 

i

S
t
r
a
t
e
g
c
R
e
p
o
r
t

G
o
v
e
r
n
a
n
c
e

i

F
n
a
n
c
i
a
l
S
t
a
t
e
m
e
n
t
s

U
s
e
f
u
l

I

n
f
o
r
m
a
t
i
o
n

www.tateandlyle.com  167
www.tateandlyle.com  167 

Strategic ReportGovernanceFinancial StatementsUseful Information 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Notes to the Consolidated Financial Statements continued 

38. Full listing of subsidiaries, joint ventures and associates continued 

Joint ventures 

Percentage of 
ordinary shares 
attributable to 
Tate & Lyle PLC   

Percentage of 
preference 
shares 
attributable to 

Tate & Lyle PLC 

Registered address 

50   

50   

50   

–    Calle 26 No. 2756, Zona Industrial, 
Guadalajara, Jal., 44940, Mexico 

–    Calle 26 No. 2756, Zona Industrial, 
Guadalajara, Jal., 44940, Mexico 

-    Calle 26 No. 2756, Zona Industrial, 
Guadalajara, Jal., 44940, Mexico 

Country of incorporation  
or registration 

  Company 

  Type of business 

Mexico 

  Almidones Mexicanos 

  Primary Products and Food & 

S.A. de C.V.1 

Beverage Solutions 
production 

  Promotora de Productos 
y Mercados Mexicanos, 
S.A. de C.V.1 

  Primary Products and Food & 

Beverage Solutions 
production 

  Estacion de 

  Primary Products and Food & 

Beverage Solutions 
production 

Transferencia 
Coatzacoalcos, S.A. de 
C.V.1 

  DuPont Tate & Lyle Bio 
Products Company, LLC 

USA 

1  Non-coterminous year-end. 

  Industrial ingredients 

50   

–    1209 North Orange Street, 

Wilmington, Delaware 19801, United 
States 

The results, assets and liabilities and cash flows of those entities whose financial years are not coterminous with that of the Group are 
consolidated or equity accounted in the Group’s financial statements on the basis of management accounts for the year to 31 March. 

168  Tate & Lyle PLC Annual Report 2018
168  Tate & Lyle PLC Annual Report 2018 

 
 
 
 
 
 
 
 
 
 
Parent Company Balance Sheet 

ASSETS 

Fixed assets 

Tangible fixed assets 

Intangible assets 

Investments in subsidiary undertakings 

Investments in associates 

Total 

Current assets 

Debtors 

Cash at bank 

Creditors – amounts falling due within one year 

Net current assets 

Total assets less current liabilities 

Creditors – amounts falling due after more than one year 

Net assets 

Capital and reserves 

Called up share capital  

Share premium account 

Capital redemption reserve 

Retained earnings 

Total shareholders’ funds 

i

S
t
r
a
t
e
g
c
R
e
p
o
r
t

G
o
v
e
r
n
a
n
c
e

i

F
n
a
n
c
i
a
l
S
t
a
t
e
m
e
n
t
s

U
s
e
f
u
l

I

n
f
o
r
m
a
t
i
o
n

Notes    

2018 
£m    

At 31 March 

2017 
£m 

2   

3   

4   

5   

6   

7   

8   

11   

3   

2   

1 037   

–   

1 042   

1 480   

–   

1 480   

(1 208)  

272   

1 314   

(2)  

1 312   

117   

406   

8   

781   

2 

3 

1 028 

4 

1 037 

1 554 

– 

1 554 

(1 314) 

240 

1 277 

(2) 

1 275 

117 

406 

8 

744 

1 312   

1 275 

The Company recognised profit for the year of £180 million (2017 – £298 million). 

The Parent Company’s financial statements on pages 169 to 176 were approved by the Board of Directors on 23 May 2018 and signed on its 
behalf by: 

Nick Hampton 
Director 

The notes on pages 171 to 176 form part of these financial statements. 

Tate & Lyle PLC  
Registered number: 76535 

www.tateandlyle.com  169
www.tateandlyle.com  169 

Strategic ReportGovernanceFinancial StatementsUseful Information 
 
 
 
 
 
 
 
   
   
   
 
   
   
 
 
   
   
 
 
 
 
 
 
   
 
   
   
 
 
 
   
 
 
   
 
 
   
 
   
 
 
   
 
 
   
   
 
 
   
   
 
 
 
   
 
   
 
   
 
   
 
 
 
Parent Company Statement of Changes in Equity  

At 1 April 2016 

Year ended 31 March 2017: 

Profit for the year  

Purchase of own shares 

Share-based payments 

Dividends paid 

At 31 March 2017 

Year ended 31 March 2018: 

Profit for the year 

Purchase of own shares 

Share-based payments 

Dividends paid 

At 31 March 2018 

Called up  
share  
capital 

 £m   

117   

Share  
premium  
account 

£m   

406   

Capital  
redemption 
reserves 

£m   

8   

Retained  
earnings 

£m   

579   

–   

–   

–   

–   

–   

–   

–   

–   

117   

406   

–   

–   

–   

–   

–   

–   

–   

–   

117   

406   

–   

–   

–   

–   

8   

–   

–   

–   

–   

8   

298   

(18)   

15   

(130)   

744   

180   

(27)  

15   

(131)  

781   

Total  
equity 
£m 

1 110 

298 

(18) 

15 

(130) 

1 275 

180 

(27) 

15 

(131) 

1 312 

At 31 March 2018, the Company had realised profits available for distribution in excess of £650 million (2017 - in excess of £625 million). 

170  Tate & Lyle PLC Annual Report 2018
170  Tate & Lyle PLC Annual Report 2018 

   
 
 
   
   
   
   
 
 
 
 
 
 
 
   
   
   
   
 
 
 
 
 
 
 
Notes to the Parent Company Financial Statements 

1. Principal accounting policies 
Basis of preparation  
Tate & Lyle PLC (the Company) is a public limited company 
incorporated in the United Kingdom and registered in England. The 
Company’s ordinary shares are listed on the London Stock Exchange.  

The Company’s financial statements are prepared under the 
historical cost convention in accordance with Financial Reporting 
Standard 101 Reduced Disclosure Framework (FRS 101) and with 
UK accounting presentation as at 31 March 2018, with comparative 
figures as at 31 March 2017.  

For the reasons set out on page 105, the Company’s financial 
statements are prepared on a going concern basis.  

As permitted by Section 408 of the Companies Act 2006, the 
Company’s profit and loss account is not presented in these 
financial statements. Profit and loss account disclosures are 
presented in Note 13. 

The results of the Company are included in the preceding Group 
financial statements.  

The following disclosure exemptions from the requirements of 
IFRS have been applied in the preparation of these financial 
statements, in accordance with FRS 101:  

•  the requirements of IAS 7 Statement of Cash Flows  
•  the requirements of paragraph 17 and 18(a) of IAS 24 Related 

Party Disclosures  

•  the requirements in IAS 24 Related Party Disclosures to disclose 
related party transactions entered into between two or more 
members of a group, provided that any subsidiary which is a 
party to the transaction is wholly owned by such a member  

•  the requirement in paragraph 38 of IAS 1 Presentation of 

Financial Statements to present comparative information in 
respect of paragraph 79(a)(iv) of IAS 1  

•  the requirements of IFRS 7 Financial Instruments: Disclosures  
•  the requirements of paragraphs 30 and 31 of IAS 8 Accounting 

Policies, Changes in Accounting Estimates and Errors  

•  the requirements of IFRS 2 Share-Based Payments  
•  the requirements of paragraphs 91 to 99 of IFRS 13 Fair Value 

Measurement  

•  the requirements of paragraphs 10(d) (statement of cash flows), 
10(f) (statement of financial position as at the beginning of the 
preceding period when an entity applies an accounting policy 
retrospectively), 38(A to D) (comparative information), 40(A to D) 
(presentation of third balance sheet), 111 (statement of cash 
flows) and 134 to 136 (capital management) of IAS 1 Presentation 
of Financial Statements. 

The Company intends to maintain these disclosure exemptions in 
future years.  

Judgements and key sources of uncertainty  
Estimating fair value for share-based transactions requires 
determination of the most appropriate valuation model  
which depends on the terms and conditions of each individual 
grant. This estimation also requires determination of the most 
appropriate inputs to the valuation model.  

i

S
t
r
a
t
e
g
c
R
e
p
o
r
t

G
o
v
e
r
n
a
n
c
e

i

F
n
a
n
c
i
a
l
S
t
a
t
e
m
e
n
t
s

U
s
e
f
u
l

I

n
f
o
r
m
a
t
i
o
n

Investments  
Subsidiaries are all entities over which the Company has control. 
The Company controls an entity when it is exposed to, or has rights 
to, variable returns from its involvement with the entity and has the 
ability to affect those returns through its power over the entity.  

An associate is an entity over which the Company has significant 
influence. Significant influence is the power to participate in 
financial and operating policy decisions but not to control or jointly 
control them.  

Investments in subsidiary undertakings and in associates represent 
interests that are directly owned by the Company and are stated  
at cost less amounts written off for any permanent diminution  
in value.  

Amounts owed by or to subsidiary undertakings  
Amounts owed by or to subsidiary undertakings are stated at amortised 
cost using the effective interest method. Amounts owed by subsidiary 
undertakings are written off where deemed unrecoverable.  

Leases  
Operating lease payments are charged to the profit and loss 
account on a straight-line basis over the lease term.  

Retirement benefits  
The Company participates in a defined benefit pension scheme in 
which certain of its subsidiaries also participate. The Company, 
which is not the principal employer, cannot identify its share of the 
underlying assets and liabilities of the scheme. Accordingly, as 
permitted by IAS 19 Employee Benefits, the Company accounts for 
the scheme as a defined contribution scheme and charges its 
contributions to the scheme to the profit and loss account in the 
periods in which they fall due.  

Deferred tax  
Deferred tax is recognised in respect of all temporary differences 
that have originated but which have not reversed at the balance 
sheet date where transactions or events have occurred at that date 
that will result in an obligation to pay more, or a right to pay less, or 
to receive more tax. Deferred tax assets are recognised to the 
extent that they are regarded as recoverable. Assets are regarded 
as recoverable when it is regarded as more likely than not there 
will be suitable taxable profits from which the future reversal of the 
underlying timing differences can be deducted. 

Foreign currency translation  
Transactions denominated in foreign currencies are translated into 
pounds sterling at the exchange rate ruling on the date of the 
transaction. Monetary assets and liabilities denominated in foreign 
currencies are retranslated into pounds sterling at the exchange 
rate ruling on the balance sheet date. Currency translation 
differences are credited or charged to the profit and loss account. 
Non-monetary assets denominated in foreign currencies and 
carried at historical cost are translated using the exchange rate 
ruling on the date of transaction.  

www.tateandlyle.com  171
www.tateandlyle.com  171 

Strategic ReportGovernanceFinancial StatementsUseful Information 
 
 
 
 
 
 
 
 
 
 
 
Notes to the Parent Company Financial Statements continued 

Own shares  
Own shares represent the Company’s ordinary shares that are held 
by the Company in treasury or by a sponsored Employee Benefit 
Trust that are used to satisfy awards made under the Company’s 
share-based incentive plans. When own shares are acquired, the 
cost of purchase in the market is deducted from the profit and  
loss account reserve. Gains or losses on the subsequent transfer  
or sale of own shares are also recognised in the profit and loss 
account reserve.  

Dividends  
Dividends on the Company’s ordinary shares are recognised when 
they have been appropriately authorised and are no longer at the 
Company’s discretion. Accordingly, interim dividends are 
recognised when they are paid and final dividends are recognised 
when they are declared following approval by shareholders at the 
Company’s AGM. Dividends are recognised as an appropriation of 
shareholders’ funds. Details of dividends paid and proposed are set 
out in Note 12.  

Dividend income received from subsidiary companies is recognised 
when the right to receive the payment is established. 

1. Principal accounting policies continued 
Share-based payments  
As described in Note 31 to the consolidated financial statements, 
the Company operates share-based incentive plans under which it 
grants awards over its ordinary shares to its own employees and to 
those of its subsidiary undertakings. All of the awards granted 
under the existing plans are classified as equity-settled awards.  

For awards granted to its own employees, the Company recognises 
an expense that is based on the fair value of the awards measured 
at the grant date using the Black-Scholes option pricing formula. 
Fair value reflects any market performance conditions and all non-
vesting conditions. Adjustments are made to the compensation 
expense to reflect actual and expected forfeitures due to failure to 
satisfy service conditions or non-market performance conditions. 
Generally, the expense is recognised in the profit and loss account 
on a straight-line basis over the vesting period and a corresponding 
credit is recognised in the profit and loss account reserve. For 
awards granted to employees of its subsidiary undertakings, the 
Company recognises a capital contribution to the subsidiary and a 
corresponding credit to equity calculated on the same basis as the 
expense that it recognises for awards to its own employees.  

Provisions  
Provisions are recognised when the Company has a present 
obligation as a result of a past event, it is probable that a transfer of 
economic benefits will be required to settle the obligation, and a 
reliable estimate can be made of the amount of the obligation.  

Guarantees  
From time to time, the Company provides guarantees to third 
parties in respect of the indebtedness of its subsidiary undertakings 
and joint ventures. The Directors consider these guarantees to be 
insurance arrangements and, therefore, the Company recognises a 
liability in respect of such guarantees only in the event that it 
becomes probable that the guarantee will be called upon and the 
Company will be required to make a payment to the third party. 
Commitments in respect of retirement benefit obligations are 
detailed in Note 14.  

172  Tate & Lyle PLC Annual Report 2018
172  Tate & Lyle PLC Annual Report 2018 

 
 
 
 
 
 
 
 
 
 
 
2. Tangible fixed assets 

Cost 

At 1 April 2017 

Additions 

Disposals 

At 31 March 2018 

Accumulated depreciation 

At 1 April 2017 

Depreciation charge 

Disposals 

At 31 March 2018 

Net book value at 31 March 2017 

Net book value at 31 March 2018 

3. Intangible assets 

Cost 

At 1 April 2017 

Additions 

At 31 March 2018 

Accumulated amortisation 

At 1 April 2017 

Amortisation charge 

At 31 March 2018 

Net book value at 31 March 2017 

Net book value at 31 March 2018 

4. Investments in subsidiary undertakings 

Cost 

At 1 April 2017 

Additions 

At 31 March 2018 

Impairment 

At 1 April 2017 

Reversal of impairment 

At 31 March 2018 

Net book value at 31 March 2017 

Net book value at 31 March 2018 

i

S
t
r
a
t
e
g
c
R
e
p
o
r
t

G
o
v
e
r
n
a
n
c
e

i

F
n
a
n
c
i
a
l
S
t
a
t
e
m
e
n
t
s

U
s
e
f
u
l

I

n
f
o
r
m
a
t
i
o
n

Plant and 
machinery 
£m 

5 

1 

– 

6 

3 

– 

– 

3 

2 

3 

Other  
intangible  
assets 
£m 

5 

– 

5 

2 

1 

3 

3 

2 

£m 

1 587 

8 

1 595 

559 

(1) 

558 

1 028 

1 037 

5. Investments in associates 
On 2 November 2017, the Company disposed of its 33.3% interest in the ordinary shares in Tapioca Development Corporation, a company 
incorporated in Thailand.  

www.tateandlyle.com  173
www.tateandlyle.com  173 

Strategic ReportGovernanceFinancial StatementsUseful Information 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Notes to the Parent Company Financial Statements continued 

6. Debtors 

Due within one year 

Current tax 

Amounts owed by subsidiary undertakings 

Other debtors 

Total 

2018 

£m   

8   

1 469   

3   

1 480   

At 31 March 

2017 
£m 

– 

1 551 

3 

1 554 

The effective interest rate applicable to amounts owed by subsidiary undertakings at 31 March 2018 is 2.1% (2017 – 1.8%). Amounts owed 
by subsidiary undertakings are receivable on demand. There is no security for non-trading amounts. 

7. Creditors – amounts falling due within one year 

Amounts owed to subsidiary undertakings  

Other creditors 

Accruals and deferred income 

Total 

2018 

£m   

1 187   

5   

16   

At 31 March 

2017 
£m 

1 292 

6 

16 

1 208   

1 314 

The effective interest rate applicable to amounts owed to subsidiary undertakings at 31 March 2018 was 2.5% (2017 – 2.3%). Amounts owed 
to subsidiary undertakings are repayable on demand. There is no security for non-trading amounts. 

8. Creditors – amounts falling due after more than one year 

Total 

2018 

£m   

2   

At 31 March 

2017 
£m 

2 

On a return of capital on a winding-up, the holders of 6.5% cumulative preference shares shall be entitled to £1 per share, in preference to 
all other classes of shareholders. Holders of these shares are entitled to vote at meetings, except on the following matters: any question 
as to the disposal of the surplus profits after the dividend on these shares has been provided for; the election of directors; their 
remuneration; any agreement between the directors and the Company; or the alteration of the Articles of Association dealing with any 
such matters. 

9. Contingent liabilities 
At 31 March 2018, the Company had given guarantees in respect of committed financing of certain of its subsidiaries and joint ventures 
totalling £1,196 million (2017 – £2,117 million), against which amounts drawn totalled £571 million (2017 – £700 million). The Company had 
given guarantees in respect of operating lease commitments of certain of its subsidiaries and joint ventures totalling £234 million  
(2017 – £288 million). The Company provides other guarantees in the normal course of business. The Company has assessed the 
probability of material loss under these guarantees as remote.  

In addition, commitments in respect of retirement benefit obligations are detailed in Note 14. 

10. Financial commitments 
Operating lease rentals payable during the year were £1 million (2017 – £1 million), all in respect of land and buildings. At 31 March 2018, 
the Company has outstanding commitments under non-cancellable operating leases which fall due as follows: 

Within one year 

Between one year and five years 

After five years 

Total 

At 31 March 2018 and 31 March 2017, the Company had no outstanding capital commitments. 

2018 

£m   

2   

7   

5   

14   

At 31 March 

2017 
£m 

1 

6 

6 

13 

174  Tate & Lyle PLC Annual Report 2018
174  Tate & Lyle PLC Annual Report 2018 

   
   
 
   
 
 
 
 
 
   
   
 
 
 
 
   
   
 
   
   
 
 
 
 
 
 
11. Share capital and share premium 
Allotted, called up and fully paid equity share capital 

At 1 April 

Allotted under share option schemes 

At 31 March 

Number  
of shares 

2018   

Cost 

£m   

Number  
of shares   

468 256 866   

117   

468 235 944   

52 068   

–   

20 922   

468 308 934   

117   

468 256 866   

2017 

Cost 
£m 

117 

– 

117 

See Note 22 in the consolidated financial statements for details of treasury shares and shares held in the Employee Benefit Trust. 

12. Dividends on ordinary shares 
Dividends on ordinary shares in respect of the financial year: 

Per ordinary share: 

– interim dividend paid 

– final dividend proposed 

Total dividend 

Year ended 31 March 

2018 
pence   

8.4   

20.3   

28.7   

2017 
pence 

8.2 

19.8 

28.0 

The Directors propose a final dividend for the financial year of 20.3p per ordinary share that, subject to approval by shareholders, will be 
paid on 1 August 2018 to shareholders who are on the Register of Members on 22 June 2018. 

Dividends on ordinary shares paid in the year: 

Final dividend paid relating to the prior year  

Interim dividend paid relating to the year 

Total dividend paid 

Year ended 31 March 

2018 

£m   

92   

39   

131   

2017 
£m 

92 

38 

130 

Based on the number of ordinary shares outstanding at 31 March 2018 and the proposed amount, the final dividend for the financial year is 
expected to amount to £94 million. 

13. Profit and loss account disclosures 
The Company recognised a profit for the year of £180 million (2017 – £298 million).  

Fees payable to the Company’s external auditors, PricewaterhouseCoopers LLP, for the audit of the Company’s financial statements 
amounted to £0.1 million (2017 – £0.1 million).  

The Company employed an average of 168 people (including Directors) during the year (2017 – 149). Staff costs are shown below: 

i

S
t
r
a
t
e
g
c
R
e
p
o
r
t

G
o
v
e
r
n
a
n
c
e

i

F
n
a
n
c
i
a
l
S
t
a
t
e
m
e
n
t
s

U
s
e
f
u
l

I

n
f
o
r
m
a
t
i
o
n

Wages and salaries  

Social security costs 

Other pension costs 

Share-based incentives 

Total 

Year ended 31 March 

2018 

£m   

27   

5   

2   

7   

41   

2017 
£m 

26 

5 

2 

8 

41 

Directors’ emoluments disclosures are provided in the Directors’ Remuneration Report on pages 72 to 89 and in Note 10 of the 
consolidated financial statements.  

No deferred tax assets have been recognised in respect of tax losses of £341 million as there is uncertainty as to whether taxable profits 
against which these assets may be recovered will be available. 

www.tateandlyle.com  175
www.tateandlyle.com  175 

Strategic ReportGovernanceFinancial StatementsUseful Information 
 
 
 
 
 
 
 
   
   
 
 
 
 
   
   
 
   
 
 
 
 
   
   
 
 
 
   
   
 
 
 
 
 
 
 
Notes to the Parent Company Financial Statements continued 

14. Retirement benefit obligations 
Plan information 
The Company participates in a defined benefit plan together with another subsidiary company, Tate & Lyle Industries Ltd. Payments made 
by contributing companies principally comprise funding contributions agreed with the trustees that are determined to ensure that 
appropriate funding levels are maintained and funding deficits are eliminated over a reasonable period of time. The plan is closed to new 
entrants and future accruals. The Company has 332 pensioners and deferred pensioners out of a total membership of circa 5,600 
(excluding dependent beneficiaries).  

The Company also operates a defined contribution pension plan. Contributions payable by the Company to the plan during the year 
amounted to £2 million (2017 – £2 million).  

The Company has provided a full liability guarantee in respect of the pension obligations of Tate & Lyle Industries Ltd, the other 
participating employer. Whilst there is no agreed allocation of deficit or surplus, the trustees have discretion to distribute any surplus on 
winding up as they consider appropriate, after increase of benefits consistent with Inland Revenue Limits which applied up to 5 April 2006. 

Funding commitments of the plan  
As required by UK regulations, actuarial valuations are carried out at least every three years. The main UK scheme triennial valuation as at 
31 March 2016 was concluded during the prior year, with agreed core funding contributions maintained at £12 million per year, and 
supplementary contributions payable into the secured funding account of £6 million per year until 31 March 2023. The deficit or surplus in 
the plan impacts the future contributions which are determined with reference to the triennial actuarial valuations.  

For further details on the defined benefit plan see Note 30 in the consolidated financial statements. 

176  Tate & Lyle PLC Annual Report 2018
176  Tate & Lyle PLC Annual Report 2018 

 
Group Five-year Summary  

Employment of capital 

Goodwill and intangible assets 

Property, plant and equipment 

Other assets 

Working capital (including provisions and non-debt  

derivatives) 

Net pension (deficit)/surplus 

Net assets held for sale (excluding cash included in net debt) 

Net operating assets 

Investment in joint ventures and associates 

Net debt 

Net tax liability 

Total net assets 

Capital employed 

Called up share capital 

Reserves 

Non-controlling interests 

Results summary 

Continuing operations 

Sales 

Adjusted operating profit 

Amortisation of acquired intangible assets 

Exceptional items 

Operating profit 

Adjusted net finance expense 

Net retirement benefit interest expense 

Net finance expense 

Share of profit after tax of joint ventures and associates 

Profit before tax 

Income tax (expense)/credit 

Profit for the year from continuing operations 

Profit for the year from discontinued operations 

Non-controlling interests 

Profit for the year attributable to owners of the Company 

i

S
t
r
a
t
e
g
c
R
e
p
o
r
t

G
o
v
e
r
n
a
n
c
e

i

F
n
a
n
c
i
a
l
S
t
a
t
e
m
e
n
t
s

U
s
e
f
u
l

I

n
f
o
r
m
a
t
i
o
n

2014 
£m 

307 

732 

28 

351   

(220) 

– 

2015 

£m   

340   

750   

33   

339   

(227)   

–   

2016 

£m   

390   

926   

23   

323   

(208)   

5   

2017 

£m   

401   

1 061   

30   

394   

(139)  

–   

At 31 March 

2018 
£m 

360 

965 

37 

385 

18 

– 

1 198 

1 235   

1 459   

1 747   

1 765 

312 

(385) 

(75) 

1 050    

117    

932 

1 049   

1 

1 050    

327   

(555)   

(71)   

936   

117   

818   

935   

1   

936   

85   

(434)   

(81)   

96   

(452)  

(59)  

85 

(392) 

(91) 

1 029   

1 332   

1 367 

117   

911   

1 028   

1   

117   

1 215   

1 332   

–   

117 

1 250 

1 367 

– 

1 029   

1 332   

1 367 

2014 
£m 

2015 
£m 

2016 
£m 

Year ended 31 March 

2017 
£m 

2018 
£m 

2 737    

2 341   

2 355   

2 753   

2 710 

274 

(10) 

(14) 

250    

(27) 

(8) 

(35)   

22 

237 

(32)   

205 

68 

– 

273    

184   

(9)   

(142)   

33   

(23)   

(8)   

(31)   

23   

25   

(21)   

4   

26   

–   

30   

188   

(11)   

(50)   

127   

(23)   

(6)   

(29)   

28   

126   

(5)   

121   

42   

–   

163   

264   

(12)  

(19)  

233   

(25)  

(7)  

(32)  

32   

233   

22   

255   

1   

–   

300 

(12) 

2 

290 

(27) 

(5) 

(32) 

28 

286 

(23) 

263 

2 

– 

256   

265 

Adjusted profit before tax 

269 

184   

193   

271   

301 

www.tateandlyle.com  177
www.tateandlyle.com  177 

Strategic ReportGovernanceFinancial StatementsUseful Information 
 
 
 
 
 
 
   
   
   
   
   
 
   
 
 
   
   
   
   
 
 
 
 
 
   
   
   
   
 
 
 
 
 
 
 
 
 
 
   
   
   
    
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
     
    
    
    
  
 
     
    
    
    
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
   
   
 
 
Group Five-year Summary continued 

Per share information 

Earnings per share continuing operations: 

– basic (pence) 

– diluted (pence) 

Earnings per share total operations: 

– basic (pence) 

– adjusted basic (pence) 

Earnings per share total operations: 

– diluted (pence) 

– adjusted diluted (pence) 

Dividends per ordinary share (pence) 

Closing share price at 31 March (pence) 

Closing market capitalisation at 31 March (£million) 

Business ratios 

Interest cover (times)1 

Operating profit before exceptional items and amortisation  

of intangible assets divided by net finance expense 

Net debt to EBITDA (times)1 

Net debt divided by pre-exceptional EBITDA 

Gearing 

Net debt as a percentage of total net assets2 

Adjusted operating margin 

Adjusted operating profit as a percentage of sales2 

2014 

2015   

2016   

2017   

2018 

Year ended 31 March 

44.2p   

43.6p   

58.8p 

56.5p 

58.0p 

55.7p 

27.6p 

667.5p 

3 125 

0.9p   

0.8p   

6.6p   

38.0p   

6.5p   

37.7p   

28.0p   

26.1p   

25.9p   

35.1p   

34.9p   

34.8p   

34.7p   

28.0p   

55.0p   

54.2p   

55.2p   

47.9p   

54.4p   

47.1p   

28.0p   

57.0p 

56.1p 

57.4p 

50.9p 

56.5p 

50.1p 

28.7p 

597.5p   

578.0p   

764.5p   

544.6p 

2 798   

2 706   

3 580   

2 550 

11.6x 

10.7x   

10.7x   

13.9x   

14.6x 

0.8x 

1.3x   

1.2x   

0.9x   

0.8x 

37% 

59%   

42%   

34%   

29% 

10.0% 

7.8%   

7.9%   

9.6%   

11.1% 

Return on net operating assets 

21.7% 

14.4%   

13.1%   

15.7%   

16.4% 

Profit before interest, tax and exceptional items as a  

percentage of average net operating assets2 

Dividend cover (times) 

Basic earnings per share divided by dividends per share2 

2.1x 

0.2x   

1.3x   

2.0x   

2.0x 

Adjusted basic earnings per share divided by dividends  

per share2 

2.0x   

1.4x   

1.2x   

1.7x   

1.8x 

1  Interest cover and net debt to EBITDA have been calculated using the same basis as set out in the Group’s external financial covenants. (see Note 4 of the attached 

consolidated financial statements). 

2  These metrics have been calculated using the results of both continuing and discontinued operations.  

178  Tate & Lyle PLC Annual Report 2018
178  Tate & Lyle PLC Annual Report 2018 

   
   
   
   
 
 
     
    
    
    
  
 
 
 
 
 
 
   
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
   
 
 
 
 
 
 
   
 
 
   
   
   
   
 
 
 
 
 
 
   
 
 
 
 
 
 
   
 
 
 
 
 
 
   
 
 
 
 
 
 
   
 
 
   
   
   
   
 
 
 
 
 
   
 
 
 
   
   
   
   
 
 
 
 
 
Additional Information  

Calculation of changes in constant currency 
Where changes in constant currency are presented in this statement, they are calculated by retranslating current year results at prior year 
exchange rates. The following table provides a reconciliation between the 2018 performance at actual exchange rates and at constant 
currency exchange rates. Absolute numbers presented in the tables are rounded for presentational purposes, whereas the growth 
percentages are calculated on unrounded numbers. 

Adjusted performance 
Continuing operations 

Sales  

Food & Beverage Solutions 

Sucralose 

Primary Products 

Central 

Adjusted operating profit 

Adjusted net finance expense 

Share of profit after tax of joint  

ventures and associates 

Adjusted profit before tax 

Adjusted income tax expense 

Adjusted profit after tax 

2018 

£m   

2 710   

137   

55   

166   

(58)  

300   

(27)  

28   

301   

(66)  

235   

2018 at 
constant 
currency 

£m   

2 730   

139   

55   

168   

(58)  

304   

(27)  

28   

305   

(68)  

237   

Underlying 
growth 

£m   

(23)  

10   

3   

39   

(12)  

40   

(2)  

(4)  

34   

(19)  

15   

FX 
£m   

20  

2   

–   

2   

–   

4   

–   

–   

4   

(2)  

2   

2017* 

£m    

2 753    

129*   

52*   

129    

(46)   

264    

(25)   

32    

271    

(49)   

222    

Adjusted diluted EPS (pence) 

50.1p   

0.4p  

50.5p   

3.4p   

47.1p    

Change 

%   

(2%)  

5%   

6%   

28%   

(22%)  

14%   

(8%)  

(14%)  

11%   

(34%)  

6%   

6%   

Change in 
constant 
currency 
% 

(1%) 

8% 

5% 

30% 

15% 

(14%) 

13% 

(37%) 

7% 

7% 

*  Restated to reflect the change in reportable segments made in the 2018 financial year.  

If the above segmental information were presented on a basis consistent with the prior year, Food & Beverage Solutions and Sucralose 
would be combined as Speciality Food Ingredients to show adjusted operating profit for the year ended 31 March 2018 of £192 million  
(2017 – £181 million). Primary Products was renamed from Bulk Ingredients in the year. 

i

S
t
r
a
t
e
g
c
R
e
p
o
r
t

G
o
v
e
r
n
a
n
c
e

i

F
n
a
n
c
i
a
l
S
t
a
t
e
m
e
n
t
s

U
s
e
f
u
l

I

n
f
o
r
m
a
t
i
o
n

www.tateandlyle.com  179
www.tateandlyle.com  179 

Strategic ReportGovernanceFinancial StatementsUseful Information 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
   
   
   
   
  
 
 
 
 
 
 
 
 
Information for Investors 

Shareholder enquiries 

Ordinary shares 

Equiniti Limited  
Information on how to manage your 
shareholdings can be found at 
www.shareview.co.uk. The website also 
provides answers to commonly asked 
shareholder questions and has links  
to downloadable forms, guidance notes  
and Company history fact sheets. You can 
also send your enquiry via secure email 
from the Shareview website.  

Telephone enquiries 
0371 384 2063 (for UK calls)1  
+44 (0)121 415 0235 (for calls from outside 
the UK) 

1  Lines open 8.30am to 5.30pm (UK time), Monday  
to Friday (excluding public holidays in England  
and Wales). 

Written enquiries 
Equiniti Limited, Aspect House, Spencer 
Road, Lancing, West Sussex BN99 6DA. 

American Depositary Shares 
(ADSs) 
The Bank of New York Mellon 
The Company’s shares trade in the US  
on the over-the-counter (OTC) market in 
the form of ADSs and these are evidenced 
by American Depositary Receipts (ADRs). 
The shares are traded under the ticker 
symbol TATYY. 

Telephone and email enquiries 
+1 888 269 2377 (for US calls) 
+1 201 680 6825 (for calls from outside the US) 
shrrelations@cpushareownerservices.com 

Written enquiries  
BNY Mellon Shareowner Services 
PO Box 505000 
Louisville, KY 40233-5000 
USA 

Tate & Lyle website and share 
price information 

Tate & Lyle’s website provides direct  
links to other Group company sites and  
to sites providing financial and other 
information relevant to the Company.  
The share price is available on the website 
with a 20-minute delay. 

180  Tate & Lyle PLC Annual Report 2018 
180  Tate & Lyle PLC Annual Report 2018

Financial calendar 
2018 Annual General Meeting 
Announcement of half-year results for the six months to 30 September 2018 
Announcement of full-year results for the year ending 31 March 2019 
2019 Annual General Meeting 

26 July 2018  
8 Nov 20181 
23 May 20191 
25 July 20191 

Dividends paid on ordinary shares during the year ended  
31 March 2018 

Payment date 
1 August 2017 
5 Jan 2018 

Dividend 
description   
Final 2017   
Interim 2018   

Dividend per 
share 
19.8p 
8.4p 

Dividend calendar for dividends on ordinary shares 

Announced 
Payment date 

1  Provisional date. 

2  Subject to approval of shareholders. 

2018 final    

2019 interim    
24 May 2018     8 November 20181   
4 January 20191   

1 August 20182   

2019 final   
23 May 20191  
31 July 20191, 2 

Dividends paid on 6.5% cumulative preference shares 
Paid each 31 March and 30 September. 

Capital gains tax 
The market values on 31 March 1982 for the purposes of indexation up to April 1998 in 
relation to capital gains tax of Tate & Lyle PLC shares then in issue were: 

Ordinary share of £1 each 
Equivalent value per ordinary share of 25p 
6.5% cumulative preference share 

201.00p 
50.25p 
43.50p 

Electronic communications 
Shareholder documents are only sent in paper format to shareholders who have elected to 
receive documents in this way. This approach enables the Company to reduce printing and 
distribution costs and the impact of the documents on the environment. 

Shareholders who wish to receive email notification should register online at 
www.shareview.co.uk, using their shareholder reference number that is on either their 
share certificate or other correspondence. 

Dividend payments 
Dividend reinvestment plan 
The Company operates a Dividend Reinvestment Plan (DRIP) which enables shareholders 
to use their cash dividend to buy additional shares in Tate & Lyle PLC. Further information 
can be obtained from Equiniti. 

Direct into your bank account 
We encourage shareholders to have their dividends paid directly into their bank or building 
society account; dividend confirmations are then mailed to shareholders separately.  
This method avoids the risk of dividend cheques being delayed or lost in the post. If you live 
outside the UK, Equiniti also offers an overseas payment service whereby your dividend  
is converted into your local currency. Further information on mandating your dividend 
payments and the overseas payment service can be obtained from Equiniti. 

Beware of share fraud 
Shareholders should be very wary of any unsolicited calls or correspondence offering to 
buy or sell shares at a discounted price. These calls are typically from fraudsters operating 
‘boiler rooms’. Boiler rooms use increasingly sophisticated means to approach investors 
and often leave their victims out of pocket. If you are concerned that you may have been 
targeted by fraudsters please contact the Financial Conduct Authority (FCA) Consumer 
Helpline on 0800 111 6768. 

 
 
 
 
 
 
 
   
 
 
 
 
 
 
i

S
t
r
a
t
e
g
c
R
e
p
o
r
t

G
o
v
e
r
n
a
n
c
e

i

F
n
a
n
c
a
l

i

S
t
a
t
e
m
e
n
t
s

U
s
e
f
u
l

I
n
f
o
r
m
a
t
i
o
n

Glossary  

A 

C 

D 

Acidulants 
Ingredients such as citric acid that are used 
to add a ‘sour’ taste to food and soft drinks 
and to act as a preservative. 

Adjusted free cash flow 
Adjusted free cash flow represents cash 
generated from continuing operations 
excluding the impact of exceptional items, 
less net interest paid, less income tax paid, 
less capital expenditure. 

Adjusted operating cash flow 
Adjusted operating cash flow is defined as 
adjusted free cash flow from continuing 
operations, adding back net interest and tax 
paid, retirement cash contributions, and 
excluding derivative and margin call 
movements within working capital. 

Adjusted operating profit (PBITEA) 
Operating profit (as defined separately), 
adjusted for amortisation of acquired 
intangible assets and net exceptional items. 

Adjusted profit before tax (PBTEA) 
Profit before tax (as defined separately), 
adjusted for amortisation of acquired 
intangible assets, net exceptional items  
and net retirement benefit interest. 

B 

Bio-PDOTM 
Multi-purpose monomer propanediol  
made from corn (as opposed to being  
made from a petrochemical source).  
Used in cosmetics, detergents, carpets  
and textiles. 

Carbon dioxide equivalent (CO2e) 
One metric tonne of carbon dioxide or an 
amount of any other greenhouse gas with 
an equivalent global warming potential, 
calculated consistently with international 
carbon reporting practices. 

CLARIA® Functional Clean-Label 
Starches 
A line of clean-label starches with neutral 
taste and colour comparable to normal 
modified starches that is versatile across a 
broad range of applications and 
sophisticated processes. 

‘Clean label’ 
A term used in the food and beverage 
industry generally to refer to shorter or 
simpler ingredient lists or less processed 
ingredients that appeal more to some 
consumers than those containing complex 
ingredients. Interpretations may vary. 

Commodities 
Commodities include US ethanol and  
co-products. 

Constant currency 
Where changes in constant currency  
are presented, they are calculated by 
retranslating current year results at prior 
year exchange rates. Reconciliation 
between the 2018 performance at actual 
exchange rates and at constant currency 
exchange rates have been included in the 
additional information on page 179. 

Continuing operations 
Operations of the Group excluding any 
discontinued operations (as defined 
separately). 

Co-products 
Corn gluten feed, corn gluten meal and 
corn oil. 

Corn gluten feed 
The largest Tate & Lyle co-product, used in 
animal feed for dairy and beef cattle. 

Discontinued operations 
An operation is classified as discontinued if 
it is a component of the Group that: (i) has 
been disposed of, or meets the criteria to be 
classified as held for sale; and (ii) 
represents a separate major line of 
business or geographic area of operations; 
or will be disposed of as part of a single co-
ordinated plan to dispose of a separate 
major line of business or geographic area of 
operations. 

DOLCIA PRIMA® Allulose 
Low-calorie sugar that offers a superior, 
new taste experience. 

E 

ETHYLEX® Surface Treatment Starch 
An industrial starch used in paper. 

F 

Food & Beverage Solutions (F & B 
Solutions) 
Including Sucralose, previously named 
Speciality Food Ingredients (SFI) division. 

Food Systems 
The previous name of our stabiliser 
business which is part of the Food & 
Beverage Solutions division. It sources 
ingredients and uses them to develop 
bespoke combinations of ingredients for 
customers, principally for stabilisation. 

G 

Greenhouse gas (GHG) 
Any of the following: carbon dioxide (CO2), 
methane (CH4), nitrous oxide (N2O), 
hydrofluorocarbons (HFCs), 
perfluorocarbons (PFCs), sulphur 
hexafluoride (SF6). 

H 

HFCS 
High fructose corn syrup widely used as  
a substitute for sugar in North America. 
Also called isoglucose in Europe. 

www.tateandlyle.com  181 
www.tateandlyle.com  181

Strategic ReportGovernanceFinancial StatementsUseful Information 
 
 
 
 
 
 
 
 
Glossary continued 

I 

P 

ICD 
Innovation and Commercial Development 
group, supporting our two business 
divisions, Food & Beverage Solutions and 
Primary Products. 

L 

Label friendly 
Denotes ingredients that, when listed on 
product ingredient labels, may appeal more 
to some consumers who show a preference 
for ingredients in food products which they 
feel are more transparent, authentic, 
simpler or easier to understand than 
alternatives which may be perceived by 
some consumers as being artificial, 
chemical or in some way less authentic. 

N 

Natural 
A ‘natural’ description usually refers to a 
food ingredient that is present in nature and 
has been minimally processed. However, 
interpretations vary according to the 
different legal and regulatory landscape in 
different countries. 

New Products 
New Products are products in the first 
seven years after launch. 

O 

Operating profit (also referred to as 
profit before interest and tax (PBIT)) 
Sales less net operating expense.  

Primary capacity 
Processing capacity for the first stage of 
production, at which the agricultural raw 
material enters the production process. 

Primary Products (PP) 
Previously named Bulk Ingredients (BI) 
division. 

Profit before tax (PBT) 
Sales, less net operating expense, less net 
finance expense and including the Group’s 
share of profit after tax of joint ventures. 

PROMITOR® Soluble Fibre 
A prebiotic soluble fibre. 

PromOat® Beta Glucan 
A soluble fibre made from wholegrain oats 
used to bring the health benefits of oat beta 
glucan to food and beverages. 

R 

REZISTA® Speciality Food Starch  
A modified starch made from waxy corn 
which builds and protects texture in foods. 

S 

SPLENDA® Sucralose  
A zero-calorie sweetener, the 
manufacturing process for which starts 
with sugar. 

Stabiliser Systems 
Systems customising ingredient blends to 
improve product mouthfeel, texture and 
stability profile. 

STA-LITE® Polydextrose 
A soluble fibre with prebiotic properties 
made from corn and used to provide body 
and texture in reduced calorie, no-added 
sugar and high-fibre foods. 

STA-LOK® Cationic Corn Starch 
An industrial starch used in paper. 

STA-TAPETM Starches 
An industrial starch used for adhesives. 

Sucralose  
A reportable segment and part of the Food 
& Beverage Solutions division.  

182  Tate & Lyle PLC Annual Report 2018 
182  Tate & Lyle PLC Annual Report 2018

i

S
t
r
a
t
e
g
c
R
e
p
o
r
t

G
o
v
e
r
n
a
n
c
e

i

F
n
a
n
c
a
l

i

S
t
a
t
e
m
e
n
t
s

U
s
e
f
u
l

I
n
f
o
r
m
a
t
i
o
n

Definitions/explanatory notes 

Non-reliance statement 
This Annual Report has been prepared 
solely to provide additional information to 
shareholders to assess the Group’s 
strategy and the potential of that strategy to 
succeed, and should not be relied upon by 
any other party or for any other purpose. 

Cautionary statement 
This Annual Report contains certain 
forward-looking statements with respect to 
the financial condition, results, operations 
and businesses of Tate & Lyle PLC. These 
statements and forecasts involve risk and 
uncertainty because they relate to events 
and depend upon circumstances that may 
occur in the future. There are a number of 
factors that could cause actual results or 
developments to differ materially from 
those expressed or implied by these 
forward-looking statements and forecasts. 

Tate & Lyle PLC 
Tate & Lyle PLC is a public limited company 
listed on the London Stock Exchange and is 
registered in England and Wales.  

More information about Tate & Lyle can be 
found on the Company’s website, 
www.tateandlyle.com. 

Sources for Digestive health 
chart on page 5 
1. Institute of Medicine, Food and Nutrition 
Board. Dietary Reference Intakes: Energy, 
Carbohydrates, Fiber, Fat, Fatty Acids, 
Cholesterol, Protein and Amino Acids. 
Washington, DC: National Academies 
Press; 2002/2005. 

2. Stephen AM, Champ MM-J, Cloran, SJ,  
et al. Dietary fibre in Europe: current state 
of knowledge on definitions, sources, 
recommendations, intakes and 
relationships to health. Nutrition Research 
Reviews. July 2017. 

3. World Health Organization Diet, Nutrition 
and the Prevention of Chronic Diseases. 
Geneva: WHO. 2003. 

4. Auestad N, Hurley J, Fulgoni VL, et al. 
Contribution of Food Groups to Energy  
and Nutrient Intakes in Five Developed 
Countries. Nutrients. 2015 Jun 8;7(6): 
4593-618. 

5. Murphy N, Norat T, Ferrari P, et al. 
Dietary fibre intake and risks of cancers of 
the colon and rectum in the European 
prospective investigation into cancer and 
nutrition (EPIC). PLoS One. 2012;7:e39361. 

6. Wang HJ et al. Trends in dietary fiber 
intake in Chinese aged 45 years and above, 
1991-2011. Eur J Clin Nutr. 2014 May; 
68(5):619-22. 

7. CODEX-aligned dietary fiber definitions 
help to bridge the ‘fiber gap’. Jones JM. 
Nutr J. 2014;13:34. 

8. Flores M, Macias N, Rivera M, et al. 
Dietary patterns in Mexican adults are 
associated with risk of being overweight or 
obese J Nutr. 2010 Oct;140(10). 

9. Sardinha AN, Canella DS, Martins AP, et 
al. Dietary sources of fiber intake in Brazil. 
Appetite. 2014 Aug;79:134-8. 

Basis of preparation 
Unless stated otherwise, the Group’s 
financial statements are prepared in 
accordance with International Financial 
Reporting Standards (IFRSs) as adopted by 
the EU. 

Amortisation 
Unless stated otherwise, the use of the 
word ‘amortisation’ on pages 1 to 91 in this 
Annual Report relates to the amortisation of 
intangible assets acquired through 
business combinations. 

Continuing operations 
Unless stated otherwise, all comments in 
this Annual Report refer to the continuing 
operations adjusted to exclude exceptional 
items, amortisation of intangible assets 
acquired through business combinations, 
net retirement benefit interest and tax on 
the above items and tax items that 
themselves meet these definitions. A 
reconciliation of reported and adjusted 
information is included in Note 4 of the 
consolidated financial statements. 

Definitions 
In this Annual Report:  

  ‘Company’ means Tate & Lyle PLC 
  ‘Tate & Lyle’, ‘Group’, ‘we’, ‘us’ or  
‘our’ means Tate & Lyle PLC and  
its subsidiaries 

  ‘Gemacom’ means Tate & Lyle 

Gemacom Tech Indústria e Comércio 
S.A. 

  ‘Almex’ means Almidones Mexicanos SA 
  ‘Bio-PDO’ means DuPont Tate & Lyle  

Bio Products Company, LLC 

  ‘during the year’ means during the 
financial year ended 31 March 2018. 

Environmental statement 
This Annual Report has been printed on 
UPM Fine offset, a paper produced using 
wood fibre from fully sustainable forests 
with Forest Stewardship Council® (FSC®) 
certification. All pulps used are elemental 
chlorine free and the manufacturing mill 
holds the ISO 14001 and the EMAS 
accreditations for their environmental 
management systems.  

Printed in the UK by Pureprint using 
vegetable inks and its Alcofree and 
Pureprint environmental printing 
technology. Pureprint is a CarbonNeutral® 
company, is registered to the 
Environmental Management System 
Standard ISO 14001 and is FSC® chain-of-
custody certified.  

If you have finished with this Annual Report 
and no longer wish to retain it, please pass 
it on to other interested readers or dispose 
of it in your recycled paper waste.  

The CO2 emissions from the production and 
distribution of this Annual Report have been 
offset through the purchase of carbon 
credits in the Pureprint Gold programme. 
The offsets are always in Gold Standard 
accredited projects and currently come 
from the Basa Magogo project in South 
Africa. The first Gold Standard project of its 
kind in the world, this innovative behaviour-
change programme teaches local 
communities in South Africa to burn coal 
more efficiently, thereby reducing carbon 
emissions and reducing health risks by 
producing less smoke. 

Registered office 
Tate & Lyle PLC 
1 Kingsway 
London WC2B 6AT 
Tel: +44 (0)20 7257 2100 
Fax: +44 (0)20 7257 2200 
Company number: 76535 

Designed and produced by  
Black Sun Plc 

www.tateandlyle.com  183 
www.tateandlyle.com  183

Strategic ReportGovernanceFinancial StatementsUseful Information 
 
 
 
 
 
 
 
 
 
Registered office 
Tate & Lyle PLC 
1 Kingsway 
London WC2B 6AT 
Tel: +44 (0)20 7257 2100 
Fax: +44 (0)20 7257 2200 
Company number: 76535

184  Tate & Lyle PLC Annual Report 2018

Designed and produced by  
Black Sun Plc

T

a

t

e

&

L

y

l

e

A

n

n

u

a

l

R

e

p

o

r

t

2

0

1

8

www.tateandlyle.com